# EDGAR Filing Document

**Accession Number:** 0001053425
**File Stem:** 0001193125-26-060530
**Filing Date:** 2026-2
**Character Count:** 942455
**Document Hash:** b551ae50ba123d89e10ea59d65303226
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-060530.hdr.sgml**: 20260220

**ACCESSION NUMBER**: 0001193125-26-060530

**CONFORMED SUBMISSION TYPE**: N-CSR

**PUBLIC DOCUMENT COUNT**: 46

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260220

**DATE AS OF CHANGE**: 20260220

**EFFECTIVENESS DATE**: 20260220

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HARTFORD SERIES FUND INC
- **CENTRAL INDEX KEY:** 0001053425

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-CSR
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08629
- **FILM NUMBER:** 26656973

**BUSINESS ADDRESS:**
- **STREET 1:** 690 LEE ROAD
- **CITY:** WAYNE
- **STATE:** PA
- **ZIP:** 19087
- **BUSINESS PHONE:** 610-386-4068

**MAIL ADDRESS:**
- **STREET 1:** 690 LEE ROAD
- **CITY:** WAYNE
- **STATE:** PA
- **ZIP:** 19087

## Series and Classes Contracts Data

### HARTFORD BALANCED HLS FUND (Series ID: S000003205)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008596 | IA           | HADAX           |
| C000008597 | IB           | HAIBX           |

### HARTFORD HEALTHCARE HLS FUND (Series ID: S000003206)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008598 | IA           | HIAHX           |
| C000008599 | IB           | HBGHX           |

### HARTFORD INTERNATIONAL OPPORTUNITIES HLS FUND (Series ID: S000003213)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008612 | IA           | HIAOX           |
| C000008613 | IB           | HBIOX           |

### HARTFORD MIDCAP HLS FUND (Series ID: S000003215)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008616 | IA           | HIMCX           |
| C000008617 | IB           | HBMCX           |

### HARTFORD CAPITAL APPRECIATION HLS FUND (Series ID: S000003216)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008618 | IA           | HIACX           |
| C000008619 | IB           | HIBCX           |
| C000141206 | IC           | HCPCX           |

### HARTFORD ULTRASHORT BOND HLS FUND (Series ID: S000003218)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008622 | IA           | HUBAX           |
| C000008623 | IB           | HUBBX           |

### HARTFORD SMALL COMPANY HLS FUND (Series ID: S000003220)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008626 | IA           | HIASX           |
| C000008627 | IB           | HDMBX           |

### HARTFORD STOCK HLS FUND (Series ID: S000003221)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008628 | IA           | HSTAX           |
| C000008629 | IB           | HIBSX           |

### HARTFORD TOTAL RETURN BOND HLS FUND (Series ID: S000003222)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008630 | IA           | HIABX           |
| C000008631 | IB           | HBNBX           |

### HARTFORD DISCIPLINED EQUITY HLS FUND (Series ID: S000003224)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008634 | IA           | HIAGX           |
| C000008635 | IB           | HBGIX           |
| C000221440 | IC           | HLSCX           |

### HARTFORD DIVIDEND AND GROWTH HLS FUND (Series ID: S000003225)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000008636 | IA           | HIADX           |
| C000008637 | IB           | HDGBX           |

### HARTFORD SMALL CAP GROWTH HLS FUND (Series ID: S000084804)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000249287 | IA           | HISCX           |
| C000249288 | IB           | HBSGX           |

?xml version='1.0' encoding='ASCII'? HARTFORD SERIES FUND INC

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

### FORM N-CSR

#### CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number

#### 811-08629

## Hartford Series Fund, Inc.
(Exact name of registrant as specified in charter)

690 Lee Road, Wayne, Pennsylvania 19087

(Address of Principal Executive Offices) (Zip Code)

Thomas R. Phillips, Esquire

Hartford Funds Management Company, LLC

690 Lee Road

Wayne, Pennsylvania 19087

(Name and Address of Agent for Service)

Copy to:

John V. O'Hanlon, Esquire

Dechert LLP

One International Place, 40th Floor

100 Oliver Street

Boston, Massachusetts 02110-2605

Registrant's telephone number, including area code:

&nbsp;&nbsp;&nbsp;&nbsp;(610) 386-4068

Date of fiscal year end:

December 31

Date of reporting period:

December 31, 2025

Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 100 F Street, NE, Washington, DC 20549-1090. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.

 **Item 1. Reports to Stockholders.**

(a) ![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Balanced HLS Fund

### Class IA/HADAX
This annual shareholder report contains important information about the Hartford Balanced HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $67 | 0.63% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities registered a sizable return for 2025 with markets bolstered by robust corporate earnings, resilient consumer spending, and solid economic growth, although anxiety about lofty valuations in the technology sector and concerns surrounding massive Artificial Intelligence (AI) spending drove capital toward value/cyclical areas of the market. The cooling labor market and worries about upside inflation risks also kept the markets on edge. In the third quarter, the U.S. economy grew at the fastest pace in two years; Gross Domestic Product (GDP) surged 4.3% annually, primarily fueled by robust consumer spending but also aided by a rebound in exports, business investment on equipment and AI, and increased government spending on defense. Most fixed income sectors generated positive total returns during the trailing twelve-month period ending December 31, 2025, as coupon income and periods of spread tightening helped offset the impact of volatile, and in some regions, higher global sovereign yields. Most spread sectors produced positive excess returns over duration-equivalent government bonds, with higher-yielding and emerging market sectors leading the outperformance. Political instability and policy uncertainty were prominent, with leadership changes in France and Japan, and the U.S. experiencing its longest government shutdown on record. Fund performance described below is relative to the Fund's blended index, 60% S&P 500 Index/35% Bloomberg US Government/Credit Bond Index/5% ICE BofA US 3-Month Treasury Bill Index (the "Blended Benchmark"), for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Equity security selection within the Communication Services, Industrials, and Utilities sectors contributed positively to relative performance. 

* Sector allocation in the equity portion of the Fund, a result of our bottom-up stock selection process, contributed to relative results. The Fund's underweight allocations to the Consumer Discretionary, Information Technology, and Consumer Staples sectors contributed most to relative performance. 

* Top individual equity contributors over the period were an out-of-benchmark position in BAE Systems (Industrials), not holding benchmark constituent Apple (Information Technology) and an overweight position in Alphabet (Communication Services). 

* In the fixed-income portion of the Fund, security selection within Investment-Grade Corporate Credit was the primary positive contributor to performance, particularly within the Industrials and Financial Institutions sectors. An overweight to Financial Institutions also contributed to relative returns. 

* In the fixed income portion of the Fund, out-of-benchmark exposure to Agency Mortgage-backed Securities (MBS), Commercial Mortgage-backed Securities (CMBS) and Non-agency Residential Mortgage-backed Securities (RMBS) had positive impacts on relative returns. 

#### Top Detractors to Performance
* Within the equity portion of the Fund, security selection was the primary relative detractor during the period, driven by weak selection within the Information Technology, Consumer Discretionary, and Financials sectors. 

* The Fund's underweight allocation to the Communication Services sector and overweight allocations to Energy and HealthCare sectors detracted most from relative performance. 

* The largest individual equity detractors over the period were overweight positions in Salesforce (Information Technology), UnitedHealth Group (HealthCare), and Centene (HealthCare). 

* Within the fixed income portion of the Fund, positioning within Investment-Grade Corporate Credit was the primary driver of relative underperformance over the period. An underweight to the Industrials sector and an underweight to and security selection within the Utilities sector detracted from relative performance. 

* In the fixed income portion of the Fund, an underweight to non-corporates, particularly within sovereigns, detracted from relative returns. 

* In the fixed-income portion of the Fund, security selection within Asset-backed Securities (ABS) detracted from relative returns. 

* Duration and yield curve positioning had a negative impact on relative performance over the period. 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative indices. Performance information for the Fund in the graph and table reflects fee waivers, if any. Absent any applicable waivers, performance would have been lower. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189309.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 12.14% | 8.20% | 8.97% |
| Blended Benchmark | 13.38% | 8.59% | 9.86% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |
| Bloomberg US Government/Credit Bond Index | 6.88% | (0.59)% | 2.16% |
| ICE BofA US 3-Month Treasury Bill Index | 4.18% | 3.17% | 2.18% |

---

The Blended Benchmark is calculated by Hartford Funds Management Company, LLC.

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$1616506513 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;488 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$9748373 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate (excludes to be announced (TBA) roll transactions) | &nbsp;&nbsp;&nbsp;&nbsp;66% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Security Type**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Common Stocks | 64.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Securities | 19.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate Bonds | 11.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-Backed & Commercial Mortgage-Backed Securities | 1.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Agencies<sup>^</sup> | 1.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal Bonds | 0.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign Government Obligations | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 1.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (0.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>^</sup></sup> <sup>All, or a portion of the securities categorized as U.S. Government Agencies, were agency mortgage-backed securities.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHADAX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Balanced HLS Fund

### Class IB/HAIBX
This annual shareholder report contains important information about the Hartford Balanced HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $93 | 0.88% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities registered a sizable return for 2025 with markets bolstered by robust corporate earnings, resilient consumer spending, and solid economic growth, although anxiety about lofty valuations in the technology sector and concerns surrounding massive Artificial Intelligence (AI) spending drove capital toward value/cyclical areas of the market. The cooling labor market and worries about upside inflation risks also kept the markets on edge. In the third quarter, the U.S. economy grew at the fastest pace in two years; Gross Domestic Product (GDP) surged 4.3% annually, primarily fueled by robust consumer spending but also aided by a rebound in exports, business investment on equipment and AI, and increased government spending on defense. Most fixed income sectors generated positive total returns during the trailing twelve-month period ending December 31, 2025, as coupon income and periods of spread tightening helped offset the impact of volatile, and in some regions, higher global sovereign yields. Most spread sectors produced positive excess returns over duration-equivalent government bonds, with higher-yielding and emerging market sectors leading the outperformance. Political instability and policy uncertainty were prominent, with leadership changes in France and Japan, and the U.S. experiencing its longest government shutdown on record. Fund performance described below is relative to the Fund's blended index, 60% S&P 500 Index/35% Bloomberg US Government/Credit Bond Index/5% ICE BofA US 3-Month Treasury Bill Index (the "Blended Benchmark"), for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Equity security selection within the Communication Services, Industrials, and Utilities sectors contributed positively to relative performance. 

* Sector allocation in the equity portion of the Fund, a result of our bottom-up stock selection process, contributed to relative results. The Fund's underweight allocations to the Consumer Discretionary, Information Technology, and Consumer Staples sectors contributed most to relative performance. 

* Top individual equity contributors over the period were an out-of-benchmark position in BAE Systems (Industrials), not holding benchmark constituent Apple (Information Technology) and an overweight position in Alphabet (Communication Services). 

* In the fixed-income portion of the Fund, security selection within Investment-Grade Corporate Credit was the primary positive contributor to performance, particularly within the Industrials and Financial Institutions sectors. An overweight to Financial Institutions also contributed to relative returns. 

* In the fixed income portion of the Fund, out-of-benchmark exposure to Agency Mortgage-backed Securities (MBS), Commercial Mortgage-backed Securities (CMBS) and Non-agency Residential Mortgage-backed Securities (RMBS) had positive impacts on relative returns. 

#### Top Detractors to Performance
* Within the equity portion of the Fund, security selection was the primary relative detractor during the period, driven by weak selection within the Information Technology, Consumer Discretionary, and Financials sectors. 

* The Fund's underweight allocation to the Communication Services sector and overweight allocations to Energy and HealthCare sectors detracted most from relative performance. 

* The largest individual equity detractors over the period were overweight positions in Salesforce (Information Technology), UnitedHealth Group (HealthCare), and Centene (HealthCare). 

* Within the fixed income portion of the Fund, positioning within Investment-Grade Corporate Credit was the primary driver of relative underperformance over the period. An underweight to the Industrials sector and an underweight to and security selection within the Utilities sector detracted from relative performance. 

* In the fixed income portion of the Fund, an underweight to non-corporates, particularly within sovereigns, detracted from relative returns. 

* In the fixed-income portion of the Fund, security selection within Asset-backed Securities (ABS) detracted from relative returns. 

* Duration and yield curve positioning had a negative impact on relative performance over the period. 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative indices. Performance information for the Fund in the graph and table reflects fee waivers, if any. Absent any applicable waivers, performance would have been lower. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189310.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 11.86% | 7.93% | 8.70% |
| Blended Benchmark | 13.38% | 8.59% | 9.86% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |
| Bloomberg US Government/Credit Bond Index | 6.88% | (0.59)% | 2.16% |
| ICE BofA US 3-Month Treasury Bill Index | 4.18% | 3.17% | 2.18% |

---

The Blended Benchmark is calculated by Hartford Funds Management Company, LLC.

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$1616506513 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;488 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$9748373 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate (excludes to be announced (TBA) roll transactions) | &nbsp;&nbsp;&nbsp;&nbsp;66% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Security Type**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Common Stocks | 64.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Securities | 19.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate Bonds | 11.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-Backed & Commercial Mortgage-Backed Securities | 1.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Agencies<sup>^</sup> | 1.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal Bonds | 0.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign Government Obligations | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 1.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (0.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>^</sup></sup> <sup>All, or a portion of the securities categorized as U.S. Government Agencies, were agency mortgage-backed securities.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHAIBX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Capital Appreciation HLS Fund

### Class IA/HIACX
This annual shareholder report contains important information about the Hartford Capital Appreciation HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
 *(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br> of a $10,000 investment<sup>\*</sup>** |
| Class IA | $72 | 0.67% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
 **Management's Discussion of Fund Performance**

United States (U.S.) equities, as measured by the Russell 3000 Index, rose over the twelve-month period ending December 31, 2025. Following initial uncertainty around new administration policies, trade tensions, and fears of stagflation, the market rebounded strongly as trade risks eased, and corporate earnings exceeded expectations. Technology and growth stocks led much of the recovery, especially as mega-cap tech regained leadership. Robust consumer spending, solid Gross Domestic Product (GDP) growth, and resilient corporate earnings supported the market, though concerns about inflation, labor market cooling, and high valuations persisted. The U.S. Federal Reserve (Fed) maintained a cautious stance, adjusting interest rates as needed amid ongoing uncertainty. By year-end, U.S. equities posted a sizable gain, with the S&P 500 Index showing strong year-over-year earnings growth, reflecting the market's resilience despite persistent macroeconomic challenges. Fund performance described below is relative to the Russell 3000 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Sector allocation, a result of our bottom-up stock selection process, contributed to relative performance over the period. The Fund's overweight allocation to the Communication Services sector and underweight allocations to the Consumer Staples and HealthCare sectors benefitted relative results. 

* Security selection within the Communication Services and Utilities sectors contributed to relative performance. 

* The Fund's smaller cap footprint relative to the benchmark contributed to relative results. 

* Top individual contributors over the period were overweight positions in Alphabet (Communication Services), Broadcom (Information Technology), and an out-of-benchmark allocation to Barrick Mining (Materials). 

#### Top Detractors to Performance
* Security selection was the primary driver of relative underperformance during the period, driven by weak selection within the Consumer Discretionary, Information Technology, and HealthCare sectors. 

* Overweight allocations to the Consumer Discretionary, Real Estate, and Materials sectors detracted from relative performance. 

* From a style factor perspective, the Fund's underweight exposure to stocks with higher momentum detracted from relative performance. 

* The largest individual detractors over the period were overweight positions in Accenture (Information Technology) and UnitedHealth Group (HealthCare), as well as an underweight position in Tesla (Consumer Discretionary). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

 **Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189330.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br> For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 13.72% | 9.96% | 11.93% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |

---

 **The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$3732598436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$23494078 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;58% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

 **Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 30.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 12.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 12.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 12.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 10.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 7.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 3.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 3.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 1.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 1.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to reduce the limit in which the Fund may invest in foreign issuers and non-dollar securities from 25% of the Fund's net assets to 15% of the Fund's net assets. Effective April 30, 2025, "Quantitative Investing Risk" was added as a principal risk of the Fund.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIACX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Capital Appreciation HLS Fund

### Class IB/HIBCX
This annual shareholder report contains important information about the Hartford Capital Appreciation HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $98 | 0.92% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities, as measured by the Russell 3000 Index, rose over the twelve-month period ending December 31, 2025. Following initial uncertainty around new administration policies, trade tensions, and fears of stagflation, the market rebounded strongly as trade risks eased, and corporate earnings exceeded expectations. Technology and growth stocks led much of the recovery, especially as mega-cap tech regained leadership. Robust consumer spending, solid Gross Domestic Product (GDP) growth, and resilient corporate earnings supported the market, though concerns about inflation, labor market cooling, and high valuations persisted. The U.S. Federal Reserve (Fed) maintained a cautious stance, adjusting interest rates as needed amid ongoing uncertainty. By year-end, U.S. equities posted a sizable gain, with the S&P 500 Index showing strong year-over-year earnings growth, reflecting the market's resilience despite persistent macroeconomic challenges. Fund performance described below is relative to the Russell 3000 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Sector allocation, a result of our bottom-up stock selection process, contributed to relative performance over the period. The Fund's overweight allocation to the Communication Services sector and underweight allocations to the Consumer Staples and HealthCare sectors benefitted relative results. 

* Security selection within the Communication Services and Utilities sectors contributed to relative performance. 

* The Fund's smaller cap footprint relative to the benchmark contributed to relative results. 

* Top individual contributors over the period were overweight positions in Alphabet (Communication Services), Broadcom (Information Technology), and an out-of-benchmark allocation to Barrick Mining (Materials). 

#### Top Detractors to Performance
* Security selection was the primary driver of relative underperformance during the period, driven by weak selection within the Consumer Discretionary, Information Technology, and HealthCare sectors. 

* Overweight allocations to the Consumer Discretionary, Real Estate, and Materials sectors detracted from relative performance. 

* From a style factor perspective, the Fund's underweight exposure to stocks with higher momentum detracted from relative performance. 

* The largest individual detractors over the period were overweight positions in Accenture (Information Technology) and UnitedHealth Group (HealthCare), as well as an underweight position in Tesla (Consumer Discretionary). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189331.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 13.42% | 9.68% | 11.64% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$3732598436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$23494078 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;58% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 30.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 12.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 12.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 12.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 10.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 7.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 3.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 3.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 1.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 1.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to reduce the limit in which the Fund may invest in foreign issuers and non-dollar securities from 25% of the Fund's net assets to 15% of the Fund's net assets. Effective April 30, 2025, "Quantitative Investing Risk" was added as a principal risk of the Fund.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIBCX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Capital Appreciation HLS Fund

### Class IC/HCPCX
This annual shareholder report contains important information about the Hartford Capital Appreciation HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IC | $125 | 1.17% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities, as measured by the Russell 3000 Index, rose over the twelve-month period ending December 31, 2025. Following initial uncertainty around new administration policies, trade tensions, and fears of stagflation, the market rebounded strongly as trade risks eased, and corporate earnings exceeded expectations. Technology and growth stocks led much of the recovery, especially as mega-cap tech regained leadership. Robust consumer spending, solid Gross Domestic Product (GDP) growth, and resilient corporate earnings supported the market, though concerns about inflation, labor market cooling, and high valuations persisted. The U.S. Federal Reserve (Fed) maintained a cautious stance, adjusting interest rates as needed amid ongoing uncertainty. By year-end, U.S. equities posted a sizable gain, with the S&P 500 Index showing strong year-over-year earnings growth, reflecting the market's resilience despite persistent macroeconomic challenges. Fund performance described below is relative to the Russell 3000 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Sector allocation, a result of our bottom-up stock selection process, contributed to relative performance over the period. The Fund's overweight allocation to the Communication Services sector and underweight allocations to the Consumer Staples and HealthCare sectors benefitted relative results. 

* Security selection within the Communication Services and Utilities sectors contributed to relative performance. 

* The Fund's smaller cap footprint relative to the benchmark contributed to relative results. 

* Top individual contributors over the period were overweight positions in Alphabet (Communication Services), Broadcom (Information Technology), and an out-of-benchmark allocation to Barrick Mining (Materials). 

#### Top Detractors to Performance
* Security selection was the primary driver of relative underperformance during the period, driven by weak selection within the Consumer Discretionary, Information Technology, and HealthCare sectors. 

* Overweight allocations to the Consumer Discretionary, Real Estate, and Materials sectors detracted from relative performance. 

* From a style factor perspective, the Fund's underweight exposure to stocks with higher momentum detracted from relative performance. 

* The largest individual detractors over the period were overweight positions in Accenture (Information Technology) and UnitedHealth Group (HealthCare), as well as an underweight position in Tesla (Consumer Discretionary). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IC shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189332.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IC | 13.16% | 9.41% | 11.37% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$3732598436 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$23494078 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;58% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 30.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 12.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 12.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 12.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 10.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 7.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 3.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 3.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 1.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 1.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to reduce the limit in which the Fund may invest in foreign issuers and non-dollar securities from 25% of the Fund's net assets to 15% of the Fund's net assets. Effective April 30, 2025, "Quantitative Investing Risk" was added as a principal risk of the Fund.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHCPCX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Disciplined Equity HLS Fund

### Class IA/HIAGX
This annual shareholder report contains important information about the Hartford Disciplined Equity HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $63 | 0.59% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, buoyed by easing inflation, robust corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Volatility, initially sparked by tariff escalations, later compounded by artificial intelligence (AI) valuation concerns, U.S. Federal Reserve policy uncertainty, and a prolonged government shutdown, gradually subsided as trade tensions eased, earnings beat expectations, and consumer spending remained resilient. The Federal Reserve lowered rates to bolster a cooling labor market yet maintained caution amid uneven inflation and lingering data gaps following the shutdown. Fund performance described below is relative to the S&P 500 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the Industrials, Financials, and Real Estate sectors contributed to relative performance. 

* An underweight allocation to the HealthCare sector and an overweight to both the Utilities and Communication Services sectors contributed to relative performance. 

* Top individual contributors over the period were overweight positions in KLA (Information Technology), GE Vernova (Industrials), and RTX (Industrials). 

#### Top Detractors to Performance
* Security selection was the primary relative detractor during the period, driven by weak selection within the Information Technology, HealthCare, and Consumer Discretionary sectors. 

* Sector allocation, a result of the team's bottom-up stock selection process, also detracted during the period due to overweight allocations to the Consumer Staples and Real Estate sectors and an underweight to the Information Technology sector. 

* The largest individual detractors over the period were not owning Micron Technology (Information Technology) and an overweight in Pool (Consumer Discretionary) and Philip Morris International (Consumer Staples). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189315.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 14.32% | 12.07% | 13.46% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$3002384862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$16613665 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;35% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 32.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 13.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 11.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 10.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 9.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 9.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 5.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 2.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 2.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 1.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIAGX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Disciplined Equity HLS Fund

### Class IB/HBGIX
This annual shareholder report contains important information about the Hartford Disciplined Equity HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $90 | 0.84% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, buoyed by easing inflation, robust corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Volatility, initially sparked by tariff escalations, later compounded by artificial intelligence (AI) valuation concerns, U.S. Federal Reserve policy uncertainty, and a prolonged government shutdown, gradually subsided as trade tensions eased, earnings beat expectations, and consumer spending remained resilient. The Federal Reserve lowered rates to bolster a cooling labor market yet maintained caution amid uneven inflation and lingering data gaps following the shutdown. Fund performance described below is relative to the S&P 500 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the Industrials, Financials, and Real Estate sectors contributed to relative performance. 

* An underweight allocation to the HealthCare sector and an overweight to both the Utilities and Communication Services sectors contributed to relative performance. 

* Top individual contributors over the period were overweight positions in KLA (Information Technology), GE Vernova (Industrials), and RTX (Industrials). 

#### Top Detractors to Performance
* Security selection was the primary relative detractor during the period, driven by weak selection within the Information Technology, HealthCare, and Consumer Discretionary sectors. 

* Sector allocation, a result of the team's bottom-up stock selection process, also detracted during the period due to overweight allocations to the Consumer Staples and Real Estate sectors and an underweight to the Information Technology sector. 

* The largest individual detractors over the period were not owning Micron Technology (Information Technology) and an overweight in Pool (Consumer Discretionary) and Philip Morris International (Consumer Staples). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189316.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 14.01% | 11.78% | 13.18% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$3002384862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$16613665 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;35% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 32.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 13.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 11.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 10.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 9.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 9.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 5.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 2.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 2.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 1.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHBGIX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Disciplined Equity HLS Fund

### Class IC/HLSCX
This annual shareholder report contains important information about the Hartford Disciplined Equity HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IC | $116 | 1.09% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, buoyed by easing inflation, robust corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Volatility, initially sparked by tariff escalations, later compounded by artificial intelligence (AI) valuation concerns, U.S. Federal Reserve policy uncertainty, and a prolonged government shutdown, gradually subsided as trade tensions eased, earnings beat expectations, and consumer spending remained resilient. The Federal Reserve lowered rates to bolster a cooling labor market yet maintained caution amid uneven inflation and lingering data gaps following the shutdown. Fund performance described below is relative to the S&P 500 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the Industrials, Financials, and Real Estate sectors contributed to relative performance. 

* An underweight allocation to the HealthCare sector and an overweight to both the Utilities and Communication Services sectors contributed to relative performance. 

* Top individual contributors over the period were overweight positions in KLA (Information Technology), GE Vernova (Industrials), and RTX (Industrials). 

#### Top Detractors to Performance
* Security selection was the primary relative detractor during the period, driven by weak selection within the Information Technology, HealthCare, and Consumer Discretionary sectors. 

* Sector allocation, a result of the team's bottom-up stock selection process, also detracted during the period due to overweight allocations to the Consumer Staples and Real Estate sectors and an underweight to the Information Technology sector. 

* The largest individual detractors over the period were not owning Micron Technology (Information Technology) and an overweight in Pool (Consumer Discretionary) and Philip Morris International (Consumer Staples). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IC shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189317.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IC | 13.75% | 11.51% | 12.90% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |

---

Class IC shares commenced operations on September 18, 2020. Class IC shares performance prior to that date reflects the Fund's Class IA shares performance adjusted to reflect the 12b-1 fee of 0.25% and the administrative services fee of 0.25% applicable to Class IC shares.

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$3002384862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$16613665 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;35% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 32.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 13.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 11.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 10.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 9.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 9.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 5.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 2.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 2.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 1.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHLSCX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Dividend and Growth HLS Fund

### Class IA/HIADX
This annual shareholder report contains important information about the Hartford Dividend and Growth HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $72 | 0.66% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, buoyed by easing inflation, robust corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Volatility, initially sparked by tariff escalations, later compounded by artificial intelligence (AI) valuation concerns, U.S. Federal Reserve policy uncertainty, and a prolonged government shutdown, gradually subsided as trade tensions eased, earnings beat expectations, and consumer spending remained resilient. The Federal Reserve lowered rates to bolster a cooling labor market yet maintained caution amid uneven inflation and lingering data gaps following the shutdown. Fund performance described below is relative to the S&P 500 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection was the primary relative contributor during the period, driven by strong selection within the Financials, Consumer Discretionary, and Communication Services sectors. 

* The Fund's underweight allocation to the Consumer Discretionary sector also contributed to relative performance. 

* Top individual contributors over the period were overweight allocations to Micron Technology (Information Technology) and Alphabet (Communication Services) and an out-of-benchmark position in Airbus (Industrials). 

#### Top Detractors to Performance
* The Fund's underweight allocation to the Information Technology sector and overweight allocation to the Energy sector detracted the most from relative performance. 

* Security selection within the HealthCare, Materials, and Information Technology sectors also detracted from relative performance. 

* The largest individual detractors over the period were not owning NVIDIA (Information Technology) and overweight allocations to UnitedHealth Group (HealthCare) and Marsh & McLennan (Financials). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189313.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 17.49% | 12.68% | 12.48% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |
| Russell 1000 Value Index | 15.91% | 11.33% | 10.53% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$3412837660 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$20696010 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;62% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 18.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 18.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 13.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 11.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 8.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 6.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 6.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 5.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 4.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 3.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 2.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 1.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (1.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised (1) to reflect that the sub-adviser also invests in growth companies trading at a discount; and (2) to remove the disclosure related to the sub-adviser's evaluation of ESG (environmental, social and/or governance) characteristics. As of the same date, "Growth Investing Style Risk" was added as a principal risk of the Fund and "ESG Integration Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIADX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Dividend and Growth HLS Fund

### Class IB/HDGBX
This annual shareholder report contains important information about the Hartford Dividend and Growth HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $99 | 0.91% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, buoyed by easing inflation, robust corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Volatility, initially sparked by tariff escalations, later compounded by artificial intelligence (AI) valuation concerns, U.S. Federal Reserve policy uncertainty, and a prolonged government shutdown, gradually subsided as trade tensions eased, earnings beat expectations, and consumer spending remained resilient. The Federal Reserve lowered rates to bolster a cooling labor market yet maintained caution amid uneven inflation and lingering data gaps following the shutdown. Fund performance described below is relative to the S&P 500 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection was the primary relative contributor during the period, driven by strong selection within the Financials, Consumer Discretionary, and Communication Services sectors. 

* The Fund's underweight allocation to the Consumer Discretionary sector also contributed to relative performance. 

* Top individual contributors over the period were overweight allocations to Micron Technology (Information Technology) and Alphabet (Communication Services) and an out-of-benchmark position in Airbus (Industrials). 

#### Top Detractors to Performance
* The Fund's underweight allocation to the Information Technology sector and overweight allocation to the Energy sector detracted the most from relative performance. 

* Security selection within the HealthCare, Materials, and Information Technology sectors also detracted from relative performance. 

* The largest individual detractors over the period were not owning NVIDIA (Information Technology) and overweight allocations to UnitedHealth Group (HealthCare) and Marsh & McLennan (Financials). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189314.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 17.19% | 12.41% | 12.20% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |
| Russell 1000 Value Index | 15.91% | 11.33% | 10.53% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$3412837660 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$20696010 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;62% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 18.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 18.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 13.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 11.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 8.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 6.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 6.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 5.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 4.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 3.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 2.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 1.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (1.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised (1) to reflect that the sub-adviser also invests in growth companies trading at a discount; and (2) to remove the disclosure related to the sub-adviser's evaluation of ESG (environmental, social and/or governance) characteristics. As of the same date, "Growth Investing Style Risk" was added as a principal risk of the Fund and "ESG Integration Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHDGBX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Healthcare HLS Fund

### Class IA/HIAHX
This annual shareholder report contains important information about the Hartford Healthcare HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $102 | 0.94% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, supported by easing inflation, strong corporate earnings, improved trade sentiment, and above trend gross domestic product (GDP) growth. Early year volatility driven by tariff escalations, artificial intelligence (AI) related valuation concerns, U.S. Federal Reserve (Fed) policy uncertainty, and the prolonged government shutdown gradually dissipated as trade tensions eased, earnings outperformed expectations, and consumer spending remained resilient. Market leadership shifted at times as richly valued technology shares faced pressure, prompting rotation into value and cyclical sectors, even as a concentrated group of mega cap tech companies ultimately accounted for an outsized share of full-year returns. Corporate earnings were a significant tailwind, with a large majority of S&P 500 companies exceeding expectations and delivering robust year-over-year profit growth. Economic momentum strengthened further as GDP expanded at its fastest pace in two years, supported by AI related investment, strong consumer demand, and increased government spending. The Fed cut rates multiple times to support a cooling labor market, though policymakers remained divided amid uneven inflation progress and incomplete data following the shutdown. Fund performance described below is relative to the S&P Composite 1500 Healthcare Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection was the primary relative contributor during the period, driven by strong selection within the mid-cap Biopharma and large-cap Biopharma subsectors. 

* An underweight allocation to the Medical Technology sector contributed positively to relative performance. 

* Top individual contributors over the period were the Fund's out-of-benchmark positions in Galderma Group (large-cap Biopharma), Avidity Biosciences (mid-cap Biopharma) and Merus (mid-cap Biopharma). 

#### Top Detractors to Performance
* Security selection within the HealthCare Services subsector detracted from relative performance. 

* Sector allocation, a result of the team's bottom-up stock selection process, was a relative detractor during the period, largely due to the Fund's underweight allocation to the large-cap Biopharma sector. 

* The largest individual detractors over the period were an underweight position in Johnson & Johnson (large-cap Biopharma), an overweight in UnitedHealth Group (HealthCare Services), and an underweight in CVS Health (HealthCare Services). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189307.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 16.10% | 3.45% | 7.85% |
| S&P Composite 1500 Health Care Index | 13.71% | 7.54% | 9.81% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$115419940 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;78 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$933096 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;50% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by subsector <sup>\*</sup>** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Pharmaceuticals | 31.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Biotechnology | 22.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care Providers & Services | 17.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care Equipment & Services & Supplies | 17.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Life Sciences Tools & Services | 9.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care Technology | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 1.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, "Emerging Markets Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIAHX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Healthcare HLS Fund

### Class IB/HBGHX
This annual shareholder report contains important information about the Hartford Healthcare HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $128 | 1.19% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, supported by easing inflation, strong corporate earnings, improved trade sentiment, and above trend gross domestic product (GDP) growth. Early year volatility driven by tariff escalations, artificial intelligence (AI) related valuation concerns, U.S. Federal Reserve (Fed) policy uncertainty, and the prolonged government shutdown gradually dissipated as trade tensions eased, earnings outperformed expectations, and consumer spending remained resilient. Market leadership shifted at times as richly valued technology shares faced pressure, prompting rotation into value and cyclical sectors, even as a concentrated group of mega cap tech companies ultimately accounted for an outsized share of full-year returns. Corporate earnings were a significant tailwind, with a large majority of S&P 500 companies exceeding expectations and delivering robust year-over-year profit growth. Economic momentum strengthened further as GDP expanded at its fastest pace in two years, supported by AI related investment, strong consumer demand, and increased government spending. The Fed cut rates multiple times to support a cooling labor market, though policymakers remained divided amid uneven inflation progress and incomplete data following the shutdown. Fund performance described below is relative to the S&P Composite 1500 Healthcare Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection was the primary relative contributor during the period, driven by strong selection within the mid-cap Biopharma and large-cap Biopharma subsectors. 

* An underweight allocation to the Medical Technology sector contributed positively to relative performance. 

* Top individual contributors over the period were the Fund's out-of-benchmark positions in Galderma Group (large-cap Biopharma), Avidity Biosciences (mid-cap Biopharma) and Merus (mid-cap Biopharma). 

#### Top Detractors to Performance
* Security selection within the HealthCare Services subsector detracted from relative performance. 

* Sector allocation, a result of the team's bottom-up stock selection process, was a relative detractor during the period, largely due to the Fund's underweight allocation to the large-cap Biopharma sector. 

* The largest individual detractors over the period were an underweight position in Johnson & Johnson (large-cap Biopharma), an overweight in UnitedHealth Group (HealthCare Services), and an underweight in CVS Health (HealthCare Services). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189308.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 15.79% | 3.19% | 7.58% |
| S&P Composite 1500 Health Care Index | 13.71% | 7.54% | 9.81% |
| S&P 500 Index | 17.88% | 14.42% | 14.82% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$115419940 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;78 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$933096 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;50% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by subsector <sup>\*</sup>** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Pharmaceuticals | 31.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Biotechnology | 22.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care Providers & Services | 17.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care Equipment & Services & Supplies | 17.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Life Sciences Tools & Services | 9.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care Technology | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 1.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, "Emerging Markets Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHBGHX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford International Opportunities HLS Fund

### Class IA/HIAOX
This annual shareholder report contains important information about the Hartford International Opportunities HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $88 | 0.76% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

International equities rose over the trailing twelve-month period ending December 31, 2025 despite macroeconomic and geopolitical volatility. Early-year weakness driven by shifting United States (U.S.) policy and tariff concerns gave way to improving sentiment as inflation eased, trade tensions moderated, and central banks diverged in policy. The U.S. Federal Reserve (Fed) moved from caution to cuts while the European Central Bank eased then paused. Stabilizing geopolitics and strong corporate earnings, artificial intelligence (AI) driven investment, and a weaker dollar supported markets. Emerging markets outperformed despite China's softness. The year ended on a constructive note, supported by liquidity, steady demand, and selective policy easing extending. Fund performance described below is relative to the MSCI ACWI ex USA Index (Net) for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the HealthCare, Communication Services, and Information Technology sectors contributed to relative results during the period. 

* An underweight allocation to the HealthCare sector and an overweight to the Communication Services sector contributed to relative performance. 

* Top individual contributors over the period were overweight positions in SK Hynix (Information Technology), Societe Generale (Financials), and UniCredit (Financials). 

#### Top Detractors to Performance
* Sector allocation, a result of the team's bottom-up stock selection process, was the primary relative detractor during the period, driven by the Fund's underweight to the Financials and Materials sectors, and an overweight allocation to the Real Estate sector. 

* Security selection within the Industrials, Consumer Discretionary, and Real Estate sectors detracted from relative results during the period. 

* The largest individual detractors over the period were overweight positions in London Stock Exchange Group (Financials), Adidas (Consumer Discretionary), and not owning Samsung Electronics (Information Technology). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189320.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 30.41% | 6.86% | 8.14% |
| MSCI ACWI ex USA Index (Net) | 32.39% | 7.91% | 8.41% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$837337199 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;84 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$5954790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;43% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Country <sup>\*</sup>** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Japan | 14.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;United Kingdom | 12.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Germany | 12.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;France | 7.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;China | 6.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Canada | 5.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Taiwan | 5.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;United States | 5.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;South Korea | 4.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Italy | 4.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other<sup>\*\*</sup> | 21.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;\*&nbsp;&nbsp;&nbsp; <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;\*\*&nbsp;&nbsp;&nbsp; <sup>Ten largest country/geographic regions are presented. Additional country/geographic regions are found in Other.</sup> |

---

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to remove the disclosure related to the sub-adviser's evaluation of ESG (environmental, social and/or governance) characteristics. As of the same date, "ESG Integration Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIAOX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford International Opportunities HLS Fund

### Class IB/HBIOX
This annual shareholder report contains important information about the Hartford International Opportunities HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $116 | 1.01% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

International equities rose over the trailing twelve-month period ending December 31, 2025 despite macroeconomic and geopolitical volatility. Early-year weakness driven by shifting United States (U.S.) policy and tariff concerns gave way to improving sentiment as inflation eased, trade tensions moderated, and central banks diverged in policy. The U.S. Federal Reserve (Fed) moved from caution to cuts while the European Central Bank eased then paused. Stabilizing geopolitics and strong corporate earnings, artificial intelligence (AI) driven investment, and a weaker dollar supported markets. Emerging markets outperformed despite China's softness. The year ended on a constructive note, supported by liquidity, steady demand, and selective policy easing extending. Fund performance described below is relative to the MSCI ACWI ex USA Index (Net) for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the HealthCare, Communication Services, and Information Technology sectors contributed to relative results during the period. 

* An underweight allocation to the HealthCare sector and an overweight to the Communication Services sector contributed to relative performance. 

* Top individual contributors over the period were overweight positions in SK Hynix (Information Technology), Societe Generale (Financials), and UniCredit (Financials). 

#### Top Detractors to Performance
* Sector allocation, a result of the team's bottom-up stock selection process, was the primary relative detractor during the period, driven by the Fund's underweight to the Financials and Materials sectors, and an overweight allocation to the Real Estate sector. 

* Security selection within the Industrials, Consumer Discretionary, and Real Estate sectors detracted from relative results during the period. 

* The largest individual detractors over the period were overweight positions in London Stock Exchange Group (Financials), Adidas (Consumer Discretionary), and not owning Samsung Electronics (Information Technology). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189321.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 30.06% | 6.60% | 7.86% |
| MSCI ACWI ex USA Index (Net) | 32.39% | 7.91% | 8.41% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$837337199 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;84 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$5954790 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;43% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Country <sup>\*</sup>** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Japan | 14.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;United Kingdom | 12.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Germany | 12.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;France | 7.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;China | 6.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Canada | 5.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Taiwan | 5.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;United States | 5.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;South Korea | 4.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Italy | 4.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other<sup>\*\*</sup> | 21.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;\*&nbsp;&nbsp;&nbsp; <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;\*\*&nbsp;&nbsp;&nbsp; <sup>Ten largest country/geographic regions are presented. Additional country/geographic regions are found in Other.</sup> |

---

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to remove the disclosure related to the sub-adviser's evaluation of ESG (environmental, social and/or governance) characteristics. As of the same date, "ESG Integration Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHBIOX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford MidCap HLS Fund

### Class IA/HIMCX
This annual shareholder report contains important information about the Hartford MidCap HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $76 | 0.76% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, supported by easing inflation, strong corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Early-year volatility driven by tariff escalations, AI-related valuation concerns, U.S. Federal Reserve (Fed) policy uncertainty, and the prolonged government shutdown gradually dissipated as trade tensions eased, earnings outperformed expectations, and consumer spending remained resilient. Economic momentum strengthened further as GDP expanded at its fastest pace in two years, supported by Artificial Intelligence (AI)-related investment, strong consumer demand, and increased government spending. The Federal Reserve cut rates multiple times to support a cooling labor market, though policymakers remained divided amid uneven inflation progress and incomplete data following the shutdown. Fund performance described below is relative to the Russell Midcap Growth Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* The Fund's overweight allocation to the Utilities and Industrials sectors contributed to relative performance. 

* Security selection within the Consumer Staples, Information Technology, and Financials sectors contributed positively to relative performance. 

* Top individual contributors over the period were out-of-benchmark positions in Celestica (Information Technology), Rocket (Financials), and Interactive Brokers Group (Financials). 

#### Top Detractors to Performance
* Security selection was the primary relative detractor during the period, driven by weak selection within the Industrials, Consumer Discretionary, and Communication services sectors. 

* Sector allocation, a result of the team's bottom-up stock selection process, also detracted from relative performance. Allocation effect was driven by an underweight allocation to the HealthCare sector and an overweight to the Financials sector. 

* The largest individual detractors over the period were underweight allocations to ROBLOX (Communication Services) and Palantir Technologies (Information Technology) and an overweight allocation to Deckers Outdoor (Consumer Discretionary). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189324.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | (0.38)% | 0.24% | 8.05% |
| Russell Midcap Growth Index | 8.66% | 6.65% | 12.49% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$720077610 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;63 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$5625560 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;60% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 26.5 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 20.6 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 16.9 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 10.6 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 9.0 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 8.1 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 2.2 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.1 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 1.5 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 0.7 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 1.8 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.0 | %<sup>†</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0 | % |

---

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; <sup><sup>\*</sup></sup>&nbsp;&nbsp;&nbsp; <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp; <sup><sup>†</sup></sup>&nbsp;&nbsp;&nbsp; <sup>Percentage rounds to zero.</sup> |

---

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to remove the disclosure related to the sub-adviser's evaluation of ESG (environmental, social and/or governance) characteristics. As of the same date, "ESG Integration Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIMCX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford MidCap HLS Fund

### Class IB/HBMCX
This annual shareholder report contains important information about the Hartford MidCap HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $101 | 1.01% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, supported by easing inflation, strong corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Early-year volatility driven by tariff escalations, AI-related valuation concerns, U.S. Federal Reserve (Fed) policy uncertainty, and the prolonged government shutdown gradually dissipated as trade tensions eased, earnings outperformed expectations, and consumer spending remained resilient. Economic momentum strengthened further as GDP expanded at its fastest pace in two years, supported by Artificial Intelligence (AI)-related investment, strong consumer demand, and increased government spending. The Federal Reserve cut rates multiple times to support a cooling labor market, though policymakers remained divided amid uneven inflation progress and incomplete data following the shutdown. Fund performance described below is relative to the Russell Midcap Growth Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* The Fund's overweight allocation to the Utilities and Industrials sectors contributed to relative performance. 

* Security selection within the Consumer Staples, Information Technology, and Financials sectors contributed positively to relative performance. 

* Top individual contributors over the period were out-of-benchmark positions in Celestica (Information Technology), Rocket (Financials), and Interactive Brokers Group (Financials). 

#### Top Detractors to Performance
* Security selection was the primary relative detractor during the period, driven by weak selection within the Industrials, Consumer Discretionary, and Communication services sectors. 

* Sector allocation, a result of the team's bottom-up stock selection process, also detracted from relative performance. Allocation effect was driven by an underweight allocation to the HealthCare sector and an overweight to the Financials sector. 

* The largest individual detractors over the period were underweight allocations to ROBLOX (Communication Services) and Palantir Technologies (Information Technology) and an overweight allocation to Deckers Outdoor (Consumer Discretionary). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189325.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | (0.65)% | (0.02)% | 7.78% |
| Russell Midcap Growth Index | 8.66% | 6.65% | 12.49% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$720077610 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;63 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$5625560 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;60% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 26.5 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 20.6 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 16.9 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 10.6 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 9.0 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 8.1 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 2.2 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.1 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 1.5 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 0.7 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 1.8 | % |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.0 | %<sup>†</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0 | % |

---

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; <sup><sup>\*</sup></sup>&nbsp;&nbsp;&nbsp; <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp; <sup><sup>†</sup></sup>&nbsp;&nbsp;&nbsp; <sup>Percentage rounds to zero.</sup> |

---

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to remove the disclosure related to the sub-adviser's evaluation of ESG (environmental, social and/or governance) characteristics. As of the same date, "ESG Integration Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHBMCX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Small Cap Growth HLS Fund

### Class IA/HISCX
This annual shareholder report contains important information about the Hartford Small Cap Growth HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| |
|:---|
| **Class Name** |
| Class IA $68<sup>\*\*</sup> 0.66%<sup>\*\*</sup> |

---

---

| |
|:---|
| \*<sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup> |
| \*\*<sup>Costs paid excludes fees and expenses incurred indirectly as a result of investments in other investment companies.</sup> |

---

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, supported by easing inflation, strong corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Early-year volatility tied to tariff escalation, artificial intelligence (AI) valuation concerns, Federal Reserve (Fed) policy uncertainty, and the prolonged government shutdown faded as trade tensions eased, earnings exceeded expectations, and consumer spending remained resilient. Market leadership shifted at times, with pressure on richly valued technology stocks driving rotation into value and cyclical sectors, though a small group of mega-cap technology companies ultimately generated an outsized share of full-year returns. Corporate earnings were a key tailwind, with most S&P 500 companies surpassing expectations, while economic momentum strengthened as GDP grew at its fastest pace in two years. The Fed cut rates multiple times to support a cooling labor market, even as policymakers remained divided amid uneven inflation progress. Fund performance described below is relative to the Russell 2000 Growth Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Sector allocation, a result of the team's bottom-up stock selection process, contributed to relative performance over the period due to the Fund's underweight allocations to the Communication Services and Financials sectors and an overweight allocation to the Industrials sector. 

* Security selection within the Financials and HealthCare sectors contributed positively to performance. 

* Top individual contributors over the period were out-of-benchmark positions in Lumentum Holdings (Information Technology) and ATI (Industrials) and an underweight position in Him & Hers Health (HealthCare). 

#### Top Detractors to Performance
* Security selection was the primary detractor from relative performance, driven by weak selection within the Industrials, Materials, and Consumer Staples sectors. 

* Overweight allocations to the Consumer Discretionary, Consumer Staples, and Utilities sectors detracted from relative performance. 

* The largest individual detractors over the period were out-of-benchmark positions in Freshpet (Consumer Staples) and BellRing Brands (Consumer Staples) and an overweight in Sweetgreen (Consumer Discretionary). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189326.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 6.83% | 1.27% | 8.66% |
| Russell 2000 Growth Index | 13.01% | 3.18% | 9.57% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$546500047 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;163 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$3280570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;86% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 24.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 23.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 20.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 11.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 9.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 3.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 1.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 1.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 0.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 2.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (2.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHISCX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Small Cap Growth HLS Fund

### Class IB/HBSGX
This annual shareholder report contains important information about the Hartford Small Cap Growth HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| |
|:---|
| **Class Name** |
| Class IB $94<sup>\*\*</sup> 0.91%<sup>\*\*</sup> |

---

---

| |
|:---|
| \*<sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup> |
| \*\*<sup>Costs paid excludes fees and expenses incurred indirectly as a result of investments in other investment companies.</sup> |

---

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, supported by easing inflation, strong corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Early-year volatility tied to tariff escalation, artificial intelligence (AI) valuation concerns, Federal Reserve (Fed) policy uncertainty, and the prolonged government shutdown faded as trade tensions eased, earnings exceeded expectations, and consumer spending remained resilient. Market leadership shifted at times, with pressure on richly valued technology stocks driving rotation into value and cyclical sectors, though a small group of mega-cap technology companies ultimately generated an outsized share of full-year returns. Corporate earnings were a key tailwind, with most S&P 500 companies surpassing expectations, while economic momentum strengthened as GDP grew at its fastest pace in two years. The Fed cut rates multiple times to support a cooling labor market, even as policymakers remained divided amid uneven inflation progress. Fund performance described below is relative to the Russell 2000 Growth Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Sector allocation, a result of the team's bottom-up stock selection process, contributed to relative performance over the period due to the Fund's underweight allocations to the Communication Services and Financials sectors and an overweight allocation to the Industrials sector. 

* Security selection within the Financials and HealthCare sectors contributed positively to performance. 

* Top individual contributors over the period were out-of-benchmark positions in Lumentum Holdings (Information Technology) and ATI (Industrials) and an underweight position in Him & Hers Health (HealthCare). 

#### Top Detractors to Performance
* Security selection was the primary detractor from relative performance, driven by weak selection within the Industrials, Materials, and Consumer Staples sectors. 

* Overweight allocations to the Consumer Discretionary, Consumer Staples, and Utilities sectors detracted from relative performance. 

* The largest individual detractors over the period were out-of-benchmark positions in Freshpet (Consumer Staples) and BellRing Brands (Consumer Staples) and an overweight in Sweetgreen (Consumer Discretionary). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189327.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 6.54% | 1.01% | 8.39% |
| Russell 2000 Growth Index | 13.01% | 3.18% | 9.57% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$546500047 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;163 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$3280570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;86% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 24.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 23.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 20.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 11.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 9.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 3.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 2.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 1.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 1.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Utilities | 0.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 2.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (2.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHBSGX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Small Company HLS Fund

### Class IA/HIASX
This annual shareholder report contains important information about the Hartford Small Company HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $86 | 0.81% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, supported by easing inflation, strong corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Early-year volatility tied to tariff escalation, artificial intelligence (AI) valuation concerns, Federal Reserve (Fed) policy uncertainty, and the prolonged government shutdown faded as trade tensions eased, earnings exceeded expectations, and consumer spending remained resilient. Market leadership shifted at times, with pressure on richly valued technology stocks driving rotation into value and cyclical sectors, though a small group of mega-cap technology companies ultimately generated an outsized share of full-year returns. Corporate earnings were a key tailwind, with most S&P 500 companies surpassing expectations, while economic momentum strengthened as GDP grew at its fastest pace in two years. The Fed cut rates multiple times to support a cooling labor market, even as policymakers remained divided amid uneven inflation progress. Fund performance described below is relative to the Russell 2000 Growth Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the HealthCare, Information Technology, and Financials sectors contributed positively to relative performance. 

* Sector allocation, a result of the team's bottom-up stock selection process, contributed to relative performance mainly driven by the Fund's overweight allocations to the HealthCare and Industrials sectors, as well as an underweight to the Financials sector. 

* Top individual contributors over the period were overweight positions in Hims & Hers Health (HealthCare), SiTime (Information Technology), and Insmed (HealthCare). 

#### Top Detractors to Performance
* An overweight allocation to the Consumer Discretionary sector and an underweight to the Information Technology sector detracted from relative performance. 

* Security selection within the Industrials, Materials, and Communication Services sectors detracted from relative results during the period. 

* The largest individual detractors over the period were an average underweight to Bloom Energy (Industrials) and overweights to PROCEPT BioRobotics (HealthCare) and BellRing Brands (Consumer Staples). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189328.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 12.96% | 0.71% | 10.55% |
| Russell 2000 Growth Index | 13.01% | 3.18% | 9.57% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$426175092 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;107 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$3072466 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;68% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 29.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 23.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 19.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 9.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 8.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 3.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 2.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 1.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (1.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to remove the disclosure related to the sub-adviser's evaluation of ESG (environmental, social and/or governance) characteristics. As of the same date, "ESG Integration Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIASX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Small Company HLS Fund

### Class IB/HDMBX
This annual shareholder report contains important information about the Hartford Small Company HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### This report describes changes to the Fund that occurred during the reporting period.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $113 | 1.06% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities rose over the twelve-month period ending December 31, 2025, supported by easing inflation, strong corporate earnings, improved trade sentiment, and above-trend Gross Domestic Product (GDP) growth. Early-year volatility tied to tariff escalation, artificial intelligence (AI) valuation concerns, Federal Reserve (Fed) policy uncertainty, and the prolonged government shutdown faded as trade tensions eased, earnings exceeded expectations, and consumer spending remained resilient. Market leadership shifted at times, with pressure on richly valued technology stocks driving rotation into value and cyclical sectors, though a small group of mega-cap technology companies ultimately generated an outsized share of full-year returns. Corporate earnings were a key tailwind, with most S&P 500 companies surpassing expectations, while economic momentum strengthened as GDP grew at its fastest pace in two years. The Fed cut rates multiple times to support a cooling labor market, even as policymakers remained divided amid uneven inflation progress. Fund performance described below is relative to the Russell 2000 Growth Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the HealthCare, Information Technology, and Financials sectors contributed positively to relative performance. 

* Sector allocation, a result of the team's bottom-up stock selection process, contributed to relative performance mainly driven by the Fund's overweight allocations to the HealthCare and Industrials sectors, as well as an underweight to the Financials sector. 

* Top individual contributors over the period were overweight positions in Hims & Hers Health (HealthCare), SiTime (Information Technology), and Insmed (HealthCare). 

#### Top Detractors to Performance
* An overweight allocation to the Consumer Discretionary sector and an underweight to the Information Technology sector detracted from relative performance. 

* Security selection within the Industrials, Materials, and Communication Services sectors detracted from relative results during the period. 

* The largest individual detractors over the period were an average underweight to Bloom Energy (Industrials) and overweights to PROCEPT BioRobotics (HealthCare) and BellRing Brands (Consumer Staples). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189329.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 12.68% | 0.45% | 10.27% |
| Russell 2000 Growth Index | 13.01% | 3.18% | 9.57% |
| Russell 3000 Index | 17.15% | 13.15% | 14.29% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$426175092 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;107 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$3072466 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;68% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 29.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 23.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 19.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 9.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 8.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Real Estate | 3.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 2.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 1.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 2.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (1.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Material Fund Changes
This is a summary of certain changes to the Fund since the beginning of the reporting period. For more complete information, you may review the Fund's current prospectus dated April 30, 2025, as may be amended, supplemented or restated, at hartfordfunds.com/reports-hls or upon request by calling 1-888-843-7824 or sending an e-mail to orders@mysummaryprospectus.com.

Effective April 30, 2025, the Fund's principal investment strategy was revised to remove the disclosure related to the sub-adviser's evaluation of ESG (environmental, social and/or governance) characteristics. As of the same date, "ESG Integration Risk" was removed from the Fund's principal risks and was designated instead as an additional risk.

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHDMBX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Stock HLS Fund

### Class IA/HSTAX
This annual shareholder report contains important information about the Hartford Stock HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $54 | 0.52% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities registered a sizable return for 2025 with markets bolstered by robust corporate earnings, resilient consumer spending, and solid economic growth even as anxiety about lofty valuations in the technology sector and concerns surrounding massive artificial intelligence (AI) spending drove capital toward value areas of the market. The cooling labor market and worries about upside inflation risks also kept the markets on edge. In the third quarter, the U.S. economy grew at the fastest pace in two years; Gross Domestic Product (GDP) surged 4.3% annually, primarily fueled by robust consumer spending but also aided by a rebound in exports, business investment on equipment and AI, and increased government spending on defense. Fund performance described below is relative to the Russell 1000 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the Communication Services sector contributed positively to relative performance. 

* The Fund's overweight allocation to the HealthCare sector and lack of exposure to the Energy sector also contributed to relative performance. 

* Top individual contributors over the period were new positions in Broadcom (Information Technology), Eli Lilly (HealthCare) and not holding Amazon (Consumer Discretionary). 

#### Top Detractors to Performance
* Security selection was the primary relative detractor during the period, driven by weak selection within the Information Technology, Industrials, and HealthCare sectors. 

* Sector allocation, a result of our bottom-up stock selection process, was also a relative detractor during the period due to the Fund's underweight allocation to the Communication Services sector and overweight allocation to the Consumer Staples sector. 

* The largest individual detractors over the period were an overweight position in UnitedHealth Group (HealthCare), not owning NVIDIA (Information Technology), and an overweight position in Accenture (Information Technology). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189322.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 7.97% | 8.44% | 10.98% |
| Russell 1000 Index | 17.37% | 13.59% | 14.59% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$1211572058 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;47 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$5988917 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;36% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 23.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 19.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 17.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 14.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 11.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 7.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 4.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 2.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHSTAX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Stock HLS Fund

### Class IB/HIBSX
This annual shareholder report contains important information about the Hartford Stock HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $80 | 0.77% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

United States (U.S.) equities registered a sizable return for 2025 with markets bolstered by robust corporate earnings, resilient consumer spending, and solid economic growth even as anxiety about lofty valuations in the technology sector and concerns surrounding massive artificial intelligence (AI) spending drove capital toward value areas of the market. The cooling labor market and worries about upside inflation risks also kept the markets on edge. In the third quarter, the U.S. economy grew at the fastest pace in two years; Gross Domestic Product (GDP) surged 4.3% annually, primarily fueled by robust consumer spending but also aided by a rebound in exports, business investment on equipment and AI, and increased government spending on defense. Fund performance described below is relative to the Russell 1000 Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* Security selection within the Communication Services sector contributed positively to relative performance. 

* The Fund's overweight allocation to the HealthCare sector and lack of exposure to the Energy sector also contributed to relative performance. 

* Top individual contributors over the period were new positions in Broadcom (Information Technology), Eli Lilly (HealthCare) and not holding Amazon (Consumer Discretionary). 

#### Top Detractors to Performance
* Security selection was the primary relative detractor during the period, driven by weak selection within the Information Technology, Industrials, and HealthCare sectors. 

* Sector allocation, a result of our bottom-up stock selection process, was also a relative detractor during the period due to the Fund's underweight allocation to the Communication Services sector and overweight allocation to the Consumer Staples sector. 

* The largest individual detractors over the period were an overweight position in UnitedHealth Group (HealthCare), not owning NVIDIA (Information Technology), and an overweight position in Accenture (Information Technology). 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189323.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 7.69% | 8.17% | 10.70% |
| Russell 1000 Index | 17.37% | 13.59% | 14.59% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$1211572058 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;47 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$5988917 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;36% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Sector** <sup>\*</sup>

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Information Technology | 23.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Financials | 19.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Health Care | 17.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrials | 14.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Discretionary | 11.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consumer Staples | 7.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;Communication Services | 4.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;Materials | 2.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>\*</sup></sup> <sup>For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIBSX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Total Return Bond HLS Fund

### Class IA/HIABX
This annual shareholder report contains important information about the Hartford Total Return Bond HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $53 | 0.51% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

Most United States (U.S.) fixed income sectors generated positive total returns during the trailing twelve-month period ended December 31, 2025, as coupon income and periods of spread tightening helped offset the impact of volatile and higher global sovereign yields in some regions. The U.S. dollar faced early periods of depreciation around tariff announcements but rebounded in the second half of the year supported by robust growth and shifting policy expectations. Fund performance described below is relative to the Bloomberg US Aggregate Bond Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* The Fund's allocation to structured finance sectors had the greatest positive effect on performance overall, including an allocation to Non-Agency Residential Mortgage-Backed Securities (RMBS), an overweight to agency Mortgage-Backed Securities (MBS) pass-throughs, and exposure to Commercial Mortgage-Backed Securities (CMBS) and Collateralized Loan Obligations (CLOs). 

* Corporate credit positioning contributed positively to relative results overall. The Fund's out-of-benchmark exposure to High Yield benefited results the most, led by Industrials. Broadly, security selection within Investment Grade Credit also aided performance. 

* An allocation to Emerging Market sovereign debt had a favorable impact on results. 

#### Top Detractors to Performance
* The Fund's allocation to Treasury Inflation Protected Securities (TIPS) detracted from relative results during the period. 

* An overall underweight in Investment Grade Corporates detracted from results. 

The Fund held interest rate positions during the period, including interest rate futures and interest rate swaps as well as currency forwards to implement non-U.S. rate and currency positions. The use of derivatives contributed positively to results.

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189318.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 7.30% | (0.04)% | 2.75% |
| Bloomberg US Aggregate Bond Index | 7.30% | (0.36)% | 2.01% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$1386416983 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings | &nbsp;&nbsp;&nbsp;&nbsp;1362 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$7190272 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate (excludes to be announced (TBA) roll transactions) | &nbsp;&nbsp;&nbsp;&nbsp;53% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Security Type**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Agencies<sup>^</sup> | 41.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate Bonds | 26.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Securities | 23.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-Backed & Commercial Mortgage-Backed Securities | 17.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign Government Obligations | 1.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal Bonds | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Convertible Bonds | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Floating Rate Interests | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 1.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (11.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100 |

---

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; <sup><sup>^</sup></sup>&nbsp;&nbsp;&nbsp; <sup>All, or a portion of the securities categorized as U.S. Government Agencies, were agency mortgage-backed securities.</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp; <sup><sup>†</sup></sup>&nbsp;&nbsp;&nbsp; <sup>Percentage rounds to zero.</sup> |

---

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHIABX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Total Return Bond HLS Fund

### Class IB/HBNBX
This annual shareholder report contains important information about the Hartford Total Return Bond HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $79 | 0.76% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

Most United States (U.S.) fixed income sectors generated positive total returns during the trailing twelve-month period ended December 31, 2025, as coupon income and periods of spread tightening helped offset the impact of volatile and higher global sovereign yields in some regions. The U.S. dollar faced early periods of depreciation around tariff announcements but rebounded in the second half of the year supported by robust growth and shifting policy expectations. Fund performance described below is relative to the Bloomberg US Aggregate Bond Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* The Fund's allocation to structured finance sectors had the greatest positive effect on performance overall, including an allocation to Non-Agency Residential Mortgage-Backed Securities (RMBS), an overweight to agency Mortgage-Backed Securities (MBS) pass-throughs, and exposure to Commercial Mortgage-Backed Securities (CMBS) and Collateralized Loan Obligations (CLOs). 

* Corporate credit positioning contributed positively to relative results overall. The Fund's out-of-benchmark exposure to High Yield benefited results the most, led by Industrials. Broadly, security selection within Investment Grade Credit also aided performance. 

* An allocation to Emerging Market sovereign debt had a favorable impact on results. 

#### Top Detractors to Performance
* The Fund's allocation to Treasury Inflation Protected Securities (TIPS) detracted from relative results during the period. 

* An overall underweight in Investment Grade Corporates detracted from results. 

The Fund held interest rate positions during the period, including interest rate futures and interest rate swaps as well as currency forwards to implement non-U.S. rate and currency positions. The use of derivatives contributed positively to results.

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative index. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189319.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 7.04% | (0.29)% | 2.49% |
| Bloomberg US Aggregate Bond Index | 7.30% | (0.36)% | 2.01% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$1386416983 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings | &nbsp;&nbsp;&nbsp;&nbsp;1362 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$7190272 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate (excludes to be announced (TBA) roll transactions) | &nbsp;&nbsp;&nbsp;&nbsp;53% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Security Type**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Agencies<sup>^</sup> | 41.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate Bonds | 26.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Securities | 23.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-Backed & Commercial Mortgage-Backed Securities | 17.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign Government Obligations | 1.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal Bonds | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Convertible Bonds | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Senior Floating Rate Interests | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 1.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | (11.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100 |

---

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; <sup><sup>^</sup></sup>&nbsp;&nbsp;&nbsp; <sup>All, or a portion of the securities categorized as U.S. Government Agencies, were agency mortgage-backed securities.</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp; <sup><sup>†</sup></sup>&nbsp;&nbsp;&nbsp; <sup>Percentage rounds to zero.</sup> |

---

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHBNBX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Ultrashort Bond HLS Fund

### Class IA/HUBAX
This annual shareholder report contains important information about the Hartford Ultrashort Bond HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IA | $46 | 0.45% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

Most United States (U.S.) fixed income sectors generated positive total returns during the trailing twelve-month period ending December 31, 2025, as coupon income and periods of spread tightening helped offset the impact of volatile and higher global sovereign yields in some regions. Most spread sectors produced positive excess returns over duration-equivalent government bonds with higher-yielding and emerging market sectors leading the outperformance. Political instability and policy uncertainty were prominent with leadership changes in France and Japan and the United States experiencing its longest government shutdown on record. Central bank policy divergence and fiscal developments were key drivers, with more accommodative stances across most regions. Fund performance described below is relative to the Bloomberg Short Treasury 9-12 Month Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* The Fund's duration and yield curve positioning contributed positively to relative performance. The portfolio maintained an overweight duration posture in the front and belly of the curve as Treasury rates rallied during the period. 

* The Fund's allocation to structured finance sectors was another key contributor to positive results. An out-of-benchmark position in Asset-Backed Securities (ABS), particularly in Autos and Equipment, added meaningfully to performance. The allocation to Mortgage-Backed Securities also contributed positively. 

* The Fund's out-of-benchmark allocation to Investment-Grade Credit contributed positively, led by positioning in Financials and Industrials. Positioning within Financials, Banking and Insurance were key contributors, while Consumer Cyclical stood out within Industrials. 

#### Top Detractors to Performance
* The Fund's underweight duration positioning at the one-year segment of the yield curve as rates rallied over the period negatively impacted performance. 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IA shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189311.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IA | 4.51% | 2.88% | 2.21% |
| Bloomberg Short Treasury 9-12 Month Index | 4.39% | 2.78% | 2.18% |
| Bloomberg US Aggregate Bond Index | 7.30% | (0.36)% | 2.01% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$493721184 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;299 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$2051409 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;70% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Security Type**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-Backed & Commercial Mortgage-Backed Securities | 37.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate Bonds | 25.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Securities | 14.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Agencies<sup>^</sup> | 6.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal Bonds | 0.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 14.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>^</sup></sup> <sup>All, or a portion of the securities categorized as U.S. Government Agencies, were agency mortgage-backed securities.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHUBAX_1225

![HF_Logo_Tag](g949371images_241.jpg)

### Annual Shareholder Report

### December 31, 2025

### Hartford Ultrashort Bond HLS Fund

### Class IB/HUBBX
This annual shareholder report contains important information about the Hartford Ultrashort Bond HLS Fund (the "Fund") for the period of January 1, 2025 to December 31, 2025. You can find additional information about the Fund at hartfordfunds.com/reports-hls. You can also request this information by contacting us by calling 1-888-843-7824.

#### What were the Fund costs for the last year?
*(Based on a hypothetical $10,000 investment)*

---

| | | |
|:---|:---|:---|
| **Class Name** | **Costs of a $10,000 investment<sup>\*</sup>** | **Costs paid as a percentage<br>of a $10,000 investment<sup>\*</sup>** |
| Class IB | $72 | 0.70% |

---

\* <sup>This does not reflect any transactional costs, such as sales charges (loads) or fees which may be applied at the variable life insurance, variable annuity, or qualified retirement plan product level.</sup>

#### How did the Fund perform last year and what impacted its performance?
**Management's Discussion of Fund Performance**

Most United States (U.S.) fixed income sectors generated positive total returns during the trailing twelve-month period ending December 31, 2025, as coupon income and periods of spread tightening helped offset the impact of volatile and higher global sovereign yields in some regions. Most spread sectors produced positive excess returns over duration-equivalent government bonds with higher-yielding and emerging market sectors leading the outperformance. Political instability and policy uncertainty were prominent with leadership changes in France and Japan and the United States experiencing its longest government shutdown on record. Central bank policy divergence and fiscal developments were key drivers, with more accommodative stances across most regions. Fund performance described below is relative to the Bloomberg Short Treasury 9-12 Month Index for the trailing twelve-month period ended December 31, 2025.

#### Top Contributors to Performance
* The Fund's duration and yield curve positioning contributed positively to relative performance. The portfolio maintained an overweight duration posture in the front and belly of the curve as Treasury rates rallied during the period. 

* The Fund's allocation to structured finance sectors was another key contributor to positive results. An out-of-benchmark position in Asset-Backed Securities (ABS), particularly in Autos and Equipment, added meaningfully to performance. The allocation to Mortgage-Backed Securities also contributed positively. 

* The Fund's out-of-benchmark allocation to Investment-Grade Credit contributed positively, led by positioning in Financials and Industrials. Positioning within Financials, Banking and Insurance were key contributors, while Consumer Cyclical stood out within Industrials. 

#### Top Detractors to Performance
* The Fund's underweight duration positioning at the one-year segment of the yield curve as rates rallied over the period negatively impacted performance. 

The views expressed in this section reflect the opinions of the Fund's sub-adviser, Wellington Management Company LLP, as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

**Comparison of Change in Value of $10,000 Investment**

The graph below represents the hypothetical growth of a $10,000 investment in Class IB shares and the comparative indices. **The Fund's past performance is not a good predictor of the Fund's future performance.**

![Fund Performance - Growth of 10K](g949371chartimages_189312.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **Average Annual Total Returns<br>For the Periods Ended December 31, 2025** | **1 Year** | **5 Years** | **10 Years** |
| Class IB | 4.32% | 2.62% | 1.96% |
| Bloomberg Short Treasury 9-12 Month Index | 4.39% | 2.78% | 2.18% |
| Bloomberg US Aggregate Bond Index | 7.30% | (0.36)% | 2.01% |

---

**The Fund's past performance is not a good predictor of the Fund's future performance.** The Fund's performance in the graph and table do not reflect the deductions of taxes, sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges or other fees or expenses would lower the contract's or plan's performance. Visit hartfordfunds.com for the most recent performance information.

#### Key Fund Statistics

#### as of December 31, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Fund's net assets | &nbsp;&nbsp;&nbsp;&nbsp;$493721184 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total number of portfolio holdings (excluding derivatives, if any) | &nbsp;&nbsp;&nbsp;&nbsp;299 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total investment management fees paid | &nbsp;&nbsp;&nbsp;&nbsp;$2051409 |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio turnover rate | &nbsp;&nbsp;&nbsp;&nbsp;70% |

---

#### Graphical Representation of Holdings

#### as of December 31, 2025
The table below shows the investment makeup of the Fund, representing the percentage of net assets of the Fund.

**Composition by Security Type**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Asset-Backed & Commercial Mortgage-Backed Securities | 37.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate Bonds | 25.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Securities | 14.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government Agencies<sup>^</sup> | 6.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal Bonds | 0.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-Term Investments | 14.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets & Liabilities | 0.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 100.0% |

---

<sup><sup>^</sup></sup> <sup>All, or a portion of the securities categorized as U.S. Government Agencies, were agency mortgage-backed securities.</sup>

#### Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information, please visit the Fund's website at the website address included at the beginning of this report.

The Fund is distributed by Hartford Funds Distributors, LLC (HFD).

AR_AHUBBX_1225

------

(b) Not applicable.

#### Item 2. Code of Ethics.
The registrant, as of the end of the period covered by this report, has adopted a code of ethics that applies to the registrant's principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party. There have been no amendments, during the period covered by this report, to a provision of the code of ethics that applies to the registrant's principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party, and that relates to any element of the code of ethics description. The registrant has not granted any waivers, including an implicit waiver, from a provision of the code of ethics that applies to the registrant's principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party, that relates to one or more of the items set forth in paragraph (b) of this item's instructions. A copy of the code of ethics is filed herewith.

#### Item 3. Audit Committee Financial Expert.
The Board of Directors of the registrant (the "Board") has designated David Sung as an Audit Committee Financial Expert. Mr. Sung is considered by the Board to be an independent director.

#### Item 4. Principal Accountant Fees and Services.
(a) <u>Audit Fees</u>: The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the audit of the registrant's annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years were: $365,803 for the fiscal year ended December 31, 2025; $349,321 for the fiscal year ended December 31, 2024.

(b) <u>Audit Related Fees</u>: The aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountant that are reasonably related to the performance of the audit of the registrant's financial statements and are not reported under paragraph (a) of this Item were: $0 for the fiscal year ended December 31, 2025; $0 for the fiscal year ended December 31, 2024.

(c) <u>Tax Fees</u>: The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning were: $60,384 for the fiscal year ended December 31, 2025; $58,056 for the fiscal year ended December 31, 2024; Tax-related services were principally in connection with, but not limited to, general tax services and excise tax services.

(d) <u>All Other Fees</u>: The aggregate fees billed in each of the last two fiscal years for products and services provided by the principal accountant, other than the services reported in paragraphs (a) through (c) of this Item were: $322 for the fiscal year ended December 31, 2025; $303 for the fiscal year ended December 31, 2024. These fees were principally in connection with, but not limited to, general audit related products and services and an accounting research tool subscription.

(e) (1) The Pre-Approval Policies and Procedures (the "Policy") adopted by the Audit Committee of the registrant (also, the "Fund") sets forth the procedures pursuant to which services performed by the independent registered

------

---

| | |
|:---|:---|
|  | public accounting firm for the registrant may be pre-approved. The following summarizes the pre-approval requirements under the Policy.<br>a) The Audit Committee must pre-approve all audit services and non-audit services that the independent registered public accounting firm provides to the Fund.<br>b) The Audit Committee must pre-approve any engagement of the independent registered public accounting firm to provide non-audit services to any Service Affiliate (which is defined to include any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the Fund) during the period of the independent registered public accounting firm's engagement to provide audit services to the Fund, if the non-audit services to the Service Affiliate directly impact the Fund's operations and financial reporting.<br>c) The Audit Committee, from time to time, may designate one or more of its members who are Independent Directors (each a "Designated Member") to consider, on the Audit Committee's behalf, any non-audit services, whether to the Fund or to any Service Affiliate, that have not been pre-approved by the Audit Committee. The Designated Member also shall review, on the Audit Committee's behalf, any proposed material change in the nature or extent of any non-audit services previously approved. In considering any requested non-audit services or proposed material change in such services, the Designated Member shall not authorize services which would exceed $50,000 in fees for such services.<br>d) The independent registered public accounting firm may not provide specified prohibited non-audit services set forth in the Policy to the Fund, the Fund's investment adviser, the Service Affiliates or any other member of the investment company complex. |
| (e) | (2) One hundred percent of the services described in items 4(b) through 4(d) were approved in accordance with the Audit Committee's Pre-Approval Policy. As a result, none of such services was approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X. |
| (f) | Less than 50% of the hours expended on the principal accountant's engagement to audit the registrant's financial statements for the year ended December 31, 2025, were attributed to work performed by persons other than the principal accountant's full-time, permanent employees. |
| (g) | The aggregate non-audit fees billed by the registrant's accountant for services rendered to the registrant, and rendered to the registrant's investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant for each of the last two fiscal years of the registrant were:<br>The aggregate non-audit fees billed by the registrant's accountant for services rendered to the registrant: $60,706 for the fiscal year ended December 31, 2025; $58,359 for the fiscal year ended December 31, 2024.<br>The aggregate non-audit fees billed by the registrant's accountant for services rendered to the registrant's investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the adviser was $121,199 for the fiscal year ended December 31, 2025 and $121,199 for the fiscal year ended December 31, 2024. |
| (h) | The registrant's audit committee of the board of directors has considered whether the provision of non-audit services that were rendered to the registrant's investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant's independence. |
| (i) | Not applicable. |

---

------

(j) Not applicable.

#### Item 5. Audit Committee of Listed Registrants.
Not applicable.

#### Item 6. Investments.
(a) The information required by this Item 6(a) is included in the Annual Financial Statements and Other Information filed under Item 7 of this form.

(b) Not applicable.

#### Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.

#### Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.

#### Item 9. Proxy Disclosures for Open-End Management Investment Companies.

#### Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.

#### Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.

------

![](g949371img51c0a3d11.jpg)

Hartford HLS Funds

Annual Financial Statements

and Other Information

December 31, 2025

---

| |
|:---|
| ◼Hartford Balanced HLS Fund |
| ◼Hartford Capital Appreciation HLS Fund |
| ◼Hartford Disciplined Equity HLS Fund |
| ◼Hartford Dividend and Growth HLS Fund |
| ◼Hartford Healthcare HLS Fund |
| ◼Hartford International Opportunities HLS Fund |
| ◼Hartford MidCap HLS Fund |
| ◼Hartford Small Cap Growth HLS Fund |
| ◼Hartford Small Company HLS Fund |
| ◼Hartford Stock HLS Fund |
| ◼Hartford Total Return Bond HLS Fund |
| ◼Hartford Ultrashort Bond HLS Fund |

---

------

**Hartford HLS Funds**

**Table of Contents** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Please note that this report includes responses to Items 7-11 of Form N-CSR, which is a reporting form filed with <br> the U.S. Securities and Exchange Commission by mutual funds and exchange traded funds. Certain Form N-CSR <br> items listed below may not be applicable.<br>|  |
| **[Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_1)** |  |
| [Schedules of Investments:](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_1) |  |
| [Hartford Balanced HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_1)  | 3 |
| [Hartford Capital Appreciation HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_9)  | 11 |
| [Hartford Disciplined Equity HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_12)  | 14 |
| [Hartford Dividend and Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_14)  | 16 |
| [Hartford Healthcare HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_16)  | 18 |
| [Hartford International Opportunities HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_18)  | 20 |
| [Hartford MidCap HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_20)  | 22 |
| [Hartford Small Cap Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_22)  | 24 |
| [Hartford Small Company HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_25)  | 27 |
| [Hartford Stock HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_27)  | 29 |
| [Hartford Total Return Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_29)  | 31 |
| [Hartford Ultrashort Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_46)  | 48 |
| [Glossary](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SOI-BookHeader-593_52)  | 54 |
| [Statements of Assets and Liabilities:](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_1) |  |
| [Hartford Balanced HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_1) | 55 |
| [Hartford Capital Appreciation HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_1) | 55 |
| [Hartford Disciplined Equity HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_1) | 55 |
| [Hartford Dividend and Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_1) | 55 |
| [Hartford Healthcare HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_1) | 55 |
| [Hartford International Opportunities HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_1) | 55 |
| [Hartford MidCap HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_2) | 56 |
| [Hartford Small Cap Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_2) | 56 |
| [Hartford Small Company HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_2) | 56 |
| [Hartford Stock HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_2) | 56 |
| [Hartford Total Return Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_2) | 56 |
| [Hartford Ultrashort Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_2) | 56 |
| [Statements of Operations:](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_3) |  |
| [Hartford Balanced HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_3) | 57 |
| [Hartford Capital Appreciation HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_3) | 57 |
| [Hartford Disciplined Equity HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_3) | 57 |
| [Hartford Dividend and Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_3) | 57 |
| [Hartford Healthcare HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_3) | 57 |
| [Hartford International Opportunities HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_3) | 57 |
| [Hartford MidCap HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_4) | 58 |
| [Hartford Small Cap Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_4) | 58 |
| [Hartford Small Company HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_4) | 58 |
| [Hartford Stock HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_4) | 58 |
| [Hartford Total Return Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_4) | 58 |
| [Hartford Ultrashort Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_4) | 58 |

---

------

**Hartford HLS Funds**

---

| | |
|:---|:---|
| [Statements of Changes in Net Assets:](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_5) |  |
| [Hartford Balanced HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_5) | 59 |
| [Hartford Capital Appreciation HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_5) | 59 |
| [Hartford Disciplined Equity HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_6) | 60 |
| [Hartford Dividend and Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_6) | 60 |
| [Hartford Healthcare HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_7) | 61 |
| [Hartford International Opportunities HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_7) | 61 |
| [Hartford MidCap HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_8) | 62 |
| [Hartford Small Cap Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_8) | 62 |
| [Hartford Small Company HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_9) | 63 |
| [Hartford Stock HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_9) | 63 |
| [Hartford Total Return Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_10) | 64 |
| [Hartford Ultrashort Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIN-BookHeader-593_10) | 64 |
| [Financial Highlights:](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_1) |  |
| [Hartford Balanced HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_1) | 65 |
| [Hartford Capital Appreciation HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_1) | 65 |
| [Hartford Disciplined Equity HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_1) | 65 |
| [Hartford Dividend and Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_2) | 66 |
| [Hartford Healthcare HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_2) | 66 |
| [Hartford International Opportunities HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_3) | 67 |
| [Hartford MidCap HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_3) | 67 |
| [Hartford Small Cap Growth HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_3) | 67 |
| [Hartford Small Company HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_4) | 68 |
| [Hartford Stock HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_4) | 68 |
| [Hartford Total Return Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_4) | 68 |
| [Hartford Ultrashort Bond HLS Fund](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_FIHI-BookHeader_5) | 69 |
| [Notes to Financial Statements](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_NFS-BookHeader-593_1) | 70 |
| [Report of Independent Registered Public Accounting Firm](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_Audit-BookHeader-593_1) | 92 |
| **[Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_CDA-BookHeader_1)** | 93 |
| **[Item 9. Proxy Disclosures for Open-End Management Companies](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_SPI-BookHeader_1)** | 94 |
| **[Item 10. Remuneration Paid to](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_REMUN-BookHeader_1)[Directors](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_REMUN-BookHeader_1)[, Officers, and Others of Open-End Management Companies](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_REMUN-BookHeader_1)**  | 95 |
| **[Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_InvestAgr-BookHeader_1)** |  |
| [Approval of Investment Management and Investment Sub-Advisory Agreements (Unaudited)](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_InvestAgr-BookHeader_1) | 96 |
| [Index Glossary for Indices Included in the Annual Shareholder Report (Unaudited)](#xx_38543390-3e9a-4ce1-9289-ed723562a84f_cBench-BookHeader-593_1)  | 103 |

---

------

**Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.**

**Hartford Balanced HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 1.4%** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 1.4%** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 1.4%** |
|  | **Asset-Backed - Automobile - 0.3%** | **Asset-Backed - Automobile - 0.3%** |
| $126198 | CFMT LLC 1.39%, 09/22/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $125799 |
| 815562 | Enterprise Fleet Financing LLC 6.40%, <br> 03/20/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 825594 |
| 1215000 | Toyota Lease Owner Trust 3.96%, <br> 11/20/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1217993 |
| 1565000 | Volkswagen Auto Lease Trust 4.01%, <br> 01/22/2029 | &nbsp;&nbsp;&nbsp; 1571126 |
|  | Wheels Fleet Lease Funding 1 LLC |  |
| 1008993 | 4.87%, 06/21/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1018930 |
| 510780 | 6.46%, 08/18/2038<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 516774 |
|  |  | &nbsp;&nbsp;&nbsp; 5276216 |
|  | **Asset-Backed - Student Loan - 0.1%** | **Asset-Backed - Student Loan - 0.1%** |
| 1031212 | Navient Private Education Refi Loan Trust <br> 5.51%, 10/15/2071<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1059897 |
|  | **Commercial Mortgage-Backed Securities - 0.3%** | **Commercial Mortgage-Backed Securities - 0.3%** |
| 395000 | BX Trust 5.03%, 12/13/2042<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 398581 |
| 330000 | Durst Commercial Mortgage Trust 5.15%, <br> 08/10/2042<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 336614 |
| 3004174 | RFR Trust 5.38%, 03/11/2041<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 3074235 |
|  |  | &nbsp;&nbsp;&nbsp; 3809430 |
|  | **Other Asset-Backed Securities - 0.2%** | **Other Asset-Backed Securities - 0.2%** |
|  | Castlelake Aircraft Structured Trust |  |
| 17979 | 3.47%, 01/15/2046<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 17827 |
| 176491 | 3.97%, 04/15/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 172961 |
|  | CF Hippolyta Issuer LLC |  |
| 204892 | 1.53%, 03/15/2061<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 165492 |
| 193120 | 5.97%, 08/15/2062<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 189974 |
| 1319307 | Home Partners of America Trust 2.30%, <br> 12/17/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1291266 |
| 66940 | Horizon Aircraft Finance II Ltd. 3.72%, <br> 07/15/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 65799 |
| 157453 | Horizon Aircraft Finance III Ltd. 3.43%, <br> 11/15/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 153885 |
| 885270 | Kubota Credit Owner Trust 5.28%, <br> 01/18/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 891872 |
| 39188 | MACH 1 Cayman Ltd. 3.47%, 10/15/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 38848 |
| 91717 | Start II Ltd. 4.09%, 03/15/2044<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 91495 |
|  |  | &nbsp;&nbsp;&nbsp; 3079419 |
|  | **Whole Loan Collateral CMO - 0.5%** | **Whole Loan Collateral CMO - 0.5%** |
| 15214 | Angel Oak Mortgage Trust 2.62%, <br> 11/25/2059<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 15072 |
| 297081 | Federal Home Loan Mortgage Corp. <br> Seasoned Credit Risk Transfer Trust 3.50%, <br> 10/25/2058 | &nbsp;&nbsp;&nbsp; 291158 |
|  | Federal National Mortgage Association <br> Connecticut Avenue Securities Trust |  |
| 138896 | 5.42%, 10/25/2041, 30 day USD SOFR <br> Average + 1.55%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 139458 |
| 38095 | 9.89%, 10/25/2028, 30 day USD SOFR <br> Average + 6.01%<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 38658 |
|  | Flagstar Mortgage Trust |  |
| 465155 | 2.00%, 09/25/2041<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 412651 |
| 217197 | 4.00%, 05/25/2048<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 203037 |
| 131818 | MetLife Securitization Trust 3.00%, <br> 04/25/2055<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 127563 |
|  | PRET Trust |  |
| 2865638 | 3.85%, 09/25/2069<sup>(1)(3)</sup>  | &nbsp;&nbsp;&nbsp; 2868495 |
| 1892485 | 4.00%, 08/25/2064<sup>(1)(3)</sup>  | &nbsp;&nbsp;&nbsp; 1836763 |
|  | Towd Point Mortgage Trust |  |
| 82149 | 2.75%, 06/25/2057<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 80745 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 1.4% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 1.4% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 1.4% -** <br> **(continued)** |
|  | **Whole Loan Collateral CMO - 0.5% - (continued)** | **Whole Loan Collateral CMO - 0.5% - (continued)** |
| $14097 | 3.00%, 01/25/2058<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; $14011 |
| 2450000 | Verus Securitization Trust 5.09%, <br> 07/25/2067<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2455548 |
|  |  | &nbsp;&nbsp;&nbsp; 8483159 |
|  | Total Asset-Backed & Commercial <br> Mortgage-Backed Securities <br>(cost $21,579,810) | &nbsp;&nbsp;&nbsp; $21708121 |
| **CORPORATE BONDS - 11.1%** | **CORPORATE BONDS - 11.1%** | **CORPORATE BONDS - 11.1%** |
|  | **Aerospace & Defense - 0.2%** | **Aerospace & Defense - 0.2%** |
|  | Boeing Co. |  |
| 860000 | 5.71%, 05/01/2040 | &nbsp;&nbsp;&nbsp; $877869 |
| 1809000 | 6.86%, 05/01/2054 | &nbsp;&nbsp;&nbsp; 2031758 |
| 560000 | Lockheed Martin Corp. 4.85%, 09/15/2041 | &nbsp;&nbsp;&nbsp; 518620 |
|  |  | &nbsp;&nbsp;&nbsp; 3428247 |
|  | **Agriculture - 0.3%** | **Agriculture - 0.3%** |
|  | BAT Capital Corp. |  |
| 820000 | 5.35%, 08/15/2032 | &nbsp;&nbsp;&nbsp; 851976 |
| 545000 | 5.63%, 08/15/2035 | &nbsp;&nbsp;&nbsp; 567688 |
| 175000 | JBS USA LUX SARL/JBS USA Food Co./JBS <br> USA Foods Group 5.95%, 04/20/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 184010 |
|  | Philip Morris International, Inc. |  |
| 2080000 | 4.25%, 10/29/2032 | &nbsp;&nbsp;&nbsp; 2046837 |
| 755000 | 5.25%, 02/13/2034 | &nbsp;&nbsp;&nbsp; 780377 |
|  |  | &nbsp;&nbsp;&nbsp; 4430888 |
|  | **Airlines - 0.0%** | **Airlines - 0.0%** |
| 58938 | United Airlines Pass-Through Trust 4.60%, <br> 09/01/2027 | &nbsp;&nbsp;&nbsp; 58896 |
|  | **Commercial Banks - 3.0%** | **Commercial Banks - 3.0%** |
| 1200000 | Banco Santander SA 5.37%, 07/15/2028, <br> (5.37% fixed rate until 07/15/2027; 1 yr. <br> USD CMT + 0.95% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1223123 |
|  | Bank of America Corp. |  |
| 1610000 | 3.59%, 07/21/2028, (3.59% fixed rate until <br> 07/21/2027; 3 mo. USD Term SOFR + <br> 1.63% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1598903 |
| 1384000 | 4.95%, 07/22/2028, (4.95% fixed rate until <br> 07/22/2027; 6 mo. USD SOFR + 2.04% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1403596 |
| 2280000 | 5.16%, 01/24/2031, (5.16% fixed rate until <br> 01/24/2030; 6 mo. USD SOFR + 1.00% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 2353768 |
| 688000 | 5.51%, 01/24/2036, (5.51% fixed rate until <br> 01/24/2035; 6 mo. USD SOFR + 1.31% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 717307 |
| 2239000 | 5.82%, 09/15/2029, (5.82% fixed rate until <br> 09/15/2028; 6 mo. USD SOFR + 1.57% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 2335465 |
| 574000 | 5.87%, 09/15/2034, (5.87% fixed rate until <br> 09/15/2033; 6 mo. USD SOFR + 1.84% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 612546 |
|  | BPCE SA |  |
| 1130000 | 5.39%, 05/28/2031, (5.39% fixed rate until <br> 05/28/2030; 6 mo. USD SOFR + 1.58% <br> thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1159912 |
| 1450000 | 5.88%, 01/14/2031, (5.88% fixed rate until <br> 01/14/2030; 6 mo. USD SOFR + 1.68% <br> thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1514651 |
| 508000 | 6.61%, 10/19/2027, (6.61% fixed rate until <br> 10/19/2026; 6 mo. USD SOFR + 1.98% <br> thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 517565 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

3 <br>

------

**Hartford Balanced HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** |
|  | **Commercial Banks - 3.0% - (continued)** | **Commercial Banks - 3.0% - (continued)** |
|  | Citigroup, Inc. |  |
| $635000 | 4.50%, 09/11/2031, (4.50% fixed rate until <br> 09/11/2030; 6 mo. USD SOFR + 1.17% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; $636965 |
| 1182000 | 4.95%, 05/07/2031, (4.95% fixed rate until <br> 05/07/2030; 6 mo. USD SOFR + 1.46% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1207277 |
| 400000 | 5.17%, 09/11/2036, (5.17% fixed rate until <br> 09/11/2035; 6 mo. USD SOFR + 1.49% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 403739 |
|  | Citizens Financial Group, Inc. |  |
| 455000 | 5.84%, 01/23/2030, (5.84% fixed rate until <br> 01/23/2029; 6 mo. USD SOFR + 2.01% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 474567 |
| 2100000 | 6.65%, 04/25/2035, (6.65% fixed rate until <br> 04/25/2034; 6 mo. USD SOFR + 2.33% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 2309100 |
| 2505000 | Commonwealth Bank of Australia 5.07%, <br> 09/14/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2588687 |
|  | Credit Agricole SA |  |
| 1540000 | 4.63%, 09/11/2028, (4.63% fixed rate until <br> 09/11/2027; 6 mo. USD SOFR + 1.21% <br> thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1551710 |
| 2733000 | 6.32%, 10/03/2029, (6.32% fixed rate until <br> 10/03/2028; 6 mo. USD SOFR + 1.86% <br> thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2880402 |
| 1150000 | Goldman Sachs Group, Inc. 6.25%, <br> 02/01/2041 | &nbsp;&nbsp;&nbsp; 1259155 |
|  | HSBC Holdings PLC |  |
| 550000 | 4.62%, 11/06/2031, (4.62% fixed rate until <br> 11/06/2030; 6 mo. USD SOFR + 1.19% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 551696 |
| 1130000 | 5.74%, 09/10/2036, (5.74% fixed rate until <br> 09/10/2035; 6 mo. USD SOFR + 1.96% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1163210 |
|  | JP Morgan Chase & Co. |  |
| 620000 | 2.52%, 04/22/2031, (2.52% fixed rate until <br> 04/22/2030; 6 mo. USD SOFR + 2.04% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 577547 |
| 390000 | 3.11%, 04/22/2041, (3.11% fixed rate until <br> 04/22/2040; 3 mo. USD Term SOFR + <br> 2.46% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 306203 |
| 705000 | 3.70%, 05/06/2030, (3.70% fixed rate until <br> 05/06/2029; 3 mo. USD Term SOFR + <br> 1.42% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 694386 |
| 805000 | 4.45%, 12/05/2029, (4.45% fixed rate until <br> 12/05/2028; 3 mo. USD Term SOFR + <br> 1.59% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 813295 |
| 463000 | 4.91%, 07/25/2033, (4.91% fixed rate until <br> 07/25/2032; 6 mo. USD SOFR + 2.08% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 471662 |
| 1389000 | 5.04%, 01/23/2028, (5.04% fixed rate until <br> 01/23/2027; 6 mo. USD SOFR + 1.19% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1403375 |
| 1335000 | 5.10%, 04/22/2031, (5.10% fixed rate until <br> 04/22/2030; 6 mo. USD SOFR + 1.44% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1378356 |
| 930000 | 5.14%, 01/24/2031, (5.14% fixed rate until <br> 01/24/2030; 6 mo. USD SOFR + 1.01% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 961242 |
| 1071000 | 5.57%, 04/22/2036, (5.57% fixed rate until <br> 04/22/2035; 6 mo. USD SOFR + 1.68% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1123649 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** |
|  | **Commercial Banks - 3.0% - (continued)** | **Commercial Banks - 3.0% - (continued)** |
| $1145000 | Lloyds Banking Group PLC 4.43%, <br> 11/04/2031, (4.43% fixed rate until <br> 11/04/2030; 1 yr. USD CMT + 0.82% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; $1141428 |
|  | Morgan Stanley |  |
| 1283000 | 4.65%, 10/18/2030, (4.65% fixed rate until <br> 10/18/2029; 6 mo. USD SOFR + 1.10% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1298521 |
| 925000 | 5.23%, 01/15/2031, (5.23% fixed rate until <br> 01/15/2030; 6 mo. USD SOFR + 1.11% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 954126 |
| 795000 | 5.59%, 01/18/2036, (5.59% fixed rate until <br> 01/18/2035; 6 mo. USD SOFR + 1.42% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 830763 |
|  | Morgan Stanley Private Bank NA |  |
| 1985000 | 4.20%, 11/17/2028, (4.20% fixed rate until <br> 11/17/2027; 6 mo. USD SOFR + 0.78% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1991201 |
| 1215000 | 4.47%, 11/19/2031, (4.47% fixed rate until <br> 11/19/2030; 6 mo. USD SOFR + 1.02% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1218181 |
| 550000 | 4.73%, 07/18/2031, (4.73% fixed rate until <br> 07/18/2030; 6 mo. USD SOFR + 1.08% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 557534 |
|  | Wells Fargo & Co. |  |
| 1750000 | 4.61%, 04/25/2053, (4.61% fixed rate until <br> 04/25/2052; 6 mo. USD SOFR + 2.13% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1505883 |
| 1352000 | 5.71%, 04/22/2028, (5.71% fixed rate until <br> 04/22/2027; 6 mo. USD SOFR + 1.07% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1379985 |
| 1665000 | 6.30%, 10/23/2029, (6.30% fixed rate until <br> 10/23/2028; 6 mo. USD SOFR + 1.79% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1759227 |
|  |  | &nbsp;&nbsp;&nbsp; 48829908 |
|  | **Commercial Services - 0.0%** | **Commercial Services - 0.0%** |
| 205000 | S&P Global, Inc. 4.80%, 12/04/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 204368 |
|  | **Diversified Financial Services - 0.7%** | **Diversified Financial Services - 0.7%** |
|  | American Express Co. |  |
| 1325000 | 4.92%, 07/20/2033, (4.92% fixed rate until <br> 07/20/2032; 6 mo. USD SOFR + 1.22% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1348448 |
| 3900000 | 5.28%, 07/27/2029, (5.28% fixed rate until <br> 07/27/2028; 6 mo. USD SOFR + 1.28% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 4016751 |
| 1649000 | 5.67%, 04/25/2036, (5.67% fixed rate until <br> 04/25/2035; 6 mo. USD SOFR + 1.79% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1741121 |
| 1715000 | Aviation Capital Group LLC 1.95%, <br> 09/20/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1687040 |
| 2615000 | Blackstone Holdings Finance Co. LLC 2.55%, <br> 03/30/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2320117 |
| 405000 | Equitable America Global Funding 3.95%, <br> 09/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 404371 |
|  |  | &nbsp;&nbsp;&nbsp; 11517848 |
|  | **Electric - 1.3%** | **Electric - 1.3%** |
| 120000 | Alabama Power Co. 5.10%, 04/02/2035 | &nbsp;&nbsp;&nbsp; 122832 |
|  | Arizona Public Service Co. |  |
| 500000 | 3.75%, 05/15/2046 | &nbsp;&nbsp;&nbsp; 378955 |
| 530000 | 5.90%, 08/15/2055 | &nbsp;&nbsp;&nbsp; 538867 |
| 1960000 | Cleveland Electric Illuminating Co. 3.50%, <br> 04/01/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1927701 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

4 <br>

------

**Hartford Balanced HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** |
|  | **Electric - 1.3% - (continued)** | **Electric - 1.3% - (continued)** |
|  | Consolidated Edison Co. of New York, Inc. |  |
| $650000 | 5.50%, 03/15/2055 | &nbsp;&nbsp;&nbsp; $630112 |
| 650000 | 5.70%, 05/15/2054 | &nbsp;&nbsp;&nbsp; 647901 |
|  | Duke Energy Corp. |  |
| 340000 | 4.95%, 09/15/2035 | &nbsp;&nbsp;&nbsp; 337147 |
| 2880000 | 5.70%, 09/15/2055 | &nbsp;&nbsp;&nbsp; 2798367 |
|  | FirstEnergy Pennsylvania Electric Co. |  |
| 241000 | 3.60%, 06/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 235811 |
| 60000 | 5.15%, 03/30/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 60142 |
| 75000 | 5.20%, 04/01/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 76572 |
|  | Georgia Power Co. |  |
| 756000 | 4.30%, 03/15/2042 | &nbsp;&nbsp;&nbsp; 661527 |
| 245000 | 4.75%, 09/01/2040 | &nbsp;&nbsp;&nbsp; 232303 |
| 826000 | 5.13%, 05/15/2052 | &nbsp;&nbsp;&nbsp; 770516 |
| 165000 | Ohio Edison Co. 4.95%, 12/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 168731 |
|  | Pacific Gas & Electric Co. |  |
| 560000 | 4.75%, 02/15/2044 | &nbsp;&nbsp;&nbsp; 472919 |
| 1573200 | 4.95%, 07/01/2050 | &nbsp;&nbsp;&nbsp; 1329719 |
| 1395000 | Public Service Co. of Oklahoma 5.45%, <br> 01/15/2036<sup>(4)</sup>  | &nbsp;&nbsp;&nbsp; 1430268 |
| 600000 | Public Service Electric & Gas Co. 3.65%, <br> 09/01/2042 | &nbsp;&nbsp;&nbsp; 480721 |
|  | SCE Recovery Funding LLC |  |
| 298342 | 0.86%, 11/15/2033 | &nbsp;&nbsp;&nbsp; 269692 |
| 220000 | 1.94%, 05/15/2040 | &nbsp;&nbsp;&nbsp; 171327 |
| 125000 | 2.51%, 11/15/2043 | &nbsp;&nbsp;&nbsp; 85359 |
| 1156000 | Sempra 4.13%, 04/01/2052, (4.13% fixed rate <br> until 01/01/2027; 5 yr. USD CMT + 2.87% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1132507 |
|  | Southern California Edison Co. |  |
| 1108000 | 4.00%, 04/01/2047 | &nbsp;&nbsp;&nbsp; 830885 |
| 968000 | 4.65%, 10/01/2043 | &nbsp;&nbsp;&nbsp; 823002 |
| 59000 | 6.20%, 09/15/2055 | &nbsp;&nbsp;&nbsp; 59278 |
| 1292502 | Texas Electric Market Stabilization Funding N <br> LLC 4.27%, 08/01/2036<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1287773 |
| 170000 | Trans-Allegheny Interstate Line Co. 5.00%, <br> 01/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 174635 |
|  | Virginia Electric & Power Co. |  |
| 1422000 | 4.90%, 09/15/2035 | &nbsp;&nbsp;&nbsp; 1415264 |
| 873000 | 5.60%, 09/15/2055 | &nbsp;&nbsp;&nbsp; 847895 |
|  |  | &nbsp;&nbsp;&nbsp; 20398728 |
|  | **Food - 0.5%** | **Food - 0.5%** |
|  | JBS USA Holding Lux SARL/JBS USA Food <br> Co./JBS Lux Co. SARL |  |
| 335000 | 3.00%, 05/15/2032 | &nbsp;&nbsp;&nbsp; 300713 |
| 1450000 | 5.75%, 04/01/2033 | &nbsp;&nbsp;&nbsp; 1514834 |
| 2578000 | 6.75%, 03/15/2034 | &nbsp;&nbsp;&nbsp; 2848175 |
|  | JBS USA Holding Lux SARL/JBS USA Foods <br> Group Holdings, Inc./JBS USA Food Co. |  |
| 540000 | 6.25%, 03/01/2056<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 537452 |
| 455000 | 6.38%, 04/15/2066<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 453033 |
|  | Mars, Inc. |  |
| 1510000 | 5.20%, 03/01/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1552023 |
| 848000 | 5.65%, 05/01/2045<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 854797 |
| 924000 | 5.70%, 05/01/2055<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 920422 |
|  |  | &nbsp;&nbsp;&nbsp; 8981449 |
|  | **Gas - 0.2%** | **Gas - 0.2%** |
| 500000 | CenterPoint Energy Resources Corp. 5.40%, <br> 07/01/2034 | &nbsp;&nbsp;&nbsp; 515443 |
|  | NiSource, Inc. |  |
| 1484000 | 5.35%, 07/15/2035 | &nbsp;&nbsp;&nbsp; 1517232 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** |
|  | **Gas - 0.2% - (continued)** | **Gas - 0.2% - (continued)** |
| $608000 | 5.85%, 04/01/2055 | &nbsp;&nbsp;&nbsp; $606084 |
| 455000 | Southern Co. Gas Capital Corp. 5.10%, <br> 09/15/2035 | &nbsp;&nbsp;&nbsp; 458486 |
|  |  | &nbsp;&nbsp;&nbsp; 3097245 |
|  | **Healthcare - Products - 0.0%** | **Healthcare - Products - 0.0%** |
| 200000 | Alcon Finance Corp. 5.75%, 12/06/2052<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 201922 |
|  | **Healthcare - Services - 0.2%** | **Healthcare - Services - 0.2%** |
|  | Ascension Health |  |
| 1056000 | 4.29%, 11/15/2030 | &nbsp;&nbsp;&nbsp; 1057639 |
| 250000 | 4.92%, 11/15/2035 | &nbsp;&nbsp;&nbsp; 250378 |
| 920000 | Providence St. Joseph Health Obligated <br> Group 5.40%, 10/01/2033 | &nbsp;&nbsp;&nbsp; 948484 |
| 175000 | Sutter Health 2.29%, 08/15/2030 | &nbsp;&nbsp;&nbsp; 160938 |
| 155000 | Toledo Hospital 5.75%, 11/15/2038 | &nbsp;&nbsp;&nbsp; 157185 |
| 430000 | UnitedHealth Group, Inc. 5.63%, 07/15/2054 | &nbsp;&nbsp;&nbsp; 421752 |
|  |  | &nbsp;&nbsp;&nbsp; 2996376 |
|  | **Household Products - 0.1%** | **Household Products - 0.1%** |
| 1108000 | Kenvue, Inc. 4.90%, 03/22/2033 | &nbsp;&nbsp;&nbsp; 1130613 |
|  | **Insurance - 1.2%** | **Insurance - 1.2%** |
|  | American International Group, Inc. |  |
| 437000 | 3.40%, 06/30/2030 | &nbsp;&nbsp;&nbsp; 421285 |
| 375000 | 4.38%, 06/30/2050 | &nbsp;&nbsp;&nbsp; 313010 |
| 390000 | 4.85%, 05/07/2030 | &nbsp;&nbsp;&nbsp; 399696 |
|  | Athene Global Funding |  |
| 2815000 | 2.50%, 03/24/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2703675 |
| 1280000 | 5.58%, 01/09/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1314847 |
| 1960000 | Brighthouse Financial Global Funding 5.65%, <br> 06/10/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2002836 |
| 355000 | CNO Global Funding 4.88%, 12/10/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 359560 |
| 1005000 | Fortitude Global Funding 4.63%, 10/06/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1005198 |
| 805000 | Liberty Mutual Group, Inc. 4.57%, <br> 02/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 808681 |
| 425000 | Lincoln Financial Global Funding 4.63%, <br> 05/28/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 429036 |
| 975000 | NLG Global Funding 4.35%, 09/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 962167 |
| 215000 | Pricoa Global Funding I 4.70%, 05/28/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 218792 |
|  | Protective Life Global Funding |  |
| 510000 | 4.80%, 06/05/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 518172 |
| 1375000 | 5.43%, 01/14/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1430303 |
|  | RGA Global Funding |  |
| 1645000 | 4.35%, 08/25/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1651961 |
| 370000 | 5.00%, 08/25/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 372803 |
| 1220000 | 5.25%, 01/09/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1260010 |
| 1010000 | 5.45%, 05/24/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1044991 |
| 2090000 | Sammons Financial Group Global Funding <br> 4.95%, 06/12/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2119619 |
|  |  | &nbsp;&nbsp;&nbsp; 19336642 |
|  | **Internet - 0.1%** | **Internet - 0.1%** |
|  | Meta Platforms, Inc. |  |
| 330000 | 4.60%, 11/15/2032 | &nbsp;&nbsp;&nbsp; 332653 |
| 815000 | 5.50%, 11/15/2045 | &nbsp;&nbsp;&nbsp; 791380 |
|  |  | &nbsp;&nbsp;&nbsp; 1124033 |
|  | **Media - 0.1%** | **Media - 0.1%** |
|  | Charter Communications <br> Operating LLC/Charter Communications <br> Operating Capital |  |
| 1050000 | 3.50%, 03/01/2042 | &nbsp;&nbsp;&nbsp; 728428 |
| 80000 | 5.85%, 12/01/2035<sup>(4)</sup>  | &nbsp;&nbsp;&nbsp; 79806 |
|  | Comcast Corp. |  |
| 170000 | 2.80%, 01/15/2051 | &nbsp;&nbsp;&nbsp; 98483 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

5 <br>

------

**Hartford Balanced HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** |
|  | **Media - 0.1% - (continued)** | **Media - 0.1% - (continued)** |
| $379000 | 2.89%, 11/01/2051 | &nbsp;&nbsp;&nbsp; $221637 |
| 64000 | 4.00%, 11/01/2049 | &nbsp;&nbsp;&nbsp; 47192 |
|  |  | &nbsp;&nbsp;&nbsp; 1175546 |
|  | **Mining - 0.5%** | **Mining - 0.5%** |
|  | Anglo American Capital PLC |  |
| 2645000 | 2.63%, 09/10/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2437881 |
| 632000 | 4.50%, 03/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 635610 |
| 746000 | 4.75%, 04/10/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 751716 |
|  | Glencore Funding LLC |  |
| 805000 | 5.37%, 04/04/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 830779 |
| 563000 | 5.89%, 04/04/2054<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 560055 |
| 265000 | 6.14%, 04/01/2055<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 273465 |
| 3073000 | 6.38%, 10/06/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 3307127 |
|  |  | &nbsp;&nbsp;&nbsp; 8796633 |
|  | **Oil & Gas - 0.1%** | **Oil & Gas - 0.1%** |
|  | QatarEnergy |  |
| 780000 | 3.13%, 07/12/2041<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 600642 |
| 550000 | 3.30%, 07/12/2051<sup>(5)</sup>  | &nbsp;&nbsp;&nbsp; 385385 |
| 1085000 | Saudi Arabian Oil Co. 6.38%, 06/02/2055<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1134538 |
|  |  | &nbsp;&nbsp;&nbsp; 2120565 |
|  | **Pipelines - 0.6%** | **Pipelines - 0.6%** |
|  | Columbia Pipelines Holding Co. LLC |  |
| 140000 | 5.00%, 11/17/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 139988 |
| 305000 | 5.68%, 01/15/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 314250 |
|  | Columbia Pipelines Operating Co. LLC |  |
| 1179000 | 6.50%, 08/15/2043<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1245502 |
| 419000 | 6.54%, 11/15/2053<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 446157 |
|  | Enbridge, Inc. |  |
| 395000 | 4.90%, 06/20/2030 | &nbsp;&nbsp;&nbsp; 403810 |
| 400000 | 5.55%, 06/20/2035 | &nbsp;&nbsp;&nbsp; 413840 |
| 957000 | Energy Transfer LP 5.35%, 05/15/2045 | &nbsp;&nbsp;&nbsp; 865486 |
| 1450819 | Galaxy Pipeline Assets Bidco Ltd. 2.16%, <br> 03/31/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1313109 |
| 100000 | Gray Oak Pipeline LLC 3.45%, 10/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 98832 |
|  | Greensaif Pipelines Bidco SARL |  |
| 920000 | 5.85%, 02/23/2036<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 961233 |
| 1796000 | 6.10%, 08/23/2042<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1869718 |
|  | Whistler Pipeline LLC |  |
| 1454000 | 5.40%, 09/30/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1498893 |
| 995000 | 5.70%, 09/30/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1032616 |
|  |  | &nbsp;&nbsp;&nbsp; 10603434 |
|  | **Real Estate - 0.2%** | **Real Estate - 0.2%** |
| 3480000 | CBRE Services, Inc. 4.90%, 01/15/2033 | &nbsp;&nbsp;&nbsp; 3496719 |
|  | **Real Estate Investment Trusts - 1.2%** | **Real Estate Investment Trusts - 1.2%** |
| 2410000 | American Tower Trust I 5.49%, 03/15/2053<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2450357 |
|  | Crown Castle, Inc. |  |
| 1382000 | 5.00%, 01/11/2028 | &nbsp;&nbsp;&nbsp; 1403595 |
| 633000 | 5.10%, 05/01/2033 | &nbsp;&nbsp;&nbsp; 638330 |
| 891000 | 5.20%, 09/01/2034 | &nbsp;&nbsp;&nbsp; 900073 |
|  | Extra Space Storage LP |  |
| 330000 | 4.95%, 01/15/2033 | &nbsp;&nbsp;&nbsp; 333571 |
| 1451000 | 5.40%, 06/15/2035 | &nbsp;&nbsp;&nbsp; 1487487 |
| 935000 | 5.90%, 01/15/2031 | &nbsp;&nbsp;&nbsp; 991352 |
|  | GLP Capital LP/GLP Financing II, Inc. |  |
| 2200000 | 3.25%, 01/15/2032 | &nbsp;&nbsp;&nbsp; 1990470 |
| 395000 | 5.25%, 02/15/2033 | &nbsp;&nbsp;&nbsp; 396431 |
| 1789000 | 6.75%, 12/01/2033 | &nbsp;&nbsp;&nbsp; 1944418 |
|  | Kilroy Realty LP |  |
| 756000 | 2.65%, 11/15/2033 | &nbsp;&nbsp;&nbsp; 620253 |
| 410000 | 3.05%, 02/15/2030 | &nbsp;&nbsp;&nbsp; 381234 |
| 640000 | 5.88%, 10/15/2035 | &nbsp;&nbsp;&nbsp; 642934 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** | **CORPORATE BONDS - 11.1% - (continued)** |
|  | **Real Estate Investment Trusts - 1.2% - (continued)** | **Real Estate Investment Trusts - 1.2% - (continued)** |
| $195000 | Kite Realty Group LP 5.20%, 08/15/2032 | &nbsp;&nbsp;&nbsp; $199227 |
| 672000 | LXP Industrial Trust 6.75%, 11/15/2028 | &nbsp;&nbsp;&nbsp; 713130 |
| 1504000 | Prologis Targeted U.S. Logistics Fund LP <br> 5.25%, 01/15/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1530578 |
| 1116000 | Realty Income Corp. 5.13%, 04/15/2035 | &nbsp;&nbsp;&nbsp; 1135166 |
|  | SBA Tower Trust |  |
| 545000 | 1.63%, 05/15/2051<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 533223 |
| 300000 | 1.88%, 07/15/2050<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 299666 |
|  | WEA Finance LLC |  |
| 160000 | 2.88%, 01/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 157476 |
| 350000 | 3.50%, 06/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 338664 |
|  |  | &nbsp;&nbsp;&nbsp; 19087635 |
|  | **Semiconductors - 0.3%** | **Semiconductors - 0.3%** |
|  | Foundry JV Holdco LLC |  |
| 305000 | 5.90%, 01/25/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 318992 |
| 389000 | 5.90%, 01/25/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 407029 |
| 1211000 | 6.20%, 01/25/2037<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1272521 |
| 200000 | 6.25%, 01/25/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 212078 |
| 200000 | 6.40%, 01/25/2038<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 213335 |
| 1936000 | Intel Corp. 4.60%, 03/25/2040 | &nbsp;&nbsp;&nbsp; 1726659 |
|  |  | &nbsp;&nbsp;&nbsp; 4150614 |
|  | **Software - 0.1%** | **Software - 0.1%** |
| 1975000 | Oracle Corp. 3.60%, 04/01/2050 | &nbsp;&nbsp;&nbsp; 1230249 |
|  | **Telecommunications - 0.2%** | **Telecommunications - 0.2%** |
|  | AT&T, Inc. |  |
| 267000 | 4.35%, 06/15/2045 | &nbsp;&nbsp;&nbsp; 220301 |
| 1295000 | 4.55%, 11/01/2032 | &nbsp;&nbsp;&nbsp; 1286579 |
| 1320000 | 5.55%, 11/01/2045 | &nbsp;&nbsp;&nbsp; 1271195 |
|  |  | &nbsp;&nbsp;&nbsp; 2778075 |
|  | **Trucking & Leasing - 0.0%** | **Trucking & Leasing - 0.0%** |
| 775000 | Penske Truck Leasing Co. LP/PTL Finance <br> Corp. 5.25%, 02/01/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 798029 |
|  | Total Corporate Bonds <br>(cost $178,570,451) | &nbsp;&nbsp;&nbsp; $179974662 |
| **FOREIGN GOVERNMENT OBLIGATIONS - 0.2%** | **FOREIGN GOVERNMENT OBLIGATIONS - 0.2%** | **FOREIGN GOVERNMENT OBLIGATIONS - 0.2%** |
|  | **Israel - 0.1%** | **Israel - 0.1%** |
| 1630000 | Israel Government International Bonds 5.38%, <br> 03/12/2029 | &nbsp;&nbsp;&nbsp; $1677473 |
|  | **Saudi Arabia - 0.1%** | **Saudi Arabia - 0.1%** |
| 2015000 | Saudi Government International Bonds 5.38%, <br> 01/13/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2111032 |
|  | Total Foreign Government Obligations <br>(cost $3,629,715)<br>| &nbsp;&nbsp;&nbsp; $3788505 |
| **MUNICIPAL BONDS - 0.6%** | **MUNICIPAL BONDS - 0.6%** | **MUNICIPAL BONDS - 0.6%** |
|  | **Airport - 0.0%** | **Airport - 0.0%** |
| 60000 | Dallas Fort Worth International Airport, TX, <br> Rev 4.09%, 11/01/2051 | &nbsp;&nbsp;&nbsp; $49205 |
| 710000 | Port Auth of New York & New Jersey, NY, Rev <br> 3.18%, 07/15/2060 | &nbsp;&nbsp;&nbsp; 456488 |
|  |  | &nbsp;&nbsp;&nbsp; 505693 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

6 <br>

------

**Hartford Balanced HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **MUNICIPAL BONDS - 0.6% - (continued)** | **MUNICIPAL BONDS - 0.6% - (continued)** | **MUNICIPAL BONDS - 0.6% - (continued)** |
|  | **General - 0.1%** | **General - 0.1%** |
| $162831 | Chicago Transit Auth Sales & Transfer Tax <br> Receipts, IL, Rev 6.90%, 12/01/2040 | &nbsp;&nbsp;&nbsp; $182775 |
| 540000 | Kansas Dev Finance Auth, KS, Rev, (BAM) <br> 2.77%, 05/01/2051 | &nbsp;&nbsp;&nbsp; 385950 |
| 1250000 | Philadelphia Auth for Industrial Dev, PA, Rev, <br> (NPFG) 6.55%, 10/15/2028 | &nbsp;&nbsp;&nbsp; 1329085 |
|  |  | &nbsp;&nbsp;&nbsp; 1897810 |
|  | **General Obligation - 0.3%** | **General Obligation - 0.3%** |
| 4436912 | State of Illinois, IL, GO 5.10%, 06/01/2033 | &nbsp;&nbsp;&nbsp; 4547256 |
|  | **Tobacco - 0.0%** | **Tobacco - 0.0%** |
| 115000 | Golden State Tobacco Securitization Corp., <br> CA, Rev, (ST APPROP) 3.00%, 06/01/2046 | &nbsp;&nbsp;&nbsp; 104423 |
|  | **Transportation - 0.1%** | **Transportation - 0.1%** |
|  | Metropolitan Transportation Auth, NY, Rev |  |
| 375000 | 6.67%, 11/15/2039 | &nbsp;&nbsp;&nbsp; 408260 |
| 390000 | 6.81%, 11/15/2040 | &nbsp;&nbsp;&nbsp; 435262 |
|  |  | &nbsp;&nbsp;&nbsp; 843522 |
|  | **Utilities - 0.0%** | **Utilities - 0.0%** |
| 774509 | Texas Natural Gas Securitization Finance <br> Corp., TX, Rev 5.10%, 04/01/2035 | &nbsp;&nbsp;&nbsp; 795070 |
|  | **Utility - Electric - 0.1%** | **Utility - Electric - 0.1%** |
| 305000 | Illinois Municipal Electric Agency, IL, Rev <br> 6.83%, 02/01/2035 | &nbsp;&nbsp;&nbsp; 320996 |
| 802000 | Municipal Electric Auth of Georgia, GA, Rev <br> 6.64%, 04/01/2057 | &nbsp;&nbsp;&nbsp; 867322 |
|  |  | &nbsp;&nbsp;&nbsp; 1188318 |
|  | Total Municipal Bonds <br>(cost $10,449,316)<br>| &nbsp;&nbsp;&nbsp; $9882092 |
| **U.S. GOVERNMENT AGENCIES - 1.0%** | **U.S. GOVERNMENT AGENCIES - 1.0%** | **U.S. GOVERNMENT AGENCIES - 1.0%** |
|  | **Mortgage-Backed Agencies - 1.0%** | **Mortgage-Backed Agencies - 1.0%** |
|  | **Federal Home Loan Mortgage Corp. - 0.0%** | **Federal Home Loan Mortgage Corp. - 0.0%** |
| 203 | 6.44%, 04/01/2029, 1 yr. USD CMT + <br> 2.28%<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; $203 |
|  | **Federal National Mortgage Association - 0.9%** | **Federal National Mortgage Association - 0.9%** |
| 2520000 | 4.20%, 10/01/2030 | &nbsp;&nbsp;&nbsp; 2532895 |
| 2270000 | 4.34%, 08/01/2030 | &nbsp;&nbsp;&nbsp; 2288243 |
| 2650000 | 4.40%, 09/01/2030 | &nbsp;&nbsp;&nbsp; 2679978 |
| 2611000 | 4.42%, 08/01/2030 | &nbsp;&nbsp;&nbsp; 2640791 |
| 2310000 | 4.47%, 05/01/2030 | &nbsp;&nbsp;&nbsp; 2337634 |
| 1304000 | 4.60%, 04/01/2030 | &nbsp;&nbsp;&nbsp; 1331475 |
|  |  | &nbsp;&nbsp;&nbsp; 13811016 |
|  | **Government National Mortgage Association - 0.1%** | **Government National Mortgage Association - 0.1%** |
| 1746243 | 2.50%, 10/20/2049 | &nbsp;&nbsp;&nbsp; 1572265 |
| 23295 | 5.00%, 07/15/2037 | &nbsp;&nbsp;&nbsp; 23931 |
| 289 | 6.00%, 03/15/2028 | &nbsp;&nbsp;&nbsp; 292 |
| 289 | 6.00%, 04/15/2028 | &nbsp;&nbsp;&nbsp; 294 |
| 4466 | 6.00%, 05/15/2028 | &nbsp;&nbsp;&nbsp; 4530 |
| 2869 | 6.00%, 07/15/2028 | &nbsp;&nbsp;&nbsp; 2945 |
| 1053 | 6.00%, 08/15/2028 | &nbsp;&nbsp;&nbsp; 1090 |
| 4890 | 6.00%, 09/15/2028 | &nbsp;&nbsp;&nbsp; 4981 |
| 16043 | 6.00%, 10/15/2028 | &nbsp;&nbsp;&nbsp; 16167 |
| 15290 | 6.00%, 11/15/2028 | &nbsp;&nbsp;&nbsp; 15567 |
| 11331 | 6.00%, 12/15/2028 | &nbsp;&nbsp;&nbsp; 11561 |
| 303 | 6.00%, 12/15/2031 | &nbsp;&nbsp;&nbsp; 310 |
| 4363 | 6.00%, 09/15/2032 | &nbsp;&nbsp;&nbsp; 4449 |
| 2623 | 6.00%, 11/15/2032 | &nbsp;&nbsp;&nbsp; 2684 |
| 1198 | 6.00%, 04/15/2033 | &nbsp;&nbsp;&nbsp; 1208 |
| 30250 | 6.00%, 06/15/2033 | &nbsp;&nbsp;&nbsp; 31002 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 1.0% - (continued)** | **U.S. GOVERNMENT AGENCIES - 1.0% - (continued)** | **U.S. GOVERNMENT AGENCIES - 1.0% - (continued)** |
|  | **Mortgage-Backed Agencies - 1.0% - (continued)** | **Mortgage-Backed Agencies - 1.0% - (continued)** |
|  | **Government National Mortgage Association - 0.1% - (continued)** | **Government National Mortgage Association - 0.1% - (continued)** |
| $8306 | 6.00%, 10/15/2033 | &nbsp;&nbsp;&nbsp; $8698 |
| 681 | 6.00%, 11/15/2033 | &nbsp;&nbsp;&nbsp; 720 |
| 15070 | 6.00%, 10/15/2034 | &nbsp;&nbsp;&nbsp; 15350 |
| 38913 | 6.00%, 01/15/2035 | &nbsp;&nbsp;&nbsp; 40133 |
| 4339 | 6.00%, 05/15/2035 | &nbsp;&nbsp;&nbsp; 4377 |
| 4086 | 6.00%, 06/15/2035 | &nbsp;&nbsp;&nbsp; 4215 |
| 4 | 6.50%, 03/15/2026 | &nbsp;&nbsp;&nbsp; 4 |
| 8 | 6.50%, 01/15/2028 | &nbsp;&nbsp;&nbsp; 8 |
| 8187 | 6.50%, 03/15/2028 | &nbsp;&nbsp;&nbsp; 8438 |
| 8061 | 6.50%, 04/15/2028 | &nbsp;&nbsp;&nbsp; 8190 |
| 3329 | 6.50%, 05/15/2028 | &nbsp;&nbsp;&nbsp; 3431 |
| 9408 | 6.50%, 06/15/2028 | &nbsp;&nbsp;&nbsp; 9596 |
| 1669 | 6.50%, 10/15/2028 | &nbsp;&nbsp;&nbsp; 1719 |
| 383 | 6.50%, 02/15/2035 | &nbsp;&nbsp;&nbsp; 397 |
| 528 | 7.00%, 11/15/2031 | &nbsp;&nbsp;&nbsp; 538 |
| 300 | 7.00%, 03/15/2032 | &nbsp;&nbsp;&nbsp; 306 |
| 252505 | 7.00%, 11/15/2032 | &nbsp;&nbsp;&nbsp; 265834 |
| 20536 | 7.00%, 01/15/2033 | &nbsp;&nbsp;&nbsp; 21330 |
| 23577 | 7.00%, 05/15/2033 | &nbsp;&nbsp;&nbsp; 24364 |
| 2686 | 7.00%, 07/15/2033 | &nbsp;&nbsp;&nbsp; 2777 |
| 27256 | 7.00%, 11/15/2033 | &nbsp;&nbsp;&nbsp; 28193 |
| 8609 | 7.50%, 09/16/2035 | &nbsp;&nbsp;&nbsp; 8587 |
| 2 | 8.00%, 09/15/2026 | &nbsp;&nbsp;&nbsp; 2 |
| 143 | 8.00%, 12/15/2026 | &nbsp;&nbsp;&nbsp; 143 |
| 279 | 8.00%, 07/15/2029 | &nbsp;&nbsp;&nbsp; 284 |
| 334 | 8.00%, 12/15/2029 | &nbsp;&nbsp;&nbsp; 343 |
| 1885 | 8.00%, 01/15/2030 | &nbsp;&nbsp;&nbsp; 1918 |
| 818 | 8.00%, 02/15/2030 | &nbsp;&nbsp;&nbsp; 828 |
| 364 | 8.00%, 03/15/2030 | &nbsp;&nbsp;&nbsp; 368 |
| 2432 | 8.00%, 04/15/2030 | &nbsp;&nbsp;&nbsp; 2461 |
| 1899 | 8.00%, 05/15/2030 | &nbsp;&nbsp;&nbsp; 1933 |
| 8207 | 8.00%, 06/15/2030 | &nbsp;&nbsp;&nbsp; 8377 |
| 549 | 8.00%, 07/15/2030 | &nbsp;&nbsp;&nbsp; 556 |
| 16445 | 8.00%, 08/15/2030 | &nbsp;&nbsp;&nbsp; 16789 |
| 7566 | 8.00%, 09/15/2030 | &nbsp;&nbsp;&nbsp; 7703 |
| 18304 | 8.00%, 12/15/2030 | &nbsp;&nbsp;&nbsp; 18659 |
|  |  | &nbsp;&nbsp;&nbsp; 2210845 |
|  | Total U.S. Government Agencies <br>(cost $15,822,569)<br>| &nbsp;&nbsp;&nbsp; $16022064 |
| **U.S. GOVERNMENT SECURITIES - 19.8%** | **U.S. GOVERNMENT SECURITIES - 19.8%** | **U.S. GOVERNMENT SECURITIES - 19.8%** |
|  | **U.S. Treasury Securities - 19.8%** | **U.S. Treasury Securities - 19.8%** |
|  | **U.S. Treasury Bonds - 6.1%** | **U.S. Treasury Bonds - 6.1%** |
| 2781200 | 2.38%, 05/15/2051 | &nbsp;&nbsp;&nbsp; $1752699 |
| 4659200 | 2.50%, 02/15/2045 | &nbsp;&nbsp;&nbsp; 3299660 |
| 2041900 | 2.75%, 11/15/2047 | &nbsp;&nbsp;&nbsp; 1454614 |
| 5152000 | 2.88%, 05/15/2052 | &nbsp;&nbsp;&nbsp; 3599960 |
| 400000 | 3.25%, 05/15/2042 | &nbsp;&nbsp;&nbsp; 333594 |
| 4488500 | 3.38%, 08/15/2042 | &nbsp;&nbsp;&nbsp; 3792783 |
| 4012200 | 3.63%, 02/15/2053 | &nbsp;&nbsp;&nbsp; 3248315 |
| 2560100 | 3.63%, 05/15/2053 | &nbsp;&nbsp;&nbsp; 2070981 |
| 5250000 | 3.88%, 02/15/2043 | &nbsp;&nbsp;&nbsp; 4722949 |
| 4748300 | 3.88%, 05/15/2043 | &nbsp;&nbsp;&nbsp; 4259559 |
| 6040000 | 4.00%, 11/15/2042 | &nbsp;&nbsp;&nbsp; 5536037 |
| 4436100 | 4.00%, 11/15/2052 | &nbsp;&nbsp;&nbsp; 3846757 |
| 3288900 | 4.13%, 08/15/2044 | &nbsp;&nbsp;&nbsp; 3018465 |
| 2696900 | 4.13%, 08/15/2053 | &nbsp;&nbsp;&nbsp; 2387389 |
| 1499700 | 4.25%, 02/15/2054 | &nbsp;&nbsp;&nbsp; 1355823 |
| 3289300 | 4.25%, 08/15/2054 | &nbsp;&nbsp;&nbsp; 2973990 |
| 6600000 | 4.38%, 11/15/2039 | &nbsp;&nbsp;&nbsp; 6511055 |
| 5725900 | 4.38%, 08/15/2043 | &nbsp;&nbsp;&nbsp; 5469353 |
| 3865900 | 4.50%, 02/15/2044 | &nbsp;&nbsp;&nbsp; 3739956 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

7 <br>

------

**Hartford Balanced HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT SECURITIES - 19.8% - (continued)** | **U.S. GOVERNMENT SECURITIES - 19.8% - (continued)** | **U.S. GOVERNMENT SECURITIES - 19.8% - (continued)** |
|  | **U.S. Treasury Securities - 19.8% - (continued)** | **U.S. Treasury Securities - 19.8% - (continued)** |
|  | **U.S. Treasury Bonds - 6.1% - (continued)** | **U.S. Treasury Bonds - 6.1% - (continued)** |
| $2720600 | 4.50%, 11/15/2054 | &nbsp;&nbsp;&nbsp; $2566078 |
| 1295700 | 4.63%, 05/15/2044 | &nbsp;&nbsp;&nbsp; 1272114 |
| 3720800 | 4.63%, 11/15/2044 | &nbsp;&nbsp;&nbsp; 3646093 |
| 1572500 | 4.63%, 11/15/2045 | &nbsp;&nbsp;&nbsp; 1536627 |
| 2765000 | 4.63%, 05/15/2054 | &nbsp;&nbsp;&nbsp; 2662933 |
| 1329600 | 4.63%, 02/15/2055 | &nbsp;&nbsp;&nbsp; 1280727 |
| 3065700 | 4.63%, 11/15/2055 | &nbsp;&nbsp;&nbsp; 2953610 |
| 3964000 | 4.75%, 11/15/2043 | &nbsp;&nbsp;&nbsp; 3964465 |
| 367200 | 4.75%, 02/15/2045 | &nbsp;&nbsp;&nbsp; 365335 |
| 3955400 | 4.75%, 11/15/2053 | &nbsp;&nbsp;&nbsp; 3882936 |
| 1570100 | 4.75%, 05/15/2055 | &nbsp;&nbsp;&nbsp; 1542869 |
| 3226800 | 4.75%, 08/15/2055 | &nbsp;&nbsp;&nbsp; 3172348 |
| 3135300 | 4.88%, 08/15/2045 | &nbsp;&nbsp;&nbsp; 3165673 |
| 3511200 | 5.00%, 05/15/2045 | &nbsp;&nbsp;&nbsp; 3604466 |
|  |  | &nbsp;&nbsp;&nbsp; 98990213 |
|  | **U.S. Treasury Notes - 13.7%** | **U.S. Treasury Notes - 13.7%** |
| 590000 | 2.63%, 07/31/2029 | &nbsp;&nbsp;&nbsp; 570595 |
| 890000 | 2.75%, 05/31/2029 | &nbsp;&nbsp;&nbsp; 866151 |
| 326000 | 3.25%, 06/30/2029 | &nbsp;&nbsp;&nbsp; 322282 |
| 2799600 | 3.38%, 11/30/2027 | &nbsp;&nbsp;&nbsp; 2794241 |
| 4492800 | 3.38%, 12/31/2027 | &nbsp;&nbsp;&nbsp; 4484025 |
| 2265200 | 3.50%, 09/30/2027 | &nbsp;&nbsp;&nbsp; 2265642 |
| 14227800 | 3.50%, 10/31/2027 | &nbsp;&nbsp;&nbsp; 14231135 |
| 5186200 | 3.50%, 09/30/2029 | &nbsp;&nbsp;&nbsp; 5162092 |
| 635000 | 3.50%, 04/30/2030 | &nbsp;&nbsp;&nbsp; 630411 |
| 6423300 | 3.50%, 11/30/2030 | &nbsp;&nbsp;&nbsp; 6358565 |
| 12254300 | 3.63%, 08/31/2027 | &nbsp;&nbsp;&nbsp; 12281585 |
| 5696100 | 3.63%, 08/31/2029 | &nbsp;&nbsp;&nbsp; 5695210 |
| 512000 | 3.63%, 03/31/2030 | &nbsp;&nbsp;&nbsp; 511040 |
| 10285100 | 3.63%, 08/31/2030 | &nbsp;&nbsp;&nbsp; 10248540 |
| 4379200 | 3.63%, 09/30/2030 | &nbsp;&nbsp;&nbsp; 4362265 |
| 8518100 | 3.63%, 10/31/2030 | &nbsp;&nbsp;&nbsp; 8482164 |
| 258600 | 3.63%, 09/30/2031 | &nbsp;&nbsp;&nbsp; 256014 |
| 7242600 | 3.75%, 04/30/2027 | &nbsp;&nbsp;&nbsp; 7265233 |
| 6588100 | 3.75%, 06/30/2027 | &nbsp;&nbsp;&nbsp; 6613577 |
| 3510900 | 3.75%, 08/15/2027 | &nbsp;&nbsp;&nbsp; 3525437 |
| 3224200 | 3.75%, 05/15/2028 | &nbsp;&nbsp;&nbsp; 3241706 |
| 620000 | 3.75%, 05/31/2030 | &nbsp;&nbsp;&nbsp; 621526 |
| 758000 | 3.75%, 12/31/2030 | &nbsp;&nbsp;&nbsp; 758385 |
| 544900 | 3.75%, 08/31/2031 | &nbsp;&nbsp;&nbsp; 543091 |
| 390600 | 3.75%, 10/31/2032 | &nbsp;&nbsp;&nbsp; 386267 |
| 867200 | 3.75%, 11/30/2032 | &nbsp;&nbsp;&nbsp; 857173 |
| 5438000 | 3.88%, 03/31/2027 | &nbsp;&nbsp;&nbsp; 5461579 |
| 1368400 | 3.88%, 05/31/2027 | &nbsp;&nbsp;&nbsp; 1375402 |
| 8590100 | 3.88%, 07/31/2027 | &nbsp;&nbsp;&nbsp; 8640097 |
| 685000 | 3.88%, 11/30/2029 | &nbsp;&nbsp;&nbsp; 690726 |
| 4451400 | 3.88%, 04/30/2030 | &nbsp;&nbsp;&nbsp; 4486177 |
| 5772100 | 3.88%, 06/30/2030 | &nbsp;&nbsp;&nbsp; 5815616 |
| 3949500 | 3.88%, 07/31/2030 | &nbsp;&nbsp;&nbsp; 3978658 |
| 2332600 | 3.88%, 08/31/2032 | &nbsp;&nbsp;&nbsp; 2326495 |
| 5718700 | 4.00%, 07/31/2029 | &nbsp;&nbsp;&nbsp; 5792641 |
| 150000 | 4.00%, 10/31/2029 | &nbsp;&nbsp;&nbsp; 151963 |
| 1488300 | 4.00%, 02/28/2030 | &nbsp;&nbsp;&nbsp; 1507253 |
| 5910000 | 4.00%, 03/31/2030 | &nbsp;&nbsp;&nbsp; 5985260 |
| 3432700 | 4.00%, 05/31/2030 | &nbsp;&nbsp;&nbsp; 3476413 |
| 483900 | 4.00%, 07/31/2030 | &nbsp;&nbsp;&nbsp; 490043 |
| 891300 | 4.00%, 06/30/2032 | &nbsp;&nbsp;&nbsp; 896418 |
| 3071900 | 4.00%, 07/31/2032 | &nbsp;&nbsp;&nbsp; 3087980 |
| 6390100 | 4.00%, 11/15/2035 | &nbsp;&nbsp;&nbsp; 6298242 |
| 4580600 | 4.13%, 03/31/2029 | &nbsp;&nbsp;&nbsp; 4656466 |
| 5031800 | 4.13%, 10/31/2029 | &nbsp;&nbsp;&nbsp; 5117891 |
| 5728100 | 4.13%, 11/30/2029 | &nbsp;&nbsp;&nbsp; 5826999 |
| 754300 | 4.13%, 08/31/2030 | &nbsp;&nbsp;&nbsp; 767559 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT SECURITIES - 19.8% - (continued)** | **U.S. GOVERNMENT SECURITIES - 19.8% - (continued)** | **U.S. GOVERNMENT SECURITIES - 19.8% - (continued)** |
|  | **U.S. Treasury Securities - 19.8% - (continued)** | **U.S. Treasury Securities - 19.8% - (continued)** |
|  | **U.S. Treasury Notes - 13.7% - (continued)** | **U.S. Treasury Notes - 13.7% - (continued)** |
| $913100 | 4.13%, 07/31/2031 | &nbsp;&nbsp;&nbsp; $927938 |
| 824200 | 4.13%, 10/31/2031 | &nbsp;&nbsp;&nbsp; 836885 |
| 497800 | 4.13%, 03/31/2032 | &nbsp;&nbsp;&nbsp; 504625 |
| 1790400 | 4.13%, 05/31/2032 | &nbsp;&nbsp;&nbsp; 1813899 |
| 2697800 | 4.25%, 06/30/2029 | &nbsp;&nbsp;&nbsp; 2754812 |
| 3448800 | 4.25%, 01/31/2030 | &nbsp;&nbsp;&nbsp; 3525455 |
| 1487500 | 4.25%, 11/15/2034 | &nbsp;&nbsp;&nbsp; 1503130 |
| 2085300 | 4.25%, 05/15/2035 | &nbsp;&nbsp;&nbsp; 2102569 |
| 3720900 | 4.25%, 08/15/2035 | &nbsp;&nbsp;&nbsp; 3747644 |
| 4392000 | 4.38%, 12/31/2029 | &nbsp;&nbsp;&nbsp; 4509349 |
| 170000 | 4.38%, 01/31/2032 | &nbsp;&nbsp;&nbsp; 174728 |
| 6392700 | 4.50%, 05/31/2029 | &nbsp;&nbsp;&nbsp; 6576490 |
| 988400 | 4.50%, 12/31/2031 | &nbsp;&nbsp;&nbsp; 1022840 |
| 3654600 | 4.63%, 04/30/2029 | &nbsp;&nbsp;&nbsp; 3772661 |
| 1733700 | 4.63%, 04/30/2031 | &nbsp;&nbsp;&nbsp; 1804606 |
| 1012100 | 4.63%, 05/31/2031 | &nbsp;&nbsp;&nbsp; 1053454 |
| 3671600 | 4.63%, 02/15/2035 | &nbsp;&nbsp;&nbsp; 3811150 |
| 927000 | 4.88%, 10/31/2030 | &nbsp;&nbsp;&nbsp; 973785 |
|  |  | &nbsp;&nbsp;&nbsp; 221580250 |
|  | Total U.S. Government Securities <br>(cost $325,315,016)<br>| &nbsp;&nbsp;&nbsp; $320570463 |
| **COMMON STOCKS - 64.9%** | **COMMON STOCKS - 64.9%** | **COMMON STOCKS - 64.9%** |
|  | **Automobiles & Components - 0.6%** | **Automobiles & Components - 0.6%** |
| 450990 | Gentex Corp. | &nbsp;&nbsp;&nbsp; $10494537 |
|  | **Banks - 2.5%** | **Banks - 2.5%** |
| 82508 | JP Morgan Chase & Co. | &nbsp;&nbsp;&nbsp; 26585728 |
| 71163 | M&T Bank Corp. | &nbsp;&nbsp;&nbsp; 14337921 |
|  |  | &nbsp;&nbsp;&nbsp; 40923649 |
|  | **Capital Goods - 5.7%** | **Capital Goods - 5.7%** |
| 68724 | 3M Co. | &nbsp;&nbsp;&nbsp; 11002712 |
| 111637 | Emerson Electric Co. | &nbsp;&nbsp;&nbsp; 14816463 |
| 56236 | Ferguson Enterprises, Inc. | &nbsp;&nbsp;&nbsp; 12519821 |
| 114406 | Johnson Controls International PLC | &nbsp;&nbsp;&nbsp; 13700118 |
| 50017 | L3Harris Technologies, Inc. | &nbsp;&nbsp;&nbsp; 14683491 |
| 69858 | Middleby Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10385789 |
| 135198 | PACCAR, Inc. | &nbsp;&nbsp;&nbsp; 14805533 |
|  |  | &nbsp;&nbsp;&nbsp; 91913927 |
|  | **Consumer Discretionary Distribution & Retail - 2.5%** | **Consumer Discretionary Distribution & Retail - 2.5%** |
| 67761 | Dick's Sporting Goods, Inc. | &nbsp;&nbsp;&nbsp; 13414645 |
| 249679 | Industria de Diseno Textil SA | &nbsp;&nbsp;&nbsp; 16469991 |
| 208536 | Tractor Supply Co. | &nbsp;&nbsp;&nbsp; 10428885 |
|  |  | &nbsp;&nbsp;&nbsp; 40313521 |
|  | **Consumer Services - 1.4%** | **Consumer Services - 1.4%** |
| 104901 | Airbnb, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 14237164 |
| 207562 | H&R Block, Inc. | &nbsp;&nbsp;&nbsp; 9045552 |
|  |  | &nbsp;&nbsp;&nbsp; 23282716 |
|  | **Energy - 2.6%** | **Energy - 2.6%** |
| 368766 | Antero Resources Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 12707676 |
| 125158 | ConocoPhillips | &nbsp;&nbsp;&nbsp; 11716040 |
| 95041 | Targa Resources Corp. | &nbsp;&nbsp;&nbsp; 17535065 |
|  |  | &nbsp;&nbsp;&nbsp; 41958781 |
|  | **Equity Real Estate Investment Trusts (REITs) - 1.4%** | **Equity Real Estate Investment Trusts (REITs) - 1.4%** |
| 150653 | Crown Castle, Inc. REIT | &nbsp;&nbsp;&nbsp; 13388532 |
| 188527 | Gaming & Leisure Properties, Inc. REIT | &nbsp;&nbsp;&nbsp; 8425272 |
|  |  | &nbsp;&nbsp;&nbsp; 21813804 |
|  | **Financial Services - 7.0%** | **Financial Services - 7.0%** |
| 68964 | Ares Management Corp. Class A | &nbsp;&nbsp;&nbsp; 11146651 |
| 148151 | Block, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 9643149 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

8 <br>

------

**Hartford Balanced HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 64.9% - (continued)** | **COMMON STOCKS - 64.9% - (continued)** | **COMMON STOCKS - 64.9% - (continued)** |
|  | **Financial Services - 7.0% - (continued)** | **Financial Services - 7.0% - (continued)** |
| 80794 | Intercontinental Exchange, Inc. | &nbsp;&nbsp;&nbsp; $13085396 |
| 100129 | KKR & Co., Inc. | &nbsp;&nbsp;&nbsp; 12764445 |
| 38687 | LPL Financial Holdings, Inc. | &nbsp;&nbsp;&nbsp; 13817836 |
| 82193 | Morgan Stanley | &nbsp;&nbsp;&nbsp; 14591723 |
| 125309 | Nasdaq, Inc. | &nbsp;&nbsp;&nbsp; 12171263 |
| 79413 | Raymond James Financial, Inc. | &nbsp;&nbsp;&nbsp; 12752934 |
| 26296 | S&P Global, Inc. | &nbsp;&nbsp;&nbsp; 13742027 |
|  |  | &nbsp;&nbsp;&nbsp; 113715424 |
|  | **Food, Beverage & Tobacco - 0.9%** | **Food, Beverage & Tobacco - 0.9%** |
| 500230 | Keurig Dr. Pepper, Inc. | &nbsp;&nbsp;&nbsp; 14011442 |
|  | **Health Care Equipment & Services - 2.7%** | **Health Care Equipment & Services - 2.7%** |
| 70869 | Align Technology, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 11066194 |
| 45777 | Elevance Health, Inc. | &nbsp;&nbsp;&nbsp; 16047127 |
| 51214 | UnitedHealth Group, Inc. | &nbsp;&nbsp;&nbsp; 16906254 |
|  |  | &nbsp;&nbsp;&nbsp; 44019575 |
|  | **Household & Personal Products - 0.8%** | **Household & Personal Products - 0.8%** |
| 188199 | Unilever PLC ADR<sup>(4)</sup>  | &nbsp;&nbsp;&nbsp; 12308215 |
|  | **Insurance - 1.8%** | **Insurance - 1.8%** |
| 180652 | MetLife, Inc. | &nbsp;&nbsp;&nbsp; 14260669 |
| 64491 | Progressive Corp. | &nbsp;&nbsp;&nbsp; 14685890 |
|  |  | &nbsp;&nbsp;&nbsp; 28946559 |
|  | **Media & Entertainment - 4.5%** | **Media & Entertainment - 4.5%** |
| 229209 | Alphabet, Inc. Class C | &nbsp;&nbsp;&nbsp; 71925784 |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 5.6%** | **Pharmaceuticals, Biotechnology & Life Sciences - 5.6%** |
| 105992 | AstraZeneca PLC ADR | &nbsp;&nbsp;&nbsp; 9743845 |
| 25172 | Eli Lilly & Co. | &nbsp;&nbsp;&nbsp; 27051845 |
| 125047 | Gilead Sciences, Inc. | &nbsp;&nbsp;&nbsp; 15348269 |
| 507945 | Pfizer, Inc. | &nbsp;&nbsp;&nbsp; 12647830 |
| 27142 | Roche Holding AG | &nbsp;&nbsp;&nbsp; 11208836 |
| 114639 | Zoetis, Inc. | &nbsp;&nbsp;&nbsp; 14423879 |
|  |  | &nbsp;&nbsp;&nbsp; 90424504 |
|  | **Semiconductors & Semiconductor Equipment - 10.5%** | **Semiconductors & Semiconductor Equipment - 10.5%** |
| 86016 | Advanced Micro Devices, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 18421186 |
| 123917 | Broadcom, Inc. | &nbsp;&nbsp;&nbsp; 42887674 |
| 433006 | NVIDIA Corp. | &nbsp;&nbsp;&nbsp; 80755619 |
| 67930 | NXP Semiconductors NV | &nbsp;&nbsp;&nbsp; 14744886 |
| 76763 | Onto Innovation, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 12117807 |
|  |  | &nbsp;&nbsp;&nbsp; 168927172 |
|  | **Software & Services - 8.8%** | **Software & Services - 8.8%** |
| 62868 | Accenture PLC Class A | &nbsp;&nbsp;&nbsp; 16867484 |
| 192379 | Amdocs Ltd. | &nbsp;&nbsp;&nbsp; 15488433 |
| 160782 | Microsoft Corp. | &nbsp;&nbsp;&nbsp; 77757391 |
| 68998 | Salesforce, Inc. | &nbsp;&nbsp;&nbsp; 18278260 |
| 29359 | Synopsys, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 13790510 |
|  |  | &nbsp;&nbsp;&nbsp; 142182078 |
|  | **Technology Hardware & Equipment - 3.3%** | **Technology Hardware & Equipment - 3.3%** |
| 236741 | Cisco Systems, Inc. | &nbsp;&nbsp;&nbsp; 18236159 |
| 129066 | Corning, Inc. | &nbsp;&nbsp;&nbsp; 11301019 |
| 40238 | F5, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10271152 |
| 125184 | NetApp, Inc. | &nbsp;&nbsp;&nbsp; 13405955 |
|  |  | &nbsp;&nbsp;&nbsp; 53214285 |
|  | **Telecommunication Services - 0.8%** | **Telecommunication Services - 0.8%** |
| 64701 | T-Mobile U.S., Inc. | &nbsp;&nbsp;&nbsp; 13136891 |
|  | **Transportation - 0.7%** | **Transportation - 0.7%** |
| 144442 | Uber Technologies, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 11802356 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 64.9% - (continued)** | **COMMON STOCKS - 64.9% - (continued)** | **COMMON STOCKS - 64.9% - (continued)** | **COMMON STOCKS - 64.9% - (continued)** |
|  | **Utilities - 0.8%** | **Utilities - 0.8%** | **Utilities - 0.8%** |
| 151677 | Sempra | Sempra | &nbsp;&nbsp;&nbsp; $13391562 |
|  | Total Common Stocks <br>(cost $638,859,161)<br>|  | &nbsp;&nbsp;&nbsp; $1048706782 |
|  | Total Long-Term Investments <br>(cost $1,194,226,038)<br>|  | &nbsp;&nbsp;&nbsp; $1600652689 |
| **SHORT-TERM INVESTMENTS - 1.1%** | **SHORT-TERM INVESTMENTS - 1.1%** | **SHORT-TERM INVESTMENTS - 1.1%** | **SHORT-TERM INVESTMENTS - 1.1%** |
|  | **Repurchase Agreements - 0.2%** | **Repurchase Agreements - 0.2%** | **Repurchase Agreements - 0.2%** |
| $2361829 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $2,362,330; collateralized by <br> U.S. Treasury Bond at 4.63%, maturing <br> 11/15/2055, with a market value of <br> $2,409,181 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $2,362,330; collateralized by <br> U.S. Treasury Bond at 4.63%, maturing <br> 11/15/2055, with a market value of <br> $2,409,181 | &nbsp;&nbsp;&nbsp; $2361829 |
|  | **Securities Lending Collateral - 0.9%** | **Securities Lending Collateral - 0.9%** | **Securities Lending Collateral - 0.9%** |
| 14729893 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(6)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 14729893 |
|  | Total Short-Term Investments <br>(cost $17,091,722) | Total Short-Term Investments <br>(cost $17,091,722) | &nbsp;&nbsp;&nbsp; $17091722 |
|  | Total Investments <br>(cost $1,211,317,760)<br>| 100.1<br> %<br>| &nbsp;&nbsp;&nbsp; $1617744411 |
|  | Other Assets and Liabilities | (0.1)%<br>| &nbsp;&nbsp;&nbsp; (1237898)<br>|
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $1616506513 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service approved by Hartford Funds Management Company, LLC in order to reflect an adjustment for factors occurring after the close of certain foreign markets but before the close of the New York Stock Exchange.

The Fund may refer to any one or more of the industry classifications used by one or more widely recognized market indices, ratings group and/or as defined by Fund management. Industry classifications may not be identical across all security types.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

\* Non-income producing.

<sup>(1)</sup> Security was purchased pursuant to Rule 144A under the Securities Act of 1933 and may be sold in transactions that are exempt from registration (typically only to qualified institutional buyers) or in a public offering registered under the Securities Act of 1933. At December 31, 2025, the aggregate value of these securities was $91,568,768, representing 5.7% of net assets. 

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

9 <br>

------

**Hartford Balanced HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(2)</sup> Variable or floating rate securities. Interest rate resets periodically. The rate shown is the effective interest rate as of period end. Security description also includes the reference rate and spread if published and available. Variable rate securities with a floor or ceiling feature are disclosed at the inherent rate, where applicable. Certain variable rate securities are not based on a published reference rate and spread but are determined by the issuer or agent and are based on current market conditions; these securities do not indicate a reference rate and spread in the description. For fixed to variable securities, the rate remains fixed until designated date stated in security description. 

<sup>(3)</sup> Security is a "step-up" bond where coupon increases or steps up at a predetermined date. Rate shown is current coupon rate. 

<sup>(4)</sup> Represents entire or partial securities on loan. See Note 8 in the accompanying Notes to Financial Statements for securities lending information. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| <sup>(5)</sup> <br>| Security is exempt from registration under Regulation S under the Securities Act of <br> 1933, which exempts from registration securities offered and sold outside of the <br> United States. Security may not be offered or sold in the United States except <br> pursuant to an exemption from, or in a transaction not subject to, the registration <br> requirements of the Securities Act of 1933. At December 31, 2025, the aggregate <br> value of this security was $385,385, representing 0.0% of net assets.<br>|
| <sup>(6)</sup> <br>| Current yield as of period end. |
| <sup>†</sup> | See Significant Accounting Policies of accompanying Notes to Financial <br> Statements regarding valuation of investments.<br>|

---

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Asset-Backed & Commercial Mortgage-Backed Securities | &nbsp;&nbsp; $21708121 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $21708121 | &nbsp;&nbsp; $— |
| Corporate Bonds | &nbsp;&nbsp; 179974662 | &nbsp;&nbsp; — | &nbsp;&nbsp; 179974662 | &nbsp;&nbsp; — |
| Foreign Government Obligations | &nbsp;&nbsp; 3788505 | &nbsp;&nbsp; — | &nbsp;&nbsp; 3788505 | &nbsp;&nbsp; — |
| Municipal Bonds | &nbsp;&nbsp; 9882092 | &nbsp;&nbsp; — | &nbsp;&nbsp; 9882092 | &nbsp;&nbsp; — |
| U.S. Government Agencies | &nbsp;&nbsp; 16022064 | &nbsp;&nbsp; — | &nbsp;&nbsp; 16022064 | &nbsp;&nbsp; — |
| U.S. Government Securities | &nbsp;&nbsp; 320570463 | &nbsp;&nbsp; — | &nbsp;&nbsp; 320570463 | &nbsp;&nbsp; — |
| Common Stocks | &nbsp;&nbsp; 1048706782 | &nbsp;&nbsp; 1021027955 | &nbsp;&nbsp; 27678827 | &nbsp;&nbsp; — |
| Short-Term Investments | &nbsp;&nbsp; 17091722 | &nbsp;&nbsp; 14729893 | &nbsp;&nbsp; 2361829 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $1617744411 | &nbsp;&nbsp; $1035757848 | &nbsp;&nbsp; $581986563 | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

10 <br>

------

**Hartford Capital Appreciation HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 98.3%** | **COMMON STOCKS - 98.3%** | **COMMON STOCKS - 98.3%** |
|  | **Automobiles & Components - 1.8%** | **Automobiles & Components - 1.8%** |
| 145668 | Tesla, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $65509813 |
|  | **Banks - 1.3%** | **Banks - 1.3%** |
| 629893 | KeyCorp | &nbsp;&nbsp;&nbsp; 13000991 |
| 108889 | M&T Bank Corp. | &nbsp;&nbsp;&nbsp; 21938956 |
| 163515 | Wells Fargo & Co. | &nbsp;&nbsp;&nbsp; 15239598 |
|  |  | &nbsp;&nbsp;&nbsp; 50179545 |
|  | **Capital Goods - 5.9%** | **Capital Goods - 5.9%** |
| 21894 | Airbus SE | &nbsp;&nbsp;&nbsp; 5084307 |
| 38150 | AMETEK, Inc. | &nbsp;&nbsp;&nbsp; 7832577 |
| 10742 | Axon Enterprise, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6100704 |
| 105016 | Builders FirstSource, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10805096 |
| 47050 | Deere & Co. | &nbsp;&nbsp;&nbsp; 21905069 |
| 116246 | Dover Corp. | &nbsp;&nbsp;&nbsp; 22695869 |
| 166821 | Emerson Electric Co. | &nbsp;&nbsp;&nbsp; 22140483 |
| 40699 | General Dynamics Corp. | &nbsp;&nbsp;&nbsp; 13701726 |
| 126535 | Honeywell International, Inc. | &nbsp;&nbsp;&nbsp; 24685713 |
| 350600 | Mammoth, Inc.<sup>\*(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 6503630 |
| 48387 | Northrop Grumman Corp. | &nbsp;&nbsp;&nbsp; 27590751 |
| 160353 | PACCAR, Inc. | &nbsp;&nbsp;&nbsp; 17560257 |
| 14936 | Quanta Services, Inc. | &nbsp;&nbsp;&nbsp; 6303888 |
| 44175 | RTX Corp. | &nbsp;&nbsp;&nbsp; 8101695 |
| 1088000 | Techtronic Industries Co. Ltd. | &nbsp;&nbsp;&nbsp; 12515402 |
| 44981 | Vertiv Holdings Co. Class A | &nbsp;&nbsp;&nbsp; 7287372 |
|  |  | &nbsp;&nbsp;&nbsp; 220814539 |
|  | **Commercial & Professional Services - 0.9%** | **Commercial & Professional Services - 0.9%** |
| 80665 | Booz Allen Hamilton Holding Corp. | &nbsp;&nbsp;&nbsp; 6804900 |
| 20230 | CACI International, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10778746 |
| 207949 | TransUnion | &nbsp;&nbsp;&nbsp; 17831627 |
|  |  | &nbsp;&nbsp;&nbsp; 35415273 |
|  | **Consumer Discretionary Distribution & Retail - 6.9%** | **Consumer Discretionary Distribution & Retail - 6.9%** |
| 705499 | Amazon.com, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 162843279 |
| 131124 | Dick's Sporting Goods, Inc. | &nbsp;&nbsp;&nbsp; 25958618 |
| 94735 | Home Depot, Inc. | &nbsp;&nbsp;&nbsp; 32598314 |
| 194928 | TJX Cos., Inc. | &nbsp;&nbsp;&nbsp; 29942890 |
| 115140 | Tory Burch LLC<sup>\*(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 6648164 |
|  |  | &nbsp;&nbsp;&nbsp; 257991265 |
|  | **Consumer Durables & Apparel - 0.8%** | **Consumer Durables & Apparel - 0.8%** |
| 355795 | NIKE, Inc. Class B | &nbsp;&nbsp;&nbsp; 22667699 |
| 130583 | On Holding AG Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6069498 |
|  |  | &nbsp;&nbsp;&nbsp; 28737197 |
|  | **Consumer Services - 2.8%** | **Consumer Services - 2.8%** |
| 128478 | Airbnb, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 17437034 |
| 61012 | DoorDash, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 13817998 |
| 47732 | Flutter Entertainment PLC<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10264289 |
| 92075 | Hyatt Hotels Corp. Class A | &nbsp;&nbsp;&nbsp; 14761464 |
| 74111 | Marriott International, Inc. Class A | &nbsp;&nbsp;&nbsp; 22992197 |
| 79216 | McDonald's Corp. | &nbsp;&nbsp;&nbsp; 24210786 |
|  |  | &nbsp;&nbsp;&nbsp; 103483768 |
|  | **Consumer Staples Distribution & Retail - 0.4%** | **Consumer Staples Distribution & Retail - 0.4%** |
| 239074 | Kroger Co. | &nbsp;&nbsp;&nbsp; 14937344 |
|  | **Energy - 2.8%** | **Energy - 2.8%** |
| 400796 | Canadian Natural Resources Ltd. | &nbsp;&nbsp;&nbsp; 13566945 |
| 201709 | ConocoPhillips | &nbsp;&nbsp;&nbsp; 18881980 |
| 135752 | Exxon Mobil Corp. | &nbsp;&nbsp;&nbsp; 16336396 |
| 714338 | SLB Ltd. | &nbsp;&nbsp;&nbsp; 27416292 |
| 40200 | Targa Resources Corp. | &nbsp;&nbsp;&nbsp; 7416900 |
| 123855 | Valero Energy Corp. | &nbsp;&nbsp;&nbsp; 20162355 |
|  |  | &nbsp;&nbsp;&nbsp; 103780868 |
|  | **Equity Real Estate Investment Trusts (REITs) - 1.6%** | **Equity Real Estate Investment Trusts (REITs) - 1.6%** |
| 46103 | AvalonBay Communities, Inc. REIT | &nbsp;&nbsp;&nbsp; 8358935 |
| 25563 | Equinix, Inc. REIT | &nbsp;&nbsp;&nbsp; 19585348 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 98.3% - (continued)** | **COMMON STOCKS - 98.3% - (continued)** | **COMMON STOCKS - 98.3% - (continued)** |
|  | **Equity Real Estate Investment Trusts (REITs) - 1.6% - (continued)** | **Equity Real Estate Investment Trusts (REITs) - 1.6% - (continued)** |
| 165428 | Prologis, Inc. REIT | &nbsp;&nbsp;&nbsp; $21118539 |
| 303325 | UDR, Inc. REIT | &nbsp;&nbsp;&nbsp; 11125961 |
|  |  | &nbsp;&nbsp;&nbsp; 60188783 |
|  | **Financial Services - 8.2%** | **Financial Services - 8.2%** |
| 423430 | Ally Financial, Inc. | &nbsp;&nbsp;&nbsp; 19177145 |
| 86429 | American Express Co. | &nbsp;&nbsp;&nbsp; 31974409 |
| 29620 | Evercore, Inc. Class A | &nbsp;&nbsp;&nbsp; 10078205 |
| 339541 | KKR & Co., Inc. | &nbsp;&nbsp;&nbsp; 43284687 |
| 59155 | Mastercard, Inc. Class A | &nbsp;&nbsp;&nbsp; 33770406 |
| 141115 | Morgan Stanley | &nbsp;&nbsp;&nbsp; 25052146 |
| 31281 | Morningstar, Inc. | &nbsp;&nbsp;&nbsp; 6797674 |
| 169704 | Raymond James Financial, Inc. | &nbsp;&nbsp;&nbsp; 27252765 |
| 59591 | S&P Global, Inc. | &nbsp;&nbsp;&nbsp; 31141661 |
| 277864 | TPG, Inc. | &nbsp;&nbsp;&nbsp; 17738838 |
| 263762 | Tradeweb Markets, Inc. Class A | &nbsp;&nbsp;&nbsp; 28364965 |
| 66038 | Visa, Inc. Class A | &nbsp;&nbsp;&nbsp; 23160187 |
| 93504 | Voya Financial, Inc. | &nbsp;&nbsp;&nbsp; 6965113 |
|  |  | &nbsp;&nbsp;&nbsp; 304758201 |
|  | **Food, Beverage & Tobacco - 2.1%** | **Food, Beverage & Tobacco - 2.1%** |
| 239299 | Archer-Daniels-Midland Co. | &nbsp;&nbsp;&nbsp; 13757300 |
| 291077 | Coca-Cola Co. | &nbsp;&nbsp;&nbsp; 20349193 |
| 54293 | Constellation Brands, Inc. Class A | &nbsp;&nbsp;&nbsp; 7490262 |
| 430522 | Keurig Dr. Pepper, Inc. | &nbsp;&nbsp;&nbsp; 12058921 |
| 71000 | Monster Beverage Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5443570 |
| 346157 | Tyson Foods, Inc. Class A | &nbsp;&nbsp;&nbsp; 20291723 |
|  |  | &nbsp;&nbsp;&nbsp; 79390969 |
|  | **Health Care Equipment & Services - 3.3%** | **Health Care Equipment & Services - 3.3%** |
| 76300 | Becton Dickinson & Co. | &nbsp;&nbsp;&nbsp; 14807541 |
| 57421 | Cardinal Health, Inc. | &nbsp;&nbsp;&nbsp; 11800016 |
| 121541 | Centene Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5001412 |
| 213202 | Cooper Cos., Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 17474036 |
| 115112 | Dexcom, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7639983 |
| 43621 | Elevance Health, Inc. | &nbsp;&nbsp;&nbsp; 15291342 |
| 67820 | Stryker Corp. | &nbsp;&nbsp;&nbsp; 23836695 |
| 62059 | UnitedHealth Group, Inc. | &nbsp;&nbsp;&nbsp; 20486296 |
| 24878 | Veeva Systems, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5553516 |
|  |  | &nbsp;&nbsp;&nbsp; 121890837 |
|  | **Household & Personal Products - 1.1%** | **Household & Personal Products - 1.1%** |
| 168119 | Procter & Gamble Co. | &nbsp;&nbsp;&nbsp; 24093134 |
| 277816 | Unilever PLC | &nbsp;&nbsp;&nbsp; 18151722 |
|  |  | &nbsp;&nbsp;&nbsp; 42244856 |
|  | **Insurance - 3.3%** | **Insurance - 3.3%** |
| 200596 | Chubb Ltd. | &nbsp;&nbsp;&nbsp; 62610023 |
| 37461 | Everest Group Ltd. | &nbsp;&nbsp;&nbsp; 12712390 |
| 161021 | Marsh & McLennan Cos., Inc. | &nbsp;&nbsp;&nbsp; 29872616 |
| 143941 | MetLife, Inc. | &nbsp;&nbsp;&nbsp; 11362703 |
| 23820 | Willis Towers Watson PLC | &nbsp;&nbsp;&nbsp; 7827252 |
|  |  | &nbsp;&nbsp;&nbsp; 124384984 |
|  | **Materials - 3.2%** | **Materials - 3.2%** |
| 520564 | Freeport-McMoRan, Inc. | &nbsp;&nbsp;&nbsp; 26439446 |
| 963896 | James Hardie Industries PLC ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 20000842 |
| 70227 | Linde PLC | &nbsp;&nbsp;&nbsp; 29944090 |
| 206632 | Nutrien Ltd. | &nbsp;&nbsp;&nbsp; 12753327 |
| 100811 | PPG Industries, Inc. | &nbsp;&nbsp;&nbsp; 10329095 |
| 67338 | Reliance, Inc. | &nbsp;&nbsp;&nbsp; 19451928 |
|  |  | &nbsp;&nbsp;&nbsp; 118918728 |
|  | **Media & Entertainment - 11.6%** | **Media & Entertainment - 11.6%** |
| 730677 | Alphabet, Inc. Class A | &nbsp;&nbsp;&nbsp; 228701901 |
| 113168 | Alphabet, Inc. Class C | &nbsp;&nbsp;&nbsp; 35512118 |
| 104661 | Liberty Media Corp.-Liberty Formula One <br> Class C<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10310155 |
| 46875 | Live Nation Entertainment, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6679688 |
| 96381 | Meta Platforms, Inc. Class A | &nbsp;&nbsp;&nbsp; 63620134 |
| 343858 | Netflix, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 32240126 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

11 <br>

------

**Hartford Capital Appreciation HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 98.3% - (continued)** | **COMMON STOCKS - 98.3% - (continued)** | **COMMON STOCKS - 98.3% - (continued)** |
|  | **Media & Entertainment - 11.6% - (continued)** | **Media & Entertainment - 11.6% - (continued)** |
| 28717 | Reddit, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $6601177 |
| 28171 | Spotify Technology SA<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 16359181 |
| 227432 | Walt Disney Co. | &nbsp;&nbsp;&nbsp; 25874939 |
| 273188 | Warner Bros Discovery, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7873278 |
|  |  | &nbsp;&nbsp;&nbsp; 433772697 |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 6.9%** | **Pharmaceuticals, Biotechnology & Life Sciences - 6.9%** |
| 119964 | Agilent Technologies, Inc. | &nbsp;&nbsp;&nbsp; 16323502 |
| 227534 | AstraZeneca PLC ADR | &nbsp;&nbsp;&nbsp; 20917201 |
| 78940 | Charles River Laboratories International, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 15746951 |
| 119660 | Danaher Corp. | &nbsp;&nbsp;&nbsp; 27392567 |
| 71733 | Eli Lilly & Co. | &nbsp;&nbsp;&nbsp; 77090021 |
| 3106700 | Haleon PLC | &nbsp;&nbsp;&nbsp; 15699340 |
| 78971 | ICON PLC<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 14390096 |
| 289450 | Merck & Co., Inc. | &nbsp;&nbsp;&nbsp; 30467507 |
| 78460 | Natera, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 17974401 |
| 79794 | Neurocrine Biosciences, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 11317183 |
| 226279 | Sanofi SA ADR | &nbsp;&nbsp;&nbsp; 10965480 |
|  |  | &nbsp;&nbsp;&nbsp; 258284249 |
|  | **Real Estate Management & Development - 0.1%** | **Real Estate Management & Development - 0.1%** |
| 73754 | Zillow Group, Inc. Class C<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5031498 |
|  | **Semiconductors & Semiconductor Equipment - 13.3%** | **Semiconductors & Semiconductor Equipment - 13.3%** |
| 34884 | Advanced Micro Devices, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7470757 |
| 119488 | ARM Holdings PLC ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 13061233 |
| 23916 | ASML Holding NV | &nbsp;&nbsp;&nbsp; 25586772 |
| 426367 | Broadcom, Inc. | &nbsp;&nbsp;&nbsp; 147565619 |
| 1298548 | NVIDIA Corp. | &nbsp;&nbsp;&nbsp; 242179202 |
| 84711 | NXP Semiconductors NV | &nbsp;&nbsp;&nbsp; 18387370 |
| 99595 | QUALCOMM, Inc. | &nbsp;&nbsp;&nbsp; 17035725 |
| 145795 | Texas Instruments, Inc. | &nbsp;&nbsp;&nbsp; 25293974 |
|  |  | &nbsp;&nbsp;&nbsp; 496580652 |
|  | **Software & Services - 9.8%** | **Software & Services - 9.8%** |
| 146363 | Accenture PLC Class A | &nbsp;&nbsp;&nbsp; 39269193 |
| 10772 | AppLovin Corp. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7258389 |
| 34612 | Cloudflare, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6823756 |
| 26851 | Crowdstrike Holdings, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 12586675 |
| 366706 | Dynatrace, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 15893038 |
| 35506 | Intuit, Inc. | &nbsp;&nbsp;&nbsp; 23519884 |
| 410784 | Microsoft Corp. | &nbsp;&nbsp;&nbsp; 198663358 |
| 129415 | Nutanix, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6689461 |
| 87466 | Oracle Corp. | &nbsp;&nbsp;&nbsp; 17047998 |
| 143853 | Palantir Technologies, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 25569871 |
| 23922 | Synopsys, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 11236642 |
|  |  | &nbsp;&nbsp;&nbsp; 364558265 |
|  | **Technology Hardware & Equipment - 7.6%** | **Technology Hardware & Equipment - 7.6%** |
| 46600 | Amphenol Corp. Class A | &nbsp;&nbsp;&nbsp; 6297524 |
| 851312 | Apple, Inc. | &nbsp;&nbsp;&nbsp; 231437680 |
| 72774 | Arista Networks, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 9535577 |
| 37683 | Celestica, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 11139472 |
| 113522 | Corning, Inc. | &nbsp;&nbsp;&nbsp; 9939986 |
| 161445 | Flex Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 9754507 |
| 92271 | Trimble, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7229433 |
|  |  | &nbsp;&nbsp;&nbsp; 285334179 |
|  | **Telecommunication Services - 0.9%** | **Telecommunication Services - 0.9%** |
| 159822 | T-Mobile U.S., Inc. | &nbsp;&nbsp;&nbsp; 32450259 |
|  | **Transportation - 0.4%** | **Transportation - 0.4%** |
| 30526 | CH Robinson Worldwide, Inc. | &nbsp;&nbsp;&nbsp; 4907360 |
| 177337 | Knight-Swift Transportation Holdings, Inc. | &nbsp;&nbsp;&nbsp; 9271178 |
|  |  | &nbsp;&nbsp;&nbsp; 14178538 |
|  | **Utilities - 1.3%** | **Utilities - 1.3%** |
| 185998 | Eversource Energy | &nbsp;&nbsp;&nbsp; 12523246 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 98.3% - (continued)** | **COMMON STOCKS - 98.3% - (continued)** | **COMMON STOCKS - 98.3% - (continued)** | **COMMON STOCKS - 98.3% - (continued)** |
|  | **Utilities - 1.3% - (continued)** | **Utilities - 1.3% - (continued)** | **Utilities - 1.3% - (continued)** |
| 325168 | Exelon Corp. | Exelon Corp. | &nbsp;&nbsp;&nbsp; $14174073 |
| 240632 | Sempra | Sempra | &nbsp;&nbsp;&nbsp; 21245399 |
|  |  |  | &nbsp;&nbsp;&nbsp; 47942718 |
|  | Total Common Stocks <br>(cost $2,414,591,533)<br>|  | &nbsp;&nbsp;&nbsp; $3670760025 |
| **CONVERTIBLE PREFERRED STOCKS - 0.0%** | **CONVERTIBLE PREFERRED STOCKS - 0.0%** | **CONVERTIBLE PREFERRED STOCKS - 0.0%** | **CONVERTIBLE PREFERRED STOCKS - 0.0%** |
|  | **Software & Services - 0.0%** | **Software & Services - 0.0%** | **Software & Services - 0.0%** |
| 58 | Magic Leap, Inc. Class A<sup>\*(1)(2)(3)</sup>  | Magic Leap, Inc. Class A<sup>\*(1)(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; $55 |
|  | Total Convertible Preferred Stocks <br>(cost $679,566)<br>|  | &nbsp;&nbsp;&nbsp; $55 |
|  | Total Long-Term Investments <br>(cost $2,415,271,099)<br>|  | &nbsp;&nbsp;&nbsp; $3670760080 |
| **SHORT-TERM INVESTMENTS - 0.4%** | **SHORT-TERM INVESTMENTS - 0.4%** | **SHORT-TERM INVESTMENTS - 0.4%** | **SHORT-TERM INVESTMENTS - 0.4%** |
|  | **Repurchase Agreements - 0.4%** | **Repurchase Agreements - 0.4%** | **Repurchase Agreements - 0.4%** |
| $13874197 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $13,877,141; collateralized by <br> U.S. Treasury Bond at 4.63%, maturing <br> 11/15/2055, with a market value of <br> $14,151,682 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $13,877,141; collateralized by <br> U.S. Treasury Bond at 4.63%, maturing <br> 11/15/2055, with a market value of <br> $14,151,682 | &nbsp;&nbsp;&nbsp; $13874197 |
|  | Total Short-Term Investments <br>(cost $13,874,197) | Total Short-Term Investments <br>(cost $13,874,197) | &nbsp;&nbsp;&nbsp; $13874197 |
|  | Total Investments <br>(cost $2,429,145,296)<br>| 98.7<br> %<br>| &nbsp;&nbsp;&nbsp; $3684634277 |
|  | Other Assets and Liabilities | 1.3<br> %<br>| &nbsp;&nbsp;&nbsp; 47964159 |
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $3732598436 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service approved by Hartford Funds Management Company, LLC in order to reflect an adjustment for factors occurring after the close of certain foreign markets but before the close of the New York Stock Exchange.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

\* Non-income producing.

<sup>(1)</sup> Investment in securities not registered under the Securities Act of 1933 (excluding securities acquired pursuant to Rule 144A and Regulation S). At the end of the period, the value of such restricted securities amounted to $13,151,849 or 0.4% of net assets. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

12 <br>

------

**Hartford Capital Appreciation HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** <br>**Acquired**<br>| **Security Name** | **Shares/** <br>**Par Value**<br>| **Total Cost** | **Market Value** |
| 12/2015 | &nbsp;&nbsp; Magic Leap, Inc. <br> Class A <br> Convertible <br> Preferred<br>| &nbsp;&nbsp; 58 | &nbsp;&nbsp; $679566 | &nbsp;&nbsp; $55 |
| 06/2015 | Mammoth, Inc.  | &nbsp;&nbsp; 350600 | &nbsp;&nbsp; 4713607 | &nbsp;&nbsp; 6503630 |
| 11/2013 | Tory Burch LLC  | &nbsp;&nbsp; 115140 | &nbsp;&nbsp; 9024247 | &nbsp;&nbsp; 6648164 |
|  |  |  | &nbsp;&nbsp; $14417420 | &nbsp;&nbsp; $13151849 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(2)</sup> Investment valued using significant unobservable inputs. <br> <sup>(3)</sup> Currently no rate available.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Futures Contracts Outstanding at December 31, 2025**  | **Futures Contracts Outstanding at December 31, 2025**  | **Futures Contracts Outstanding at December 31, 2025**  | **Futures Contracts Outstanding at December 31, 2025**  | **Futures Contracts Outstanding at December 31, 2025**  |
| **Description** | **Number of** <br>**Contracts**<br>| **Expiration** <br>**Date**<br>| **Current** <br>**Notional** <br>**Amount**<br>| **Value and** <br>**Unrealized** <br>**Appreciation/** <br>**(Depreciation)**<br>|
| **Long position contracts:** | **Long position contracts:** | **Long position contracts:** | **Long position contracts:** | **Long position contracts:** |
| S&P 500 (E-Mini) Future | 194 | 03/20/2026 | &nbsp;&nbsp; $66857250 | &nbsp;&nbsp; $(720606)<br>|
| **Total futures contracts** | **Total futures contracts** | **Total futures contracts** | **Total futures contracts** | &nbsp;&nbsp; $(720606)<br>|

---

<sup>†</sup> See Significant Accounting Policies of accompanying Notes to Financial Statements regarding valuation of investments.

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $3670760025 | &nbsp;&nbsp; $3606157460 | &nbsp;&nbsp; $51450771 | &nbsp;&nbsp; $13151794 |
| Convertible Preferred Stocks | &nbsp;&nbsp; 55 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 55 |
| Short-Term Investments | &nbsp;&nbsp; 13874197 | &nbsp;&nbsp; — | &nbsp;&nbsp; 13874197 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $3684634277 | &nbsp;&nbsp; $3606157460 | &nbsp;&nbsp; $65324968 | &nbsp;&nbsp; $13151849 |
| **Liabilities** |  |  |  |  |
| Futures Contracts<sup>(2)</sup> <br>| &nbsp;&nbsp; $(720606)<br>| &nbsp;&nbsp; $(720606)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— |
| **Total** | &nbsp;&nbsp; $(720606)<br>| &nbsp;&nbsp; $(720606)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3. <br> <sup>(2)</sup> Derivative instruments (excluding purchased and written options, if applicable) are valued at the unrealized appreciation/(depreciation) on the investments.

Level 3 investments at the beginning and/or end of the period in relation to net assets were not significant and accordingly, a reconciliation of Level 3 assets for the year ended December 31, 2025 is not presented.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

13 <br>

------

**Hartford Disciplined Equity HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 99.7%** | **COMMON STOCKS - 99.7%** | **COMMON STOCKS - 99.7%** |
|  | **Automobiles & Components - 0.7%** | **Automobiles & Components - 0.7%** |
| 43664 | Tesla, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $19636574 |
|  | **Banks - 4.1%** | **Banks - 4.1%** |
| 225922 | JP Morgan Chase & Co. | &nbsp;&nbsp;&nbsp; 72796587 |
| 530599 | Wells Fargo & Co. | &nbsp;&nbsp;&nbsp; 49451827 |
|  |  | &nbsp;&nbsp;&nbsp; 122248414 |
|  | **Capital Goods - 8.8%** | **Capital Goods - 8.8%** |
| 127914 | Builders FirstSource, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 13161071 |
| 70056 | Caterpillar, Inc. | &nbsp;&nbsp;&nbsp; 40132981 |
| 161981 | Emerson Electric Co. | &nbsp;&nbsp;&nbsp; 21498118 |
| 100775 | Ferguson Enterprises, Inc. | &nbsp;&nbsp;&nbsp; 22435538 |
| 98664 | FTAI Aviation Ltd. | &nbsp;&nbsp;&nbsp; 19422008 |
| 30914 | GE Vernova, Inc. | &nbsp;&nbsp;&nbsp; 20204463 |
| 121817 | General Electric Co. | &nbsp;&nbsp;&nbsp; 37523291 |
| 31370 | Parker-Hannifin Corp. | &nbsp;&nbsp;&nbsp; 27572975 |
| 197397 | RTX Corp. | &nbsp;&nbsp;&nbsp; 36202610 |
| 66054 | Trane Technologies PLC | &nbsp;&nbsp;&nbsp; 25708217 |
|  |  | &nbsp;&nbsp;&nbsp; 263861272 |
|  | **Commercial & Professional Services - 0.7%** | **Commercial & Professional Services - 0.7%** |
| 98988 | Republic Services, Inc. | &nbsp;&nbsp;&nbsp; 20978527 |
|  | **Consumer Discretionary Distribution & Retail - 7.8%** | **Consumer Discretionary Distribution & Retail - 7.8%** |
| 645293 | Amazon.com, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 148946530 |
| 7753 | AutoZone, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 26294300 |
| 120945 | Lowe's Cos., Inc. | &nbsp;&nbsp;&nbsp; 29167096 |
| 91681 | Pool Corp. | &nbsp;&nbsp;&nbsp; 20972029 |
| 51960 | TJX Cos., Inc. | &nbsp;&nbsp;&nbsp; 7981576 |
| 38805 | Tory Burch LLC<sup>\*(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2240602 |
|  |  | &nbsp;&nbsp;&nbsp; 235602133 |
|  | **Consumer Services - 1.5%** | **Consumer Services - 1.5%** |
| 330228 | Chipotle Mexican Grill, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 12218436 |
| 106795 | Marriott International, Inc. Class A | &nbsp;&nbsp;&nbsp; 33132081 |
|  |  | &nbsp;&nbsp;&nbsp; 45350517 |
|  | **Consumer Staples Distribution & Retail - 2.8%** | **Consumer Staples Distribution & Retail - 2.8%** |
| 328767 | BJ's Wholesale Club Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 29598893 |
| 488559 | Walmart, Inc. | &nbsp;&nbsp;&nbsp; 54430358 |
|  |  | &nbsp;&nbsp;&nbsp; 84029251 |
|  | **Energy - 2.6%** | **Energy - 2.6%** |
| 112562 | Expand Energy Corp. | &nbsp;&nbsp;&nbsp; 12422342 |
| 376027 | Exxon Mobil Corp. | &nbsp;&nbsp;&nbsp; 45251089 |
| 365898 | Williams Cos., Inc. | &nbsp;&nbsp;&nbsp; 21994129 |
|  |  | &nbsp;&nbsp;&nbsp; 79667560 |
|  | **Equity Real Estate Investment Trusts (REITs) - 2.0%** | **Equity Real Estate Investment Trusts (REITs) - 2.0%** |
| 141359 | Simon Property Group, Inc. REIT | &nbsp;&nbsp;&nbsp; 26166965 |
| 183238 | Welltower, Inc. REIT | &nbsp;&nbsp;&nbsp; 34010805 |
|  |  | &nbsp;&nbsp;&nbsp; 60177770 |
|  | **Financial Services - 7.5%** | **Financial Services - 7.5%** |
| 75449 | American Express Co. | &nbsp;&nbsp;&nbsp; 27912358 |
| 43040 | Goldman Sachs Group, Inc. | &nbsp;&nbsp;&nbsp; 37832160 |
| 195167 | Intercontinental Exchange, Inc. | &nbsp;&nbsp;&nbsp; 31609247 |
| 161341 | KKR & Co., Inc. | &nbsp;&nbsp;&nbsp; 20567751 |
| 328394 | Klarna Group PLC<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 9493870 |
| 115620 | Mastercard, Inc. Class A | &nbsp;&nbsp;&nbsp; 66005146 |
| 331716 | Nasdaq, Inc. | &nbsp;&nbsp;&nbsp; 32219575 |
|  |  | &nbsp;&nbsp;&nbsp; 225640107 |
|  | **Food, Beverage & Tobacco - 2.8%** | **Food, Beverage & Tobacco - 2.8%** |
| 413272 | McCormick & Co., Inc. | &nbsp;&nbsp;&nbsp; 28147956 |
| 213266 | Monster Beverage Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 16351104 |
| 244593 | Philip Morris International, Inc. | &nbsp;&nbsp;&nbsp; 39232717 |
|  |  | &nbsp;&nbsp;&nbsp; 83731777 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 99.7% - (continued)** | **COMMON STOCKS - 99.7% - (continued)** | **COMMON STOCKS - 99.7% - (continued)** |
|  | **Health Care Equipment & Services - 2.7%** | **Health Care Equipment & Services - 2.7%** |
| 320051 | Abbott Laboratories | &nbsp;&nbsp;&nbsp; $40099190 |
| 89452 | Cencora, Inc. | &nbsp;&nbsp;&nbsp; 30212413 |
| 21254 | HCA Healthcare, Inc. | &nbsp;&nbsp;&nbsp; 9922642 |
|  |  | &nbsp;&nbsp;&nbsp; 80234245 |
|  | **Insurance - 1.6%** | **Insurance - 1.6%** |
| 91078 | Arthur J Gallagher & Co. | &nbsp;&nbsp;&nbsp; 23570076 |
| 76360 | Chubb Ltd. | &nbsp;&nbsp;&nbsp; 23833483 |
|  |  | &nbsp;&nbsp;&nbsp; 47403559 |
|  | **Materials - 1.8%** | **Materials - 1.8%** |
| 62473 | Linde PLC | &nbsp;&nbsp;&nbsp; 26637862 |
| 86688 | Sherwin-Williams Co. | &nbsp;&nbsp;&nbsp; 28089513 |
|  |  | &nbsp;&nbsp;&nbsp; 54727375 |
|  | **Media & Entertainment - 10.3%** | **Media & Entertainment - 10.3%** |
| 612297 | Alphabet, Inc. Class A | &nbsp;&nbsp;&nbsp; 191648961 |
| 121123 | Meta Platforms, Inc. Class A | &nbsp;&nbsp;&nbsp; 79952081 |
| 389170 | Netflix, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 36488579 |
|  |  | &nbsp;&nbsp;&nbsp; 308089621 |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 6.5%** | **Pharmaceuticals, Biotechnology & Life Sciences - 6.5%** |
| 66584 | Eli Lilly & Co. | &nbsp;&nbsp;&nbsp; 71556493 |
| 277878 | Gilead Sciences, Inc. | &nbsp;&nbsp;&nbsp; 34106746 |
| 189517 | Johnson & Johnson | &nbsp;&nbsp;&nbsp; 39220543 |
| 34233 | United Therapeutics Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 16680029 |
| 73329 | Vertex Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 33244436 |
|  |  | &nbsp;&nbsp;&nbsp; 194808247 |
|  | **Semiconductors & Semiconductor Equipment - 12.8%** | **Semiconductors & Semiconductor Equipment - 12.8%** |
| 309025 | Broadcom, Inc. | &nbsp;&nbsp;&nbsp; 106953553 |
| 27952 | KLA Corp. | &nbsp;&nbsp;&nbsp; 33963916 |
| 1311374 | NVIDIA Corp. | &nbsp;&nbsp;&nbsp; 244571251 |
|  |  | &nbsp;&nbsp;&nbsp; 385488720 |
|  | **Software & Services - 9.6%** | **Software & Services - 9.6%** |
| 64314 | Cadence Design Systems, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 20103270 |
| 443246 | Microsoft Corp. | &nbsp;&nbsp;&nbsp; 214362630 |
| 151362 | Oracle Corp. | &nbsp;&nbsp;&nbsp; 29501967 |
| 3397 | Roper Technologies, Inc. | &nbsp;&nbsp;&nbsp; 1512107 |
| 47762 | Tyler Technologies, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 21681560 |
|  |  | &nbsp;&nbsp;&nbsp; 287161534 |
|  | **Technology Hardware & Equipment - 9.8%** | **Technology Hardware & Equipment - 9.8%** |
| 871895 | Apple, Inc. | &nbsp;&nbsp;&nbsp; 237033375 |
| 248167 | Corning, Inc. | &nbsp;&nbsp;&nbsp; 21729502 |
| 39730 | Motorola Solutions, Inc. | &nbsp;&nbsp;&nbsp; 15229304 |
| 255426 | Trimble, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 20012627 |
|  |  | &nbsp;&nbsp;&nbsp; 294004808 |
|  | **Telecommunication Services - 0.9%** | **Telecommunication Services - 0.9%** |
| 133794 | T-Mobile U.S., Inc. | &nbsp;&nbsp;&nbsp; 27165534 |
|  | **Utilities - 2.4%** | **Utilities - 2.4%** |
| 145535 | Atmos Energy Corp. | &nbsp;&nbsp;&nbsp; 24396032 |
| 423540 | Dominion Energy, Inc. | &nbsp;&nbsp;&nbsp; 24815208 |
| 227915 | WEC Energy Group, Inc. | &nbsp;&nbsp;&nbsp; 24035916 |
|  |  | &nbsp;&nbsp;&nbsp; 73247156 |
|  | Total Common Stocks <br>(cost $1,625,104,417)<br>| &nbsp;&nbsp;&nbsp; $2993254701 |
| **CONVERTIBLE PREFERRED STOCKS - 0.1%** | **CONVERTIBLE PREFERRED STOCKS - 0.1%** | **CONVERTIBLE PREFERRED STOCKS - 0.1%** |
|  | **Health Care Equipment & Services - 0.1%** | **Health Care Equipment & Services - 0.1%** |
| 1871878 | Lumeris Group Holdings Corp.<sup>\*(1)(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; $1591096 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

14 <br>

------

**Hartford Disciplined Equity HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **CONVERTIBLE PREFERRED STOCKS - 0.1% - (continued)** | **CONVERTIBLE PREFERRED STOCKS - 0.1% - (continued)** | **CONVERTIBLE PREFERRED STOCKS - 0.1% - (continued)** | **CONVERTIBLE PREFERRED STOCKS - 0.1% - (continued)** |
|  | **Software & Services - 0.0%** | **Software & Services - 0.0%** | **Software & Services - 0.0%** |
| 287204 | Lookout, Inc. Series F<sup>\*(1)(2)(3)</sup>  | Lookout, Inc. Series F<sup>\*(1)(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; $1125840 |
|  | Total Convertible Preferred Stocks <br>(cost $6,240,761)<br>|  | &nbsp;&nbsp;&nbsp; $2716936 |
|  | Total Long-Term Investments <br>(cost $1,631,345,178)<br>|  | &nbsp;&nbsp;&nbsp; $2995971637 |
| **SHORT-TERM INVESTMENTS - 0.1%** | **SHORT-TERM INVESTMENTS - 0.1%** | **SHORT-TERM INVESTMENTS - 0.1%** | **SHORT-TERM INVESTMENTS - 0.1%** |
|  | **Repurchase Agreements - 0.1%** | **Repurchase Agreements - 0.1%** | **Repurchase Agreements - 0.1%** |
| $2184924 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $2,185,388; collateralized by <br> U.S. Treasury Note at 4.38%, maturing <br> 07/15/2027, with a market value of <br> $2,228,668 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $2,185,388; collateralized by <br> U.S. Treasury Note at 4.38%, maturing <br> 07/15/2027, with a market value of <br> $2,228,668 | &nbsp;&nbsp;&nbsp; $2184924 |
|  | Total Short-Term Investments <br>(cost $2,184,924) | Total Short-Term Investments <br>(cost $2,184,924) | &nbsp;&nbsp;&nbsp; $2184924 |
|  | Total Investments <br>(cost $1,633,530,102)<br>| 99.9<br> %<br>| &nbsp;&nbsp;&nbsp; $2998156561 |
|  | Other Assets and Liabilities | 0.1<br> %<br>| &nbsp;&nbsp;&nbsp; 4228301 |
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $3002384862 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

\* Non-income producing.

<sup>(1)</sup> Investment in securities not registered under the Securities Act of 1933 (excluding securities acquired pursuant to Rule 144A and Regulation S). At the end of the period, the value of such restricted securities amounted to $4,957,538 or 0.2% of net assets. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** <br>**Acquired**<br>| **Security Name** | **Shares/** <br>**Par Value**<br>| **Total Cost** | **Market Value** |
| 07/2014 | &nbsp;&nbsp; Lookout, Inc. Series F <br> Convertible <br> Preferred<br>| &nbsp;&nbsp; 287204 | &nbsp;&nbsp; $3280760 | &nbsp;&nbsp; $1125840 |
| 05/2014 | &nbsp;&nbsp; Lumeris Group <br> Holdings Corp. <br> Convertible <br> Preferred<br>| &nbsp;&nbsp; 1871878 | &nbsp;&nbsp; 2960001 | &nbsp;&nbsp; 1591096 |
| 11/2013 | Tory Burch LLC  | &nbsp;&nbsp; 38805 | &nbsp;&nbsp; 3041403 | &nbsp;&nbsp; 2240602 |
|  |  |  | &nbsp;&nbsp; $9282164 | &nbsp;&nbsp; $4957538 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(2)</sup> Investment valued using significant unobservable inputs. <br> <sup>(3)</sup> Currently no rate available. <br> <sup>†</sup> See Significant Accounting Policies of accompanying Notes to Financial Statements regarding valuation of investments.

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $2993254701 | &nbsp;&nbsp; $2991014099 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $2240602 |
| Convertible Preferred Stocks | &nbsp;&nbsp; 2716936 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 2716936 |
| Short-Term Investments | &nbsp;&nbsp; 2184924 | &nbsp;&nbsp; — | &nbsp;&nbsp; 2184924 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $2998156561 | &nbsp;&nbsp; $2991014099 | &nbsp;&nbsp; $2184924 | &nbsp;&nbsp; $4957538 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

Level 3 investments at the beginning and/or end of the period in relation to net assets were not significant and accordingly, a reconciliation of Level 3 assets for the year ended December 31, 2025 is not presented.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

15 <br>

------

**Hartford Dividend and Growth HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 99.6%** | **COMMON STOCKS - 99.6%** | **COMMON STOCKS - 99.6%** |
|  | **Banks - 7.7%** | **Banks - 7.7%** |
| 1633265 | Bank of America Corp. | &nbsp;&nbsp;&nbsp; $89829575 |
| 108494 | JP Morgan Chase & Co. | &nbsp;&nbsp;&nbsp; 34958937 |
| 1356416 | Truist Financial Corp. | &nbsp;&nbsp;&nbsp; 66749231 |
| 766614 | Wells Fargo & Co. | &nbsp;&nbsp;&nbsp; 71448425 |
|  |  | &nbsp;&nbsp;&nbsp; 262986168 |
|  | **Capital Goods - 10.1%** | **Capital Goods - 10.1%** |
| 152928 | Airbus SE | &nbsp;&nbsp;&nbsp; 35513517 |
| 60646 | General Dynamics Corp. | &nbsp;&nbsp;&nbsp; 20417082 |
| 119370 | Hubbell, Inc. | &nbsp;&nbsp;&nbsp; 53013411 |
| 130997 | Lockheed Martin Corp. | &nbsp;&nbsp;&nbsp; 63359319 |
| 638837 | Masco Corp. | &nbsp;&nbsp;&nbsp; 40540596 |
| 506287 | Otis Worldwide Corp. | &nbsp;&nbsp;&nbsp; 44224170 |
| 189934 | Vertiv Holdings Co. Class A | &nbsp;&nbsp;&nbsp; 30771207 |
| 261270 | Westinghouse Air Brake Technologies Corp. | &nbsp;&nbsp;&nbsp; 55768082 |
|  |  | &nbsp;&nbsp;&nbsp; 343607384 |
|  | **Consumer Discretionary Distribution & Retail - 4.5%** | **Consumer Discretionary Distribution & Retail - 4.5%** |
| 272176 | Amazon.com, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 62823664 |
| 278016 | Lowe's Cos., Inc. | &nbsp;&nbsp;&nbsp; 67046339 |
| 157305 | TJX Cos., Inc. | &nbsp;&nbsp;&nbsp; 24163621 |
|  |  | &nbsp;&nbsp;&nbsp; 154033624 |
|  | **Consumer Durables & Apparel - 0.9%** | **Consumer Durables & Apparel - 0.9%** |
| 246743 | Tapestry, Inc. | &nbsp;&nbsp;&nbsp; 31526353 |
|  | **Consumer Services - 0.7%** | **Consumer Services - 0.7%** |
| 77746 | Expedia Group, Inc. | &nbsp;&nbsp;&nbsp; 22026219 |
|  | **Consumer Staples Distribution & Retail - 1.3%** | **Consumer Staples Distribution & Retail - 1.3%** |
| 616455 | Sysco Corp. | &nbsp;&nbsp;&nbsp; 45426569 |
|  | **Energy - 5.5%** | **Energy - 5.5%** |
| 372517 | ConocoPhillips | &nbsp;&nbsp;&nbsp; 34871316 |
| 1879409 | Coterra Energy, Inc. | &nbsp;&nbsp;&nbsp; 49466045 |
| 616174 | EQT Corp. | &nbsp;&nbsp;&nbsp; 33026926 |
| 231861 | TotalEnergies SE<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 15168347 |
| 934718 | Williams Cos., Inc. | &nbsp;&nbsp;&nbsp; 56185899 |
|  |  | &nbsp;&nbsp;&nbsp; 188718533 |
|  | **Equity Real Estate Investment Trusts (REITs) - 3.0%** | **Equity Real Estate Investment Trusts (REITs) - 3.0%** |
| 110363 | AvalonBay Communities, Inc. REIT | &nbsp;&nbsp;&nbsp; 20009916 |
| 83447 | Public Storage REIT | &nbsp;&nbsp;&nbsp; 21654496 |
| 325924 | Welltower, Inc. REIT | &nbsp;&nbsp;&nbsp; 60494754 |
|  |  | &nbsp;&nbsp;&nbsp; 102159166 |
|  | **Financial Services - 8.4%** | **Financial Services - 8.4%** |
| 50298 | American Express Co. | &nbsp;&nbsp;&nbsp; 18607745 |
| 49186 | Blackrock, Inc. | &nbsp;&nbsp;&nbsp; 52645743 |
| 392036 | Intercontinental Exchange, Inc. | &nbsp;&nbsp;&nbsp; 63494151 |
| 161726 | Morgan Stanley | &nbsp;&nbsp;&nbsp; 28711217 |
| 142049 | S&P Global, Inc. | &nbsp;&nbsp;&nbsp; 74233387 |
| 142803 | Visa, Inc. Class A | &nbsp;&nbsp;&nbsp; 50082440 |
|  |  | &nbsp;&nbsp;&nbsp; 287774683 |
|  | **Food, Beverage & Tobacco - 3.5%** | **Food, Beverage & Tobacco - 3.5%** |
| 889529 | General Mills, Inc. | &nbsp;&nbsp;&nbsp; 41363098 |
| 494352 | Philip Morris International, Inc. | &nbsp;&nbsp;&nbsp; 79294061 |
|  |  | &nbsp;&nbsp;&nbsp; 120657159 |
|  | **Health Care Equipment & Services - 4.8%** | **Health Care Equipment & Services - 4.8%** |
| 49502 | HCA Healthcare, Inc. | &nbsp;&nbsp;&nbsp; 23110504 |
| 151602 | Humana, Inc. | &nbsp;&nbsp;&nbsp; 38829820 |
| 125960 | Labcorp Holdings, Inc. | &nbsp;&nbsp;&nbsp; 31600845 |
| 208716 | UnitedHealth Group, Inc. | &nbsp;&nbsp;&nbsp; 68899239 |
|  |  | &nbsp;&nbsp;&nbsp; 162440408 |
|  | **Household & Personal Products - 1.9%** | **Household & Personal Products - 1.9%** |
| 1009356 | Unilever PLC ADR<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 66011882 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 99.6% - (continued)** | **COMMON STOCKS - 99.6% - (continued)** | **COMMON STOCKS - 99.6% - (continued)** |
|  | **Insurance - 2.7%** | **Insurance - 2.7%** |
| 584940 | American International Group, Inc. | &nbsp;&nbsp;&nbsp; $50041617 |
| 218798 | Marsh & McLennan Cos., Inc. | &nbsp;&nbsp;&nbsp; 40591405 |
|  |  | &nbsp;&nbsp;&nbsp; 90633022 |
|  | **Materials - 2.3%** | **Materials - 2.3%** |
| 3904519 | Amcor PLC | &nbsp;&nbsp;&nbsp; 32563688 |
| 85900 | Avery Dennison Corp. | &nbsp;&nbsp;&nbsp; 15623492 |
| 474391 | BHP Group Ltd. ADR<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 28638985 |
|  |  | &nbsp;&nbsp;&nbsp; 76826165 |
|  | **Media & Entertainment - 8.5%** | **Media & Entertainment - 8.5%** |
| 652601 | Alphabet, Inc. Class A | &nbsp;&nbsp;&nbsp; 204264113 |
| 643723 | Omnicom Group, Inc. | &nbsp;&nbsp;&nbsp; 51980632 |
| 307023 | Walt Disney Co. | &nbsp;&nbsp;&nbsp; 34930007 |
|  |  | &nbsp;&nbsp;&nbsp; 291174752 |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 8.7%** | **Pharmaceuticals, Biotechnology & Life Sciences - 8.7%** |
| 192845 | AbbVie, Inc. | &nbsp;&nbsp;&nbsp; 44063153 |
| 351361 | AstraZeneca PLC ADR | &nbsp;&nbsp;&nbsp; 32300617 |
| 249336 | Danaher Corp. | &nbsp;&nbsp;&nbsp; 57077997 |
| 364227 | Gilead Sciences, Inc. | &nbsp;&nbsp;&nbsp; 44705222 |
| 681245 | Merck & Co., Inc. | &nbsp;&nbsp;&nbsp; 71707849 |
| 1904675 | Pfizer, Inc. | &nbsp;&nbsp;&nbsp; 47426407 |
|  |  | &nbsp;&nbsp;&nbsp; 297281245 |
|  | **Semiconductors & Semiconductor Equipment - 6.7%** | **Semiconductors & Semiconductor Equipment - 6.7%** |
| 83782 | Broadcom, Inc. | &nbsp;&nbsp;&nbsp; 28996950 |
| 128942 | Micron Technology, Inc. | &nbsp;&nbsp;&nbsp; 36801336 |
| 357670 | NXP Semiconductors NV | &nbsp;&nbsp;&nbsp; 77635850 |
| 502294 | QUALCOMM, Inc. | &nbsp;&nbsp;&nbsp; 85917389 |
|  |  | &nbsp;&nbsp;&nbsp; 229351525 |
|  | **Software & Services - 7.5%** | **Software & Services - 7.5%** |
| 618664 | Cognizant Technology Solutions Corp. Class A | &nbsp;&nbsp;&nbsp; 51349112 |
| 261053 | Microsoft Corp. | &nbsp;&nbsp;&nbsp; 126250452 |
| 73863 | Roper Technologies, Inc. | &nbsp;&nbsp;&nbsp; 32878637 |
| 169444 | Salesforce, Inc. | &nbsp;&nbsp;&nbsp; 44887410 |
|  |  | &nbsp;&nbsp;&nbsp; 255365611 |
|  | **Technology Hardware & Equipment - 4.7%** | **Technology Hardware & Equipment - 4.7%** |
| 78504 | Apple, Inc. | &nbsp;&nbsp;&nbsp; 21342098 |
| 1257341 | Cisco Systems, Inc. | &nbsp;&nbsp;&nbsp; 96852977 |
| 337177 | Dell Technologies, Inc. Class C | &nbsp;&nbsp;&nbsp; 42443841 |
|  |  | &nbsp;&nbsp;&nbsp; 160638916 |
|  | **Transportation - 1.8%** | **Transportation - 1.8%** |
| 550667 | Delta Air Lines, Inc. | &nbsp;&nbsp;&nbsp; 38216290 |
| 111995 | JB Hunt Transport Services, Inc. | &nbsp;&nbsp;&nbsp; 21765108 |
|  |  | &nbsp;&nbsp;&nbsp; 59981398 |
|  | **Utilities - 4.4%** | **Utilities - 4.4%** |
| 357421 | Duke Energy Corp. | &nbsp;&nbsp;&nbsp; 41893315 |
| 1193262 | Exelon Corp. | &nbsp;&nbsp;&nbsp; 52014291 |
| 639397 | Sempra | &nbsp;&nbsp;&nbsp; 56452361 |
|  |  | &nbsp;&nbsp;&nbsp; 150359967 |
|  | Total Common Stocks <br>(cost $2,320,195,662)<br>| &nbsp;&nbsp;&nbsp; $3398980749 |
| **SHORT-TERM INVESTMENTS - 1.4%** | **SHORT-TERM INVESTMENTS - 1.4%** | **SHORT-TERM INVESTMENTS - 1.4%** |
|  | **Repurchase Agreements - 0.1%** | **Repurchase Agreements - 0.1%** |
| $2050574 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $2,051,009; collateralized by <br> U.S. Treasury Bond at 4.63%, maturing <br> 11/15/2055, with a market value of <br> $2,091,637 | &nbsp;&nbsp;&nbsp; $2050574 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

16 <br>

------

**Hartford Dividend and Growth HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **SHORT-TERM INVESTMENTS - 1.4% - (continued)** | **SHORT-TERM INVESTMENTS - 1.4% - (continued)** | **SHORT-TERM INVESTMENTS - 1.4% - (continued)** | **SHORT-TERM INVESTMENTS - 1.4% - (continued)** |
|  | **Securities Lending Collateral - 1.3%** | **Securities Lending Collateral - 1.3%** | **Securities Lending Collateral - 1.3%** |
| 45234710 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(2)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; $45234710 |
|  | Total Short-Term Investments <br>(cost $47,285,284) | Total Short-Term Investments <br>(cost $47,285,284) | &nbsp;&nbsp;&nbsp; $47285284 |
|  | Total Investments <br>(cost $2,367,480,946)<br>| 101.0<br> %<br>| &nbsp;&nbsp;&nbsp; $3446266033 |
|  | Other Assets and Liabilities | (1.0)%<br>| &nbsp;&nbsp;&nbsp; (33428373)<br>|
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $3412837660 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service approved by Hartford Funds Management Company, LLC in order to reflect an adjustment for factors occurring after the close of certain foreign markets but before the close of the New York Stock Exchange.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

---

| | |
|:---|:---|
| \* | Non-income producing. |
| <sup>(1)</sup> <br>| Represents entire or partial securities on loan. See Note 8 in the accompanying <br> Notes to Financial Statements for securities lending information.<br>|
| <sup>(2)</sup> <br>| Current yield as of period end. |
| <sup>†</sup> | See Significant Accounting Policies of accompanying Notes to Financial <br> Statements regarding valuation of investments.<br>|

---

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $3398980749 | &nbsp;&nbsp; $3363467232 | &nbsp;&nbsp; $35513517 | &nbsp;&nbsp; $— |
| Short-Term Investments | &nbsp;&nbsp; 47285284 | &nbsp;&nbsp; 45234710 | &nbsp;&nbsp; 2050574 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $3446266033 | &nbsp;&nbsp; $3408701942 | &nbsp;&nbsp; $37564091 | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

17 <br>

------

**Hartford Healthcare HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 98.5%** | **COMMON STOCKS - 98.5%** | **COMMON STOCKS - 98.5%** |
|  | **Biotechnology - 22.8%** | **Biotechnology - 22.8%** |
| 21228 | AbbVie, Inc. | &nbsp;&nbsp;&nbsp; $4850386 |
| 1986 | Alnylam Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 789733 |
| 20657 | Apellis Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 518904 |
| 6028 | Apogee Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 454993 |
| 26903 | Arcus Biosciences, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 641099 |
| 1475 | Argenx SE ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1240401 |
| 3519 | Ascendis Pharma AS ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 750392 |
| 7118 | Biogen, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1252697 |
| 22221 | Celldex Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 603522 |
| 1300 | CG oncology, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 53976 |
| 9927 | Cytokinetics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 630762 |
| 9796 | Dianthus Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 403693 |
| 5765 | Disc Medicine, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 457799 |
| 5800 | GenFleet Therapeutics Shanghai, Inc. Class H<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 17722 |
| 12125 | Immunocore Holdings PLC ADR<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 420859 |
| 2300 | Incyte Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 227171 |
| 11428 | Ionis Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 904069 |
| 8372 | Kymera Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 651425 |
| 1275 | Madrigal Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 742484 |
| 5952 | Mirum Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 470148 |
| 2916 | Natera, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 668026 |
| 9285 | Newamsterdam Pharma Co. NV<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 325718 |
| 4103 | Nuvalent, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 412721 |
| 6254 | Protagonist Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 546224 |
| 6614 | PTC Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 502399 |
| 7924 | Revolution Medicines, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 631147 |
| 7975 | Scholar Rock Holding Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 351299 |
| 11658 | Soleno Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 539765 |
| 3149 | United Therapeutics Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1534350 |
| 9730 | Vaxcyte, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 448942 |
| 7056 | Vertex Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3198908 |
| 16993 | Viridian Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 528822 |
| 11984 | Xenon Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 537123 |
|  |  | &nbsp;&nbsp;&nbsp; 26307679 |
|  | **Health Care Distributors - 4.3%** | **Health Care Distributors - 4.3%** |
| 8387 | Cardinal Health, Inc. | &nbsp;&nbsp;&nbsp; 1723528 |
| 9432 | Cencora, Inc. | &nbsp;&nbsp;&nbsp; 3185658 |
|  |  | &nbsp;&nbsp;&nbsp; 4909186 |
|  | **Health Care Equipment - 17.1%** | **Health Care Equipment - 17.1%** |
| 23276 | Abbott Laboratories | &nbsp;&nbsp;&nbsp; 2916250 |
| 28295 | Boston Scientific Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2697928 |
| 40381 | Edwards Lifesciences Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3442480 |
| 5601 | Inspire Medical Systems, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 516580 |
| 8079 | Intuitive Surgical, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4575623 |
| 33264 | Medtronic PLC | &nbsp;&nbsp;&nbsp; 3195340 |
| 4112 | STERIS PLC | &nbsp;&nbsp;&nbsp; 1042474 |
| 3708 | Stryker Corp. | &nbsp;&nbsp;&nbsp; 1303251 |
|  |  | &nbsp;&nbsp;&nbsp; 19689926 |
|  | **Health Care Facilities - 2.5%** | **Health Care Facilities - 2.5%** |
| 28402 | Acadia Healthcare Co., Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 403024 |
| 7061 | Encompass Health Corp. | &nbsp;&nbsp;&nbsp; 749455 |
| 3623 | HCA Healthcare, Inc. | &nbsp;&nbsp;&nbsp; 1691434 |
|  |  | &nbsp;&nbsp;&nbsp; 2843913 |
|  | **Health Care Services - 2.7%** | **Health Care Services - 2.7%** |
| 21045 | CVS Health Corp. | &nbsp;&nbsp;&nbsp; 1670131 |
| 2811 | Labcorp Holdings, Inc. | &nbsp;&nbsp;&nbsp; 705224 |
| 22577 | Option Care Health, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 719303 |
|  |  | &nbsp;&nbsp;&nbsp; 3094658 |
|  | **Health Care Technology - 0.1%** | **Health Care Technology - 0.1%** |
| 5499 | HeartFlow, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 160296 |
|  | **Life Sciences Tools & Services - 9.4%** | **Life Sciences Tools & Services - 9.4%** |
| 14523 | Adaptive Biotechnologies Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 235854 |
| 12494 | Agilent Technologies, Inc. | &nbsp;&nbsp;&nbsp; 1700059 |
| 67131 | Avantor, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 769321 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 98.5% - (continued)** | **COMMON STOCKS - 98.5% - (continued)** | **COMMON STOCKS - 98.5% - (continued)** | **COMMON STOCKS - 98.5% - (continued)** |
|  | **Life Sciences Tools & Services - 9.4% - (continued)** | **Life Sciences Tools & Services - 9.4% - (continued)** | **Life Sciences Tools & Services - 9.4% - (continued)** |
| 12458 | Bio-Techne Corp. | Bio-Techne Corp. | &nbsp;&nbsp;&nbsp; $732655 |
| 15661 | Danaher Corp. | Danaher Corp. | &nbsp;&nbsp;&nbsp; 3585116 |
| 3533 | ICON PLC<sup>\*</sup>  | ICON PLC<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 643783 |
| 12495 | Qiagen NV | Qiagen NV | &nbsp;&nbsp;&nbsp; 561900 |
| 4616 | Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | &nbsp;&nbsp;&nbsp; 2674741 |
|  |  |  | &nbsp;&nbsp;&nbsp; 10903429 |
|  | **Managed Health Care - 7.7%** | **Managed Health Care - 7.7%** | **Managed Health Care - 7.7%** |
| 32047 | Alignment Healthcare, Inc.<sup>\*</sup>  | Alignment Healthcare, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 632928 |
| 5977 | Elevance Health, Inc. | Elevance Health, Inc. | &nbsp;&nbsp;&nbsp; 2095237 |
| 18752 | UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | &nbsp;&nbsp;&nbsp; 6190223 |
|  |  |  | &nbsp;&nbsp;&nbsp; 8918388 |
|  | **Pharmaceuticals - 31.9%** | **Pharmaceuticals - 31.9%** | **Pharmaceuticals - 31.9%** |
| 12487 | AstraZeneca PLC ADR | AstraZeneca PLC ADR | &nbsp;&nbsp;&nbsp; 1147930 |
| 15121 | Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | &nbsp;&nbsp;&nbsp; 815627 |
| 9424 | Crinetics Pharmaceuticals, Inc.<sup>\*</sup>  | Crinetics Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 438687 |
| 31530 | Elanco Animal Health, Inc.<sup>\*</sup>  | Elanco Animal Health, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 713524 |
| 14717 | Eli Lilly & Co. | Eli Lilly & Co. | &nbsp;&nbsp;&nbsp; 15816066 |
| 4659 | Galderma Group AG | Galderma Group AG | &nbsp;&nbsp;&nbsp; 948725 |
| 59241 | GSK PLC | GSK PLC | &nbsp;&nbsp;&nbsp; 1452424 |
| 45725 | Jiangsu Hengrui Pharmaceuticals Co. Ltd. <br> Class H<sup>\*(1)</sup>  | Jiangsu Hengrui Pharmaceuticals Co. Ltd. <br> Class H<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 419190 |
| 26614 | Johnson & Johnson | Johnson & Johnson | &nbsp;&nbsp;&nbsp; 5507767 |
| 60254 | Merck & Co., Inc. | Merck & Co., Inc. | &nbsp;&nbsp;&nbsp; 6342336 |
| 25652 | Oculis Holding AG<sup>\*</sup>  | Oculis Holding AG<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 512270 |
| 21196 | Pharvaris NV<sup>\*</sup>  | Pharvaris NV<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 588189 |
| 8227 | Structure Therapeutics, Inc. ADR<sup>\*</sup>  | Structure Therapeutics, Inc. ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 572188 |
| 5729 | UCB SA | UCB SA | &nbsp;&nbsp;&nbsp; 1596251 |
|  |  |  | &nbsp;&nbsp;&nbsp; 36871174 |
|  | Total Common Stocks <br>(cost $72,058,162)<br>|  | &nbsp;&nbsp;&nbsp; $113698649 |
| **RIGHTS - 0.0%** | **RIGHTS - 0.0%** | **RIGHTS - 0.0%** | **RIGHTS - 0.0%** |
|  | **Health Care Equipment - 0.0%** | **Health Care Equipment - 0.0%** | **Health Care Equipment - 0.0%** |
| 885 | Abiomed, Inc. CVR<sup>\*(2)(3)(4)</sup>  | Abiomed, Inc. CVR<sup>\*(2)(3)(4)</sup>  | &nbsp;&nbsp;&nbsp; $903 |
|  | Total Rights <br>(cost $903)<br>|  | &nbsp;&nbsp;&nbsp; $903 |
|  | Total Long-Term Investments <br>(cost $72,059,065)<br>|  | &nbsp;&nbsp;&nbsp; $113699552 |
| **SHORT-TERM INVESTMENTS - 0.5%** | **SHORT-TERM INVESTMENTS - 0.5%** | **SHORT-TERM INVESTMENTS - 0.5%** | **SHORT-TERM INVESTMENTS - 0.5%** |
|  | **Repurchase Agreements - 0.4%** | **Repurchase Agreements - 0.4%** | **Repurchase Agreements - 0.4%** |
| $456747 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, due <br> on 01/02/2026 with a maturity value of <br> $456,844; collateralized by U.S. Treasury Note <br> at 4.38%, maturing 07/15/2027, with a market <br> value of $466,054 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, due <br> on 01/02/2026 with a maturity value of <br> $456,844; collateralized by U.S. Treasury Note <br> at 4.38%, maturing 07/15/2027, with a market <br> value of $466,054 | &nbsp;&nbsp;&nbsp; $456747 |
|  | **Securities Lending Collateral - 0.1%** | **Securities Lending Collateral - 0.1%** | **Securities Lending Collateral - 0.1%** |
| 138450 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, 3.78%<sup>(5)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, 3.78%<sup>(5)</sup>  | &nbsp;&nbsp;&nbsp; 138450 |
|  | Total Short-Term Investments <br>(cost $595,197) | Total Short-Term Investments <br>(cost $595,197) | &nbsp;&nbsp;&nbsp; $595197 |
|  | Total Investments <br>(cost $72,654,262)<br>| 99.0<br> %<br>| &nbsp;&nbsp;&nbsp; $114294749 |
|  | Other Assets and Liabilities | 1.0<br> %<br>| &nbsp;&nbsp;&nbsp; 1125191 |
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $115419940 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

18 <br>

------

**Hartford Healthcare HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service approved by Hartford Funds Management Company, LLC in order to reflect an adjustment for factors occurring after the close of certain foreign markets but before the close of the New York Stock Exchange.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

\* Non-income producing. <br> <sup>(1)</sup> Represents entire or partial securities on loan. See Note 8 in the accompanying Notes to Financial Statements for securities lending information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(2)</sup> Investment in securities not registered under the Securities Act of 1933 (excluding securities acquired pursuant to Rule 144A and Regulation S). At the end of the period, the value of such restricted securities amounted to $903 or 0.0% of net assets. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** <br>**Acquired**<br>| **Security Name** | **Shares/** <br>**Par Value**<br>| **Total Cost** | **Market Value** |
| 12/2022 | Abiomed, Inc. CVR | &nbsp;&nbsp; 885 | &nbsp;&nbsp; $903 | &nbsp;&nbsp; $903 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| <sup>(3)</sup> <br>| Investment valued using significant unobservable inputs. |
| <sup>(4)</sup> <br>| Currently no expiration date available. |
| <sup>(5)</sup> <br>| Current yield as of period end. |
| <sup>†</sup> | See Significant Accounting Policies of accompanying Notes to Financial <br> Statements regarding valuation of investments.<br>|

---

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $113698649 | &nbsp;&nbsp; $109282059 | &nbsp;&nbsp; $4416590 | &nbsp;&nbsp; $— |
| Rights | &nbsp;&nbsp; 903 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 903 |
| Short-Term Investments | &nbsp;&nbsp; 595197 | &nbsp;&nbsp; 138450 | &nbsp;&nbsp; 456747 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $114294749 | &nbsp;&nbsp; $109420509 | &nbsp;&nbsp; $4873337 | &nbsp;&nbsp; $903 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

Level 3 investments at the beginning and/or end of the period in relation to net assets were not significant and accordingly, a reconciliation of Level 3 assets for the year ended December 31, 2025 is not presented.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

19 <br>

------

**Hartford International Opportunities HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 99.0%** | **COMMON STOCKS - 99.0%** | **COMMON STOCKS - 99.0%** |
|  | **Belgium - 1.2%** | **Belgium - 1.2%** |
| 73983 | KBC Group NV | &nbsp;&nbsp;&nbsp; $9635246 |
|  | **Brazil - 1.5%** | **Brazil - 1.5%** |
| 283976 | Cia de Saneamento Basico do Estado de Sao <br> Paulo SABESP | &nbsp;&nbsp;&nbsp; 6836093 |
| 2791 | MercadoLibre, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5621799 |
| 11300 | TIM SA | &nbsp;&nbsp;&nbsp; 43855 |
|  |  | &nbsp;&nbsp;&nbsp; 12501747 |
|  | **Canada - 5.8%** | **Canada - 5.8%** |
| 467516 | Cenovus Energy, Inc.<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 7909163 |
| 113076 | RB Global, Inc.<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 11641666 |
| 98570 | Royal Bank of Canada | &nbsp;&nbsp;&nbsp; 16804047 |
| 75282 | Shopify, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 12121469 |
|  |  | &nbsp;&nbsp;&nbsp; 48476345 |
|  | **Chile - 1.0%** | **Chile - 1.0%** |
| 375197 | Lundin Mining Corp.<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 8064050 |
|  | **China - 6.5%** | **China - 6.5%** |
| 1080474 | ENN Energy Holdings Ltd. | &nbsp;&nbsp;&nbsp; 9610692 |
| 509681 | Full Truck Alliance Co. Ltd. ADR | &nbsp;&nbsp;&nbsp; 5468877 |
| 437377 | KE Holdings, Inc. ADR | &nbsp;&nbsp;&nbsp; 6893061 |
| 310613 | Tencent Holdings Ltd. | &nbsp;&nbsp;&nbsp; 23837539 |
| 119100 | Trip.com Group Ltd. | &nbsp;&nbsp;&nbsp; 8539635 |
|  |  | &nbsp;&nbsp;&nbsp; 54349804 |
|  | **France - 7.4%** | **France - 7.4%** |
| 173756 | Accor SA | &nbsp;&nbsp;&nbsp; 9795740 |
| 47337 | Airbus SE | &nbsp;&nbsp;&nbsp; 10992777 |
| 101960 | Cie de Saint-Gobain SA | &nbsp;&nbsp;&nbsp; 10368504 |
| 173574 | Klepierre SA REIT | &nbsp;&nbsp;&nbsp; 6867504 |
| 561655 | Orange SA | &nbsp;&nbsp;&nbsp; 9372087 |
| 176921 | Societe Generale SA | &nbsp;&nbsp;&nbsp; 14242844 |
|  |  | &nbsp;&nbsp;&nbsp; 61639456 |
|  | **Germany - 12.0%** | **Germany - 12.0%** |
| 48109 | adidas AG | &nbsp;&nbsp;&nbsp; 9520098 |
| 31843 | Allianz SE | &nbsp;&nbsp;&nbsp; 14723477 |
| 303238 | Deutsche Telekom AG | &nbsp;&nbsp;&nbsp; 9870716 |
| 603954 | E.ON SE | &nbsp;&nbsp;&nbsp; 11435820 |
| 151798 | Infineon Technologies AG | &nbsp;&nbsp;&nbsp; 6623089 |
| 4517 | Rheinmetall AG | &nbsp;&nbsp;&nbsp; 8240787 |
| 60515 | SAP SE | &nbsp;&nbsp;&nbsp; 14703241 |
| 50662 | Siemens AG | &nbsp;&nbsp;&nbsp; 14189229 |
| 77997 | Siemens Energy AG<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10942086 |
|  |  | &nbsp;&nbsp;&nbsp; 100248543 |
|  | **Hong Kong - 2.6%** | **Hong Kong - 2.6%** |
| 1295285 | AIA Group Ltd. | &nbsp;&nbsp;&nbsp; 13332489 |
| 161020 | Hong Kong Exchanges & Clearing Ltd. | &nbsp;&nbsp;&nbsp; 8424784 |
|  |  | &nbsp;&nbsp;&nbsp; 21757273 |
|  | **India - 2.5%** | **India - 2.5%** |
| 1160599 | HDFC Bank Ltd. | &nbsp;&nbsp;&nbsp; 12821012 |
| 457433 | Reliance Industries Ltd. | &nbsp;&nbsp;&nbsp; 8004444 |
|  |  | &nbsp;&nbsp;&nbsp; 20825456 |
|  | **Indonesia - 1.0%** | **Indonesia - 1.0%** |
| 17501120 | Bank Central Asia Tbk. PT | &nbsp;&nbsp;&nbsp; 8451232 |
|  | **Israel - 1.1%** | **Israel - 1.1%** |
| 305248 | Teva Pharmaceutical Industries Ltd. ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 9526790 |
|  | **Italy - 4.0%** | **Italy - 4.0%** |
| 18537 | Ferrari NV | &nbsp;&nbsp;&nbsp; 6888611 |
| 105131 | Ryanair Holdings PLC ADR | &nbsp;&nbsp;&nbsp; 7589407 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 99.0% - (continued)** | **COMMON STOCKS - 99.0% - (continued)** | **COMMON STOCKS - 99.0% - (continued)** |
|  | **Italy - 4.0% - (continued)** | **Italy - 4.0% - (continued)** |
| 2507605 | Saipem SpA<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $7099019 |
| 141006 | UniCredit SpA | &nbsp;&nbsp;&nbsp; 11679060 |
|  |  | &nbsp;&nbsp;&nbsp; 33256097 |
|  | **Japan - 14.0%** | **Japan - 14.0%** |
| 134200 | Chugai Pharmaceutical Co. Ltd. | &nbsp;&nbsp;&nbsp; 7040341 |
| 50100 | Daikin Industries Ltd. | &nbsp;&nbsp;&nbsp; 6407380 |
| 20400 | Fast Retailing Co. Ltd. | &nbsp;&nbsp;&nbsp; 7396801 |
| 26400 | Hikari Tsushin, Inc. | &nbsp;&nbsp;&nbsp; 7397250 |
| 905505 | ITOCHU Corp. | &nbsp;&nbsp;&nbsp; 11442695 |
| 595100 | Kansai Electric Power Co., Inc. | &nbsp;&nbsp;&nbsp; 9345855 |
| 24022 | Keyence Corp. | &nbsp;&nbsp;&nbsp; 8689351 |
| 1002220 | Mitsubishi UFJ Financial Group, Inc. | &nbsp;&nbsp;&nbsp; 15906305 |
| 870626 | Mitsui Fudosan Co. Ltd. | &nbsp;&nbsp;&nbsp; 9894030 |
| 126500 | Nomura Research Institute Ltd. | &nbsp;&nbsp;&nbsp; 4813908 |
| 1163800 | Rakuten Group, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7457592 |
| 88404 | SoftBank Group Corp. | &nbsp;&nbsp;&nbsp; 2480025 |
| 457800 | Sony Group Corp. | &nbsp;&nbsp;&nbsp; 11743014 |
| 245700 | Sumitomo Mitsui Trust Group, Inc. | &nbsp;&nbsp;&nbsp; 7487669 |
|  |  | &nbsp;&nbsp;&nbsp; 117502216 |
|  | **Mexico - 1.0%** | **Mexico - 1.0%** |
| 724089 | Cemex SAB de CV ADR | &nbsp;&nbsp;&nbsp; 8319783 |
|  | **Netherlands - 2.3%** | **Netherlands - 2.3%** |
| 18035 | ASML Holding NV | &nbsp;&nbsp;&nbsp; 19433076 |
|  | **Singapore - 1.7%** | **Singapore - 1.7%** |
| 44372 | Sea Ltd. ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5660536 |
| 2430144 | Singapore Telecommunications Ltd. | &nbsp;&nbsp;&nbsp; 8597845 |
|  |  | &nbsp;&nbsp;&nbsp; 14258381 |
|  | **South Africa - 1.4%** | **South Africa - 1.4%** |
| 293644 | Anglo American PLC | &nbsp;&nbsp;&nbsp; 12145851 |
|  | **South Korea - 4.3%** | **South Korea - 4.3%** |
| 506463 | KT Corp. ADR | &nbsp;&nbsp;&nbsp; 9607603 |
| 137703 | Shinhan Financial Group Co. Ltd. | &nbsp;&nbsp;&nbsp; 7332648 |
| 41269 | SK Hynix, Inc. | &nbsp;&nbsp;&nbsp; 18689815 |
|  |  | &nbsp;&nbsp;&nbsp; 35630066 |
|  | **Spain - 0.7%** | **Spain - 0.7%** |
| 80458 | Amadeus IT Group SA | &nbsp;&nbsp;&nbsp; 5954777 |
|  | **Switzerland - 3.7%** | **Switzerland - 3.7%** |
| 43475 | Cie Financiere Richemont SA Class A | &nbsp;&nbsp;&nbsp; 9375424 |
| 37233 | Galderma Group AG | &nbsp;&nbsp;&nbsp; 7581855 |
| 312320 | UBS Group AG | &nbsp;&nbsp;&nbsp; 14421241 |
|  |  | &nbsp;&nbsp;&nbsp; 31378520 |
|  | **Taiwan - 5.4%** | **Taiwan - 5.4%** |
| 488000 | Quanta Computer, Inc. | &nbsp;&nbsp;&nbsp; 4214800 |
| 831806 | Taiwan Semiconductor Manufacturing Co. Ltd. | &nbsp;&nbsp;&nbsp; 40889300 |
|  |  | &nbsp;&nbsp;&nbsp; 45104100 |
|  | **United Kingdom - 12.9%** | **United Kingdom - 12.9%** |
| 93000 | AstraZeneca PLC | &nbsp;&nbsp;&nbsp; 17210514 |
| 329745 | BAE Systems PLC | &nbsp;&nbsp;&nbsp; 7589101 |
| 1034244 | Barratt Redrow PLC | &nbsp;&nbsp;&nbsp; 5313105 |
| 216911 | British American Tobacco PLC | &nbsp;&nbsp;&nbsp; 12296831 |
| 297882 | Imperial Brands PLC | &nbsp;&nbsp;&nbsp; 12508122 |
| 7876006 | Lloyds Banking Group PLC | &nbsp;&nbsp;&nbsp; 10417705 |
| 74290 | London Stock Exchange Group PLC | &nbsp;&nbsp;&nbsp; 8936236 |
| 111170 | Reckitt Benckiser Group PLC | &nbsp;&nbsp;&nbsp; 8995805 |
| 452648 | Standard Chartered PLC | &nbsp;&nbsp;&nbsp; 11044809 |
| 215433 | Unilever PLC | &nbsp;&nbsp;&nbsp; 14075791 |
|  |  | &nbsp;&nbsp;&nbsp; 108388019 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

20 <br>

------

**Hartford International Opportunities HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 99.0% - (continued)** | **COMMON STOCKS - 99.0% - (continued)** | **COMMON STOCKS - 99.0% - (continued)** | **COMMON STOCKS - 99.0% - (continued)** |
|  | **United States - 5.0%** | **United States - 5.0%** | **United States - 5.0%** |
| 148552 | GFL Environmental, Inc. | GFL Environmental, Inc. | &nbsp;&nbsp;&nbsp; $6380309 |
| 435115 | GSK PLC | GSK PLC | &nbsp;&nbsp;&nbsp; 10667808 |
| 1713421 | Haleon PLC | Haleon PLC | &nbsp;&nbsp;&nbsp; 8658570 |
| 439687 | Shell PLC | Shell PLC | &nbsp;&nbsp;&nbsp; 16287788 |
|  |  |  | &nbsp;&nbsp;&nbsp; 41994475 |
|  | Total Common Stocks <br>(cost $568,146,152)<br>|  | &nbsp;&nbsp;&nbsp; $828841303 |
| **WARRANTS - 0.0%** | **WARRANTS - 0.0%** | **WARRANTS - 0.0%** | **WARRANTS - 0.0%** |
|  | **Canada - 0.0%** | **Canada - 0.0%** | **Canada - 0.0%** |
| 5095 | Constellation Software, Inc. Expires <br> 03/31/2040<sup>\*(2)(3)</sup>  | Constellation Software, Inc. Expires <br> 03/31/2040<sup>\*(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; $— |
|  | Total Warrants <br>(cost $—)<br>|  | &nbsp;&nbsp;&nbsp; $— |
|  | Total Long-Term Investments <br>(cost $568,146,152)<br>|  | &nbsp;&nbsp;&nbsp; $828841303 |
| **SHORT-TERM INVESTMENTS - 0.7%** | **SHORT-TERM INVESTMENTS - 0.7%** | **SHORT-TERM INVESTMENTS - 0.7%** | **SHORT-TERM INVESTMENTS - 0.7%** |
|  | **Repurchase Agreements - 0.2%** | **Repurchase Agreements - 0.2%** | **Repurchase Agreements - 0.2%** |
| $1278570 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value of <br> $1,278,841; collateralized by U.S. Treasury <br> Note at 4.38%, maturing 07/15/2027, with <br> a market value of $1,304,162 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value of <br> $1,278,841; collateralized by U.S. Treasury <br> Note at 4.38%, maturing 07/15/2027, with <br> a market value of $1,304,162 | &nbsp;&nbsp;&nbsp; $1278570 |
|  | **Securities Lending Collateral - 0.5%** | **Securities Lending Collateral - 0.5%** | **Securities Lending Collateral - 0.5%** |
| 4518237 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(4)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(4)</sup>  | &nbsp;&nbsp;&nbsp; 4518237 |
|  | Total Short-Term Investments <br>(cost $5,796,807) | Total Short-Term Investments <br>(cost $5,796,807) | &nbsp;&nbsp;&nbsp; $5796807 |
|  | Total Investments <br>(cost $573,942,959)<br>| 99.7<br> %<br>| &nbsp;&nbsp;&nbsp; $834638110 |
|  | Other Assets and Liabilities | 0.3<br> %<br>| &nbsp;&nbsp;&nbsp; 2699089 |
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $837337199 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service approved by Hartford Funds Management Company, LLC in order to reflect an adjustment for factors occurring after the close of certain foreign markets but before the close of the New York Stock Exchange.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

\* Non-income producing.

<sup>(1)</sup> Represents entire or partial securities on loan. See Note 8 in the accompanying Notes to Financial Statements for securities lending information. 

<sup>(2)</sup> Investment in securities not registered under the Securities Act of 1933 (excluding securities acquired pursuant to Rule 144A and Regulation S). At the end of the period, the value of such restricted securities amounted to $0 or 0.0% of net assets. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** <br>**Acquired**<br>| **Security Name** | **Shares/** <br>**Par Value**<br>| **Total Cost** | **Market Value** |
| 08/2023 | &nbsp;&nbsp; Constellation Software, <br> Inc. Expires <br> 03/31/2040 Warrants<br>| &nbsp;&nbsp; 5095 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(3)</sup> Investment valued using significant unobservable inputs. <br> <sup>(4)</sup> Current yield as of period end. <br> <sup>†</sup> See Significant Accounting Policies of accompanying Notes to Financial Statements regarding valuation of investments.

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $828841303 | &nbsp;&nbsp; $121608560 | &nbsp;&nbsp; $707232743 | &nbsp;&nbsp; $— |
| Warrants | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Short-Term Investments | &nbsp;&nbsp; 5796807 | &nbsp;&nbsp; 4518237 | &nbsp;&nbsp; 1278570 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $834638110 | &nbsp;&nbsp; $126126797 | &nbsp;&nbsp; $708511313 | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

Level 3 investments at the beginning and/or end of the period in relation to net assets were not significant and accordingly, a reconciliation of Level 3 assets for the year ended December 31, 2025 is not presented.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

21 <br>

------

**Hartford MidCap HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 98.2%** | **COMMON STOCKS - 98.2%** | **COMMON STOCKS - 98.2%** |
|  | **Capital Goods - 18.8%** | **Capital Goods - 18.8%** |
| 39008 | Acuity, Inc. | &nbsp;&nbsp;&nbsp; $14044440 |
| 31974 | Axon Enterprise, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 18158995 |
| 48170 | Builders FirstSource, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4956211 |
| 6889 | EMCOR Group, Inc. | &nbsp;&nbsp;&nbsp; 4214621 |
| 471618 | Fastenal Co. | &nbsp;&nbsp;&nbsp; 18926030 |
| 53756 | FTAI Aviation Ltd. | &nbsp;&nbsp;&nbsp; 10581869 |
| 105537 | Graco, Inc. | &nbsp;&nbsp;&nbsp; 8650868 |
| 46377 | HEICO Corp. Class A | &nbsp;&nbsp;&nbsp; 11706946 |
| 102925 | Howmet Aerospace, Inc. | &nbsp;&nbsp;&nbsp; 21101684 |
| 79872 | Ingersoll Rand, Inc. | &nbsp;&nbsp;&nbsp; 6327460 |
| 104819 | Vertiv Holdings Co. Class A | &nbsp;&nbsp;&nbsp; 16981726 |
|  |  | &nbsp;&nbsp;&nbsp; 135650850 |
|  | **Commercial & Professional Services - 7.6%** | **Commercial & Professional Services - 7.6%** |
| 65201 | Clean Harbors, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 15288330 |
| 370052 | Rollins, Inc. | &nbsp;&nbsp;&nbsp; 22210521 |
| 99896 | TransUnion | &nbsp;&nbsp;&nbsp; 8566082 |
| 37939 | Verisk Analytics, Inc. | &nbsp;&nbsp;&nbsp; 8486575 |
|  |  | &nbsp;&nbsp;&nbsp; 54551508 |
|  | **Consumer Discretionary Distribution & Retail - 6.4%** | **Consumer Discretionary Distribution & Retail - 6.4%** |
| 59404 | Boot Barn Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10483024 |
| 47661 | Carvana Co.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 20113895 |
| 123294 | O'Reilly Automotive, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 11245646 |
| 17284 | Pool Corp. | &nbsp;&nbsp;&nbsp; 3953715 |
|  |  | &nbsp;&nbsp;&nbsp; 45796280 |
|  | **Consumer Durables & Apparel - 3.8%** | **Consumer Durables & Apparel - 3.8%** |
| 145887 | Deckers Outdoor Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 15124105 |
| 1693 | NVR, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 12346660 |
|  |  | &nbsp;&nbsp;&nbsp; 27470765 |
|  | **Consumer Services - 6.8%** | **Consumer Services - 6.8%** |
| 115039 | Compass Group PLC ADR | &nbsp;&nbsp;&nbsp; 3680098 |
| 45240 | DoorDash, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10245955 |
| 116324 | Hyatt Hotels Corp. Class A | &nbsp;&nbsp;&nbsp; 18649064 |
| 46938 | Royal Caribbean Cruises Ltd. | &nbsp;&nbsp;&nbsp; 13091947 |
| 12570 | Wingstop, Inc. | &nbsp;&nbsp;&nbsp; 2997819 |
|  |  | &nbsp;&nbsp;&nbsp; 48664883 |
|  | **Consumer Staples Distribution & Retail - 1.5%** | **Consumer Staples Distribution & Retail - 1.5%** |
| 19657 | Casey's General Stores, Inc. | &nbsp;&nbsp;&nbsp; 10864620 |
|  | **Energy - 2.1%** | **Energy - 2.1%** |
| 83769 | Targa Resources Corp. | &nbsp;&nbsp;&nbsp; 15455381 |
|  | **Equity Real Estate Investment Trusts (REITs) - 0.7%** | **Equity Real Estate Investment Trusts (REITs) - 0.7%** |
| 40957 | Lamar Advertising Co. Class A, REIT | &nbsp;&nbsp;&nbsp; 5184337 |
|  | **Financial Services - 6.9%** | **Financial Services - 6.9%** |
| 320577 | Interactive Brokers Group, Inc. Class A | &nbsp;&nbsp;&nbsp; 20616307 |
| 765713 | Rocket Cos., Inc. Class A | &nbsp;&nbsp;&nbsp; 14824204 |
| 133038 | Tradeweb Markets, Inc. Class A | &nbsp;&nbsp;&nbsp; 14306906 |
|  |  | &nbsp;&nbsp;&nbsp; 49747417 |
|  | **Health Care Equipment & Services - 3.0%** | **Health Care Equipment & Services - 3.0%** |
| 15859 | IDEXX Laboratories, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10729089 |
| 18536 | STERIS PLC | &nbsp;&nbsp;&nbsp; 4699247 |
| 26476 | Veeva Systems, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5910237 |
|  |  | &nbsp;&nbsp;&nbsp; 21338573 |
|  | **Insurance - 1.2%** | **Insurance - 1.2%** |
| 4043 | Markel Group, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 8691035 |
|  | **Media & Entertainment - 8.1%** | **Media & Entertainment - 8.1%** |
| 72205 | Live Nation Entertainment, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10289212 |
| 83111 | Reddit, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 19104726 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 98.2% - (continued)** | **COMMON STOCKS - 98.2% - (continued)** | **COMMON STOCKS - 98.2% - (continued)** | **COMMON STOCKS - 98.2% - (continued)** |
|  | **Media & Entertainment - 8.1% - (continued)** | **Media & Entertainment - 8.1% - (continued)** | **Media & Entertainment - 8.1% - (continued)** |
| 199451 | ROBLOX Corp. Class A<sup>\*</sup>  | ROBLOX Corp. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $16161515 |
| 48633 | Take-Two Interactive Software, Inc.<sup>\*</sup>  | Take-Two Interactive Software, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 12451507 |
|  |  |  | &nbsp;&nbsp;&nbsp; 58006960 |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 7.6%** | **Pharmaceuticals, Biotechnology & Life Sciences - 7.6%** | **Pharmaceuticals, Biotechnology & Life Sciences - 7.6%** |
| 60586 | Bio-Techne Corp. | Bio-Techne Corp. | &nbsp;&nbsp;&nbsp; 3563063 |
| 6809 | Mettler-Toledo International, Inc.<sup>\*</sup>  | Mettler-Toledo International, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 9493040 |
| 98926 | Natera, Inc.<sup>\*</sup>  | Natera, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 22662957 |
| 67814 | Tempus AI, Inc.<sup>\*(1)</sup>  | Tempus AI, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 4004417 |
| 40093 | Waters Corp.<sup>\*</sup>  | Waters Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 15228524 |
|  |  |  | &nbsp;&nbsp;&nbsp; 54952001 |
|  | **Semiconductors & Semiconductor Equipment - 4.4%** | **Semiconductors & Semiconductor Equipment - 4.4%** | **Semiconductors & Semiconductor Equipment - 4.4%** |
| 75290 | MKS, Inc. | MKS, Inc. | &nbsp;&nbsp;&nbsp; 12031342 |
| 21743 | Monolithic Power Systems, Inc. | Monolithic Power Systems, Inc. | &nbsp;&nbsp;&nbsp; 19706985 |
|  |  |  | &nbsp;&nbsp;&nbsp; 31738327 |
|  | **Software & Services - 11.7%** | **Software & Services - 11.7%** | **Software & Services - 11.7%** |
| 178277 | Clearwater Analytics Holdings, Inc. Class A<sup>\*</sup>  | Clearwater Analytics Holdings, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4300041 |
| 134029 | Cloudflare, Inc. Class A<sup>\*</sup>  | Cloudflare, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 26423817 |
| 1902 | Constellation Software, Inc. | Constellation Software, Inc. | &nbsp;&nbsp;&nbsp; 4574888 |
| 51189 | Datadog, Inc. Class A<sup>\*</sup>  | Datadog, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6961192 |
| 16389 | Guidewire Software, Inc.<sup>\*</sup>  | Guidewire Software, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3294353 |
| 12965 | HubSpot, Inc.<sup>\*</sup>  | HubSpot, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5202855 |
| 199567 | Procore Technologies, Inc.<sup>\*</sup>  | Procore Technologies, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 14516504 |
| 298560 | Unity Software, Inc.<sup>\*</sup>  | Unity Software, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 13187395 |
| 53808 | Wix.com Ltd.<sup>\*</sup>  | Wix.com Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5590113 |
|  |  |  | &nbsp;&nbsp;&nbsp; 84051158 |
|  | **Technology Hardware & Equipment - 4.5%** | **Technology Hardware & Equipment - 4.5%** | **Technology Hardware & Equipment - 4.5%** |
| 51781 | Celestica, Inc.<sup>\*</sup>  | Celestica, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 15306981 |
| 191880 | Flex Ltd.<sup>\*</sup>  | Flex Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 11593390 |
| 74212 | Trimble, Inc.<sup>\*</sup>  | Trimble, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5814510 |
|  |  |  | &nbsp;&nbsp;&nbsp; 32714881 |
|  | **Telecommunication Services - 0.9%** | **Telecommunication Services - 0.9%** | **Telecommunication Services - 0.9%** |
| 88737 | AST SpaceMobile, Inc.<sup>\*(1)</sup>  | AST SpaceMobile, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 6444968 |
|  | **Utilities - 2.2%** | **Utilities - 2.2%** | **Utilities - 2.2%** |
| 96723 | Vistra Corp. | Vistra Corp. | &nbsp;&nbsp;&nbsp; 15604322 |
|  | Total Common Stocks <br>(cost $579,516,458)<br>|  | &nbsp;&nbsp;&nbsp; $706928266 |
| **SHORT-TERM INVESTMENTS - 1.8%** | **SHORT-TERM INVESTMENTS - 1.8%** | **SHORT-TERM INVESTMENTS - 1.8%** | **SHORT-TERM INVESTMENTS - 1.8%** |
|  | **Repurchase Agreements - 0.3%** | **Repurchase Agreements - 0.3%** | **Repurchase Agreements - 0.3%** |
| $2638060 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value of <br> $2,638,620; collateralized by U.S. Treasury <br> Note at 4.38%, maturing 07/15/2027, with <br> a market value of $2,690,962 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value of <br> $2,638,620; collateralized by U.S. Treasury <br> Note at 4.38%, maturing 07/15/2027, with <br> a market value of $2,690,962 | &nbsp;&nbsp;&nbsp; $2638060 |
|  | **Securities Lending Collateral - 1.5%** | **Securities Lending Collateral - 1.5%** | **Securities Lending Collateral - 1.5%** |
| 10674516 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(2)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 10674516 |
|  | Total Short-Term Investments <br>(cost $13,312,576) | Total Short-Term Investments <br>(cost $13,312,576) | &nbsp;&nbsp;&nbsp; $13312576 |
|  | Total Investments <br>(cost $592,829,034)<br>| 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $720240842 |
|  | Other Assets and Liabilities | (0.0)%<br>| &nbsp;&nbsp;&nbsp; (163232)<br>|
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $720077610 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

22 <br>

------

**Hartford MidCap HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service approved by Hartford Funds Management Company, LLC in order to reflect an adjustment for factors occurring after the close of certain foreign markets but before the close of the New York Stock Exchange.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

---

| | |
|:---|:---|
| \* | Non-income producing. |
| <sup>(1)</sup> <br>| Represents entire or partial securities on loan. See Note 8 in the accompanying <br> Notes to Financial Statements for securities lending information.<br>|
| <sup>(2)</sup> <br>| Current yield as of period end. |
| <sup>†</sup> | See Significant Accounting Policies of accompanying Notes to Financial <br> Statements regarding valuation of investments.<br>|

---

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $706928266 | &nbsp;&nbsp; $706928266 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— |
| Short-Term Investments | &nbsp;&nbsp; 13312576 | &nbsp;&nbsp; 10674516 | &nbsp;&nbsp; 2638060 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $720240842 | &nbsp;&nbsp; $717602782 | &nbsp;&nbsp; $2638060 | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

23 <br>

------

**Hartford Small Cap Growth HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 98.9%** | **COMMON STOCKS - 98.9%** | **COMMON STOCKS - 98.9%** |
|  | **Automobiles & Components - 1.6%** | **Automobiles & Components - 1.6%** |
| 41157 | Dorman Products, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $5070131 |
| 35482 | Patrick Industries, Inc. | &nbsp;&nbsp;&nbsp; 3847313 |
|  |  | &nbsp;&nbsp;&nbsp; 8917444 |
|  | **Banks - 1.3%** | **Banks - 1.3%** |
| 102786 | Cadence Bank | &nbsp;&nbsp;&nbsp; 4403352 |
| 49170 | Synovus Financial Corp. | &nbsp;&nbsp;&nbsp; 2460959 |
|  |  | &nbsp;&nbsp;&nbsp; 6864311 |
|  | **Capital Goods - 18.2%** | **Capital Goods - 18.2%** |
| 44581 | AAON, Inc.<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 3399301 |
| 20409 | AeroVironment, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4936733 |
| 209562 | Archer Aviation, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1575906 |
| 48529 | ATI, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5569188 |
| 95721 | Atmus Filtration Technologies, Inc. | &nbsp;&nbsp;&nbsp; 4968877 |
| 33151 | AZZ, Inc. | &nbsp;&nbsp;&nbsp; 3553124 |
| 83923 | Bloom Energy Corp. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7292069 |
| 22405 | Boise Cascade Co. | &nbsp;&nbsp;&nbsp; 1649008 |
| 13602 | Carpenter Technology Corp. | &nbsp;&nbsp;&nbsp; 4282454 |
| 19417 | DXP Enterprises, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2131792 |
| 105392 | Eos Energy Enterprises, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1207792 |
| 18469 | ESCO Technologies, Inc. | &nbsp;&nbsp;&nbsp; 3608658 |
| 44107 | FTAI Aviation Ltd. | &nbsp;&nbsp;&nbsp; 8682463 |
| 428964 | Hillman Solutions Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3714828 |
| 41479 | Loar Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2820572 |
| 50199 | Modine Manufacturing Co.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6702068 |
| 25981 | Moog, Inc. Class A | &nbsp;&nbsp;&nbsp; 6327673 |
| 17033 | MYR Group, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3721711 |
| 63171 | Nextpower, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5502826 |
| 43963 | Primoris Services Corp. | &nbsp;&nbsp;&nbsp; 5457567 |
| 35260 | SPX Technologies, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7054116 |
| 40923 | Transcat, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2321562 |
| 12865 | WESCO International, Inc. | &nbsp;&nbsp;&nbsp; 3147294 |
|  |  | &nbsp;&nbsp;&nbsp; 99627582 |
|  | **Commercial & Professional Services - 5.0%** | **Commercial & Professional Services - 5.0%** |
| 31686 | Casella Waste Systems, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3103327 |
| 87938 | CBIZ, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4436472 |
| 15332 | Clean Harbors, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3595047 |
| 17593 | Huron Consulting Group, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3042006 |
| 40627 | Innodata, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2069946 |
| 188111 | Upwork, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3728360 |
| 317837 | Verra Mobility Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7122727 |
|  |  | &nbsp;&nbsp;&nbsp; 27097885 |
|  | **Consumer Discretionary Distribution & Retail - 2.3%** | **Consumer Discretionary Distribution & Retail - 2.3%** |
| 19917 | Boot Barn Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3514753 |
| 99544 | National Vision Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2570226 |
| 27975 | Ollie's Bargain Outlet Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3066340 |
| 14270 | Pool Corp. | &nbsp;&nbsp;&nbsp; 3264262 |
|  |  | &nbsp;&nbsp;&nbsp; 12415581 |
|  | **Consumer Durables & Apparel - 2.0%** | **Consumer Durables & Apparel - 2.0%** |
| 9619 | Installed Building Products, Inc. | &nbsp;&nbsp;&nbsp; 2495072 |
| 62545 | Kontoor Brands, Inc. | &nbsp;&nbsp;&nbsp; 3820874 |
| 75148 | Smith Douglas Homes Corp.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 1260232 |
| 70921 | YETI Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3132581 |
|  |  | &nbsp;&nbsp;&nbsp; 10708759 |
|  | **Consumer Services - 3.8%** | **Consumer Services - 3.8%** |
| 29438 | Adtalem Global Education, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3045950 |
| 297628 | Genius Sports Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3279861 |
| 26904 | Hyatt Hotels Corp. Class A | &nbsp;&nbsp;&nbsp; 4313249 |
| 136401 | Life Time Group Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3625539 |
| 26529 | Navan, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 453115 |
| 305523 | Super Group SGHC Ltd. | &nbsp;&nbsp;&nbsp; 3651000 |
| 99594 | Universal Technical Institute, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2602391 |
|  |  | &nbsp;&nbsp;&nbsp; 20971105 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 98.9% - (continued)** | **COMMON STOCKS - 98.9% - (continued)** | **COMMON STOCKS - 98.9% - (continued)** |
|  | **Consumer Staples Distribution & Retail - 1.5%** | **Consumer Staples Distribution & Retail - 1.5%** |
| 42879 | BJ's Wholesale Club Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $3860396 |
| 71962 | Chefs' Warehouse, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4485392 |
|  |  | &nbsp;&nbsp;&nbsp; 8345788 |
|  | **Energy - 2.0%** | **Energy - 2.0%** |
| 60093 | Cactus, Inc. Class A | &nbsp;&nbsp;&nbsp; 2745048 |
| 1781 | Centrus Energy Corp. Class A<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 432356 |
| 53711 | Energy Fuels, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 780958 |
| 13648 | Gulfport Energy Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2838648 |
| 338149 | TETRA Technologies, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3168456 |
| 71206 | Uranium Energy Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 831686 |
|  |  | &nbsp;&nbsp;&nbsp; 10797152 |
|  | **Equity Real Estate Investment Trusts (REITs) - 1.4%** | **Equity Real Estate Investment Trusts (REITs) - 1.4%** |
| 121752 | CareTrust, Inc. REIT | &nbsp;&nbsp;&nbsp; 4402552 |
| 164237 | Urban Edge Properties REIT | &nbsp;&nbsp;&nbsp; 3151708 |
|  |  | &nbsp;&nbsp;&nbsp; 7554260 |
|  | **Financial Services - 7.6%** | **Financial Services - 7.6%** |
| 13014 | Dave, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2881430 |
| 10740 | Evercore, Inc. Class A | &nbsp;&nbsp;&nbsp; 3654285 |
| 45052 | FirstCash Holdings, Inc. | &nbsp;&nbsp;&nbsp; 7180388 |
| 28103 | Hamilton Lane, Inc. Class A | &nbsp;&nbsp;&nbsp; 3774514 |
| 153815 | Marex Group PLC | &nbsp;&nbsp;&nbsp; 5900343 |
| 195997 | Perella Weinberg Partners | &nbsp;&nbsp;&nbsp; 3390748 |
| 170493 | Remitly Global, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2352803 |
| 12268 | Sezzle, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 778711 |
| 69919 | StepStone Group, Inc. Class A | &nbsp;&nbsp;&nbsp; 4486702 |
| 50768 | Stifel Financial Corp. | &nbsp;&nbsp;&nbsp; 6357169 |
| 66233 | Wealthfront Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 900107 |
|  |  | &nbsp;&nbsp;&nbsp; 41657200 |
|  | **Food, Beverage & Tobacco - 1.7%** | **Food, Beverage & Tobacco - 1.7%** |
| 24899 | Freshpet, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1517096 |
| 41197 | Turning Point Brands, Inc. | &nbsp;&nbsp;&nbsp; 4465755 |
| 64419 | Vita Coco Co., Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3414851 |
|  |  | &nbsp;&nbsp;&nbsp; 9397702 |
|  | **Health Care Equipment & Services - 8.4%** | **Health Care Equipment & Services - 8.4%** |
| 85079 | Acadia Healthcare Co., Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1207271 |
| 203330 | Alignment Healthcare, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4015768 |
| 87796 | AtriCure, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3473210 |
| 52414 | Ensign Group, Inc. | &nbsp;&nbsp;&nbsp; 9130519 |
| 26529 | GeneDx Holdings Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3450362 |
| 16869 | Guardant Health, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1723000 |
| 46953 | HealthEquity, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4301364 |
| 43003 | Hims & Hers Health, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1396307 |
| 19731 | Inspire Medical Systems, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1819790 |
| 25980 | iRhythm Technologies, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4609891 |
| 60856 | Merit Medical Systems, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5363848 |
| 54498 | RadNet, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3888432 |
| 12576 | TransMedics Group, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 1529870 |
|  |  | &nbsp;&nbsp;&nbsp; 45909632 |
|  | **Insurance - 1.1%** | **Insurance - 1.1%** |
| 94042 | SiriusPoint Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2058579 |
| 1855 | White Mountains Insurance Group Ltd. | &nbsp;&nbsp;&nbsp; 3854746 |
|  |  | &nbsp;&nbsp;&nbsp; 5913325 |
|  | **Materials - 1.5%** | **Materials - 1.5%** |
| 25063 | Cabot Corp. | &nbsp;&nbsp;&nbsp; 1661176 |
| 166551 | Ivanhoe Electric, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2661485 |
| 184755 | James Hardie Industries PLC ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3833666 |
|  |  | &nbsp;&nbsp;&nbsp; 8156327 |
|  | **Media & Entertainment - 1.7%** | **Media & Entertainment - 1.7%** |
| 136642 | Cargurus, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5240221 |
| 145293 | Magnite, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2358105 |
| 149361 | MNTN, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1783370 |
|  |  | &nbsp;&nbsp;&nbsp; 9381696 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

24 <br>

------

**Hartford Small Cap Growth HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 98.9% - (continued)** | **COMMON STOCKS - 98.9% - (continued)** | **COMMON STOCKS - 98.9% - (continued)** |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 15.5%** | **Pharmaceuticals, Biotechnology & Life Sciences - 15.5%** |
| 61614 | Alkermes PLC<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $1723960 |
| 30138 | Apogee Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2274816 |
| 60515 | Avidity Biosciences, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4364947 |
| 30438 | Axsome Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5559196 |
| 84352 | Bridgebio Pharma, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6452085 |
| 62514 | Celldex Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1697880 |
| 64940 | CG oncology, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2696309 |
| 94667 | Cogent Biosciences, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3362572 |
| 73308 | Crinetics Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3412487 |
| 36295 | Cytokinetics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2306184 |
| 36433 | Disc Medicine, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2893145 |
| 32078 | Ionis Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2537691 |
| 74279 | Janux Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1025050 |
| 34970 | Kymera Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2721016 |
| 9222 | Madrigal Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5370339 |
| 40271 | Mirum Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3181006 |
| 32655 | Nuvalent, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3284766 |
| 48468 | Protagonist Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4233195 |
| 52989 | PTC Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4025044 |
| 23441 | Revolution Medicines, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1867076 |
| 62730 | Scholar Rock Holding Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2763257 |
| 48308 | Soleno Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2236660 |
| 53502 | Spyre Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1752726 |
| 34536 | Structure Therapeutics, Inc. ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2401979 |
| 69528 | Travere Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2656665 |
| 30525 | Ultragenyx Pharmaceutical, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 702075 |
| 30202 | Vaxcyte, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1393520 |
| 87443 | Veracyte, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3681350 |
| 53471 | Vericel Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1925491 |
|  |  | &nbsp;&nbsp;&nbsp; 84502487 |
|  | **Semiconductors & Semiconductor Equipment - 6.2%** | **Semiconductors & Semiconductor Equipment - 6.2%** |
| 31005 | Cirrus Logic, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3674092 |
| 70539 | Credo Technology Group Holding Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 10149857 |
| 14209 | MACOM Technology Solutions Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2433717 |
| 30771 | MKS, Inc. | &nbsp;&nbsp;&nbsp; 4917206 |
| 50760 | Rambus, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4664336 |
| 104679 | Rigetti Computing, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2318640 |
| 16377 | SiTime Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5784193 |
|  |  | &nbsp;&nbsp;&nbsp; 33942041 |
|  | **Software & Services - 8.0%** | **Software & Services - 8.0%** |
| 120611 | ACI Worldwide, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5766412 |
| 26632 | Agilysys, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3164947 |
| 64400 | Applied Digital Corp.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 1579088 |
| 147651 | AvePoint, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2050872 |
| 49470 | Bill Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2698094 |
| 205284 | CCC Intelligent Solutions Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1632008 |
| 186807 | Clearwater Analytics Holdings, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4505785 |
| 27340 | Commvault Systems, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3427342 |
| 55965 | D-Wave Quantum, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 1463485 |
| 64504 | Intapp, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2955573 |
| 253166 | Porch Group, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2311406 |
| 102170 | Riot Platforms, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1294494 |
| 240854 | Terawulf, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 2767412 |
| 51396 | Unity Software, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2270161 |
| 96277 | Vertex, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1922652 |
| 187387 | Zeta Global Holdings Corp. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3813325 |
|  |  | &nbsp;&nbsp;&nbsp; 43623056 |
|  | **Technology Hardware & Equipment - 5.9%** | **Technology Hardware & Equipment - 5.9%** |
| 10615 | Advanced Energy Industries, Inc. | &nbsp;&nbsp;&nbsp; 2222463 |
| 29465 | Coherent Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5438355 |
| 11348 | Fabrinet<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5166517 |
| 23789 | Insight Enterprises, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1938090 |
| 70590 | IonQ, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 3167373 |
| 55862 | Mirion Technologies, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1308288 |
| 95717 | Napco Security Technologies, Inc. | &nbsp;&nbsp;&nbsp; 3991399 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 98.9% - (continued)** | **COMMON STOCKS - 98.9% - (continued)** | **COMMON STOCKS - 98.9% - (continued)** | **COMMON STOCKS - 98.9% - (continued)** |
|  | **Technology Hardware & Equipment - 5.9% - (continued)** | **Technology Hardware & Equipment - 5.9% - (continued)** | **Technology Hardware & Equipment - 5.9% - (continued)** |
| 28365 | Sanmina Corp.<sup>\*</sup>  | Sanmina Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $4256736 |
| 263149 | Viavi Solutions, Inc.<sup>\*</sup>  | Viavi Solutions, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4689315 |
|  |  |  | &nbsp;&nbsp;&nbsp; 32178536 |
|  | **Transportation - 1.5%** | **Transportation - 1.5%** | **Transportation - 1.5%** |
| 544199 | FTAI Infrastructure, Inc. | FTAI Infrastructure, Inc. | &nbsp;&nbsp;&nbsp; 2508757 |
| 140029 | RXO, Inc.<sup>\*</sup>  | RXO, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1769967 |
| 21474 | Ryder System, Inc. | Ryder System, Inc. | &nbsp;&nbsp;&nbsp; 4109909 |
|  |  |  | &nbsp;&nbsp;&nbsp; 8388633 |
|  | **Utilities - 0.7%** | **Utilities - 0.7%** | **Utilities - 0.7%** |
| 29555 | Chesapeake Utilities Corp. | Chesapeake Utilities Corp. | &nbsp;&nbsp;&nbsp; 3687282 |
| 5875 | Oklo, Inc.<sup>\*</sup>  | Oklo, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 421590 |
|  |  |  | &nbsp;&nbsp;&nbsp; 4108872 |
|  | Total Common Stocks <br>(cost $411,276,503)<br>|  | &nbsp;&nbsp;&nbsp; $540459374 |
| **EXCHANGE-TRADED FUNDS - 1.0%** | **EXCHANGE-TRADED FUNDS - 1.0%** | **EXCHANGE-TRADED FUNDS - 1.0%** | **EXCHANGE-TRADED FUNDS - 1.0%** |
|  | **Other Investment Pools & Funds - 1.0%** | **Other Investment Pools & Funds - 1.0%** | **Other Investment Pools & Funds - 1.0%** |
| 17096 | iShares Russell 2000 Growth ETF <sup>(1)</sup>  | iShares Russell 2000 Growth ETF <sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $5522179 |
|  | Total Exchange-Traded Funds <br>(cost $5,644,683)<br>|  | &nbsp;&nbsp;&nbsp; $5522179 |
|  | Total Long-Term Investments <br>(cost $416,921,186)<br>|  | &nbsp;&nbsp;&nbsp; $545981553 |
| **SHORT-TERM INVESTMENTS - 2.3%** | **SHORT-TERM INVESTMENTS - 2.3%** | **SHORT-TERM INVESTMENTS - 2.3%** | **SHORT-TERM INVESTMENTS - 2.3%** |
|  | **Repurchase Agreements - 0.1%** | **Repurchase Agreements - 0.1%** | **Repurchase Agreements - 0.1%** |
| $346267 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value of <br> $346,340; collateralized by U.S. Treasury <br> Note at 4.38%, maturing 07/15/2027, with <br> a market value of $353,202 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value of <br> $346,340; collateralized by U.S. Treasury <br> Note at 4.38%, maturing 07/15/2027, with <br> a market value of $353,202 | &nbsp;&nbsp;&nbsp; $346267 |
|  | **Securities Lending Collateral - 2.2%** | **Securities Lending Collateral - 2.2%** | **Securities Lending Collateral - 2.2%** |
| 12073029 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(2)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 12073029 |
|  | Total Short-Term Investments <br>(cost $12,419,296) | Total Short-Term Investments <br>(cost $12,419,296) | &nbsp;&nbsp;&nbsp; $12419296 |
|  | Total Investments <br>(cost $429,340,482)<br>| 102.2<br> %<br>| &nbsp;&nbsp;&nbsp; $558400849 |
|  | Other Assets and Liabilities | (2.2)%<br>| &nbsp;&nbsp;&nbsp; (11900802)<br>|
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $546500047 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

\* Non-income producing. <br> <sup>(1)</sup> Represents entire or partial securities on loan. See Note 8 in the accompanying Notes to Financial Statements for securities lending information. <br> <sup>(2)</sup> Current yield as of period end.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

25 <br>

------

**Hartford Small Cap Growth HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

<sup>†</sup> See Significant Accounting Policies of accompanying Notes to Financial Statements regarding valuation of investments.

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $540459374 | &nbsp;&nbsp; $540459374 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— |
| Exchange-Traded Funds | &nbsp;&nbsp; 5522179 | &nbsp;&nbsp; 5522179 | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Short-Term Investments | &nbsp;&nbsp; 12419296 | &nbsp;&nbsp; 12073029 | &nbsp;&nbsp; 346267 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $558400849 | &nbsp;&nbsp; $558054582 | &nbsp;&nbsp; $346267 | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

26 <br>

------

**Hartford Small Company HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 99.4%** | **COMMON STOCKS - 99.4%** | **COMMON STOCKS - 99.4%** |
|  | **Automobiles & Components - 0.6%** | **Automobiles & Components - 0.6%** |
| 26954 | Visteon Corp. | &nbsp;&nbsp;&nbsp; $2563325 |
|  | **Banks - 3.2%** | **Banks - 3.2%** |
| 167735 | Cadence Bank | &nbsp;&nbsp;&nbsp; 7185767 |
| 206236 | Seacoast Banking Corp. of Florida | &nbsp;&nbsp;&nbsp; 6479935 |
|  |  | &nbsp;&nbsp;&nbsp; 13665702 |
|  | **Capital Goods - 17.4%** | **Capital Goods - 17.4%** |
| 21005 | Acuity, Inc. | &nbsp;&nbsp;&nbsp; 7562640 |
| 230843 | Ameresco, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6761392 |
| 25043 | Applied Industrial Technologies, Inc. | &nbsp;&nbsp;&nbsp; 6430291 |
| 20341 | Bloom Energy Corp. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1767430 |
| 3600 | Comfort Systems USA, Inc. | &nbsp;&nbsp;&nbsp; 3359844 |
| 11879 | Curtiss-Wright Corp. | &nbsp;&nbsp;&nbsp; 6548536 |
| 42040 | DXP Enterprises, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4615572 |
| 23452 | Kratos Defense & Security Solutions, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1780241 |
| 41765 | Modine Manufacturing Co.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5576045 |
| 93529 | Nextpower, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 8147311 |
| 65144 | Rush Enterprises, Inc. Class A | &nbsp;&nbsp;&nbsp; 3513867 |
| 105721 | StandardAero, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3032078 |
| 37810 | Voyager Technologies, Inc. Class A<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 988354 |
| 79364 | Xometry, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4719777 |
| 198817 | Zurn Elkay Water Solutions Corp. | &nbsp;&nbsp;&nbsp; 9243002 |
|  |  | &nbsp;&nbsp;&nbsp; 74046380 |
|  | **Commercial & Professional Services - 5.7%** | **Commercial & Professional Services - 5.7%** |
| 62108 | Casella Waste Systems, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6082858 |
| 162802 | ExlService Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6909317 |
| 36486 | TriNet Group, Inc. | &nbsp;&nbsp;&nbsp; 2157417 |
| 405991 | Verra Mobility Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 9098258 |
|  |  | &nbsp;&nbsp;&nbsp; 24247850 |
|  | **Consumer Discretionary Distribution & Retail - 3.9%** | **Consumer Discretionary Distribution & Retail - 3.9%** |
| 29362 | Boot Barn Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5181512 |
| 28720 | Five Below, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5409699 |
| 32518 | Ollie's Bargain Outlet Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3564298 |
| 43094 | Tory Burch LLC<sup>\*(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 2488250 |
|  |  | &nbsp;&nbsp;&nbsp; 16643759 |
|  | **Consumer Durables & Apparel - 1.6%** | **Consumer Durables & Apparel - 1.6%** |
| 80368 | Champion Homes, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6791096 |
|  | **Consumer Services - 3.2%** | **Consumer Services - 3.2%** |
| 578324 | Genius Sports Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 6373131 |
| 161993 | Life Time Group Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4305774 |
| 32522 | Stride, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2111653 |
| 4068 | Wingstop, Inc. | &nbsp;&nbsp;&nbsp; 970177 |
|  |  | &nbsp;&nbsp;&nbsp; 13760735 |
|  | **Energy - 1.7%** | **Energy - 1.7%** |
| 55134 | Cactus, Inc. Class A | &nbsp;&nbsp;&nbsp; 2518521 |
| 125542 | Viper Energy, Inc. Class A | &nbsp;&nbsp;&nbsp; 4849687 |
|  |  | &nbsp;&nbsp;&nbsp; 7368208 |
|  | **Equity Real Estate Investment Trusts (REITs) - 3.4%** | **Equity Real Estate Investment Trusts (REITs) - 3.4%** |
| 178904 | American Healthcare, Inc. REIT | &nbsp;&nbsp;&nbsp; 8419222 |
| 173537 | Phillips Edison & Co., Inc. REIT | &nbsp;&nbsp;&nbsp; 6172711 |
|  |  | &nbsp;&nbsp;&nbsp; 14591933 |
|  | **Financial Services - 2.9%** | **Financial Services - 2.9%** |
| 7490 | Dave, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1658361 |
| 153391 | HA Sustainable Infrastructure Capital, Inc. | &nbsp;&nbsp;&nbsp; 4821079 |
| 34130 | PJT Partners, Inc. Class A | &nbsp;&nbsp;&nbsp; 5706536 |
|  |  | &nbsp;&nbsp;&nbsp; 12185976 |
|  | **Food, Beverage & Tobacco - 1.8%** | **Food, Beverage & Tobacco - 1.8%** |
| 143477 | Vita Coco Co., Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7605716 |
|  | **Health Care Equipment & Services - 10.7%** | **Health Care Equipment & Services - 10.7%** |
| 391220 | Alignment Healthcare, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7726595 |
| 26345 | Ensign Group, Inc. | &nbsp;&nbsp;&nbsp; 4589299 |
| 37820 | GeneDx Holdings Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4918869 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 99.4% - (continued)** | **COMMON STOCKS - 99.4% - (continued)** | **COMMON STOCKS - 99.4% - (continued)** |
|  | **Health Care Equipment & Services - 10.7% - (continued)** | **Health Care Equipment & Services - 10.7% - (continued)** |
| 28225 | Glaukos Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $3186885 |
| 101982 | Guardian Pharmacy Services, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3068638 |
| 61015 | HealthEquity, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5589584 |
| 43554 | Hims & Hers Health, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 1414198 |
| 59384 | Hinge Health, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2758387 |
| 12761 | Inspire Medical Systems, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1176947 |
| 18804 | Lantheus Holdings, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1251406 |
| 128273 | PACS Group, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4924401 |
| 39590 | TransMedics Group, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 4816124 |
|  |  | &nbsp;&nbsp;&nbsp; 45421333 |
|  | **Household & Personal Products - 0.3%** | **Household & Personal Products - 0.3%** |
| 33944 | Oddity Tech Ltd. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1363870 |
|  | **Insurance - 2.1%** | **Insurance - 2.1%** |
| 126593 | Beazley PLC | &nbsp;&nbsp;&nbsp; 1415638 |
| 341956 | SiriusPoint Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7485417 |
|  |  | &nbsp;&nbsp;&nbsp; 8901055 |
|  | **Materials - 2.2%** | **Materials - 2.2%** |
| 55052 | Cabot Corp. | &nbsp;&nbsp;&nbsp; 3648846 |
| 224733 | James Hardie Industries PLC ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4663210 |
| 25435 | MP Materials Corp.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 1284976 |
|  |  | &nbsp;&nbsp;&nbsp; 9597032 |
|  | **Media & Entertainment - 1.1%** | **Media & Entertainment - 1.1%** |
| 119816 | Cargurus, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4594944 |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 18.6%** | **Pharmaceuticals, Biotechnology & Life Sciences - 18.6%** |
| 113574 | Adaptive Biotechnologies Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1844442 |
| 200437 | Amicus Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2854223 |
| 56955 | Apellis Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1430710 |
| 39794 | Apogee Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3003651 |
| 74192 | Avidity Biosciences, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5351469 |
| 24847 | Axsome Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4538056 |
| 30626 | Bridgebio Pharma, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2342583 |
| 25984 | Celcuity, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2591644 |
| 85431 | Celldex Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2320306 |
| 57281 | CG oncology, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2378307 |
| 37468 | Cogent Biosciences, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1330863 |
| 77661 | Crinetics Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3615119 |
| 30737 | Cytokinetics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1953029 |
| 50566 | Disc Medicine, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4015446 |
| 29421 | Insmed, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5120431 |
| 38655 | Kymera Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3007746 |
| 48423 | Mineralys Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1757271 |
| 23167 | Nuvalent, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2330368 |
| 44346 | Protagonist Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3873180 |
| 50427 | PTC Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3830435 |
| 91771 | Revolution Medicines, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 7309560 |
| 49073 | Scholar Rock Holding Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2161666 |
| 26566 | Soleno Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1230006 |
| 62471 | Structure Therapeutics, Inc. ADR<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4344858 |
| 21551 | Terns Pharmaceuticals, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 870660 |
| 54322 | Vaxcyte, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2506417 |
| 39859 | Viridian Therapeutics, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1240412 |
|  |  | &nbsp;&nbsp;&nbsp; 79152858 |
|  | **Semiconductors & Semiconductor Equipment - 6.2%** | **Semiconductors & Semiconductor Equipment - 6.2%** |
| 41565 | Credo Technology Group Holding Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5980788 |
| 41550 | MKS, Inc. | &nbsp;&nbsp;&nbsp; 6639690 |
| 34912 | SiTime Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 12330569 |
| 11429 | Universal Display Corp. | &nbsp;&nbsp;&nbsp; 1334679 |
|  |  | &nbsp;&nbsp;&nbsp; 26285726 |
|  | **Software & Services - 8.7%** | **Software & Services - 8.7%** |
| 31501 | Agilysys, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3743579 |
| 294113 | Amplitude, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3405829 |
| 347867 | AvePoint, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4831873 |
| 135886 | Clearwater Analytics Holdings, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3277570 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

27 <br>

------

**Hartford Small Company HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 99.4% - (continued)** | **COMMON STOCKS - 99.4% - (continued)** | **COMMON STOCKS - 99.4% - (continued)** | **COMMON STOCKS - 99.4% - (continued)** |
|  | **Software & Services - 8.7% - (continued)** | **Software & Services - 8.7% - (continued)** | **Software & Services - 8.7% - (continued)** |
| 23686 | Commvault Systems, Inc.<sup>\*</sup>  | Commvault Systems, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; $2969277 |
| 9512 | CyberArk Software Ltd.<sup>\*</sup>  | CyberArk Software Ltd.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4242923 |
| 308338 | Freshworks, Inc. Class A<sup>\*</sup>  | Freshworks, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3777140 |
| 109220 | Intapp, Inc.<sup>\*</sup>  | Intapp, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5004460 |
| 57403 | Rubrik, Inc. Class A<sup>\*</sup>  | Rubrik, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4390181 |
| 15777 | ServiceTitan, Inc. Class A<sup>\*</sup>  | ServiceTitan, Inc. Class A<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 1680251 |
|  |  |  | &nbsp;&nbsp;&nbsp; 37323083 |
|  | **Technology Hardware & Equipment - 4.1%** | **Technology Hardware & Equipment - 4.1%** | **Technology Hardware & Equipment - 4.1%** |
| 99063 | Calix, Inc.<sup>\*</sup>  | Calix, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 5243405 |
| 9854 | Fabrinet<sup>\*</sup>  | Fabrinet<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 4486329 |
| 32081 | IonQ, Inc.<sup>\*(1)</sup>  | IonQ, Inc.<sup>\*(1)</sup>  | &nbsp;&nbsp;&nbsp; 1439474 |
| 11467 | OSI Systems, Inc.<sup>\*</sup>  | OSI Systems, Inc.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 2924773 |
| 22865 | Sanmina Corp.<sup>\*</sup>  | Sanmina Corp.<sup>\*</sup>  | &nbsp;&nbsp;&nbsp; 3431351 |
|  |  |  | &nbsp;&nbsp;&nbsp; 17525332 |
|  | Total Common Stocks <br>(cost $306,469,890)<br>|  | &nbsp;&nbsp;&nbsp; $423635913 |
| **RIGHTS - 0.0%** | **RIGHTS - 0.0%** | **RIGHTS - 0.0%** | **RIGHTS - 0.0%** |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 0.0%** | **Pharmaceuticals, Biotechnology & Life Sciences - 0.0%** | **Pharmaceuticals, Biotechnology & Life Sciences - 0.0%** |
| 40950 | Akero Therapeutics, Inc. CVR<sup>\*(2)(3)(4)</sup>  | Akero Therapeutics, Inc. CVR<sup>\*(2)(3)(4)</sup>  | &nbsp;&nbsp;&nbsp; $26618 |
|  | Total Rights <br>(cost $26,618)<br>|  | &nbsp;&nbsp;&nbsp; $26618 |
|  | Total Long-Term Investments <br>(cost $306,496,508)<br>|  | &nbsp;&nbsp;&nbsp; $423662531 |
| **SHORT-TERM INVESTMENTS - 2.2%** | **SHORT-TERM INVESTMENTS - 2.2%** | **SHORT-TERM INVESTMENTS - 2.2%** | **SHORT-TERM INVESTMENTS - 2.2%** |
|  | **Repurchase Agreements - 0.1%** | **Repurchase Agreements - 0.1%** | **Repurchase Agreements - 0.1%** |
| $575386 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, due <br> on 01/02/2026 with a maturity value of <br> $575,508; collateralized by U.S. Treasury <br> Bond at 4.63%, maturing 11/15/2055, with a <br> market value of $587,050 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, due <br> on 01/02/2026 with a maturity value of <br> $575,508; collateralized by U.S. Treasury <br> Bond at 4.63%, maturing 11/15/2055, with a <br> market value of $587,050 | &nbsp;&nbsp;&nbsp; $575386 |
|  | **Securities Lending Collateral - 2.1%** | **Securities Lending Collateral - 2.1%** | **Securities Lending Collateral - 2.1%** |
| 8891073 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(5)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(5)</sup>  | &nbsp;&nbsp;&nbsp; 8891073 |
|  | Total Short-Term Investments <br>(cost $9,466,459) | Total Short-Term Investments <br>(cost $9,466,459) | &nbsp;&nbsp;&nbsp; $9466459 |
|  | Total Investments <br>(cost $315,962,967)<br>| 101.6<br> %<br>| &nbsp;&nbsp;&nbsp; $433128990 |
|  | Other Assets and Liabilities | (1.6)%<br>| &nbsp;&nbsp;&nbsp; (6953898)<br>|
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $426175092 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

\* Non-income producing.

<sup>(1)</sup> Represents entire or partial securities on loan. See Note 8 in the accompanying Notes to Financial Statements for securities lending information. 

<sup>(2)</sup> Investment in securities not registered under the Securities Act of 1933 (excluding securities acquired pursuant to Rule 144A and Regulation S). At the end of the period, the value of such restricted securities amounted to $2,514,868 or 0.6% of net assets. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** <br>**Acquired**<br>| **Security Name** | **Shares/** <br>**Par Value**<br>| **Total Cost** | **Market Value** |
| 12/2025 | &nbsp;&nbsp; Akero Therapeutics, <br> Inc. CVR<br>| &nbsp;&nbsp; 40950 | &nbsp;&nbsp; $26618 | &nbsp;&nbsp; $26618 |
| 11/2013 | Tory Burch LLC  | &nbsp;&nbsp; 43094 | &nbsp;&nbsp; 3377559 | &nbsp;&nbsp; 2488250 |
|  |  |  | &nbsp;&nbsp; $3404177 | &nbsp;&nbsp; $2514868 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| <sup>(3)</sup> <br>| Investment valued using significant unobservable inputs. |
| <sup>(4)</sup> <br>| Currently no expiration date available. |
| <sup>(5)</sup> <br>| Current yield as of period end. |
| <sup>†</sup> | See Significant Accounting Policies of accompanying Notes to Financial <br> Statements regarding valuation of investments.<br>|

---

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $423635913 | &nbsp;&nbsp; $419732025 | &nbsp;&nbsp; $1415638 | &nbsp;&nbsp; $2488250 |
| Rights | &nbsp;&nbsp; 26618 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 26618 |
| Short-Term Investments | &nbsp;&nbsp; 9466459 | &nbsp;&nbsp; 8891073 | &nbsp;&nbsp; 575386 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $433128990 | &nbsp;&nbsp; $428623098 | &nbsp;&nbsp; $1991024 | &nbsp;&nbsp; $2514868 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

Level 3 investments at the beginning and/or end of the period in relation to net assets were not significant and accordingly, a reconciliation of Level 3 assets for the year ended December 31, 2025 is not presented.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

28 <br>

------

**Hartford Stock HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **COMMON STOCKS - 99.3%** | **COMMON STOCKS - 99.3%** | **COMMON STOCKS - 99.3%** |
|  | **Banks - 2.2%** | **Banks - 2.2%** |
| 287755 | Wells Fargo & Co. | &nbsp;&nbsp;&nbsp; $26818766 |
|  | **Capital Goods - 10.6%** | **Capital Goods - 10.6%** |
| 60244 | AMETEK, Inc. | &nbsp;&nbsp;&nbsp; 12368695 |
| 39654 | Caterpillar, Inc. | &nbsp;&nbsp;&nbsp; 22716587 |
| 24779 | Deere & Co. | &nbsp;&nbsp;&nbsp; 11536359 |
| 138885 | Honeywell International, Inc. | &nbsp;&nbsp;&nbsp; 27095075 |
| 25103 | Lockheed Martin Corp. | &nbsp;&nbsp;&nbsp; 12141568 |
| 47838 | Northrop Grumman Corp. | &nbsp;&nbsp;&nbsp; 27277706 |
| 39040 | Trane Technologies PLC | &nbsp;&nbsp;&nbsp; 15194368 |
|  |  | &nbsp;&nbsp;&nbsp; 128330358 |
|  | **Commercial & Professional Services - 1.9%** | **Commercial & Professional Services - 1.9%** |
| 89011 | Automatic Data Processing, Inc. | &nbsp;&nbsp;&nbsp; 22896300 |
|  | **Consumer Discretionary Distribution & Retail - 5.4%** | **Consumer Discretionary Distribution & Retail - 5.4%** |
| 92614 | Home Depot, Inc. | &nbsp;&nbsp;&nbsp; 31868477 |
| 221892 | TJX Cos., Inc. | &nbsp;&nbsp;&nbsp; 34084830 |
|  |  | &nbsp;&nbsp;&nbsp; 65953307 |
|  | **Consumer Durables & Apparel - 2.3%** | **Consumer Durables & Apparel - 2.3%** |
| 439308 | NIKE, Inc. Class B | &nbsp;&nbsp;&nbsp; 27988313 |
|  | **Consumer Services - 3.7%** | **Consumer Services - 3.7%** |
| 54794 | Marriott International, Inc. Class A | &nbsp;&nbsp;&nbsp; 16999290 |
| 91119 | McDonald's Corp. | &nbsp;&nbsp;&nbsp; 27848700 |
|  |  | &nbsp;&nbsp;&nbsp; 44847990 |
|  | **Consumer Staples Distribution & Retail - 1.6%** | **Consumer Staples Distribution & Retail - 1.6%** |
| 204101 | Kroger Co. | &nbsp;&nbsp;&nbsp; 12752231 |
| 56305 | Walmart, Inc. | &nbsp;&nbsp;&nbsp; 6272940 |
|  |  | &nbsp;&nbsp;&nbsp; 19025171 |
|  | **Financial Services - 12.4%** | **Financial Services - 12.4%** |
| 112578 | American Express Co. | &nbsp;&nbsp;&nbsp; 41648231 |
| 76479 | Mastercard, Inc. Class A | &nbsp;&nbsp;&nbsp; 43660332 |
| 51021 | S&P Global, Inc. | &nbsp;&nbsp;&nbsp; 26663064 |
| 109354 | Visa, Inc. Class A | &nbsp;&nbsp;&nbsp; 38351541 |
|  |  | &nbsp;&nbsp;&nbsp; 150323168 |
|  | **Food, Beverage & Tobacco - 3.4%** | **Food, Beverage & Tobacco - 3.4%** |
| 303219 | Coca-Cola Co. | &nbsp;&nbsp;&nbsp; 21198040 |
| 248796 | Diageo PLC | &nbsp;&nbsp;&nbsp; 5361037 |
| 98698 | PepsiCo, Inc. | &nbsp;&nbsp;&nbsp; 14165137 |
|  |  | &nbsp;&nbsp;&nbsp; 40724214 |
|  | **Health Care Equipment & Services - 5.4%** | **Health Care Equipment & Services - 5.4%** |
| 161830 | Abbott Laboratories | &nbsp;&nbsp;&nbsp; 20275681 |
| 52669 | Elevance Health, Inc. | &nbsp;&nbsp;&nbsp; 18463118 |
| 76997 | Stryker Corp. | &nbsp;&nbsp;&nbsp; 27062135 |
|  |  | &nbsp;&nbsp;&nbsp; 65800934 |
|  | **Household & Personal Products - 2.9%** | **Household & Personal Products - 2.9%** |
| 156069 | Colgate-Palmolive Co. | &nbsp;&nbsp;&nbsp; 12332572 |
| 157467 | Procter & Gamble Co. | &nbsp;&nbsp;&nbsp; 22566596 |
|  |  | &nbsp;&nbsp;&nbsp; 34899168 |
|  | **Insurance - 4.5%** | **Insurance - 4.5%** |
| 99530 | Chubb Ltd. | &nbsp;&nbsp;&nbsp; 31065304 |
| 127614 | Marsh & McLennan Cos., Inc. | &nbsp;&nbsp;&nbsp; 23674949 |
|  |  | &nbsp;&nbsp;&nbsp; 54740253 |
|  | **Materials - 2.3%** | **Materials - 2.3%** |
| 64554 | Linde PLC | &nbsp;&nbsp;&nbsp; 27525180 |
|  | **Media & Entertainment - 4.0%** | **Media & Entertainment - 4.0%** |
| 152700 | Alphabet, Inc. Class A | &nbsp;&nbsp;&nbsp; 47795100 |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 11.8%** | **Pharmaceuticals, Biotechnology & Life Sciences - 11.8%** |
| 130183 | Danaher Corp. | &nbsp;&nbsp;&nbsp; 29801492 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **COMMON STOCKS - 99.3% - (continued)** | **COMMON STOCKS - 99.3% - (continued)** | **COMMON STOCKS - 99.3% - (continued)** | **COMMON STOCKS - 99.3% - (continued)** |
|  | **Pharmaceuticals, Biotechnology & Life Sciences - 11.8% -** <br> **(continued)** | **Pharmaceuticals, Biotechnology & Life Sciences - 11.8% -** <br> **(continued)** | **Pharmaceuticals, Biotechnology & Life Sciences - 11.8% -** <br> **(continued)** |
| 50693 | Eli Lilly & Co. | Eli Lilly & Co. | &nbsp;&nbsp;&nbsp; $54478753 |
| 105898 | Johnson & Johnson | Johnson & Johnson | &nbsp;&nbsp;&nbsp; 21915591 |
| 205741 | Merck & Co., Inc. | Merck & Co., Inc. | &nbsp;&nbsp;&nbsp; 21656298 |
| 119809 | Zoetis, Inc. | Zoetis, Inc. | &nbsp;&nbsp;&nbsp; 15074369 |
|  |  |  | &nbsp;&nbsp;&nbsp; 142926503 |
|  | **Semiconductors & Semiconductor Equipment - 10.3%** | **Semiconductors & Semiconductor Equipment - 10.3%** | **Semiconductors & Semiconductor Equipment - 10.3%** |
| 184984 | Broadcom, Inc. | Broadcom, Inc. | &nbsp;&nbsp;&nbsp; 64022963 |
| 161984 | QUALCOMM, Inc. | QUALCOMM, Inc. | &nbsp;&nbsp;&nbsp; 27707363 |
| 193178 | Texas Instruments, Inc. | Texas Instruments, Inc. | &nbsp;&nbsp;&nbsp; 33514451 |
|  |  |  | &nbsp;&nbsp;&nbsp; 125244777 |
|  | **Software & Services - 8.5%** | **Software & Services - 8.5%** | **Software & Services - 8.5%** |
| 89447 | Accenture PLC Class A | Accenture PLC Class A | &nbsp;&nbsp;&nbsp; 23998630 |
| 35557 | Intuit, Inc. | Intuit, Inc. | &nbsp;&nbsp;&nbsp; 23553668 |
| 114315 | Microsoft Corp. | Microsoft Corp. | &nbsp;&nbsp;&nbsp; 55285020 |
|  |  |  | &nbsp;&nbsp;&nbsp; 102837318 |
|  | **Technology Hardware & Equipment - 4.5%** | **Technology Hardware & Equipment - 4.5%** | **Technology Hardware & Equipment - 4.5%** |
| 74400 | Amphenol Corp. Class A | Amphenol Corp. Class A | &nbsp;&nbsp;&nbsp; 10054416 |
| 164173 | Apple, Inc. | Apple, Inc. | &nbsp;&nbsp;&nbsp; 44632072 |
|  |  |  | &nbsp;&nbsp;&nbsp; 54686488 |
|  | **Transportation - 1.6%** | **Transportation - 1.6%** | **Transportation - 1.6%** |
| 196014 | Canadian National Railway Co. | Canadian National Railway Co. | &nbsp;&nbsp;&nbsp; 19386471 |
|  | Total Common Stocks <br>(cost $717,902,357)<br>|  | &nbsp;&nbsp;&nbsp; $1202749779 |
| **SHORT-TERM INVESTMENTS - 0.3%** | **SHORT-TERM INVESTMENTS - 0.3%** | **SHORT-TERM INVESTMENTS - 0.3%** | **SHORT-TERM INVESTMENTS - 0.3%** |
|  | **Repurchase Agreements - 0.3%** | **Repurchase Agreements - 0.3%** | **Repurchase Agreements - 0.3%** |
| $3506432 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $3,507,176; collateralized by <br> U.S. Treasury Note at 4.13%, maturing <br> 05/31/2032, with a market value of <br> $3,576,599 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value <br> of $3,507,176; collateralized by <br> U.S. Treasury Note at 4.13%, maturing <br> 05/31/2032, with a market value of <br> $3,576,599 | &nbsp;&nbsp;&nbsp; $3506432 |
|  | Total Short-Term Investments <br>(cost $3,506,432) | Total Short-Term Investments <br>(cost $3,506,432) | &nbsp;&nbsp;&nbsp; $3506432 |
|  | Total Investments <br>(cost $721,408,789)<br>| 99.6<br> %<br>| &nbsp;&nbsp;&nbsp; $1206256211 |
|  | Other Assets and Liabilities | 0.4<br> %<br>| &nbsp;&nbsp;&nbsp; 5315847 |
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $1211572058 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service approved by Hartford Funds Management Company, LLC in order to reflect an adjustment for factors occurring after the close of certain foreign markets but before the close of the New York Stock Exchange.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

29 <br>

------

**Hartford Stock HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

<sup>†</sup> See Significant Accounting Policies of accompanying Notes to Financial Statements regarding valuation of investments.

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Common Stocks | &nbsp;&nbsp; $1202749779 | &nbsp;&nbsp; $1197388742 | &nbsp;&nbsp; $5361037 | &nbsp;&nbsp; $— |
| Short-Term Investments | &nbsp;&nbsp; 3506432 | &nbsp;&nbsp; — | &nbsp;&nbsp; 3506432 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $1206256211 | &nbsp;&nbsp; $1197388742 | &nbsp;&nbsp; $8867469 | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

30 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2%** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2%** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2%** |
|  | **Asset-Backed - Automobile - 0.8%** | **Asset-Backed - Automobile - 0.8%** |
|  | Avis Budget Rental Car Funding <br> AESOP LLC |  |
| $1220000 | 5.36%, 06/20/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $1257916 |
| 645000 | 5.58%, 12/20/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 664648 |
|  | Exeter Automobile Receivables Trust |  |
| 740000 | 4.40%, 05/15/2030 | &nbsp;&nbsp;&nbsp; 743900 |
| 4425000 | 4.91%, 08/15/2029 | &nbsp;&nbsp;&nbsp; 4462000 |
| 1425000 | GLS Auto Receivables Issuer Trust 4.89%, <br> 04/16/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1433982 |
| 1145000 | Hertz Vehicle Financing III LLC 5.13%, <br> 09/25/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1163010 |
| 392123 | Securitized Term Auto Receivables Trust <br> 5.04%, 07/25/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 395557 |
| 985000 | SFS Auto Receivables Securitization Trust <br> 5.71%, 01/22/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1008697 |
|  |  | &nbsp;&nbsp;&nbsp; 11129710 |
|  | **Asset-Backed - Student Loan - 0.2%** | **Asset-Backed - Student Loan - 0.2%** |
|  | Navient Private Education Refi Loan Trust |  |
| 1274171 | 1.11%, 02/18/2070<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1135951 |
| 1588451 | 5.51%, 10/15/2071<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1632637 |
|  |  | &nbsp;&nbsp;&nbsp; 2768588 |
|  | **Commercial Mortgage-Backed Securities - 4.1%** | **Commercial Mortgage-Backed Securities - 4.1%** |
| 1688000 | 280 Park Avenue Mortgage Trust 6.20%, <br> 09/15/2034, 1 mo. USD Term SOFR + <br> 2.42%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1667869 |
| 960000 | AREIT Trust 5.75%, 07/25/2043, 1 mo. USD <br> Term SOFR + 1.75%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 961201 |
|  | BBCMS Mortgage Trust |  |
| 6606242 | 1.13%, 02/15/2062<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 542390 |
| 21311815 | 1.44%, 02/15/2050<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 195736 |
| 7897220 | 1.62%, 02/15/2057<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 730885 |
| 925000 | 3.66%, 04/15/2055<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 861970 |
|  | Benchmark Mortgage Trust |  |
| 16739052 | 0.46%, 07/15/2051<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 186344 |
| 7488783 | 0.52%, 01/15/2051<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 73975 |
| 7724672 | 1.02%, 08/15/2052<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 191900 |
| 21113747 | 1.22%, 03/15/2062<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 689681 |
| 10211496 | 1.49%, 01/15/2054<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 610569 |
| 2230935 | 1.73%, 07/15/2053<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 109714 |
| 1625000 | BOCA Commercial Mortgage Trust 5.75%, <br> 12/15/2042, 1 mo. USD Term SOFR + <br> 1.90%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1627030 |
| 820000 | BPR Trust 5.85%, 11/05/2041<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 843131 |
|  | BX Trust |  |
| 970000 | 5.18%, 12/13/2042<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 976245 |
| 328000 | 6.79%, 03/15/2041, 1 mo. USD Term <br> SOFR + 3.04%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 329332 |
| 3173671 | CD Mortgage Trust 2.46%, 08/10/2049 | &nbsp;&nbsp;&nbsp; 3161459 |
| 580000 | CENT 4.92%, 07/10/2040<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 589720 |
| 2357000 | Citigroup Commercial Mortgage Trust <br> 4.00%, 11/15/2049<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 2086968 |
|  | Commercial Mortgage Trust |  |
| 841000 | 2.82%, 01/10/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 811717 |
| 860000 | 3.90%, 01/10/2039<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 809393 |
| 1106000 | 6.51%, 12/10/2041<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1131267 |
| 4039016 | CSAIL Commercial Mortgage Trust 1.75%, <br> 01/15/2049<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 40 |
| 3368286 | DBJPM Mortgage Trust 1.59%, <br> 09/15/2053<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 143018 |
| 380000 | DC Trust 7.04%, 04/13/2040<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 380795 |
| 315000 | Extended Stay America Trust 5.35%, <br> 10/15/2042, 1 mo. USD Term SOFR + <br> 1.60%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 315492 |
| 2360000 | GS Mortgage Securities Corp. II 5.70%, <br> 03/10/2041<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2395651 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** |
|  | **Commercial Mortgage-Backed Securities - 4.1% - (continued)** | **Commercial Mortgage-Backed Securities - 4.1% - (continued)** |
| $4120005 | GS Mortgage Securities Corp. Trust 2.95%, <br> 11/05/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $3617571 |
|  | GS Mortgage Securities Trust |  |
| 345860 | 0.00%, 08/10/2044<sup>(1)(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 247 |
| 706952 | 0.00%, 07/10/2046<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 7 |
| 2006911 | 4.94%, 04/10/2047<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1577472 |
|  | HTL Commercial Mortgage Trust |  |
| 1065000 | 6.56%, 05/10/2039<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1080744 |
| 585000 | 7.09%, 05/10/2039<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 595690 |
|  | INT Commercial Mortgage Trust |  |
| 715000 | 4.88%, 11/05/2037<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 717037 |
| 135000 | 5.17%, 11/05/2037<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 134927 |
|  | JP Morgan Chase Commercial Mortgage <br> Securities Trust |  |
| 1400000 | 2.81%, 01/16/2037<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1260000 |
| 1290924 | 3.57%, 12/15/2047<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1052064 |
| 1120209 | JPMBB Commercial Mortgage Securities <br> Trust 0.33%, 09/15/2047<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 11 |
| 1895000 | MAD Commercial Mortgage Trust 5.10%, <br> 10/15/2042<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1895753 |
|  | Morgan Stanley Capital I Trust |  |
| 6340133 | 1.29%, 06/15/2050<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 79223 |
| 1645000 | 3.91%, 09/09/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1484058 |
| 1460000 | 4.94%, 07/15/2049<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1393507 |
| 92835 | 5.21%, 10/12/2052<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 27702 |
| 716000 | Natixis Commercial Mortgage Securities <br> Trust 4.77%, 06/17/2038<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 698762 |
| 230000 | NRTH Commercial Mortgage Trust 5.39%, <br> 10/15/2040, 1 mo. USD Term SOFR + <br> 1.64%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 230072 |
| 3090000 | NYC Commercial Mortgage Trust 5.44%, <br> 02/15/2042, 1 mo. USD Term SOFR + <br> 1.69%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 3084233 |
| 2695000 | RFR Trust 5.67%, 03/11/2041<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2757230 |
| 3720000 | SG Commercial Mortgage Securities Trust <br> 2.63%, 03/15/2037<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 3561946 |
| 535000 | TEXAS Commercial Mortgage Trust 5.34%, <br> 04/15/2042, 1 mo. USD Term SOFR + <br> 1.59%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 533667 |
| 2888202 | UBS Commercial Mortgage Trust 1.04%, <br> 08/15/2050<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 32264 |
|  | Wells Fargo Commercial Mortgage Trust |  |
| 3085000 | 2.94%, 10/15/2049 | &nbsp;&nbsp;&nbsp; 3058331 |
| 430000 | 3.86%, 05/15/2048<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 400339 |
|  | Wells Fargo NA |  |
| 19488823 | 0.58%, 11/15/2062<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 384380 |
| 9529556 | 0.63%, 11/15/2062<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 211832 |
| 31797216 | 0.70%, 11/15/2050<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 293806 |
| 3031691 | 0.71%, 11/15/2054<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 37942 |
| 17351773 | 0.81%, 09/15/2062<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 443294 |
| 33230168 | 0.87%, 01/15/2063<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 912620 |
| 12363128 | 0.88%, 05/15/2062<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 297925 |
| 4939887 | 1.07%, 02/15/2056<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 278614 |
| 20258816 | 1.76%, 03/15/2063<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 1334858 |
| 710000 | WFRBS Commercial Mortgage Trust 5.00%, <br> 06/15/2044<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 617700 |
|  |  | &nbsp;&nbsp;&nbsp; 56509320 |
|  | **Other Asset-Backed Securities - 4.8%** | **Other Asset-Backed Securities - 4.8%** |
| 156232 | AASET Trust 3.35%, 01/16/2040<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 155138 |
| 2220000 | Aligned Data Centers Issuer LLC 6.00%, <br> 08/17/2048<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2236343 |
| 3285000 | Battalion CLO 18 Ltd. 6.08%, 03/13/2037, <br> 3 mo. USD Term SOFR + 2.20%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 3287365 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

31 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** |
|  | **Other Asset-Backed Securities - 4.8% - (continued)** | **Other Asset-Backed Securities - 4.8% - (continued)** |
| $2590000 | Benefit Street Partners CLO XXXI Ltd. <br> 5.61%, 04/25/2038, 3 mo. USD Term <br> SOFR + 1.75%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; $2597361 |
| 375000 | Blue Owl Asset Leasing Trust LLC 5.41%, <br> 03/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 379457 |
|  | CF Hippolyta Issuer LLC |  |
| 377188 | 1.53%, 03/15/2061<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 304655 |
| 894819 | 1.69%, 07/15/2060<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 752888 |
| 1004082 | 1.99%, 07/15/2060<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 841850 |
| 572601 | 5.97%, 08/15/2062<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 563273 |
| 4485000 | Columbia Cent CLO 27 Ltd. 5.31%, <br> 01/25/2035, 3 mo. USD Term SOFR + <br> 1.45%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 4485058 |
| 1977804 | Commercial Equipment Finance LLC <br> 4.83%, 05/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1982226 |
|  | Domino's Pizza Master Issuer LLC |  |
| 2256200 | 2.66%, 04/25/2051<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2144572 |
| 1392000 | 3.67%, 10/25/2049<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1339885 |
| 2155000 | Elmwood CLO 23 Ltd. 5.64%, 04/16/2036, <br> 3 mo. USD Term SOFR + 1.75%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2158310 |
| 4061596 | FirstKey Homes Trust 4.25%, 07/17/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 4060013 |
|  | GreenSky Home Improvement Issuer Trust |  |
| 180000 | 5.02%, 06/25/2060<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 182627 |
| 560000 | 5.07%, 06/25/2060<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 565672 |
| 1270000 | Magnetite XXXI Ltd. 5.34%, 07/15/2034, <br> 3 mo. USD Term SOFR + 1.55%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1270000 |
|  | NMEF Funding LLC |  |
| 306000 | 4.64%, 01/18/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 307178 |
| 1055000 | 4.73%, 01/18/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1062254 |
| 2170000 | PEAC Solutions Receivables LLC 5.04%, <br> 07/20/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2211521 |
|  | Post Road Equipment Finance LLC |  |
| 552769 | 4.90%, 05/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 557073 |
| 510000 | 5.04%, 05/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 517891 |
|  | Progress Residential Trust |  |
| 3234011 | 1.51%, 10/17/2038<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 3183927 |
| 1080109 | 3.20%, 04/17/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1065345 |
| 1764845 | 4.30%, 03/17/2040<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1759637 |
| 831515 | 4.45%, 06/17/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 831091 |
| 1371692 | 4.75%, 10/27/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1374459 |
| 5630000 | QTS Issuer ABS I LLC 5.44%, 05/25/2055<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 5668228 |
| 2650000 | Rad CLO 12 Ltd. 5.16%, 07/30/2040, 3 mo. <br> USD Term SOFR + 1.32%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2658374 |
| 3315000 | Retained Vantage Data Centers Issuer LLC <br> 5.00%, 09/15/2048<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 3306394 |
| 1340000 | SCF Equipment Leasing LLC 5.11%, <br> 11/21/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1367865 |
|  | Stack Infrastructure Issuer LLC |  |
| 1880000 | 5.90%, 07/25/2048<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1889460 |
| 1010000 | 5.90%, 03/25/2049<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1022546 |
| 745000 | Symphony CLO 36 Ltd. 5.64%, 01/20/2036, <br> 3 mo. USD Term SOFR + 1.85%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 745000 |
| 1738146 | Tricon Residential Trust 4.85%, 03/17/2042, <br> 1 mo. USD Term SOFR + 1.10%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1739527 |
| 467444 | VFI ABS LLC 4.78%, 06/24/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 469596 |
| 1913029 | Wendy's Funding LLC 3.88%, 03/15/2048<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1880317 |
|  | Wingstop Funding LLC |  |
| 1359300 | 2.84%, 12/05/2050<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1316957 |
| 870000 | 5.86%, 12/05/2054<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 896203 |
| 2315000 | Zayo Issuer LLC 5.65%, 03/20/2055<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2356793 |
|  |  | &nbsp;&nbsp;&nbsp; 67494329 |
|  | **Whole Loan Collateral CMO - 7.3%** | **Whole Loan Collateral CMO - 7.3%** |
|  | Angel Oak Mortgage Trust |  |
| 924436 | 0.91%, 01/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 821592 |
| 434540 | 0.99%, 04/25/2053<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 419960 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** |
|  | **Whole Loan Collateral CMO - 7.3% - (continued)** | **Whole Loan Collateral CMO - 7.3% - (continued)** |
| $837443 | 0.99%, 04/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; $732109 |
| 1411812 | 1.82%, 11/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1270957 |
| 268474 | 3.35%, 01/25/2067<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 257115 |
| 717183 | Arroyo Mortgage Trust 3.35%, <br> 04/25/2049<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 700698 |
|  | BRAVO Residential Funding Trust |  |
| 435526 | 0.94%, 02/25/2049<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 409993 |
| 190076 | 0.97%, 03/25/2060<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 186176 |
| 1341182 | COLT Mortgage Loan Trust 0.91%, <br> 06/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1168814 |
|  | CSMC Trust |  |
| 1377028 | 0.94%, 05/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1174879 |
| 4048819 | 2.27%, 11/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 3711395 |
| 1674911 | 2.84%, 10/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1524169 |
| 992262 | 3.25%, 04/25/2047<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 916740 |
| 937675 | 4.15%, 12/27/2060<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 940586 |
| 553690 | Deephaven Residential Mortgage Trust <br> 0.90%, 04/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 496525 |
| 936373 | EFMT 5.38%, 12/01/2070<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 938017 |
|  | Ellington Financial Mortgage Trust |  |
| 608784 | 0.93%, 06/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 518220 |
| 1824391 | 2.21%, 01/25/2067<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1610193 |
|  | Federal Home Loan Mortgage Corp. <br> Seasoned Credit Risk Transfer Trust |  |
| 1705926 | 2.50%, 08/25/2059 | &nbsp;&nbsp;&nbsp; 1408018 |
| 1567191 | 3.50%, 11/25/2057 | &nbsp;&nbsp;&nbsp; 1513604 |
| 842856 | 3.50%, 08/25/2058 | &nbsp;&nbsp;&nbsp; 803355 |
| 3140666 | 3.50%, 10/25/2058 | &nbsp;&nbsp;&nbsp; 2873191 |
|  | Federal National Mortgage Association <br> Connecticut Avenue Securities Trust |  |
| 654800 | 6.97%, 10/25/2041, 30 day USD SOFR <br> Average + 3.10%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 665331 |
| 1547000 | 7.02%, 12/25/2041, 30 day USD SOFR <br> Average + 3.15%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1576097 |
| 3155000 | 8.37%, 01/25/2042, 30 day USD SOFR <br> Average + 4.50%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 3260365 |
| 976718 | GCAT Trust 1.92%, 08/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 912828 |
| 3881226 | Imperial Fund Mortgage Trust 3.64%, <br> 03/25/2067<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 3702212 |
|  | Legacy Mortgage Asset Trust |  |
| 897373 | 5.75%, 04/25/2061<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 895818 |
| 1230319 | 5.75%, 07/25/2061<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 1251143 |
|  | MFA Trust |  |
| 101486 | 1.01%, 01/26/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 96965 |
| 834296 | 1.03%, 11/25/2064<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 740073 |
| 518929 | 1.15%, 04/25/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 492979 |
| 2734150 | Morgan Stanley Residential Mortgage Loan <br> Trust 4.25%, 02/25/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2676135 |
|  | New Residential Mortgage Loan Trust |  |
| 346449 | 0.94%, 10/25/2058<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 341966 |
| 193402 | 2.49%, 09/25/2059<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 186619 |
| 813182 | 3.50%, 08/25/2059<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 771855 |
| 950133 | 3.75%, 11/26/2035<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 925358 |
| 968898 | 3.75%, 11/25/2056<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 933068 |
| 673122 | 4.00%, 12/25/2057<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 659647 |
| 888685 | 4.60%, 01/25/2048, 1 mo. USD Term <br> SOFR + 0.86%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 873248 |
| 1342000 | 5.01%, 10/26/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1343940 |
| 776009 | 5.35%, 06/25/2057, 1 mo. USD Term <br> SOFR + 1.61%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 785349 |
| 1590000 | 5.37%, 10/26/2065<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 1592255 |
| 2400254 | NMLT Trust 1.19%, 05/25/2056<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2076882 |
| 2093197 | OBX Trust 1.10%, 05/25/2061<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1735376 |
| 1256346 | OLIT Trust 3.00%, 11/25/2038<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1194911 |
|  | PRET LLC |  |
| 4120692 | 5.19%, 10/25/2055<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 4127936 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

32 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 17.2% -** <br> **(continued)** |
|  | **Whole Loan Collateral CMO - 7.3% - (continued)** | **Whole Loan Collateral CMO - 7.3% - (continued)** |
| $1585000 | 5.27%, 12/25/2055<sup>(1)(4)(5)</sup>  | &nbsp;&nbsp;&nbsp; $1584999 |
| 2640359 | 5.39%, 08/25/2055<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 2646608 |
| 2150362 | 5.66%, 07/25/2055<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 2153357 |
| 1991324 | 5.73%, 08/25/2055<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 1995898 |
| 3202861 | 5.74%, 06/25/2055<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 3215283 |
| 1160000 | 6.78%, 12/25/2055<sup>(1)(4)(5)</sup>  | &nbsp;&nbsp;&nbsp; 1159997 |
| 3086114 | PRET Trust 3.85%, 09/25/2069<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 3051696 |
|  | PRPM LLC |  |
| 3380376 | 3.75%, 04/25/2055<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 3303889 |
| 1257296 | 5.50%, 08/25/2030<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 1260409 |
| 496876 | 5.70%, 11/25/2029<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 496818 |
| 720357 | 5.73%, 07/25/2030<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 719017 |
| 1788321 | 5.77%, 08/25/2028<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 1788128 |
| 1558052 | 5.87%, 11/25/2029<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 1555029 |
| 175391 | RCO VIII Mortgage LLC 6.43%, <br> 05/25/2030<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 174882 |
|  | Starwood Mortgage Residential Trust |  |
| 261840 | 0.94%, 05/25/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 250774 |
| 2363686 | 1.92%, 11/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2099132 |
| 4681436 | Towd Point Mortgage Trust 2.92%, <br> 11/30/2060<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 4170790 |
|  | Verus Securitization Trust |  |
| 564075 | 0.92%, 02/25/2064<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 531513 |
| 1087165 | 0.94%, 07/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 906786 |
| 601315 | 1.03%, 02/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 550904 |
| 4210433 | 1.05%, 06/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 3714492 |
| 1562882 | 2.82%, 11/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1449731 |
| 3845121 | 2.83%, 10/25/2066<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 3532179 |
| 557673 | 4.13%, 02/25/2067<sup>(1)(4)</sup>  | &nbsp;&nbsp;&nbsp; 536896 |
|  |  | &nbsp;&nbsp;&nbsp; 101063869 |
|  | Total Asset-Backed & Commercial <br> Mortgage-Backed Securities <br>(cost $245,248,898) | &nbsp;&nbsp;&nbsp; $238965816 |
| **CONVERTIBLE BONDS - 0.0%** | **CONVERTIBLE BONDS - 0.0%** | **CONVERTIBLE BONDS - 0.0%** |
|  | **Commercial Banks - 0.0%** | **Commercial Banks - 0.0%** |
| EUR <br> 500,000<br>| Mitsubishi UFJ Investor Services & Banking <br> Luxembourg SA 6.55%, 12/15/2050, 3 <br> mo. EURIBOR + 4.50%<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; $377712 |
|  | Total Convertible Bonds <br>(cost $374,296) | &nbsp;&nbsp;&nbsp; $377712 |
| **CORPORATE BONDS - 26.1%** | **CORPORATE BONDS - 26.1%** | **CORPORATE BONDS - 26.1%** |
|  | **Advertising - 0.1%** | **Advertising - 0.1%** |
| $650000 | Outfront Media Capital LLC/Outfront Media <br> Capital Corp. 7.38%, 02/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $687999 |
|  | **Aerospace & Defense - 0.4%** | **Aerospace & Defense - 0.4%** |
| 745000 | BAE Systems PLC 5.13%, 03/26/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 765866 |
|  | Boeing Co. |  |
| 335000 | 2.95%, 02/01/2030 | &nbsp;&nbsp;&nbsp; 317386 |
| 90000 | 3.20%, 03/01/2029 | &nbsp;&nbsp;&nbsp; 87253 |
| 105000 | 3.75%, 02/01/2050 | &nbsp;&nbsp;&nbsp; 76362 |
| 1615000 | 5.15%, 05/01/2030 | &nbsp;&nbsp;&nbsp; 1659429 |
| 1920000 | 5.71%, 05/01/2040 | &nbsp;&nbsp;&nbsp; 1959894 |
| 385000 | 6.39%, 05/01/2031 | &nbsp;&nbsp;&nbsp; 417799 |
| 180000 | 7.01%, 05/01/2064 | &nbsp;&nbsp;&nbsp; 204525 |
|  |  | &nbsp;&nbsp;&nbsp; 5488514 |
|  | **Agriculture - 0.4%** | **Agriculture - 0.4%** |
| 545000 | BAT Capital Corp. 5.83%, 02/20/2031 | &nbsp;&nbsp;&nbsp; 578204 |
| 360000 | JBS USA LUX SARL/JBS USA Food <br> Co./JBS USA Foods Group 5.95%, <br> 04/20/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 378536 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Agriculture - 0.4% - (continued)** | **Agriculture - 0.4% - (continued)** |
|  | Philip Morris International, Inc. |  |
| $915000 | 4.38%, 11/01/2027 | &nbsp;&nbsp;&nbsp; $923026 |
| 690000 | 4.75%, 11/01/2031 | &nbsp;&nbsp;&nbsp; 704525 |
| 270000 | 5.13%, 02/15/2030 | &nbsp;&nbsp;&nbsp; 279092 |
| 1265000 | 5.13%, 02/13/2031 | &nbsp;&nbsp;&nbsp; 1310797 |
| 585000 | 5.38%, 02/15/2033 | &nbsp;&nbsp;&nbsp; 611728 |
| 215000 | 5.63%, 11/17/2029 | &nbsp;&nbsp;&nbsp; 226025 |
| 565000 | 5.63%, 09/07/2033 | &nbsp;&nbsp;&nbsp; 599290 |
|  |  | &nbsp;&nbsp;&nbsp; 5611223 |
|  | **Airlines - 0.0%** | **Airlines - 0.0%** |
| 350000 | JetBlue Airways Corp./JetBlue Loyalty LP <br> 9.88%, 09/20/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 352611 |
|  | **Apparel - 0.2%** | **Apparel - 0.2%** |
| 1685000 | Gildan Activewear, Inc. 5.40%, <br> 10/07/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1680172 |
|  | Tapestry, Inc. |  |
| 640000 | 5.10%, 03/11/2030 | &nbsp;&nbsp;&nbsp; 657028 |
| 245000 | 5.50%, 03/11/2035 | &nbsp;&nbsp;&nbsp; 250482 |
|  |  | &nbsp;&nbsp;&nbsp; 2587682 |
|  | **Auto Parts & Equipment - 0.1%** | **Auto Parts & Equipment - 0.1%** |
| EUR <br> 600,000<br>| Clarios Global LP/Clarios U.S. Finance Co. <br> 4.75%, 06/15/2031<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 715160 |
| $340000 | Forvia SE 6.75%, 09/15/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 351076 |
|  |  | &nbsp;&nbsp;&nbsp; 1066236 |
|  | **Beverages - 0.4%** | **Beverages - 0.4%** |
|  | Bacardi Ltd./Bacardi-Martini BV |  |
| 150000 | 5.25%, 01/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 152832 |
| 413000 | 5.40%, 06/15/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 417548 |
| 515000 | Bacardi-Martini BV 6.00%, 02/01/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 534394 |
|  | Keurig Dr. Pepper, Inc. |  |
| 1336000 | 2.25%, 03/15/2031 | &nbsp;&nbsp;&nbsp; 1191778 |
| 84000 | 3.20%, 05/01/2030 | &nbsp;&nbsp;&nbsp; 79794 |
| 475000 | 3.95%, 04/15/2029 | &nbsp;&nbsp;&nbsp; 469591 |
| 655000 | 4.05%, 04/15/2032 | &nbsp;&nbsp;&nbsp; 629584 |
| 1025000 | 4.50%, 04/15/2052 | &nbsp;&nbsp;&nbsp; 828400 |
| 77000 | 4.60%, 05/15/2030 | &nbsp;&nbsp;&nbsp; 77398 |
| 465000 | 5.15%, 05/15/2035 | &nbsp;&nbsp;&nbsp; 465906 |
| 455000 | 5.20%, 03/15/2031 | &nbsp;&nbsp;&nbsp; 467551 |
| 393000 | 5.30%, 03/15/2034<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 400736 |
|  |  | &nbsp;&nbsp;&nbsp; 5715512 |
|  | **Biotechnology - 0.2%** | **Biotechnology - 0.2%** |
| 2675000 | Royalty Pharma PLC 5.20%, 09/25/2035 | &nbsp;&nbsp;&nbsp; 2688529 |
|  | **Chemicals - 0.4%** | **Chemicals - 0.4%** |
|  | Celanese U.S. Holdings LLC |  |
| 350000 | 6.50%, 04/15/2030<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 351750 |
| 50000 | 7.00%, 02/15/2031 | &nbsp;&nbsp;&nbsp; 51193 |
| 165000 | 7.38%, 02/15/2034 | &nbsp;&nbsp;&nbsp; 167635 |
| EUR <br> 600,000<br>| Itelyum Regeneration SpA 5.75%, <br> 04/15/2030<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 702815 |
| $1390000 | LYB International Finance III LLC 5.13%, <br> 01/15/2031 | &nbsp;&nbsp;&nbsp; 1395157 |
| 710000 | Olympus Water U.S. Holding Corp. 6.25%, <br> 10/01/2029<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 690889 |
| 1405000 | Sherwin-Williams Co. 5.15%, 08/15/2035 | &nbsp;&nbsp;&nbsp; 1429736 |
| 400000 | Tronox, Inc. 4.63%, 03/15/2029<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 280023 |
|  |  | &nbsp;&nbsp;&nbsp; 5069198 |
|  | **Commercial Banks - 3.7%** | **Commercial Banks - 3.7%** |
| EUR <br> 600,000<br>| Banca Comerciala Romana SA 7.63%, <br> 05/19/2027, (7.63% fixed rate until <br> 05/19/2026; 3 mo. EURIBOR + 4.54% <br> thereafter)<sup>(2)(6)</sup>  | &nbsp;&nbsp;&nbsp; 717438 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

33 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Commercial Banks - 3.7% - (continued)** | **Commercial Banks - 3.7% - (continued)** |
| EUR <br> 740,000<br>| Banca Transilvania SA 8.88%, 04/27/2027, <br> (8.88% fixed rate until 04/27/2026; 1 yr. <br> EURIBOR ICE Swap + 5.58% <br> thereafter)<sup>(2)(6)</sup>  | &nbsp;&nbsp;&nbsp; $886739 |
|  | Bank of America Corp. |  |
| $670000 | 1.92%, 10/24/2031, (1.92% fixed rate <br> until 10/24/2030; 6 mo. USD SOFR + <br> 1.37% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 599147 |
| 985000 | 2.30%, 07/21/2032, (2.30% fixed rate <br> until 07/21/2031; 6 mo. USD SOFR + <br> 1.22% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 880746 |
| 1065000 | 2.48%, 09/21/2036, (2.48% fixed rate <br> until 09/21/2031; 5 yr. USD CMT + <br> 1.20% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 934606 |
| 1020000 | 3.19%, 07/23/2030, (3.19% fixed rate <br> until 07/23/2029; 3 mo. USD Term <br> SOFR + 1.44% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 985196 |
| 395000 | 4.95%, 07/22/2028, (4.95% fixed rate <br> until 07/22/2027; 6 mo. USD SOFR + <br> 2.04% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 400593 |
| 555000 | 5.52%, 10/25/2035, (5.52% fixed rate <br> until 10/25/2034; 6 mo. USD SOFR + <br> 1.74% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 568443 |
| 660000 | Bank of New York Mellon Corp. 5.06%, <br> 07/22/2032, (5.06% fixed rate until <br> 07/22/2031; 6 mo. USD SOFR + 1.23% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 684050 |
| 1230000 | BNP Paribas SA 5.91%, 11/19/2035, <br> (5.91% fixed rate until 11/19/2034; 6 mo. <br> USD SOFR + 1.92% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1277122 |
|  | BPCE SA |  |
| 1615000 | 5.39%, 05/28/2031, (5.39% fixed rate <br> until 05/28/2030; 6 mo. USD SOFR + <br> 1.58% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1657751 |
| 1295000 | 5.88%, 01/14/2031, (5.88% fixed rate <br> until 01/14/2030; 6 mo. USD SOFR + <br> 1.68% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1352740 |
| 1370000 | 6.51%, 01/18/2035, (6.51% fixed rate <br> until 01/18/2034; 6 mo. USD SOFR + <br> 2.79% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1452786 |
| 810000 | Citibank NA 4.91%, 05/29/2030 | &nbsp;&nbsp;&nbsp; 833254 |
|  | Citigroup, Inc. |  |
| 1785000 | 4.50%, 09/11/2031, (4.50% fixed rate <br> until 09/11/2030; 6 mo. USD SOFR + <br> 1.17% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1790524 |
| 1330000 | 4.95%, 05/07/2031, (4.95% fixed rate <br> until 05/07/2030; 6 mo. USD SOFR + <br> 1.46% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1358442 |
|  | Citizens Financial Group, Inc. |  |
| 790000 | 5.25%, 03/05/2031, (5.25% fixed rate <br> until 03/05/2030; 6 mo. USD SOFR + <br> 1.26% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 811762 |
| 120000 | 6.65%, 04/25/2035, (6.65% fixed rate <br> until 04/25/2034; 6 mo. USD SOFR + <br> 2.33% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 131948 |
| EUR <br> 250,000<br>| CrediaBank SA 9.38%, 01/31/2031, (9.38% <br> fixed rate until 01/31/2031; 5 yr. <br> EURIBOR ICE Swap + 7.28% <br> thereafter)<sup>(2)(6)(8)</sup>  | &nbsp;&nbsp;&nbsp; 314339 |
|  | Credit Agricole SA |  |
| $1450000 | 4.82%, 09/25/2033, (4.82% fixed rate <br> until 09/25/2032; 6 mo. USD SOFR + <br> 1.36% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1448104 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Commercial Banks - 3.7% - (continued)** | **Commercial Banks - 3.7% - (continued)** |
| $1590000 | 5.22%, 05/27/2031, (5.22% fixed rate <br> until 05/27/2030; 6 mo. USD SOFR + <br> 1.46% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; $1632321 |
| 1775000 | 6.25%, 01/10/2035, (6.25% fixed rate <br> until 01/10/2034; 6 mo. USD SOFR + <br> 2.67% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1884540 |
|  | Goldman Sachs Group, Inc. |  |
| 820000 | 2.38%, 07/21/2032, (2.38% fixed rate <br> until 07/21/2031; 6 mo. USD SOFR + <br> 1.25% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 734401 |
| 225000 | 2.62%, 04/22/2032, (2.62% fixed rate <br> until 04/22/2031; 6 mo. USD SOFR + <br> 1.28% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 205158 |
| 1170000 | 4.69%, 10/23/2030, (4.69% fixed rate <br> until 10/23/2029; 6 mo. USD SOFR + <br> 1.14% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1185963 |
| 140000 | 5.05%, 07/23/2030, (5.05% fixed rate <br> until 07/23/2029; 6 mo. USD SOFR + <br> 1.21% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 143446 |
| 540000 | 5.22%, 04/23/2031, (5.22% fixed rate <br> until 04/23/2030; 6 mo. USD SOFR + <br> 1.58% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 557738 |
|  | HSBC Holdings PLC |  |
| 410000 | 2.85%, 06/04/2031, (2.85% fixed rate <br> until 06/04/2030; 6 mo. USD SOFR + <br> 2.39% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 383239 |
| 605000 | 4.62%, 11/06/2031, (4.62% fixed rate <br> until 11/06/2030; 6 mo. USD SOFR + <br> 1.19% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 606866 |
| 385000 | 5.13%, 03/03/2031, (5.13% fixed rate <br> until 03/03/2030; 6 mo. USD SOFR + <br> 1.29% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 394565 |
| 1675000 | 5.24%, 05/13/2031, (5.24% fixed rate <br> until 05/13/2030; 6 mo. USD SOFR + <br> 1.57% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1725714 |
|  | JP Morgan Chase & Co. |  |
| 650000 | 2.55%, 11/08/2032, (2.55% fixed rate <br> until 11/08/2031; 6 mo. USD SOFR + <br> 1.18% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 586558 |
| 1595000 | 4.26%, 10/22/2031, (4.26% fixed rate <br> until 10/22/2030; 6 mo. USD SOFR + <br> 0.93% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1590161 |
| 1450000 | 4.51%, 10/22/2028, (4.51% fixed rate <br> until 10/22/2027; 6 mo. USD SOFR + <br> 0.86% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1464211 |
| 250000 | 4.95%, 10/22/2035, (4.95% fixed rate <br> until 10/22/2034; 6 mo. USD SOFR + <br> 1.34% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 252464 |
| 1495000 | 5.00%, 07/22/2030, (5.00% fixed rate <br> until 07/22/2029; 6 mo. USD SOFR + <br> 1.13% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1534821 |
| 510000 | 5.10%, 04/22/2031, (5.10% fixed rate <br> until 04/22/2030; 6 mo. USD SOFR + <br> 1.44% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 526563 |
| 465000 | 5.14%, 01/24/2031, (5.14% fixed rate <br> until 01/24/2030; 6 mo. USD SOFR + <br> 1.01% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 480621 |
| 1340000 | 5.30%, 07/24/2029, (5.30% fixed rate <br> until 07/24/2028; 6 mo. USD SOFR + <br> 1.45% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1380938 |
| 1070000 | 5.34%, 01/23/2035, (5.34% fixed rate <br> until 01/23/2034; 6 mo. USD SOFR + <br> 1.62% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1108968 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

34 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Commercial Banks - 3.7% - (continued)** | **Commercial Banks - 3.7% - (continued)** |
| $1260000 | 5.58%, 07/23/2036, (5.58% fixed rate <br> until 07/23/2035; 6 mo. USD SOFR + <br> 1.64% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; $1303406 |
| 1575000 | 5.58%, 04/22/2030, (5.58% fixed rate <br> until 04/22/2029; 6 mo. USD SOFR + <br> 1.16% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1643083 |
| GBP <br> 450,000<br>| Metro Bank Holdings PLC 12.00%, <br> 04/30/2029, (12.00% fixed rate until <br> 04/30/2028; 1 yr. U.K. Government Bond <br> + 7.81% thereafter)<sup>(2)(6)</sup>  | &nbsp;&nbsp;&nbsp; 691523 |
|  | Morgan Stanley |  |
| $505000 | 1.79%, 02/13/2032, (1.79% fixed rate <br> until 02/13/2031; 6 mo. USD SOFR + <br> 1.03% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 443517 |
| 1530000 | 1.93%, 04/28/2032, (1.93% fixed rate <br> until 04/28/2031; 6 mo. USD SOFR + <br> 1.02% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1342357 |
| 460000 | 3.62%, 04/01/2031, (3.62% fixed rate <br> until 04/01/2030; 6 mo. USD SOFR + <br> 3.12% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 446947 |
| 495000 | 4.65%, 10/18/2030, (4.65% fixed rate <br> until 10/18/2029; 6 mo. USD SOFR + <br> 1.10% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 500988 |
| 460000 | 5.23%, 01/15/2031, (5.23% fixed rate <br> until 01/15/2030; 6 mo. USD SOFR + <br> 1.11% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 474484 |
| 455000 | 5.45%, 07/20/2029, (5.45% fixed rate <br> until 07/20/2028; 6 mo. USD SOFR + <br> 1.63% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 469537 |
| 160000 | 6.41%, 11/01/2029, (6.41% fixed rate <br> until 11/01/2028; 6 mo. USD SOFR + <br> 1.83% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 169585 |
| 815000 | OTP Bank Nyrt 7.50%, 05/25/2027, (7.50% <br> fixed rate until 05/25/2026; 1 yr. USD <br> CMT + 3.71% thereafter)<sup>(2)(6)</sup>  | &nbsp;&nbsp;&nbsp; 823073 |
| 1080000 | Royal Bank of Canada 5.15%, 02/04/2031, <br> (5.15% fixed rate until 02/04/2030; 6 mo. <br> USD SOFR + 1.03% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1111872 |
| 865000 | Standard Chartered PLC 7.77%, <br> 11/16/2028, (7.77% fixed rate until <br> 11/16/2027; 1 yr. USD CMT + 3.45% <br> thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 921010 |
|  | Wells Fargo & Co. |  |
| 320000 | 3.35%, 03/02/2033, (3.35% fixed rate <br> until 03/02/2032; 6 mo. USD SOFR + <br> 1.50% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 298668 |
| 710000 | 4.90%, 07/25/2033, (4.90% fixed rate <br> until 07/25/2032; 6 mo. USD SOFR + <br> 2.10% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 721044 |
| 755000 | 5.15%, 04/23/2031, (5.15% fixed rate <br> until 04/23/2030; 6 mo. USD SOFR + <br> 1.50% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 779313 |
| 155000 | 5.24%, 01/24/2031, (5.24% fixed rate <br> until 01/24/2030; 6 mo. USD SOFR + <br> 1.11% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 160506 |
| 790000 | 5.57%, 07/25/2029, (5.57% fixed rate <br> until 07/25/2028; 6 mo. USD SOFR + <br> 1.74% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 818343 |
| 535000 | 6.49%, 10/23/2034, (6.49% fixed rate <br> until 10/23/2033; 6 mo. USD SOFR + <br> 2.06% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 592215 |
|  |  | &nbsp;&nbsp;&nbsp; 51176457 |
|  | **Commercial Services - 0.4%** | **Commercial Services - 0.4%** |
| 675000 | Allied Universal Holdco LLC 7.88%, <br> 02/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 711368 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Commercial Services - 0.4% - (continued)** | **Commercial Services - 0.4% - (continued)** |
|  | Ashtead Capital, Inc. |  |
| $475000 | 2.45%, 08/12/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $423690 |
| 430000 | 4.25%, 11/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 424779 |
| 1330000 | Element Fleet Management Corp. 4.64%, <br> 11/24/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1333709 |
|  | Howard University |  |
| 1000000 | 2.70%, 10/01/2029 | &nbsp;&nbsp;&nbsp; 934040 |
| 1000000 | 2.90%, 10/01/2031 | &nbsp;&nbsp;&nbsp; 898987 |
| 720000 | 3.48%, 10/01/2041 | &nbsp;&nbsp;&nbsp; 564652 |
|  |  | &nbsp;&nbsp;&nbsp; 5291225 |
|  | **Construction Materials - 0.1%** | **Construction Materials - 0.1%** |
|  | CP Atlas Buyer, Inc. |  |
| 325000 | 9.75%, 07/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 336618 |
| 175000 | 12.75%, 01/15/2031<sup>(1)(9)</sup>  | &nbsp;&nbsp;&nbsp; 165799 |
| 675000 | JH North America Holdings, Inc. 6.13%, <br> 07/31/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 692926 |
|  |  | &nbsp;&nbsp;&nbsp; 1195343 |
|  | **Diversified Financial Services - 0.9%** | **Diversified Financial Services - 0.9%** |
|  | American Express Co. |  |
| 1005000 | 5.02%, 04/25/2031, (5.02% fixed rate <br> until 04/25/2030; 6 mo. USD SOFR + <br> 1.44% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1035699 |
| 1280000 | 5.09%, 01/30/2031, (5.09% fixed rate <br> until 01/30/2030; 6 mo. USD SOFR + <br> 1.02% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1319364 |
|  | Capital One Financial Corp. |  |
| 930000 | 4.49%, 09/11/2031, (4.49% fixed rate <br> until 09/11/2030; 6 mo. USD SOFR + <br> 1.25% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 928636 |
| 275000 | 6.05%, 02/01/2035, (6.05% fixed rate <br> until 02/01/2034; 6 mo. USD SOFR + <br> 2.26% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 292735 |
| 550000 | 6.18%, 01/30/2036, (6.18% fixed rate <br> until 01/30/2035; 6 mo. USD SOFR + <br> 2.04% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 574135 |
| 1555000 | 7.62%, 10/30/2031, (7.62% fixed rate <br> until 10/30/2030; 6 mo. USD SOFR + <br> 3.07% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1757377 |
| 275000 | 7.96%, 11/02/2034, (7.96% fixed rate <br> until 11/02/2033; 6 mo. USD SOFR + <br> 3.37% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 324224 |
| 750000 | CrossCountry Intermediate HoldCo LLC <br> 6.50%, 10/01/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 764997 |
| 1305000 | Equitable America Global Funding 4.70%, <br> 09/15/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1298350 |
|  | Freedom Mortgage Holdings LLC |  |
| 350000 | 7.88%, 04/01/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 362447 |
| 325000 | 9.25%, 02/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 340876 |
| 215000 | Rfna LP 7.88%, 02/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 218665 |
|  | Synchrony Financial |  |
| 565000 | 2.88%, 10/28/2031 | &nbsp;&nbsp;&nbsp; 506895 |
| 955000 | 5.45%, 03/06/2031, (5.45% fixed rate <br> until 03/06/2030; 6 mo. USD SOFR + <br> 1.68% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 979162 |
| 1270000 | 6.00%, 07/29/2036, (6.00% fixed rate <br> until 07/29/2035; 6 mo. USD SOFR + <br> 2.07% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1303580 |
|  |  | &nbsp;&nbsp;&nbsp; 12007142 |
|  | **Electric - 4.6%** | **Electric - 4.6%** |
| 635000 | AES Andes SA 6.25%, 03/14/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 661751 |
|  | Alabama Power Co. |  |
| 945000 | 3.45%, 10/01/2049 | &nbsp;&nbsp;&nbsp; 672084 |
| 185000 | 5.10%, 04/02/2035 | &nbsp;&nbsp;&nbsp; 189366 |
| 705000 | Arizona Public Service Co. 5.70%, <br> 08/15/2034 | &nbsp;&nbsp;&nbsp; 741117 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

35 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Electric - 4.6% - (continued)** | **Electric - 4.6% - (continued)** |
| $720000 | Baltimore Gas & Electric Co. 5.45%, <br> 06/01/2035 | &nbsp;&nbsp;&nbsp; $746013 |
|  | Clearway Energy Operating LLC |  |
| 375000 | 3.75%, 02/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 350208 |
| 350000 | 4.75%, 03/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 349237 |
| 310000 | Cleco Corporate Holdings LLC 3.38%, <br> 09/15/2029 | &nbsp;&nbsp;&nbsp; 291527 |
|  | Consolidated Edison Co. of New York, Inc. |  |
| 545000 | 3.20%, 12/01/2051 | &nbsp;&nbsp;&nbsp; 361880 |
| 790000 | 5.50%, 03/15/2055 | &nbsp;&nbsp;&nbsp; 765829 |
| 640000 | 5.75%, 11/15/2055 | &nbsp;&nbsp;&nbsp; 638193 |
|  | Dominion Energy, Inc. |  |
| 810000 | 5.00%, 06/15/2030 | &nbsp;&nbsp;&nbsp; 832222 |
| 3495000 | 6.00%, 02/15/2056, (6.00% fixed rate <br> until 11/15/2030; 5 yr. USD CMT + <br> 2.26% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 3511122 |
| 625000 | Duke Energy Carolinas LLC 4.25%, <br> 12/15/2041 | &nbsp;&nbsp;&nbsp; 549297 |
|  | Duke Energy Corp. |  |
| 2040000 | 2.55%, 06/15/2031 | &nbsp;&nbsp;&nbsp; 1857620 |
| 320000 | 3.30%, 06/15/2041 | &nbsp;&nbsp;&nbsp; 246694 |
| 1645000 | 4.95%, 09/15/2035 | &nbsp;&nbsp;&nbsp; 1631198 |
| 180000 | 5.45%, 06/15/2034 | &nbsp;&nbsp;&nbsp; 187433 |
|  | Duke Energy Florida LLC |  |
| 610000 | 1.75%, 06/15/2030 | &nbsp;&nbsp;&nbsp; 550281 |
| 340000 | 4.85%, 12/01/2035 | &nbsp;&nbsp;&nbsp; 338517 |
| 780000 | Duke Energy Indiana LLC 3.25%, <br> 10/01/2049 | &nbsp;&nbsp;&nbsp; 532169 |
|  | Duke Energy Progress LLC |  |
| 670000 | 4.38%, 03/30/2044 | &nbsp;&nbsp;&nbsp; 573232 |
| 505000 | 5.05%, 03/15/2035 | &nbsp;&nbsp;&nbsp; 513477 |
| 345000 | 5.55%, 03/15/2055 | &nbsp;&nbsp;&nbsp; 340306 |
|  | Edison International |  |
| 434000 | 5.25%, 03/15/2032 | &nbsp;&nbsp;&nbsp; 433901 |
| 1000000 | 6.25%, 03/15/2030 | &nbsp;&nbsp;&nbsp; 1045299 |
|  | Eversource Energy |  |
| 1050000 | 4.45%, 12/15/2030 | &nbsp;&nbsp;&nbsp; 1044120 |
| 1120000 | 5.13%, 05/15/2033 | &nbsp;&nbsp;&nbsp; 1131157 |
| 694000 | 5.50%, 01/01/2034 | &nbsp;&nbsp;&nbsp; 713285 |
|  | Georgia Power Co. |  |
| 245000 | 4.30%, 03/15/2042 | &nbsp;&nbsp;&nbsp; 214384 |
| 590000 | 4.55%, 03/15/2030 | &nbsp;&nbsp;&nbsp; 599444 |
| 1925000 | 4.85%, 03/15/2031 | &nbsp;&nbsp;&nbsp; 1975038 |
| 1065000 | 5.20%, 03/15/2035 | &nbsp;&nbsp;&nbsp; 1093073 |
| 495000 | Interstate Power & Light Co. 5.60%, <br> 06/29/2035 | &nbsp;&nbsp;&nbsp; 515152 |
| 845000 | Investment Energy Resources Ltd. 6.25%, <br> 04/26/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 848845 |
| 195000 | Jersey Central Power & Light Co. 5.10%, <br> 01/15/2035 | &nbsp;&nbsp;&nbsp; 197190 |
| 140000 | Monongahela Power Co. 5.85%, <br> 02/15/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 147954 |
|  | NSTAR Electric Co. |  |
| 375000 | 5.20%, 03/01/2035 | &nbsp;&nbsp;&nbsp; 382780 |
| 355000 | 5.40%, 06/01/2034 | &nbsp;&nbsp;&nbsp; 367693 |
| 275000 | Ohio Edison Co. 5.50%, 01/15/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 286411 |
|  | Pacific Gas & Electric Co. |  |
| 1480000 | 2.50%, 02/01/2031 | &nbsp;&nbsp;&nbsp; 1331942 |
| 329000 | 3.30%, 08/01/2040 | &nbsp;&nbsp;&nbsp; 249037 |
| 225000 | 3.50%, 08/01/2050 | &nbsp;&nbsp;&nbsp; 151718 |
| 680000 | 4.55%, 07/01/2030 | &nbsp;&nbsp;&nbsp; 677079 |
| 131000 | 4.60%, 06/15/2043 | &nbsp;&nbsp;&nbsp; 109325 |
| 270000 | 4.75%, 02/15/2044 | &nbsp;&nbsp;&nbsp; 228014 |
| 194000 | 4.95%, 07/01/2050 | &nbsp;&nbsp;&nbsp; 163975 |
| 600000 | 5.05%, 10/15/2032<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 603347 |
| 1710000 | 5.80%, 05/15/2034 | &nbsp;&nbsp;&nbsp; 1775950 |
| 1069000 | 5.90%, 10/01/2054 | &nbsp;&nbsp;&nbsp; 1024535 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Electric - 4.6% - (continued)** | **Electric - 4.6% - (continued)** |
| $1900000 | 6.10%, 01/15/2029 | &nbsp;&nbsp;&nbsp; $1987143 |
| 727000 | 6.15%, 01/15/2033 | &nbsp;&nbsp;&nbsp; 771416 |
| 1113000 | 6.75%, 01/15/2053 | &nbsp;&nbsp;&nbsp; 1183705 |
| 1053000 | 6.95%, 03/15/2034<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 1171058 |
|  | PacifiCorp |  |
| 195000 | 4.13%, 01/15/2049 | &nbsp;&nbsp;&nbsp; 145343 |
| 447000 | 5.35%, 12/01/2053 | &nbsp;&nbsp;&nbsp; 391914 |
| 742000 | 5.50%, 05/15/2054 | &nbsp;&nbsp;&nbsp; 663098 |
| 265000 | 5.75%, 04/01/2037 | &nbsp;&nbsp;&nbsp; 268557 |
| 58000 | 5.80%, 01/15/2055 | &nbsp;&nbsp;&nbsp; 54124 |
| 68000 | 6.25%, 10/15/2037 | &nbsp;&nbsp;&nbsp; 70977 |
|  | Pinnacle West Capital Corp. |  |
| 901000 | 4.90%, 05/15/2028 | &nbsp;&nbsp;&nbsp; 917178 |
| 791000 | 5.15%, 05/15/2030 | &nbsp;&nbsp;&nbsp; 815056 |
| 1420000 | Public Service Co. of Oklahoma 5.20%, <br> 01/15/2035 | &nbsp;&nbsp;&nbsp; 1435354 |
|  | Public Service Enterprise Group, Inc. |  |
| 1215000 | 4.90%, 03/15/2030 | &nbsp;&nbsp;&nbsp; 1242402 |
| 135000 | 5.45%, 04/01/2034 | &nbsp;&nbsp;&nbsp; 139463 |
| 330000 | 6.13%, 10/15/2033 | &nbsp;&nbsp;&nbsp; 355097 |
|  | Puget Energy, Inc. |  |
| 885000 | 4.22%, 03/15/2032 | &nbsp;&nbsp;&nbsp; 848560 |
| 2025000 | 5.73%, 03/15/2035 | &nbsp;&nbsp;&nbsp; 2077966 |
| 860000 | San Diego Gas & Electric Co. 5.40%, <br> 04/15/2035 | &nbsp;&nbsp;&nbsp; 890155 |
|  | Southern California Edison Co. |  |
| 255000 | 3.65%, 02/01/2050 | &nbsp;&nbsp;&nbsp; 178305 |
| 102000 | 3.90%, 03/15/2043 | &nbsp;&nbsp;&nbsp; 78410 |
| 309000 | 4.00%, 04/01/2047 | &nbsp;&nbsp;&nbsp; 231718 |
| 701000 | 4.13%, 03/01/2048 | &nbsp;&nbsp;&nbsp; 532049 |
| 170000 | 4.65%, 10/01/2043 | &nbsp;&nbsp;&nbsp; 144536 |
| 470000 | 5.20%, 06/01/2034 | &nbsp;&nbsp;&nbsp; 472027 |
| 805000 | 5.45%, 03/01/2035 | &nbsp;&nbsp;&nbsp; 816167 |
| 725000 | 5.45%, 06/01/2052 | &nbsp;&nbsp;&nbsp; 651314 |
| 503000 | 5.70%, 03/01/2053 | &nbsp;&nbsp;&nbsp; 466816 |
| 944000 | 5.88%, 12/01/2053 | &nbsp;&nbsp;&nbsp; 903875 |
| 287000 | 5.90%, 03/01/2055 | &nbsp;&nbsp;&nbsp; 277076 |
| 540000 | 5.95%, 11/01/2032 | &nbsp;&nbsp;&nbsp; 571254 |
| 265000 | 6.00%, 01/15/2034 | &nbsp;&nbsp;&nbsp; 278083 |
| 390000 | Southern Power Co. 4.90%, 10/01/2035 | &nbsp;&nbsp;&nbsp; 385797 |
| 840000 | Trans-Allegheny Interstate Line Co. 5.00%, <br> 01/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 862902 |
|  | Virginia Electric & Power Co. |  |
| 356000 | 2.45%, 12/15/2050 | &nbsp;&nbsp;&nbsp; 204537 |
| 65000 | 4.20%, 05/15/2045 | &nbsp;&nbsp;&nbsp; 53861 |
| 700000 | 4.90%, 09/15/2035 | &nbsp;&nbsp;&nbsp; 696684 |
| 820000 | 5.00%, 04/01/2033 | &nbsp;&nbsp;&nbsp; 839699 |
| 1340000 | 5.00%, 01/15/2034 | &nbsp;&nbsp;&nbsp; 1356012 |
| 250000 | 5.05%, 08/15/2034 | &nbsp;&nbsp;&nbsp; 253125 |
| 170000 | 5.35%, 01/15/2054 | &nbsp;&nbsp;&nbsp; 159376 |
| 385000 | 5.65%, 03/15/2055 | &nbsp;&nbsp;&nbsp; 376951 |
| 640000 | Wisconsin Power & Light Co. 5.38%, <br> 03/30/2034 | &nbsp;&nbsp;&nbsp; 659793 |
|  | Xcel Energy, Inc. |  |
| 720000 | 4.60%, 06/01/2032 | &nbsp;&nbsp;&nbsp; 716056 |
| 780000 | 4.75%, 03/21/2028 | &nbsp;&nbsp;&nbsp; 790110 |
| 350000 | 5.60%, 04/15/2035 | &nbsp;&nbsp;&nbsp; 362448 |
| 675000 | XPLR Infrastructure Operating Partners LP <br> 7.25%, 01/15/2029<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 691612 |
|  |  | &nbsp;&nbsp;&nbsp; 64180580 |
|  | **Electronics - 0.1%** | **Electronics - 0.1%** |
| 750000 | Imola Merger Corp. 4.75%, 05/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 740265 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

36 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Energy-Alternate Sources - 0.0%** | **Energy-Alternate Sources - 0.0%** |
|  | Pacific Gas & Electric Co. |  |
| $313000 | 4.30%, 03/15/2045 | &nbsp;&nbsp;&nbsp; $248281 |
| 210000 | 6.70%, 04/01/2053 | &nbsp;&nbsp;&nbsp; 221596 |
|  |  | &nbsp;&nbsp;&nbsp; 469877 |
|  | **Entertainment - 0.1%** | **Entertainment - 0.1%** |
| 750000 | Cinemark USA, Inc. 7.00%, 08/01/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 778277 |
| 350000 | Great Canadian Gaming Corp./Raptor LLC <br> 8.75%, 11/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 353552 |
| 375000 | Penn Entertainment, Inc. 4.13%, <br> 07/01/2029<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 347307 |
|  |  | &nbsp;&nbsp;&nbsp; 1479136 |
|  | **Food - 1.0%** | **Food - 1.0%** |
| GBP <br> 500,000<br>| Bellis Acquisition Co. PLC 8.13%, <br> 05/14/2030<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 626850 |
| $750000 | Froneri Lux FinCo SARL 6.00%, <br> 08/01/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 760237 |
|  | JBS USA Holding Lux SARL/JBS USA Food <br> Co./JBS Lux Co. SARL |  |
| 405000 | 5.75%, 04/01/2033 | &nbsp;&nbsp;&nbsp; 423109 |
| 370000 | 6.75%, 03/15/2034 | &nbsp;&nbsp;&nbsp; 408776 |
| 375000 | 7.25%, 11/15/2053 | &nbsp;&nbsp;&nbsp; 419783 |
|  | JBS USA Holding Lux SARL/JBS USA <br> Foods Group Holdings, Inc./JBS USA <br> Food Co. |  |
| 925000 | 5.50%, 01/15/2036<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 939946 |
| 95000 | 6.25%, 03/01/2056<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 94552 |
| 2180000 | 6.38%, 04/15/2066<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2170575 |
|  | Mars, Inc. |  |
| 585000 | 4.60%, 03/01/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 593015 |
| 2025000 | 5.00%, 03/01/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2087257 |
| 1050000 | 5.20%, 03/01/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1079221 |
| 3120000 | 5.65%, 05/01/2045<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 3145007 |
| 325000 | 5.80%, 05/01/2065<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 326129 |
| 745000 | Pilgrim's Pride Corp. 4.25%, 04/15/2031 | &nbsp;&nbsp;&nbsp; 727319 |
|  |  | &nbsp;&nbsp;&nbsp; 13801776 |
|  | **Gas - 0.4%** | **Gas - 0.4%** |
| 1630000 | MPLX LP 5.50%, 06/01/2034 | &nbsp;&nbsp;&nbsp; 1662912 |
|  | NiSource, Inc. |  |
| 1280000 | 5.35%, 07/15/2035<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 1308664 |
| 485000 | 5.40%, 06/30/2033 | &nbsp;&nbsp;&nbsp; 502953 |
|  | Southern California Gas Co. |  |
| 225000 | 5.60%, 04/01/2054 | &nbsp;&nbsp;&nbsp; 220217 |
| 1320000 | 6.00%, 06/15/2055 | &nbsp;&nbsp;&nbsp; 1355293 |
| 1115000 | Southern Co. Gas Capital Corp. 5.10%, <br> 09/15/2035 | &nbsp;&nbsp;&nbsp; 1123542 |
|  |  | &nbsp;&nbsp;&nbsp; 6173581 |
|  | **Healthcare - Products - 0.5%** | **Healthcare - Products - 0.5%** |
|  | Avantor Funding, Inc. |  |
| 950000 | 3.88%, 11/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 908443 |
| 380000 | 4.63%, 07/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 377935 |
| 1145000 | Baxter International, Inc. 4.90%, 12/15/2030 | &nbsp;&nbsp;&nbsp; 1153768 |
|  | GE HealthCare Technologies, Inc. |  |
| 140000 | 4.95%, 12/15/2035 | &nbsp;&nbsp;&nbsp; 139690 |
| 1605000 | 5.50%, 06/15/2035 | &nbsp;&nbsp;&nbsp; 1667495 |
| 2465000 | Thermo Fisher Scientific, Inc. 4.47%, <br> 10/07/2032 | &nbsp;&nbsp;&nbsp; 2472856 |
| 175000 | VSP Optical Group, Inc. 5.45%, <br> 12/01/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 176165 |
|  |  | &nbsp;&nbsp;&nbsp; 6896352 |
|  | **Healthcare - Services - 0.7%** | **Healthcare - Services - 0.7%** |
|  | Acadia Healthcare Co., Inc. |  |
| 250000 | 5.00%, 04/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 240709 |
| 250000 | 7.38%, 03/15/2033<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 252501 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Healthcare - Services - 0.7% - (continued)** | **Healthcare - Services - 0.7% - (continued)** |
|  | Centene Corp. |  |
| $2080000 | 2.50%, 03/01/2031 | &nbsp;&nbsp;&nbsp; $1796228 |
| 530000 | 2.63%, 08/01/2031 | &nbsp;&nbsp;&nbsp; 455876 |
|  | CHS/Community Health Systems, Inc. |  |
| 200000 | 4.75%, 02/15/2031<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 178177 |
| 200000 | 6.88%, 04/15/2029<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 178000 |
| 135000 | 10.88%, 01/15/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 147344 |
| 1100000 | Cigna Group 4.88%, 09/15/2032 | &nbsp;&nbsp;&nbsp; 1114314 |
|  | Humana, Inc. |  |
| 985000 | 5.38%, 04/15/2031 | &nbsp;&nbsp;&nbsp; 1018376 |
| 1090000 | 5.55%, 05/01/2035 | &nbsp;&nbsp;&nbsp; 1112836 |
| 675000 | Star Parent, Inc. 9.00%, 10/01/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 720366 |
|  | UnitedHealth Group, Inc. |  |
| 1150000 | 2.75%, 05/15/2040 | &nbsp;&nbsp;&nbsp; 860046 |
| 190000 | 3.50%, 08/15/2039 | &nbsp;&nbsp;&nbsp; 158206 |
| 330000 | 3.70%, 08/15/2049 | &nbsp;&nbsp;&nbsp; 245020 |
| 240000 | 4.95%, 05/15/2062 | &nbsp;&nbsp;&nbsp; 207783 |
| 125000 | 5.30%, 02/15/2030 | &nbsp;&nbsp;&nbsp; 130320 |
| 365000 | 5.30%, 06/15/2035 | &nbsp;&nbsp;&nbsp; 377911 |
| 290000 | 5.38%, 04/15/2054 | &nbsp;&nbsp;&nbsp; 273629 |
| 490000 | 5.75%, 07/15/2064 | &nbsp;&nbsp;&nbsp; 478391 |
| 260000 | 6.05%, 02/15/2063 | &nbsp;&nbsp;&nbsp; 265550 |
|  |  | &nbsp;&nbsp;&nbsp; 10211583 |
|  | **Household Products - 0.1%** | **Household Products - 0.1%** |
| 905000 | Kenvue, Inc. 4.85%, 05/22/2032 | &nbsp;&nbsp;&nbsp; 925432 |
|  | **Insurance - 0.6%** | **Insurance - 0.6%** |
| 2310000 | Arthur J Gallagher & Co. 5.15%, 02/15/2035 | &nbsp;&nbsp;&nbsp; 2334175 |
| 210000 | Asurion LLC & Asurion Co-Issuer, Inc. <br> 8.00%, 12/31/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 217898 |
|  | Athene Global Funding |  |
| 1540000 | 2.65%, 10/04/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1361808 |
| 390000 | 2.72%, 01/07/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 368950 |
| 730000 | 4.72%, 10/08/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 730047 |
|  | Equitable Financial Life Global Funding |  |
| 745000 | 1.80%, 03/08/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 709198 |
| 650000 | 5.00%, 03/27/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 664489 |
| 865000 | GA Global Funding Trust 4.50%, <br> 09/18/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 854668 |
|  | Howden U.K. Refinance PLC/Howden U.K. <br> Refinance 2 PLC/Howden U.S. Refinance <br> LLC |  |
| 350000 | 7.25%, 02/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 360431 |
| 400000 | 8.13%, 02/15/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 412933 |
| 845000 | Lincoln Financial Global Funding 4.63%, <br> 05/28/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 853024 |
|  |  | &nbsp;&nbsp;&nbsp; 8867621 |
|  | **Internet - 0.9%** | **Internet - 0.9%** |
|  | Alphabet, Inc. |  |
| 1705000 | 5.30%, 05/15/2065 | &nbsp;&nbsp;&nbsp; 1603524 |
| 1920000 | 5.35%, 11/15/2045 | &nbsp;&nbsp;&nbsp; 1907872 |
| 1420000 | 5.70%, 11/15/2075 | &nbsp;&nbsp;&nbsp; 1397636 |
|  | Meta Platforms, Inc. |  |
| 335000 | 4.60%, 11/15/2032 | &nbsp;&nbsp;&nbsp; 337693 |
| 240000 | 5.40%, 08/15/2054 | &nbsp;&nbsp;&nbsp; 223276 |
| 1720000 | 5.50%, 11/15/2045 | &nbsp;&nbsp;&nbsp; 1670153 |
| 800000 | 5.55%, 08/15/2064 | &nbsp;&nbsp;&nbsp; 742076 |
| 300000 | 5.63%, 11/15/2055 | &nbsp;&nbsp;&nbsp; 287931 |
| 1695000 | 5.75%, 11/15/2065 | &nbsp;&nbsp;&nbsp; 1616189 |
| 1845000 | Uber Technologies, Inc. 4.80%, 09/15/2035 | &nbsp;&nbsp;&nbsp; 1835257 |
| EUR <br> 250,000<br>| United Group BV 6.50%, 10/31/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 299884 |
| $750000 | Wayfair LLC 7.25%, 10/31/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 782752 |
|  |  | &nbsp;&nbsp;&nbsp; 12704243 |
|  | **Investment Company Security - 0.4%** | **Investment Company Security - 0.4%** |
|  | Ares Strategic Income Fund |  |
| 1180000 | 5.15%, 01/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1157962 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

37 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Investment Company Security - 0.4% - (continued)** | **Investment Company Security - 0.4% - (continued)** |
| $1005000 | 5.80%, 09/09/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $1014731 |
| 2060000 | Blackstone Secured Lending Fund 5.13%, <br> 01/31/2031<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 2034352 |
|  | HPS Corporate Lending Fund |  |
| 935000 | 5.45%, 11/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 932255 |
| 875000 | 5.85%, 06/05/2030<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 885428 |
|  |  | &nbsp;&nbsp;&nbsp; 6024728 |
|  | **IT Services - 0.2%** | **IT Services - 0.2%** |
| 1300000 | Hewlett Packard Enterprise Co. 5.60%, <br> 10/15/2054 | &nbsp;&nbsp;&nbsp; 1204449 |
| 1075000 | International Business Machines Corp. <br> 4.80%, 02/10/2030 | &nbsp;&nbsp;&nbsp; 1099487 |
| 775000 | McAfee Corp. 7.38%, 02/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 675860 |
|  |  | &nbsp;&nbsp;&nbsp; 2979796 |
|  | **Leisure Time - 0.0%** | **Leisure Time - 0.0%** |
| 500000 | NCL Corp. Ltd. 6.25%, 03/01/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 507657 |
|  | **Lodging - 0.1%** | **Lodging - 0.1%** |
|  | Las Vegas Sands Corp. |  |
| 575000 | 5.63%, 06/15/2028 | &nbsp;&nbsp;&nbsp; 589545 |
| 935000 | 6.00%, 06/14/2030 | &nbsp;&nbsp;&nbsp; 979791 |
|  |  | &nbsp;&nbsp;&nbsp; 1569336 |
|  | **Machinery-Diversified - 0.1%** | **Machinery-Diversified - 0.1%** |
| 875000 | Westinghouse Air Brake Technologies Corp. <br> 4.90%, 05/29/2030 | &nbsp;&nbsp;&nbsp; 895281 |
|  | **Media - 1.0%** | **Media - 1.0%** |
| 1000000 | CCO Holdings LLC/CCO Holdings Capital <br> Corp. 4.25%, 02/01/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 918850 |
|  | Charter Communications <br> Operating LLC/Charter Communications <br> Operating Capital |  |
| 665000 | 3.70%, 04/01/2051 | &nbsp;&nbsp;&nbsp; 418572 |
| 910000 | 5.13%, 07/01/2049 | &nbsp;&nbsp;&nbsp; 712121 |
| 1145000 | 5.25%, 04/01/2053 | &nbsp;&nbsp;&nbsp; 905518 |
| 205000 | 5.75%, 04/01/2048 | &nbsp;&nbsp;&nbsp; 174862 |
| 1400000 | 6.38%, 10/23/2035 | &nbsp;&nbsp;&nbsp; 1444878 |
| 520000 | 6.48%, 10/23/2045 | &nbsp;&nbsp;&nbsp; 488887 |
| 310000 | 6.65%, 02/01/2034 | &nbsp;&nbsp;&nbsp; 326567 |
|  | Comcast Corp. |  |
| 1025000 | 2.89%, 11/01/2051 | &nbsp;&nbsp;&nbsp; 599413 |
| 854000 | 2.94%, 11/01/2056 | &nbsp;&nbsp;&nbsp; 479841 |
|  | Cox Communications, Inc. |  |
| 495000 | 2.60%, 06/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 440866 |
| 930000 | 5.95%, 09/01/2054<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 814134 |
| 350000 | Directv Financing LLC/Directv Financing <br> Co-Obligor, Inc. 10.00%, 02/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 357718 |
|  | Paramount Global |  |
| 30000 | 4.20%, 05/19/2032<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 27105 |
| 1575000 | 4.38%, 03/15/2043 | &nbsp;&nbsp;&nbsp; 1095503 |
| 320000 | 4.95%, 01/15/2031 | &nbsp;&nbsp;&nbsp; 307720 |
| 555000 | 4.95%, 05/19/2050 | &nbsp;&nbsp;&nbsp; 388656 |
| 580000 | 5.25%, 04/01/2044 | &nbsp;&nbsp;&nbsp; 437823 |
| 470000 | 5.85%, 09/01/2043 | &nbsp;&nbsp;&nbsp; 386960 |
| 750000 | Scripps Escrow II, Inc. 3.88%, 01/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 690104 |
| 880000 | Time Warner Cable Enterprises LLC 8.38%, <br> 07/15/2033 | &nbsp;&nbsp;&nbsp; 1015463 |
| 780000 | Time Warner Cable LLC 6.55%, 05/01/2037 | &nbsp;&nbsp;&nbsp; 795958 |
|  |  | &nbsp;&nbsp;&nbsp; 13227519 |
|  | **Mining - 0.4%** | **Mining - 0.4%** |
| 1160000 | Anglo American Capital PLC 4.50%, <br> 03/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1166626 |
|  | Glencore Funding LLC |  |
| 1155000 | 5.37%, 04/04/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1191988 |
| 360000 | 5.63%, 04/04/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 376125 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Mining - 0.4% - (continued)** | **Mining - 0.4% - (continued)** |
| $830000 | 6.38%, 10/06/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $893237 |
| 375000 | 6.50%, 10/06/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 414165 |
|  | Kaiser Aluminum Corp. |  |
| 370000 | 4.50%, 06/01/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 357466 |
| 350000 | 5.88%, 03/01/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 351098 |
| 935000 | Rio Tinto Alcan, Inc. 6.13%, 12/15/2033 | &nbsp;&nbsp;&nbsp; 1023011 |
| 265000 | Rio Tinto Finance USA PLC 5.00%, <br> 03/14/2032 | &nbsp;&nbsp;&nbsp; 273625 |
|  |  | &nbsp;&nbsp;&nbsp; 6047341 |
|  | **Miscellaneous Manufacturing - 0.1%** | **Miscellaneous Manufacturing - 0.1%** |
| 1360000 | Siemens Funding BV 4.60%, 05/28/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1387879 |
|  | **Oil & Gas - 1.3%** | **Oil & Gas - 1.3%** |
|  | Aker BP ASA |  |
| 865000 | 4.00%, 01/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 834975 |
| 435000 | 5.25%, 10/30/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 424969 |
| 1400000 | 5.80%, 10/01/2054<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1272870 |
| 930000 | Azule Energy Finance PLC 8.13%, <br> 01/23/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 931209 |
|  | ConocoPhillips Co. |  |
| 725000 | 3.80%, 03/15/2052 | &nbsp;&nbsp;&nbsp; 531835 |
| 265000 | 4.03%, 03/15/2062 | &nbsp;&nbsp;&nbsp; 192530 |
| 280000 | 5.30%, 05/15/2053 | &nbsp;&nbsp;&nbsp; 260834 |
| 680000 | 5.65%, 01/15/2065 | &nbsp;&nbsp;&nbsp; 652917 |
| 690000 | 5.70%, 09/15/2063 | &nbsp;&nbsp;&nbsp; 664768 |
| 715000 | Coterra Energy, Inc. 5.60%, 03/15/2034 | &nbsp;&nbsp;&nbsp; 736699 |
|  | Diamondback Energy, Inc. |  |
| 155000 | 5.40%, 04/18/2034 | &nbsp;&nbsp;&nbsp; 158708 |
| 550000 | 5.55%, 04/01/2035 | &nbsp;&nbsp;&nbsp; 565307 |
| 285000 | 5.90%, 04/18/2064 | &nbsp;&nbsp;&nbsp; 269031 |
| 300000 | 6.25%, 03/15/2053 | &nbsp;&nbsp;&nbsp; 302865 |
|  | Ecopetrol SA |  |
| 1345000 | 7.75%, 02/01/2032 | &nbsp;&nbsp;&nbsp; 1384126 |
| 1260000 | 8.38%, 01/19/2036 | &nbsp;&nbsp;&nbsp; 1296264 |
|  | Energean Israel Finance Ltd. |  |
| 1750000 | 5.88%, 03/30/2031<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 1692606 |
| 550000 | 8.50%, 09/30/2033<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 587410 |
|  | EOG Resources, Inc. |  |
| 115000 | 4.40%, 01/15/2031 | &nbsp;&nbsp;&nbsp; 115447 |
| 535000 | 5.00%, 07/15/2032 | &nbsp;&nbsp;&nbsp; 547992 |
| 355000 | 5.35%, 01/15/2036 | &nbsp;&nbsp;&nbsp; 364785 |
| 250000 | 5.65%, 12/01/2054 | &nbsp;&nbsp;&nbsp; 244514 |
| 902000 | Hess Corp. 7.13%, 03/15/2033 | &nbsp;&nbsp;&nbsp; 1043891 |
| 700000 | Matador Resources Co. 6.50%, <br> 04/15/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 709915 |
| 635000 | Phillips 66 Co. 5.88%, 03/15/2056, (5.88% <br> fixed rate until 12/15/2030; 5 yr. USD <br> CMT + 2.28% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 628206 |
| 750000 | SM Energy Co. 6.75%, 08/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 755507 |
|  | TotalEnergies Capital SA |  |
| 525000 | 5.43%, 09/10/2064 | &nbsp;&nbsp;&nbsp; 491352 |
| 855000 | 5.64%, 04/05/2064 | &nbsp;&nbsp;&nbsp; 825786 |
|  |  | &nbsp;&nbsp;&nbsp; 18487318 |
|  | **Oil & Gas Services - 0.0%** | **Oil & Gas Services - 0.0%** |
| 350000 | USA Compression Partners LP/USA <br> Compression Finance Corp. 6.25%, <br> 10/01/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 354196 |
|  | **Packaging & Containers - 0.1%** | **Packaging & Containers - 0.1%** |
|  | Clydesdale Acquisition Holdings, Inc. |  |
| 350000 | 6.63%, 04/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 356107 |
| 350000 | 8.75%, 04/15/2030<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 355838 |
| 350000 | Mauser Packaging Solutions Holding Co. <br> 9.25%, 04/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 336000 |
| 479000 | TriMas Corp. 4.13%, 04/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 465820 |
|  |  | &nbsp;&nbsp;&nbsp; 1513765 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

38 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Pharmaceuticals - 0.6%** | **Pharmaceuticals - 0.6%** |
|  | Cardinal Health, Inc. |  |
| $1965000 | 4.50%, 09/15/2030 | &nbsp;&nbsp;&nbsp; $1983616 |
| 1260000 | 5.00%, 11/15/2029 | &nbsp;&nbsp;&nbsp; 1294046 |
| 1280000 | Cencora, Inc. 4.85%, 12/15/2029 | &nbsp;&nbsp;&nbsp; 1308399 |
|  | CVS Health Corp. |  |
| 300000 | 1.75%, 08/21/2030 | &nbsp;&nbsp;&nbsp; 266466 |
| 323000 | 1.88%, 02/28/2031 | &nbsp;&nbsp;&nbsp; 283399 |
| 522000 | 2.13%, 09/15/2031 | &nbsp;&nbsp;&nbsp; 458559 |
| 940000 | 4.30%, 03/25/2028 | &nbsp;&nbsp;&nbsp; 943113 |
| 65000 | 5.45%, 09/15/2035 | &nbsp;&nbsp;&nbsp; 66535 |
| 500000 | Teva Pharmaceutical Finance Netherlands <br> III BV 6.00%, 12/01/2032 | &nbsp;&nbsp;&nbsp; 524754 |
|  | Viatris, Inc. |  |
| 965000 | 3.85%, 06/22/2040 | &nbsp;&nbsp;&nbsp; 740776 |
| 460000 | 4.00%, 06/22/2050 | &nbsp;&nbsp;&nbsp; 306343 |
|  |  | &nbsp;&nbsp;&nbsp; 8176006 |
|  | **Pipelines - 2.1%** | **Pipelines - 2.1%** |
|  | Buckeye Partners LP |  |
| 250000 | 5.85%, 11/15/2043 | &nbsp;&nbsp;&nbsp; 234444 |
| 500000 | 6.75%, 02/01/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 524876 |
| 1425000 | Cheniere Energy Partners LP 5.55%, <br> 10/30/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1456889 |
|  | Columbia Pipelines Holding Co. LLC |  |
| 970000 | 5.00%, 11/17/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 969914 |
| 363000 | 5.10%, 10/01/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 369126 |
| 565000 | 5.68%, 01/15/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 582136 |
| 62000 | Columbia Pipelines Operating Co. LLC <br> 6.04%, 11/15/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 66368 |
| 810000 | DT Midstream, Inc. 5.80%, 12/15/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 840614 |
| 465000 | Energy Transfer LP 5.00%, 05/15/2050 | &nbsp;&nbsp;&nbsp; 389041 |
|  | Enterprise Products Operating LLC |  |
| 230000 | 3.30%, 02/15/2053 | &nbsp;&nbsp;&nbsp; 153580 |
| 1465000 | 4.60%, 01/15/2031 | &nbsp;&nbsp;&nbsp; 1483000 |
| 180000 | 5.20%, 01/15/2036 | &nbsp;&nbsp;&nbsp; 183229 |
| 575000 | 5.55%, 02/16/2055 | &nbsp;&nbsp;&nbsp; 557237 |
| 966014 | Galaxy Pipeline Assets Bidco Ltd. 2.94%, <br> 09/30/2040<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 821738 |
| 1615000 | Greensaif Pipelines Bidco SARL 5.85%, <br> 02/23/2036<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1687381 |
|  | Hess Midstream Operations LP |  |
| 2244000 | 4.25%, 02/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2194825 |
| 655000 | 6.50%, 06/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 676418 |
|  | MPLX LP |  |
| 1115000 | 4.80%, 02/15/2031 | &nbsp;&nbsp;&nbsp; 1126708 |
| 1245000 | 5.00%, 01/15/2033 | &nbsp;&nbsp;&nbsp; 1249438 |
| 525000 | 5.40%, 09/15/2035 | &nbsp;&nbsp;&nbsp; 528906 |
| 750000 | Northriver Midstream Finance LP 6.75%, <br> 07/15/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 764290 |
|  | ONEOK, Inc. |  |
| 210000 | 3.10%, 03/15/2030 | &nbsp;&nbsp;&nbsp; 199676 |
| 1090000 | 4.75%, 10/15/2031 | &nbsp;&nbsp;&nbsp; 1095792 |
| 1290000 | 5.05%, 11/01/2034 | &nbsp;&nbsp;&nbsp; 1278481 |
| 570000 | 5.40%, 10/15/2035 | &nbsp;&nbsp;&nbsp; 575919 |
| 430000 | 6.05%, 09/01/2033 | &nbsp;&nbsp;&nbsp; 457425 |
| 240000 | 6.10%, 11/15/2032 | &nbsp;&nbsp;&nbsp; 256821 |
| 110000 | 6.63%, 09/01/2053 | &nbsp;&nbsp;&nbsp; 115202 |
| 60000 | 7.15%, 01/15/2051 | &nbsp;&nbsp;&nbsp; 65879 |
| 680000 | Plains All American Pipeline LP/PAA <br> Finance Corp. 5.60%, 01/15/2036 | &nbsp;&nbsp;&nbsp; 687865 |
| 500000 | Rockies Express Pipeline LLC 6.75%, <br> 03/15/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 527660 |
|  | Targa Resources Corp. |  |
| 350000 | 4.90%, 09/15/2030 | &nbsp;&nbsp;&nbsp; 356610 |
| 980000 | 5.40%, 07/30/2036 | &nbsp;&nbsp;&nbsp; 981127 |
| 1330000 | 5.55%, 08/15/2035 | &nbsp;&nbsp;&nbsp; 1361269 |
| 600000 | 5.65%, 02/15/2036 | &nbsp;&nbsp;&nbsp; 616317 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Pipelines - 2.1% - (continued)** | **Pipelines - 2.1% - (continued)** |
| $145000 | 6.50%, 03/30/2034 | &nbsp;&nbsp;&nbsp; $158251 |
| 695000 | Targa Resources Partners LP/Targa <br> Resources Partners Finance Corp. <br> 4.00%, 01/15/2032 | &nbsp;&nbsp;&nbsp; 663165 |
|  | Venture Global Plaquemines LNG LLC |  |
| 1105000 | 6.13%, 12/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1125271 |
| 625000 | 7.50%, 05/01/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 675313 |
|  | Whistler Pipeline LLC |  |
| 506000 | 5.70%, 09/30/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 525129 |
| 421000 | 5.95%, 09/30/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 435345 |
|  |  | &nbsp;&nbsp;&nbsp; 29018675 |
|  | **Real Estate Investment Trusts - 0.4%** | **Real Estate Investment Trusts - 0.4%** |
|  | Crown Castle, Inc. |  |
| 195000 | 2.10%, 04/01/2031 | &nbsp;&nbsp;&nbsp; 172096 |
| 1595000 | 2.25%, 01/15/2031 | &nbsp;&nbsp;&nbsp; 1424669 |
| 1035000 | 3.10%, 11/15/2029 | &nbsp;&nbsp;&nbsp; 986159 |
|  | Hudson Pacific Properties LP |  |
| 389000 | 4.65%, 04/01/2029<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 359578 |
| 350000 | 5.95%, 02/15/2028 | &nbsp;&nbsp;&nbsp; 344747 |
|  | Prologis Targeted U.S. Logistics Fund LP |  |
| 420000 | 4.25%, 01/15/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 416897 |
| 1210000 | 4.75%, 01/15/2036<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1181865 |
|  |  | &nbsp;&nbsp;&nbsp; 4886011 |
|  | **Retail - 0.2%** | **Retail - 0.2%** |
|  | AutoZone, Inc. |  |
| 235000 | 4.75%, 02/01/2033 | &nbsp;&nbsp;&nbsp; 235501 |
| 155000 | 5.40%, 07/15/2034 | &nbsp;&nbsp;&nbsp; 160459 |
| 307000 | 6.55%, 11/01/2033 | &nbsp;&nbsp;&nbsp; 341182 |
| EUR <br> 500,000<br>| Bertrand Franchise Finance SAS 5.75%, <br> 07/18/2030, 3 mo. EURIBOR + <br> 3.75%<sup>(2)(6)</sup>  | &nbsp;&nbsp;&nbsp; 584121 |
| GBP <br> 500,000<br>| CD&R Firefly Bidco PLC 8.63%, <br> 04/30/2029<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 705176 |
| $500000 | Specialty Building Products <br> Holdings LLC/SBP Finance Corp. 7.75%, <br> 10/15/2029<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 487840 |
| 428000 | Staples, Inc. 10.75%, 09/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 425509 |
|  |  | &nbsp;&nbsp;&nbsp; 2939788 |
|  | **Semiconductors - 1.1%** | **Semiconductors - 1.1%** |
| 1120000 | Applied Materials, Inc. 4.60%, 01/15/2036 | &nbsp;&nbsp;&nbsp; 1102897 |
|  | Broadcom, Inc. |  |
| 455000 | 4.15%, 02/15/2028 | &nbsp;&nbsp;&nbsp; 456540 |
| 1015000 | 4.20%, 10/15/2030 | &nbsp;&nbsp;&nbsp; 1014228 |
| 395000 | 5.05%, 07/12/2029 | &nbsp;&nbsp;&nbsp; 406683 |
| 1110000 | 5.20%, 07/15/2035 | &nbsp;&nbsp;&nbsp; 1137268 |
|  | Foundry JV Holdco LLC |  |
| 305000 | 5.50%, 01/25/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 314819 |
| 490000 | 5.90%, 01/25/2033<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 512710 |
| 2950000 | 6.15%, 01/25/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 3126080 |
|  | Intel Corp. |  |
| 350000 | 3.10%, 02/15/2060 | &nbsp;&nbsp;&nbsp; 195541 |
| 899000 | 3.25%, 11/15/2049 | &nbsp;&nbsp;&nbsp; 574319 |
| 2135000 | 3.73%, 12/08/2047 | &nbsp;&nbsp;&nbsp; 1519252 |
| 470000 | 4.10%, 05/11/2047 | &nbsp;&nbsp;&nbsp; 355286 |
| 340000 | 4.15%, 08/05/2032 | &nbsp;&nbsp;&nbsp; 327844 |
| 170000 | 4.75%, 03/25/2050 | &nbsp;&nbsp;&nbsp; 138737 |
|  | Marvell Technology, Inc. |  |
| 595000 | 2.45%, 04/15/2028 | &nbsp;&nbsp;&nbsp; 573020 |
| 720000 | 2.95%, 04/15/2031 | &nbsp;&nbsp;&nbsp; 666852 |
| 1050000 | Micron Technology, Inc. 5.65%, <br> 11/01/2032<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 1103701 |
| 1250000 | Qorvo, Inc. 3.38%, 04/01/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1156430 |
| 535000 | QUALCOMM, Inc. 4.75%, 05/20/2032 | &nbsp;&nbsp;&nbsp; 546469 |
|  |  | &nbsp;&nbsp;&nbsp; 15228676 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

39 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** | **CORPORATE BONDS - 26.1% - (continued)** |
|  | **Software - 0.7%** | **Software - 0.7%** |
| $1110000 | Open Text Corp. 3.88%, 12/01/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $1053424 |
|  | Oracle Corp. |  |
| 740000 | 3.60%, 04/01/2050 | &nbsp;&nbsp;&nbsp; 460954 |
| 139000 | 3.65%, 03/25/2041 | &nbsp;&nbsp;&nbsp; 101403 |
| 735000 | 3.85%, 04/01/2060 | &nbsp;&nbsp;&nbsp; 449121 |
| 835000 | 3.95%, 03/25/2051 | &nbsp;&nbsp;&nbsp; 549396 |
| 285000 | 4.10%, 03/25/2061 | &nbsp;&nbsp;&nbsp; 183581 |
| 715000 | 4.70%, 09/27/2034 | &nbsp;&nbsp;&nbsp; 663008 |
| 3160000 | 4.80%, 09/26/2032 | &nbsp;&nbsp;&nbsp; 3050734 |
| 155000 | 4.90%, 02/06/2033 | &nbsp;&nbsp;&nbsp; 149171 |
| 576000 | 5.38%, 09/27/2054 | &nbsp;&nbsp;&nbsp; 465854 |
| 480000 | 5.50%, 09/27/2064 | &nbsp;&nbsp;&nbsp; 383066 |
| 519000 | 5.55%, 02/06/2053 | &nbsp;&nbsp;&nbsp; 430707 |
| 600000 | 6.00%, 08/03/2055 | &nbsp;&nbsp;&nbsp; 529073 |
| 524000 | Rocket Software, Inc. 6.50%, 02/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 513508 |
|  |  | &nbsp;&nbsp;&nbsp; 8983000 |
|  | **Telecommunications - 0.8%** | **Telecommunications - 0.8%** |
| 375000 | Altice France SA 6.50%, 04/15/2032<sup>(1)(7)</sup>  | &nbsp;&nbsp;&nbsp; 359506 |
| 675000 | EchoStar Corp. 6.75%, 11/30/2030<sup>(9)</sup>  | &nbsp;&nbsp;&nbsp; 691516 |
| EUR <br> 575,000<br>| Iliad Holding SAS 6.88%, 04/15/2031<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 720812 |
|  | Level 3 Financing, Inc. |  |
| $350000 | 7.00%, 03/31/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 360700 |
| 180000 | 8.50%, 01/15/2036<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 184317 |
|  | NTT Finance Corp. |  |
| 1060000 | 4.88%, 07/16/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1079517 |
| 3845000 | 5.17%, 07/16/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 3945099 |
|  | T-Mobile USA, Inc. |  |
| 1235000 | 2.55%, 02/15/2031 | &nbsp;&nbsp;&nbsp; 1128276 |
| 750000 | 3.50%, 04/15/2031 | &nbsp;&nbsp;&nbsp; 717045 |
| 380000 | 3.88%, 04/15/2030 | &nbsp;&nbsp;&nbsp; 373682 |
| 355000 | 4.70%, 01/15/2035 | &nbsp;&nbsp;&nbsp; 348783 |
| 210000 | 5.05%, 07/15/2033 | &nbsp;&nbsp;&nbsp; 214295 |
| 425000 | 5.13%, 05/15/2032 | &nbsp;&nbsp;&nbsp; 437356 |
| 275000 | 5.75%, 01/15/2034 | &nbsp;&nbsp;&nbsp; 291339 |
| 395000 | Verizon Communications, Inc. 5.88%, <br> 11/30/2055 | &nbsp;&nbsp;&nbsp; 390261 |
| 385000 | WULF Compute LLC 7.75%, 10/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 396646 |
|  |  | &nbsp;&nbsp;&nbsp; 11639150 |
|  | **Transportation - 0.2%** | **Transportation - 0.2%** |
| 2295000 | CSX Corp. 5.05%, 06/15/2035 | &nbsp;&nbsp;&nbsp; 2334346 |
|  | Total Corporate Bonds <br>(cost $361,021,648) | &nbsp;&nbsp;&nbsp; $361588585 |
| **FOREIGN GOVERNMENT OBLIGATIONS - 1.7%** | **FOREIGN GOVERNMENT OBLIGATIONS - 1.7%** | **FOREIGN GOVERNMENT OBLIGATIONS - 1.7%** |
|  | **Chile - 0.0%** | **Chile - 0.0%** |
| EUR <br> 1,115,000<br>| Chile Government International Bonds <br> 1.25%, 01/22/2051 | &nbsp;&nbsp;&nbsp; $706277 |
|  | **Colombia - 0.1%** | **Colombia - 0.1%** |
| $940000 | Colombia Government International Bonds <br> 7.50%, 02/02/2034 | &nbsp;&nbsp;&nbsp; 979480 |
|  | **Israel - 0.2%** | **Israel - 0.2%** |
|  | Israel Government International Bonds |  |
| 920000 | 2.75%, 07/03/2030 | &nbsp;&nbsp;&nbsp; 856137 |
| 1090000 | 5.38%, 02/19/2030 | &nbsp;&nbsp;&nbsp; 1127408 |
|  | State of Israel |  |
| 820000 | 3.80%, 05/13/2060<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 552131 |
| 200000 | 3.80%, 05/13/2060<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 134666 |
|  |  | &nbsp;&nbsp;&nbsp; 2670342 |
|  | **Mexico - 0.7%** | **Mexico - 0.7%** |
|  | Mexico Government International Bonds |  |
| 765000 | 3.50%, 02/12/2034 | &nbsp;&nbsp;&nbsp; 661343 |
| 2775000 | 5.38%, 03/22/2033 | &nbsp;&nbsp;&nbsp; 2750025 |
| 335000 | 5.38%, 03/22/2033 | &nbsp;&nbsp;&nbsp; 331985 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **FOREIGN GOVERNMENT OBLIGATIONS - 1.7% - (continued)** | **FOREIGN GOVERNMENT OBLIGATIONS - 1.7% - (continued)** | **FOREIGN GOVERNMENT OBLIGATIONS - 1.7% - (continued)** |
|  | **Mexico - 0.7% - (continued)** | **Mexico - 0.7% - (continued)** |
| $570000 | 5.63%, 09/22/2035 | &nbsp;&nbsp;&nbsp; $562020 |
| 380000 | 6.00%, 05/07/2036 | &nbsp;&nbsp;&nbsp; 384940 |
| 1615000 | 6.63%, 01/29/2038 | &nbsp;&nbsp;&nbsp; 1685252 |
| 2050000 | 6.88%, 05/13/2037 | &nbsp;&nbsp;&nbsp; 2187350 |
| 1375000 | 7.38%, 05/13/2055 | &nbsp;&nbsp;&nbsp; 1480875 |
|  |  | &nbsp;&nbsp;&nbsp; 10043790 |
|  | **North Macedonia - 0.2%** | **North Macedonia - 0.2%** |
| EUR <br> 2,165,000<br>| North Macedonia Government International <br> Bonds 3.68%, 06/03/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2545631 |
|  | **Peru - 0.1%** | **Peru - 0.1%** |
| $880000 | Peru Government International Bonds <br> 5.88%, 08/08/2054 | &nbsp;&nbsp;&nbsp; 870804 |
|  | **Romania - 0.4%** | **Romania - 0.4%** |
|  | Romania Government International Bonds |  |
| EUR <br> 1,010,000<br>| 2.63%, 12/02/2040<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 781759 |
| 4405000 | 2.75%, 04/14/2041<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 3426978 |
| $158000 | 5.75%, 03/24/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 156547 |
| 826000 | 6.38%, 01/30/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 859065 |
|  |  | &nbsp;&nbsp;&nbsp; 5224349 |
|  | Total Foreign Government <br> Obligations <br>(cost $23,263,497)<br>| &nbsp;&nbsp;&nbsp; $23040673 |
| **MUNICIPAL BONDS - 1.0%** | **MUNICIPAL BONDS - 1.0%** | **MUNICIPAL BONDS - 1.0%** |
|  | **Development - 0.3%** | **Development - 0.3%** |
| 3315000 | New York Transportation Dev Corp., NY, <br> Rev 4.25%, 09/01/2035 | &nbsp;&nbsp;&nbsp; $3275250 |
|  | **General - 0.4%** | **General - 0.4%** |
| 5445000 | Philadelphia Auth for Industrial Dev, PA, <br> Rev, (NPFG) 6.55%, 10/15/2028 | &nbsp;&nbsp;&nbsp; 5789494 |
|  | **School District - 0.2%** | **School District - 0.2%** |
|  | Chicago Board of Education, IL, GO |  |
| 1115000 | 6.14%, 12/01/2039 | &nbsp;&nbsp;&nbsp; 1049017 |
| 1540000 | 6.32%, 11/01/2029 | &nbsp;&nbsp;&nbsp; 1535831 |
|  |  | &nbsp;&nbsp;&nbsp; 2584848 |
|  | **Transportation - 0.1%** | **Transportation - 0.1%** |
| 1390000 | Metropolitan Transportation Auth, NY, Rev <br> 6.81%, 11/15/2040 | &nbsp;&nbsp;&nbsp; 1551316 |
|  | Total Municipal Bonds <br>(cost $13,823,981)<br>| &nbsp;&nbsp;&nbsp; $13200908 |
| **SENIOR FLOATING RATE INTERESTS - 0.0%**<sup>(10)</sup> | **SENIOR FLOATING RATE INTERESTS - 0.0%**<sup>(10)</sup> | **SENIOR FLOATING RATE INTERESTS - 0.0%**<sup>(10)</sup> |
|  | **Oil & Gas Services - 0.0%** | **Oil & Gas Services - 0.0%** |
| 794179 | PES Holdings LLC 3.00%, 12/31/2026, U.S. <br> (Fed) Prime Rate + 3.00%<sup>(2)(9)(11)</sup>  | &nbsp;&nbsp;&nbsp; $3971 |
|  | Total Senior Floating Rate Interests <br>(cost $794,179) | &nbsp;&nbsp;&nbsp; $3971 |
| **U.S. GOVERNMENT AGENCIES - 41.1%** | **U.S. GOVERNMENT AGENCIES - 41.1%** | **U.S. GOVERNMENT AGENCIES - 41.1%** |
|  | **Mortgage-Backed Agencies - 41.1%** | **Mortgage-Backed Agencies - 41.1%** |
|  | **Federal Home Loan Mortgage Corp. - 9.4%** | **Federal Home Loan Mortgage Corp. - 9.4%** |
| 31069 | 0.00%, 11/15/2036<sup>(12)(13)</sup>  | &nbsp;&nbsp;&nbsp; $26303 |
| 5628908 | 0.37%, 12/25/2033<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 153024 |
| 18241811 | 0.59%, 03/25/2027<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 98900 |
| 4205772 | 0.61%, 10/25/2026<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 14069 |
| 17124527 | 0.71%, 12/25/2030<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 508888 |
| 9562088 | 0.73%, 06/25/2027<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 74402 |
| 4160574 | 0.87%, 11/25/2030<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 145645 |
| 1546975 | 1.00%, 02/25/2051 | &nbsp;&nbsp;&nbsp; 1361618 |
| 7583329 | 1.01%, 10/25/2030<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 295465 |
| 12692286 | 1.11%, 06/25/2030<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 532809 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

40 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** |
|  | **Mortgage-Backed Agencies - 41.1% - (continued)** | **Mortgage-Backed Agencies - 41.1% - (continued)** |
|  | **Federal Home Loan Mortgage Corp. - 9.4% - (continued)** | **Federal Home Loan Mortgage Corp. - 9.4% - (continued)** |
| $7194670 | 1.50%, 05/15/2037<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; $372557 |
| 753582 | 1.50%, 11/01/2051 | &nbsp;&nbsp;&nbsp; 581901 |
| 6137052 | 1.56%, 05/25/2030<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 352203 |
| 518244 | 1.75%, 10/15/2042 | &nbsp;&nbsp;&nbsp; 456543 |
| 3841823 | 1.88%, 05/25/2055, 30 day USD SOFR <br> Average + 5.75%<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 230339 |
| 466923 | 2.00%, 06/01/2036 | &nbsp;&nbsp;&nbsp; 432558 |
| 250559 | 2.00%, 12/01/2040 | &nbsp;&nbsp;&nbsp; 217085 |
| 1612097 | 2.00%, 05/01/2041 | &nbsp;&nbsp;&nbsp; 1404436 |
| 1787386 | 2.00%, 12/01/2041 | &nbsp;&nbsp;&nbsp; 1553549 |
| 1488810 | 2.00%, 10/01/2050 | &nbsp;&nbsp;&nbsp; 1215473 |
| 1415461 | 2.00%, 02/01/2051 | &nbsp;&nbsp;&nbsp; 1163809 |
| 5535029 | 2.00%, 03/01/2051 | &nbsp;&nbsp;&nbsp; 4524615 |
| 2521980 | 2.00%, 04/01/2051 | &nbsp;&nbsp;&nbsp; 2052119 |
| 1381780 | 2.00%, 05/01/2051 | &nbsp;&nbsp;&nbsp; 1141871 |
| 594582 | 2.00%, 08/01/2051 | &nbsp;&nbsp;&nbsp; 484912 |
| 606325 | 2.00%, 11/01/2051 | &nbsp;&nbsp;&nbsp; 497818 |
| 2260668 | 2.00%, 04/01/2052 | &nbsp;&nbsp;&nbsp; 1859397 |
| 3264545 | 2.00%, 06/15/2052<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 440272 |
| 68862 | 2.50%, 05/15/2028<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 1508 |
| 827200 | 2.50%, 05/01/2050 | &nbsp;&nbsp;&nbsp; 713666 |
| 936992 | 2.50%, 06/01/2050 | &nbsp;&nbsp;&nbsp; 804356 |
| 2339087 | 2.50%, 07/01/2050 | &nbsp;&nbsp;&nbsp; 2005690 |
| 1634618 | 2.50%, 11/01/2050 | &nbsp;&nbsp;&nbsp; 1401275 |
| 502104 | 2.50%, 02/01/2051 | &nbsp;&nbsp;&nbsp; 434834 |
| 1742364 | 2.50%, 03/01/2051 | &nbsp;&nbsp;&nbsp; 1488249 |
| 2188879 | 2.50%, 03/25/2051<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 324940 |
| 640102 | 2.50%, 05/01/2051 | &nbsp;&nbsp;&nbsp; 547787 |
| 767125 | 2.50%, 07/01/2051 | &nbsp;&nbsp;&nbsp; 655300 |
| 958616 | 2.50%, 10/01/2051 | &nbsp;&nbsp;&nbsp; 819320 |
| 2477339 | 2.50%, 03/15/2052<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 375872 |
| 1501879 | 2.50%, 03/25/2052 | &nbsp;&nbsp;&nbsp; 1358371 |
| 2372657 | 2.50%, 04/01/2052 | &nbsp;&nbsp;&nbsp; 2020916 |
| 2814477 | 2.50%, 08/25/2052<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 434841 |
| 142002 | 3.00%, 03/15/2028<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 3041 |
| 296077 | 3.00%, 08/01/2029 | &nbsp;&nbsp;&nbsp; 292404 |
| 1296141 | 3.00%, 10/01/2032 | &nbsp;&nbsp;&nbsp; 1265859 |
| 204728 | 3.00%, 03/15/2033<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 13690 |
| 841165 | 3.00%, 04/01/2033 | &nbsp;&nbsp;&nbsp; 822280 |
| 1442306 | 3.00%, 11/01/2036 | &nbsp;&nbsp;&nbsp; 1374945 |
| 857036 | 3.00%, 01/01/2037 | &nbsp;&nbsp;&nbsp; 816473 |
| 2025000 | 3.00%, 03/25/2040 | &nbsp;&nbsp;&nbsp; 1837885 |
| 3018569 | 3.00%, 11/01/2046 | &nbsp;&nbsp;&nbsp; 2750611 |
| 375667 | 3.00%, 12/01/2046 | &nbsp;&nbsp;&nbsp; 342093 |
| 2348733 | 3.00%, 09/25/2051<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 372097 |
| 1767347 | 3.00%, 10/01/2051 | &nbsp;&nbsp;&nbsp; 1589168 |
| 674890 | 3.00%, 01/01/2052 | &nbsp;&nbsp;&nbsp; 607213 |
| 890807 | 3.00%, 05/01/2052 | &nbsp;&nbsp;&nbsp; 798156 |
| 287293 | 3.25%, 11/15/2041 | &nbsp;&nbsp;&nbsp; 271329 |
| 11036 | 3.50%, 09/15/2026<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 94 |
| 446776 | 3.50%, 05/15/2034<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 30267 |
| 944016 | 3.50%, 08/01/2034 | &nbsp;&nbsp;&nbsp; 924393 |
| 79933 | 3.50%, 03/15/2041<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 728 |
| 440465 | 3.50%, 10/15/2045 | &nbsp;&nbsp;&nbsp; 418979 |
| 202348 | 3.50%, 06/01/2046 | &nbsp;&nbsp;&nbsp; 192082 |
| 888538 | 3.50%, 03/01/2048 | &nbsp;&nbsp;&nbsp; 840179 |
| 182223 | 3.50%, 08/01/2048 | &nbsp;&nbsp;&nbsp; 173107 |
| 1670313 | 3.50%, 04/25/2051<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 337897 |
| 1005 | 4.00%, 12/15/2026<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 6 |
| 11179 | 4.00%, 07/15/2027<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 131 |
| 6062 | 4.00%, 03/15/2028<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 23 |
| 8569 | 4.00%, 06/15/2028<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 61 |
| 147019 | 4.00%, 07/15/2030<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 7318 |
| 975329 | 4.00%, 05/25/2040<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 145415 |
| 1053637 | 4.00%, 09/15/2041 | &nbsp;&nbsp;&nbsp; 1027258 |
| 903191 | 4.00%, 05/01/2042 | &nbsp;&nbsp;&nbsp; 885297 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** |
|  | **Mortgage-Backed Agencies - 41.1% - (continued)** | **Mortgage-Backed Agencies - 41.1% - (continued)** |
|  | **Federal Home Loan Mortgage Corp. - 9.4% - (continued)** | **Federal Home Loan Mortgage Corp. - 9.4% - (continued)** |
| $289056 | 4.00%, 08/01/2042 | &nbsp;&nbsp;&nbsp; $283028 |
| 372093 | 4.00%, 09/01/2042 | &nbsp;&nbsp;&nbsp; 364333 |
| 17054 | 4.00%, 07/01/2044 | &nbsp;&nbsp;&nbsp; 16861 |
| 1818330 | 4.00%, 03/25/2045<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 297972 |
| 83247 | 4.00%, 06/01/2045 | &nbsp;&nbsp;&nbsp; 80617 |
| 257754 | 4.00%, 02/01/2046 | &nbsp;&nbsp;&nbsp; 249692 |
| 113169 | 4.00%, 04/01/2047 | &nbsp;&nbsp;&nbsp; 110329 |
| 93733 | 4.00%, 09/01/2048 | &nbsp;&nbsp;&nbsp; 90679 |
| 411392 | 4.00%, 05/01/2049 | &nbsp;&nbsp;&nbsp; 398436 |
| 1601720 | 4.00%, 07/01/2049 | &nbsp;&nbsp;&nbsp; 1552239 |
| 184101 | 4.50%, 09/01/2044 | &nbsp;&nbsp;&nbsp; 181988 |
| 1870323 | 4.50%, 05/25/2050<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 352528 |
| 718291 | 4.75%, 07/15/2039 | &nbsp;&nbsp;&nbsp; 730374 |
| 283267 | 5.00%, 09/15/2033<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 35798 |
| 3246 | 5.00%, 03/01/2039 | &nbsp;&nbsp;&nbsp; 3337 |
| 93047 | 5.00%, 08/01/2039 | &nbsp;&nbsp;&nbsp; 95794 |
| 2505 | 5.00%, 09/01/2039 | &nbsp;&nbsp;&nbsp; 2561 |
| 4938 | 5.00%, 12/01/2039 | &nbsp;&nbsp;&nbsp; 5061 |
| 720522 | 5.00%, 07/01/2040 | &nbsp;&nbsp;&nbsp; 730114 |
| 4601 | 5.00%, 04/01/2041 | &nbsp;&nbsp;&nbsp; 4737 |
| 10036 | 5.00%, 04/01/2044 | &nbsp;&nbsp;&nbsp; 10323 |
| 9522 | 5.00%, 05/01/2044 | &nbsp;&nbsp;&nbsp; 9598 |
| 393065 | 5.00%, 02/15/2048<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 76786 |
| 467977 | 5.00%, 08/01/2052 | &nbsp;&nbsp;&nbsp; 469711 |
| 780800 | 5.00%, 10/25/2052 | &nbsp;&nbsp;&nbsp; 782419 |
| 1549226 | 5.00%, 04/01/2053 | &nbsp;&nbsp;&nbsp; 1556846 |
| 1406212 | 5.00%, 07/01/2053 | &nbsp;&nbsp;&nbsp; 1413276 |
| 1274659 | 5.00%, 11/01/2054 | &nbsp;&nbsp;&nbsp; 1284107 |
| 4422 | 5.50%, 03/01/2028 | &nbsp;&nbsp;&nbsp; 4487 |
| 21499 | 5.50%, 04/01/2033 | &nbsp;&nbsp;&nbsp; 21820 |
| 227241 | 5.50%, 05/01/2034 | &nbsp;&nbsp;&nbsp; 233670 |
| 4613 | 5.50%, 05/01/2037 | &nbsp;&nbsp;&nbsp; 4829 |
| 13166 | 5.50%, 11/01/2037 | &nbsp;&nbsp;&nbsp; 13781 |
| 2260648 | 5.50%, 12/01/2037 | &nbsp;&nbsp;&nbsp; 2320127 |
| 24897 | 5.50%, 02/01/2038 | &nbsp;&nbsp;&nbsp; 25993 |
| 10762 | 5.50%, 04/01/2038 | &nbsp;&nbsp;&nbsp; 11232 |
| 13865 | 5.50%, 06/01/2038 | &nbsp;&nbsp;&nbsp; 14462 |
| 1378350 | 5.50%, 08/01/2038 | &nbsp;&nbsp;&nbsp; 1442788 |
| 142480 | 5.50%, 09/01/2038 | &nbsp;&nbsp;&nbsp; 148663 |
| 2793 | 5.50%, 12/01/2039 | &nbsp;&nbsp;&nbsp; 2914 |
| 37270 | 5.50%, 02/01/2040 | &nbsp;&nbsp;&nbsp; 38899 |
| 122712 | 5.50%, 05/01/2040 | &nbsp;&nbsp;&nbsp; 128113 |
| 119605 | 5.50%, 08/01/2040 | &nbsp;&nbsp;&nbsp; 124833 |
| 596862 | 5.50%, 06/01/2041 | &nbsp;&nbsp;&nbsp; 622582 |
| 500949 | 5.50%, 10/15/2046<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 95026 |
| 1915262 | 5.50%, 02/01/2053 | &nbsp;&nbsp;&nbsp; 1953228 |
| 1738329 | 5.50%, 06/01/2055 | &nbsp;&nbsp;&nbsp; 1774795 |
| 8736393 | 5.50%, 09/01/2055 | &nbsp;&nbsp;&nbsp; 8860499 |
| 13325049 | 5.50%, 12/01/2055 | &nbsp;&nbsp;&nbsp; 13514347 |
| 433 | 6.00%, 07/01/2029 | &nbsp;&nbsp;&nbsp; 445 |
| 53586 | 6.00%, 10/01/2032 | &nbsp;&nbsp;&nbsp; 55497 |
| 2799 | 6.00%, 11/01/2032 | &nbsp;&nbsp;&nbsp; 2874 |
| 62621 | 6.00%, 12/01/2032 | &nbsp;&nbsp;&nbsp; 64740 |
| 5786 | 6.00%, 11/01/2033 | &nbsp;&nbsp;&nbsp; 6022 |
| 11273 | 6.00%, 01/01/2034 | &nbsp;&nbsp;&nbsp; 11625 |
| 5895 | 6.00%, 02/01/2034 | &nbsp;&nbsp;&nbsp; 6131 |
| 55566 | 6.00%, 08/01/2034 | &nbsp;&nbsp;&nbsp; 57953 |
| 63048 | 6.00%, 09/01/2034 | &nbsp;&nbsp;&nbsp; 65745 |
| 78599 | 6.00%, 01/01/2035 | &nbsp;&nbsp;&nbsp; 81731 |
| 380086 | 6.00%, 11/01/2037 | &nbsp;&nbsp;&nbsp; 402354 |
| 929365 | 6.00%, 11/01/2052 | &nbsp;&nbsp;&nbsp; 958253 |
| 1014447 | 6.00%, 12/01/2052 | &nbsp;&nbsp;&nbsp; 1053556 |
| 488110 | 6.00%, 03/01/2053 | &nbsp;&nbsp;&nbsp; 509001 |
| 3842546 | 6.00%, 06/01/2054 | &nbsp;&nbsp;&nbsp; 3960403 |
| 3526092 | 6.00%, 08/01/2054 | &nbsp;&nbsp;&nbsp; 3629306 |
| 83 | 6.50%, 08/01/2032 | &nbsp;&nbsp;&nbsp; 86 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

41 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** |
|  | **Mortgage-Backed Agencies - 41.1% - (continued)** | **Mortgage-Backed Agencies - 41.1% - (continued)** |
|  | **Federal Home Loan Mortgage Corp. - 9.4% - (continued)** | **Federal Home Loan Mortgage Corp. - 9.4% - (continued)** |
| $149222 | 6.50%, 07/15/2036 | &nbsp;&nbsp;&nbsp; $155309 |
| 48379 | 6.50%, 12/01/2037 | &nbsp;&nbsp;&nbsp; 51516 |
| 1432000 | 6.77%, 04/25/2042, 30 day USD SOFR <br> Average + 2.90%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1467655 |
| 2005000 | 7.22%, 05/25/2042, 30 day USD SOFR <br> Average + 3.35%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2068919 |
| 3990000 | 7.22%, 06/25/2043, 30 day USD SOFR <br> Average + 3.35%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 4114245 |
| 3340000 | 7.27%, 10/25/2041, 30 day USD SOFR <br> Average + 3.40%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 3398747 |
| 3815000 | 7.37%, 05/25/2043, 30 day USD SOFR <br> Average + 3.50%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 3995866 |
| 620000 | 7.42%, 08/25/2042, 30 day USD SOFR <br> Average + 3.55%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 644797 |
| 12 | 7.50%, 09/01/2029 | &nbsp;&nbsp;&nbsp; 12 |
| 1629000 | 7.52%, 11/25/2041, 30 day USD SOFR <br> Average + 3.65%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1666038 |
| 1705000 | 7.57%, 09/25/2042, 30 day USD SOFR <br> Average + 3.70%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1778537 |
| 1525000 | 7.87%, 07/25/2042, 30 day USD SOFR <br> Average + 4.00%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1593152 |
| 2440000 | 8.37%, 06/25/2042, 30 day USD SOFR <br> Average + 4.50%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2566643 |
|  |  | &nbsp;&nbsp;&nbsp; 130633774 |
|  | **Federal National Mortgage Association - 12.0%** | **Federal National Mortgage Association - 12.0%** |
| 31383 | 0.00%, 03/25/2036<sup>(12)(13)</sup>  | &nbsp;&nbsp;&nbsp; 27284 |
| 306994 | 0.00%, 06/25/2041<sup>(12)(13)</sup>  | &nbsp;&nbsp;&nbsp; 234996 |
| 6908413 | 0.30%, 01/25/2030<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 56594 |
| 7792796 | 1.45%, 05/25/2029<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 252522 |
| 4282722 | 1.50%, 09/01/2051 | &nbsp;&nbsp;&nbsp; 3308398 |
| 296182 | 1.50%, 10/01/2051 | &nbsp;&nbsp;&nbsp; 228637 |
| 391575 | 1.50%, 04/01/2052 | &nbsp;&nbsp;&nbsp; 302125 |
| 675513 | 1.68%, 05/25/2046<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 33606 |
| 713758 | 1.73%, 04/25/2055<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 32601 |
| 741478 | 1.75%, 12/25/2042 | &nbsp;&nbsp;&nbsp; 677868 |
| 471263 | 1.85%, 06/25/2055<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 23437 |
| 546345 | 1.97%, 08/25/2044<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 32594 |
| 2494712 | 1.97%, 03/25/2055, 30 day USD SOFR <br> Average + 5.84%<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 136523 |
| 565902 | 2.00%, 05/01/2036 | &nbsp;&nbsp;&nbsp; 523840 |
| 1285095 | 2.00%, 08/01/2036 | &nbsp;&nbsp;&nbsp; 1190308 |
| 823001 | 2.00%, 09/01/2036 | &nbsp;&nbsp;&nbsp; 764422 |
| 598095 | 2.00%, 12/01/2036 | &nbsp;&nbsp;&nbsp; 555518 |
| 489529 | 2.00%, 09/25/2039 | &nbsp;&nbsp;&nbsp; 442503 |
| 1029603 | 2.00%, 09/01/2040 | &nbsp;&nbsp;&nbsp; 911529 |
| 2409182 | 2.00%, 12/01/2040 | &nbsp;&nbsp;&nbsp; 2120659 |
| 981698 | 2.00%, 04/01/2041 | &nbsp;&nbsp;&nbsp; 865965 |
| 324370 | 2.00%, 05/01/2041 | &nbsp;&nbsp;&nbsp; 282838 |
| 1282059 | 2.00%, 10/01/2041 | &nbsp;&nbsp;&nbsp; 1115931 |
| 927493 | 2.00%, 03/25/2050 | &nbsp;&nbsp;&nbsp; 805483 |
| 5060950 | 2.00%, 12/01/2050 | &nbsp;&nbsp;&nbsp; 4131788 |
| 8295207 | 2.00%, 02/01/2051 | &nbsp;&nbsp;&nbsp; 6778867 |
| 12179749 | 2.00%, 03/01/2051 | &nbsp;&nbsp;&nbsp; 9921642 |
| 462101 | 2.00%, 07/01/2051 | &nbsp;&nbsp;&nbsp; 376444 |
| 592641 | 2.00%, 10/01/2051 | &nbsp;&nbsp;&nbsp; 487788 |
| 3373362 | 2.00%, 03/25/2052<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 424233 |
| 18067 | 2.00%, 04/01/2052 | &nbsp;&nbsp;&nbsp; 14628 |
| 3761522 | 2.08%, 10/25/2054, 30 day USD SOFR <br> Average + 5.95%<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 202679 |
| 800230 | 2.25%, 04/01/2033 | &nbsp;&nbsp;&nbsp; 702835 |
| 64745 | 2.50%, 06/25/2028<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 1375 |
| 1776340 | 2.50%, 09/01/2040 | &nbsp;&nbsp;&nbsp; 1611746 |
| 73038 | 2.50%, 01/01/2043 | &nbsp;&nbsp;&nbsp; 65311 |
| 1759056 | 2.50%, 02/01/2043 | &nbsp;&nbsp;&nbsp; 1577345 |
| 608621 | 2.50%, 03/01/2043 | &nbsp;&nbsp;&nbsp; 545371 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** |
|  | **Mortgage-Backed Agencies - 41.1% - (continued)** | **Mortgage-Backed Agencies - 41.1% - (continued)** |
|  | **Federal National Mortgage Association - 12.0% - (continued)** | **Federal National Mortgage Association - 12.0% - (continued)** |
| $1286021 | 2.50%, 05/01/2043 | &nbsp;&nbsp;&nbsp; $1149976 |
| 1036444 | 2.50%, 06/01/2043 | &nbsp;&nbsp;&nbsp; 921985 |
| 631212 | 2.50%, 04/01/2045 | &nbsp;&nbsp;&nbsp; 549407 |
| 826011 | 2.50%, 04/01/2050 | &nbsp;&nbsp;&nbsp; 706779 |
| 946991 | 2.50%, 06/01/2050 | &nbsp;&nbsp;&nbsp; 812815 |
| 156036 | 2.50%, 07/01/2050 | &nbsp;&nbsp;&nbsp; 133080 |
| 1502527 | 2.50%, 09/01/2050 | &nbsp;&nbsp;&nbsp; 1284036 |
| 2557300 | 2.50%, 10/01/2050 | &nbsp;&nbsp;&nbsp; 2209791 |
| 1118438 | 2.50%, 01/01/2051 | &nbsp;&nbsp;&nbsp; 965597 |
| 2715312 | 2.50%, 02/25/2051<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 460019 |
| 10840387 | 2.50%, 05/01/2051 | &nbsp;&nbsp;&nbsp; 9315103 |
| 1226384 | 2.50%, 07/01/2051 | &nbsp;&nbsp;&nbsp; 1049522 |
| 807098 | 2.50%, 09/01/2051 | &nbsp;&nbsp;&nbsp; 693642 |
| 9474012 | 2.50%, 11/01/2051 | &nbsp;&nbsp;&nbsp; 8160626 |
| 1436947 | 2.50%, 12/01/2051 | &nbsp;&nbsp;&nbsp; 1240665 |
| 1406848 | 2.50%, 01/01/2052 | &nbsp;&nbsp;&nbsp; 1207454 |
| 2095860 | 2.50%, 03/01/2052 | &nbsp;&nbsp;&nbsp; 1783242 |
| 2715858 | 2.50%, 06/25/2052<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 410903 |
| 2680626 | 2.50%, 09/25/2052<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 418764 |
| 1927934 | 2.50%, 01/01/2057 | &nbsp;&nbsp;&nbsp; 1640882 |
| 35605 | 3.00%, 09/25/2027<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 567 |
| 173932 | 3.00%, 01/25/2028<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 1983 |
| 924239 | 3.00%, 04/25/2033<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 54207 |
| 345816 | 3.00%, 08/01/2033 | &nbsp;&nbsp;&nbsp; 337944 |
| 995057 | 3.00%, 03/01/2037 | &nbsp;&nbsp;&nbsp; 948836 |
| 1496814 | 3.00%, 06/01/2043 | &nbsp;&nbsp;&nbsp; 1384132 |
| 981779 | 3.00%, 09/01/2048 | &nbsp;&nbsp;&nbsp; 890709 |
| 940297 | 3.00%, 08/25/2049 | &nbsp;&nbsp;&nbsp; 861955 |
| 2295426 | 3.00%, 08/01/2050 | &nbsp;&nbsp;&nbsp; 2046487 |
| 910657 | 3.00%, 10/01/2050 | &nbsp;&nbsp;&nbsp; 808218 |
| 1308687 | 3.00%, 12/01/2050 | &nbsp;&nbsp;&nbsp; 1161679 |
| 421113 | 3.00%, 04/01/2051 | &nbsp;&nbsp;&nbsp; 374875 |
| 1186188 | 3.00%, 05/01/2051 | &nbsp;&nbsp;&nbsp; 1075616 |
| 1341949 | 3.00%, 08/01/2051 | &nbsp;&nbsp;&nbsp; 1200487 |
| 3311352 | 3.00%, 10/01/2051 | &nbsp;&nbsp;&nbsp; 2963298 |
| 3954683 | 3.00%, 11/01/2051 | &nbsp;&nbsp;&nbsp; 3528051 |
| 1801054 | 3.00%, 12/01/2051 | &nbsp;&nbsp;&nbsp; 1606624 |
| 976350 | 3.00%, 04/01/2052 | &nbsp;&nbsp;&nbsp; 873659 |
| 1235405 | 3.00%, 05/01/2052 | &nbsp;&nbsp;&nbsp; 1106294 |
| 28861 | 3.50%, 05/25/2027<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 370 |
| 76164 | 3.50%, 10/25/2027<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 1653 |
| 195855 | 3.50%, 05/25/2030<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 9356 |
| 42660 | 3.50%, 08/25/2030<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 1373 |
| 3905 | 3.50%, 02/25/2031<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 20 |
| 223384 | 3.50%, 09/25/2035<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 19385 |
| 1174789 | 3.50%, 11/25/2039<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 99682 |
| 1777223 | 3.50%, 08/01/2043 | &nbsp;&nbsp;&nbsp; 1692244 |
| 536055 | 3.50%, 10/01/2044 | &nbsp;&nbsp;&nbsp; 509984 |
| 513700 | 3.50%, 02/01/2045 | &nbsp;&nbsp;&nbsp; 487917 |
| 489622 | 3.50%, 01/01/2046 | &nbsp;&nbsp;&nbsp; 464812 |
| 361672 | 3.50%, 03/01/2046 | &nbsp;&nbsp;&nbsp; 343453 |
| 871577 | 3.50%, 09/01/2046 | &nbsp;&nbsp;&nbsp; 822605 |
| 413986 | 3.50%, 10/01/2046 | &nbsp;&nbsp;&nbsp; 391008 |
| 301668 | 3.50%, 10/25/2046<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 56470 |
| 431097 | 3.50%, 11/01/2046 | &nbsp;&nbsp;&nbsp; 408217 |
| 619769 | 3.50%, 05/01/2047 | &nbsp;&nbsp;&nbsp; 587266 |
| 306330 | 3.50%, 09/01/2047 | &nbsp;&nbsp;&nbsp; 289727 |
| 261350 | 3.50%, 12/01/2047 | &nbsp;&nbsp;&nbsp; 247683 |
| 192642 | 3.50%, 02/01/2048 | &nbsp;&nbsp;&nbsp; 181415 |
| 961830 | 3.50%, 07/01/2048 | &nbsp;&nbsp;&nbsp; 910792 |
| 2064519 | 3.50%, 04/01/2052 | &nbsp;&nbsp;&nbsp; 1928326 |
| 3557351 | 3.50%, 09/01/2057 | &nbsp;&nbsp;&nbsp; 3263602 |
| 1994415 | 3.50%, 05/01/2058 | &nbsp;&nbsp;&nbsp; 1829722 |
| 1080500 | 3.92%, 10/01/2030 | &nbsp;&nbsp;&nbsp; 1069449 |
| 1112453 | 4.00%, 10/01/2040 | &nbsp;&nbsp;&nbsp; 1089775 |
| 437677 | 4.00%, 11/01/2040 | &nbsp;&nbsp;&nbsp; 428624 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

42 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** |
|  | **Mortgage-Backed Agencies - 41.1% - (continued)** | **Mortgage-Backed Agencies - 41.1% - (continued)** |
|  | **Federal National Mortgage Association - 12.0% - (continued)** | **Federal National Mortgage Association - 12.0% - (continued)** |
| $331572 | 4.00%, 12/01/2040 | &nbsp;&nbsp;&nbsp; $324656 |
| 155445 | 4.00%, 02/01/2041 | &nbsp;&nbsp;&nbsp; 152187 |
| 404169 | 4.00%, 03/01/2041 | &nbsp;&nbsp;&nbsp; 395529 |
| 1001195 | 4.00%, 06/01/2041 | &nbsp;&nbsp;&nbsp; 987236 |
| 139242 | 4.00%, 03/25/2042<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 13812 |
| 186353 | 4.00%, 08/01/2042 | &nbsp;&nbsp;&nbsp; 182214 |
| 420720 | 4.00%, 09/01/2042 | &nbsp;&nbsp;&nbsp; 411464 |
| 70567 | 4.00%, 11/25/2042<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 6179 |
| 64265 | 4.00%, 03/01/2045 | &nbsp;&nbsp;&nbsp; 62254 |
| 244924 | 4.00%, 03/01/2046 | &nbsp;&nbsp;&nbsp; 238019 |
| 90661 | 4.00%, 05/01/2046 | &nbsp;&nbsp;&nbsp; 87655 |
| 414320 | 4.00%, 06/01/2046 | &nbsp;&nbsp;&nbsp; 400623 |
| 1043769 | 4.00%, 10/01/2047 | &nbsp;&nbsp;&nbsp; 1009160 |
| 450690 | 4.00%, 09/01/2048 | &nbsp;&nbsp;&nbsp; 435394 |
| 309973 | 4.00%, 01/01/2049 | &nbsp;&nbsp;&nbsp; 301810 |
| 103462 | 4.00%, 08/01/2049 | &nbsp;&nbsp;&nbsp; 100546 |
| 1860784 | 4.00%, 04/01/2050 | &nbsp;&nbsp;&nbsp; 1800694 |
| 1922182 | 4.00%, 11/25/2050<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 394265 |
| 303800 | 4.00%, 08/01/2051 | &nbsp;&nbsp;&nbsp; 296551 |
| 1305238 | 4.00%, 06/01/2052 | &nbsp;&nbsp;&nbsp; 1250941 |
| 1714400 | 4.12%, 11/01/2030 | &nbsp;&nbsp;&nbsp; 1710873 |
| 1385000 | 4.37%, 11/01/2030 | &nbsp;&nbsp;&nbsp; 1397358 |
| 2477609 | 4.39%, 04/01/2029 | &nbsp;&nbsp;&nbsp; 2510313 |
| 57 | 4.50%, 07/25/2027<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 0 <br><sup>(14)</sup><br>|
| 240530 | 4.50%, 09/01/2035 | &nbsp;&nbsp;&nbsp; 242604 |
| 850651 | 4.50%, 12/01/2037 | &nbsp;&nbsp;&nbsp; 857107 |
| 846498 | 4.50%, 08/01/2040 | &nbsp;&nbsp;&nbsp; 852956 |
| 859199 | 4.50%, 10/01/2040 | &nbsp;&nbsp;&nbsp; 865969 |
| 443648 | 4.50%, 10/01/2041 | &nbsp;&nbsp;&nbsp; 446664 |
| 1009154 | 4.50%, 08/25/2043<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 197754 |
| 359046 | 4.50%, 09/01/2043 | &nbsp;&nbsp;&nbsp; 361819 |
| 475274 | 4.50%, 04/01/2049 | &nbsp;&nbsp;&nbsp; 471070 |
| 2190940 | 4.50%, 01/01/2051 | &nbsp;&nbsp;&nbsp; 2142231 |
| 1491212 | 4.50%, 03/01/2053 | &nbsp;&nbsp;&nbsp; 1459240 |
| 881000 | 4.52%, 10/01/2030 | &nbsp;&nbsp;&nbsp; 894693 |
| 380000 | 4.75%, 04/01/2028 | &nbsp;&nbsp;&nbsp; 385753 |
| 94974 | 5.00%, 04/25/2038 | &nbsp;&nbsp;&nbsp; 96215 |
| 1133904 | 5.00%, 12/25/2051 | &nbsp;&nbsp;&nbsp; 1136557 |
| 1595131 | 5.00%, 07/01/2052 | &nbsp;&nbsp;&nbsp; 1601040 |
| 1099018 | 5.00%, 08/01/2052 | &nbsp;&nbsp;&nbsp; 1103769 |
| 2050000 | 5.07%, 12/01/2028 | &nbsp;&nbsp;&nbsp; 2111512 |
| 54368 | 5.50%, 06/01/2033 | &nbsp;&nbsp;&nbsp; 56338 |
| 46406 | 5.50%, 08/01/2033 | &nbsp;&nbsp;&nbsp; 47062 |
| 302918 | 5.50%, 09/01/2033 | &nbsp;&nbsp;&nbsp; 310695 |
| 246895 | 5.50%, 12/01/2033 | &nbsp;&nbsp;&nbsp; 253331 |
| 201170 | 5.50%, 01/01/2034 | &nbsp;&nbsp;&nbsp; 206522 |
| 1060862 | 5.50%, 11/01/2035 | &nbsp;&nbsp;&nbsp; 1107798 |
| 300796 | 5.50%, 04/01/2036 | &nbsp;&nbsp;&nbsp; 314487 |
| 203624 | 5.50%, 09/01/2036 | &nbsp;&nbsp;&nbsp; 209075 |
| 183679 | 5.50%, 04/25/2037 | &nbsp;&nbsp;&nbsp; 190760 |
| 713741 | 5.50%, 04/01/2038 | &nbsp;&nbsp;&nbsp; 732521 |
| 1093745 | 5.50%, 11/01/2039 | &nbsp;&nbsp;&nbsp; 1121545 |
| 2364320 | 5.50%, 08/01/2040 | &nbsp;&nbsp;&nbsp; 2426615 |
| 796097 | 5.50%, 11/25/2040<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 89255 |
| 702333 | 5.50%, 06/25/2042<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 156526 |
| 842603 | 5.50%, 08/25/2044<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 127726 |
| 1395043 | 5.50%, 03/25/2052 | &nbsp;&nbsp;&nbsp; 1413490 |
| 1294348 | 5.50%, 04/25/2052 | &nbsp;&nbsp;&nbsp; 1322363 |
| 1828026 | 5.50%, 11/01/2052 | &nbsp;&nbsp;&nbsp; 1866295 |
| 3830059 | 5.50%, 12/01/2052 | &nbsp;&nbsp;&nbsp; 3904674 |
| 1953291 | 5.50%, 06/01/2053 | &nbsp;&nbsp;&nbsp; 1990634 |
| 11081 | 5.52%, 05/25/2042<sup>(2)(3)</sup>  | &nbsp;&nbsp;&nbsp; 1091 |
| 99040 | 6.00%, 12/01/2032 | &nbsp;&nbsp;&nbsp; 101608 |
| 120728 | 6.00%, 01/01/2033 | &nbsp;&nbsp;&nbsp; 123859 |
| 16542 | 6.00%, 02/01/2033 | &nbsp;&nbsp;&nbsp; 17066 |
| 96606 | 6.00%, 03/01/2033 | &nbsp;&nbsp;&nbsp; 99801 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** |
|  | **Mortgage-Backed Agencies - 41.1% - (continued)** | **Mortgage-Backed Agencies - 41.1% - (continued)** |
|  | **Federal National Mortgage Association - 12.0% - (continued)** | **Federal National Mortgage Association - 12.0% - (continued)** |
| $287503 | 6.00%, 02/01/2037 | &nbsp;&nbsp;&nbsp; $304065 |
| 340926 | 6.00%, 01/25/2042<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 16061 |
| 1107000 | 6.00%, 05/01/2053 | &nbsp;&nbsp;&nbsp; 1151323 |
| 1201913 | 6.00%, 09/01/2054 | &nbsp;&nbsp;&nbsp; 1236556 |
| 105 | 6.50%, 05/01/2031 | &nbsp;&nbsp;&nbsp; 110 |
| 338 | 6.50%, 09/01/2031 | &nbsp;&nbsp;&nbsp; 350 |
| 325 | 6.50%, 07/01/2032 | &nbsp;&nbsp;&nbsp; 337 |
| 236 | 7.00%, 07/01/2029 | &nbsp;&nbsp;&nbsp; 248 |
| 48 | 7.00%, 12/01/2030 | &nbsp;&nbsp;&nbsp; 50 |
| 43 | 7.00%, 03/01/2032 | &nbsp;&nbsp;&nbsp; 45 |
| 149 | 7.50%, 06/01/2027 | &nbsp;&nbsp;&nbsp; 150 |
| 2472 | 7.50%, 03/01/2030 | &nbsp;&nbsp;&nbsp; 2526 |
| 4080 | 7.50%, 04/01/2030 | &nbsp;&nbsp;&nbsp; 4140 |
| 310 | 7.50%, 06/01/2030 | &nbsp;&nbsp;&nbsp; 319 |
| 694 | 7.50%, 07/01/2030 | &nbsp;&nbsp;&nbsp; 714 |
| 201 | 7.50%, 08/01/2030 | &nbsp;&nbsp;&nbsp; 206 |
| 587 | 7.50%, 05/01/2031 | &nbsp;&nbsp;&nbsp; 597 |
| 2842 | 7.50%, 06/01/2031 | &nbsp;&nbsp;&nbsp; 2890 |
| 196 | 7.50%, 08/01/2031 | &nbsp;&nbsp;&nbsp; 198 |
| 11637 | 7.50%, 09/01/2031 | &nbsp;&nbsp;&nbsp; 11848 |
| 25 | 7.50%, 05/01/2032 | &nbsp;&nbsp;&nbsp; 25 |
|  |  | &nbsp;&nbsp;&nbsp; 165863653 |
|  | **Government National Mortgage Association - 10.2%** | **Government National Mortgage Association - 10.2%** |
| 2105931 | 2.00%, 10/20/2050 | &nbsp;&nbsp;&nbsp; 1745312 |
| 4044372 | 2.00%, 12/20/2050 | &nbsp;&nbsp;&nbsp; 3350528 |
| 7820000 | 2.00%, 01/20/2055<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 6474684 |
| 320144 | 2.50%, 12/16/2039 | &nbsp;&nbsp;&nbsp; 306600 |
| 669271 | 2.50%, 07/20/2041 | &nbsp;&nbsp;&nbsp; 613073 |
| 1642528 | 2.50%, 11/20/2049 | &nbsp;&nbsp;&nbsp; 1426393 |
| 1312137 | 2.50%, 03/20/2051 | &nbsp;&nbsp;&nbsp; 1132442 |
| 4746058 | 2.50%, 04/20/2051 | &nbsp;&nbsp;&nbsp; 4096238 |
| 36050000 | 2.50%, 01/20/2055<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 31090309 |
| 44765 | 3.00%, 09/20/2028<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 250 |
| 1198861 | 3.00%, 05/20/2035<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 52912 |
| 220388 | 3.00%, 02/16/2043<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 28842 |
| 1161562 | 3.00%, 03/15/2045 | &nbsp;&nbsp;&nbsp; 1050067 |
| 58556 | 3.00%, 04/15/2045 | &nbsp;&nbsp;&nbsp; 52937 |
| 1013925 | 3.00%, 07/15/2045 | &nbsp;&nbsp;&nbsp; 916610 |
| 20204 | 3.00%, 08/15/2045 | &nbsp;&nbsp;&nbsp; 18265 |
| 6180343 | 3.00%, 04/20/2051 | &nbsp;&nbsp;&nbsp; 5561710 |
| 693924 | 3.00%, 06/20/2051 | &nbsp;&nbsp;&nbsp; 624323 |
| 1870293 | 3.00%, 08/20/2051 | &nbsp;&nbsp;&nbsp; 1682700 |
| 6345 | 3.50%, 02/16/2027<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 23 |
| 35708 | 3.50%, 03/20/2027<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 128 |
| 27032 | 3.50%, 07/20/2040<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 181 |
| 190496 | 3.50%, 04/20/2042<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 4914 |
| 1178609 | 3.50%, 10/20/2042<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 164815 |
| 133729 | 3.50%, 11/15/2042 | &nbsp;&nbsp;&nbsp; 125216 |
| 3785 | 3.50%, 12/15/2042 | &nbsp;&nbsp;&nbsp; 3536 |
| 78173 | 3.50%, 02/15/2043 | &nbsp;&nbsp;&nbsp; 72953 |
| 4168 | 3.50%, 03/15/2043 | &nbsp;&nbsp;&nbsp; 3890 |
| 795385 | 3.50%, 04/15/2043 | &nbsp;&nbsp;&nbsp; 742271 |
| 1569852 | 3.50%, 05/15/2043 | &nbsp;&nbsp;&nbsp; 1465057 |
| 393218 | 3.50%, 07/20/2043<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 60550 |
| 880788 | 3.50%, 03/20/2044 | &nbsp;&nbsp;&nbsp; 826603 |
| 1143276 | 3.50%, 06/20/2046 | &nbsp;&nbsp;&nbsp; 1064894 |
| 289037 | 3.50%, 07/20/2046 | &nbsp;&nbsp;&nbsp; 267404 |
| 306432 | 3.50%, 10/20/2046 | &nbsp;&nbsp;&nbsp; 285170 |
| 1207960 | 3.50%, 02/20/2047 | &nbsp;&nbsp;&nbsp; 1123627 |
| 355853 | 3.50%, 08/20/2047 | &nbsp;&nbsp;&nbsp; 331739 |
| 246600 | 3.50%, 11/20/2047 | &nbsp;&nbsp;&nbsp; 229625 |
| 300842 | 3.50%, 03/20/2048 | &nbsp;&nbsp;&nbsp; 279108 |
| 409373 | 3.50%, 06/20/2049 | &nbsp;&nbsp;&nbsp; 378173 |
| 926055 | 3.50%, 07/20/2049 | &nbsp;&nbsp;&nbsp; 855092 |
| 997172 | 3.50%, 11/20/2049 | &nbsp;&nbsp;&nbsp; 919728 |
| 294246 | 3.50%, 06/20/2050 | &nbsp;&nbsp;&nbsp; 271160 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

43 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** |
|  | **Mortgage-Backed Agencies - 41.1% - (continued)** | **Mortgage-Backed Agencies - 41.1% - (continued)** |
|  | **Government National Mortgage Association - 10.2% - (continued)** | **Government National Mortgage Association - 10.2% - (continued)** |
| $941003 | 3.50%, 02/20/2051 | &nbsp;&nbsp;&nbsp; $867992 |
| 703911 | 3.88%, 08/15/2042 | &nbsp;&nbsp;&nbsp; 677184 |
| 1653 | 4.00%, 12/16/2026<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 0 <br><sup>(14)</sup><br>|
| 55101 | 4.00%, 05/20/2029<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 219 |
| 1273343 | 4.00%, 07/20/2040 | &nbsp;&nbsp;&nbsp; 1238933 |
| 1403474 | 4.00%, 09/20/2040 | &nbsp;&nbsp;&nbsp; 1365437 |
| 2222421 | 4.00%, 10/20/2040 | &nbsp;&nbsp;&nbsp; 2160592 |
| 576885 | 4.00%, 12/20/2040 | &nbsp;&nbsp;&nbsp; 557739 |
| 89339 | 4.00%, 05/16/2042<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 7150 |
| 1957591 | 4.00%, 09/16/2042<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 408458 |
| 100134 | 4.00%, 01/20/2044<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 19255 |
| 732836 | 4.00%, 01/16/2046<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 118242 |
| 653466 | 4.00%, 03/20/2047<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 105987 |
| 274610 | 4.00%, 11/20/2047 | &nbsp;&nbsp;&nbsp; 260561 |
| 855024 | 4.00%, 03/20/2048 | &nbsp;&nbsp;&nbsp; 813149 |
| 2296087 | 4.00%, 07/20/2048 | &nbsp;&nbsp;&nbsp; 2205545 |
| 39712 | 4.50%, 11/15/2039 | &nbsp;&nbsp;&nbsp; 39304 |
| 393313 | 4.50%, 05/15/2040 | &nbsp;&nbsp;&nbsp; 392438 |
| 1404465 | 4.50%, 05/20/2040 | &nbsp;&nbsp;&nbsp; 1414606 |
| 84250 | 4.50%, 07/15/2041 | &nbsp;&nbsp;&nbsp; 83353 |
| 1299552 | 4.50%, 08/20/2045<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 243951 |
| 126311 | 4.50%, 01/20/2046 | &nbsp;&nbsp;&nbsp; 125821 |
| 771443 | 4.50%, 01/20/2047<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 82789 |
| 976414 | 4.50%, 05/20/2048<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 145214 |
| 279181 | 4.50%, 05/20/2052 | &nbsp;&nbsp;&nbsp; 274171 |
| 806195 | 4.50%, 08/20/2052 | &nbsp;&nbsp;&nbsp; 791476 |
| 740654 | 4.50%, 09/20/2052 | &nbsp;&nbsp;&nbsp; 726902 |
| 3372381 | 4.50%, 10/20/2052 | &nbsp;&nbsp;&nbsp; 3309244 |
| 821003 | 5.00%, 02/16/2040<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 161057 |
| 736942 | 5.00%, 05/20/2040 | &nbsp;&nbsp;&nbsp; 757822 |
| 587739 | 5.00%, 06/20/2040 | &nbsp;&nbsp;&nbsp; 606182 |
| 231321 | 5.00%, 07/20/2040 | &nbsp;&nbsp;&nbsp; 238011 |
| 431663 | 5.00%, 06/15/2041 | &nbsp;&nbsp;&nbsp; 441928 |
| 395014 | 5.00%, 10/16/2041<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 66374 |
| 625482 | 5.00%, 03/15/2044 | &nbsp;&nbsp;&nbsp; 640416 |
| 174952 | 5.00%, 01/16/2047<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 33171 |
| 3051724 | 5.00%, 07/15/2052 | &nbsp;&nbsp;&nbsp; 3049204 |
| 8912500 | 5.00%, 01/20/2055<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 8891435 |
| 312345 | 5.50%, 10/20/2034 | &nbsp;&nbsp;&nbsp; 324137 |
| 521036 | 5.50%, 03/20/2039<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 35307 |
| 538844 | 5.50%, 07/15/2041 | &nbsp;&nbsp;&nbsp; 559339 |
| 495693 | 5.50%, 02/16/2047<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 64923 |
| 330799 | 5.50%, 02/20/2047<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 47602 |
| 24515000 | 5.50%, 01/20/2055<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 24752707 |
| 265 | 6.00%, 01/15/2029 | &nbsp;&nbsp;&nbsp; 270 |
| 183 | 6.00%, 04/15/2029 | &nbsp;&nbsp;&nbsp; 186 |
| 7979 | 6.00%, 12/15/2031 | &nbsp;&nbsp;&nbsp; 8220 |
| 204 | 6.00%, 10/15/2032 | &nbsp;&nbsp;&nbsp; 215 |
| 7438 | 6.00%, 06/15/2033 | &nbsp;&nbsp;&nbsp; 7650 |
| 151 | 6.00%, 03/15/2034 | &nbsp;&nbsp;&nbsp; 158 |
| 12106 | 6.00%, 08/15/2034 | &nbsp;&nbsp;&nbsp; 12614 |
| 21933 | 6.00%, 09/15/2034 | &nbsp;&nbsp;&nbsp; 22185 |
| 14405 | 6.00%, 02/15/2035 | &nbsp;&nbsp;&nbsp; 15205 |
| 26622 | 6.00%, 03/15/2036 | &nbsp;&nbsp;&nbsp; 28013 |
| 26871 | 6.00%, 05/15/2036 | &nbsp;&nbsp;&nbsp; 27910 |
| 64612 | 6.00%, 06/15/2036 | &nbsp;&nbsp;&nbsp; 67868 |
| 7249 | 6.00%, 06/15/2037 | &nbsp;&nbsp;&nbsp; 7550 |
| 13566 | 6.00%, 08/15/2037 | &nbsp;&nbsp;&nbsp; 14107 |
| 28521 | 6.00%, 08/15/2039 | &nbsp;&nbsp;&nbsp; 29630 |
| 517250 | 6.00%, 09/20/2040<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 81570 |
| 41901 | 6.00%, 06/15/2041 | &nbsp;&nbsp;&nbsp; 44074 |
| 527793 | 6.00%, 02/20/2046<sup>(3)</sup>  | &nbsp;&nbsp;&nbsp; 61703 |
| 7913000 | 6.00%, 01/20/2055<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 8063532 |
| 714524 | 6.00%, 07/20/2055 | &nbsp;&nbsp;&nbsp; 729487 |
| 3065391 | 6.00%, 09/20/2055 | &nbsp;&nbsp;&nbsp; 3129663 |
| 5363 | 6.50%, 06/15/2028 | &nbsp;&nbsp;&nbsp; 5425 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** | **U.S. GOVERNMENT AGENCIES - 41.1% - (continued)** |
|  | **Mortgage-Backed Agencies - 41.1% - (continued)** | **Mortgage-Backed Agencies - 41.1% - (continued)** |
|  | **Government National Mortgage Association - 10.2% - (continued)** | **Government National Mortgage Association - 10.2% - (continued)** |
| $294 | 6.50%, 08/15/2028 | &nbsp;&nbsp;&nbsp; $300 |
| 375 | 6.50%, 09/15/2028 | &nbsp;&nbsp;&nbsp; 381 |
| 308 | 6.50%, 11/15/2028 | &nbsp;&nbsp;&nbsp; 318 |
| 1847 | 6.50%, 12/15/2028 | &nbsp;&nbsp;&nbsp; 1901 |
| 3572 | 6.50%, 02/15/2029 | &nbsp;&nbsp;&nbsp; 3621 |
| 17753 | 6.50%, 03/15/2029 | &nbsp;&nbsp;&nbsp; 18150 |
| 7956 | 6.50%, 04/15/2029 | &nbsp;&nbsp;&nbsp; 8157 |
| 2511 | 6.50%, 05/15/2029 | &nbsp;&nbsp;&nbsp; 2545 |
| 48362 | 6.50%, 06/15/2029 | &nbsp;&nbsp;&nbsp; 48949 |
| 1543 | 6.50%, 07/15/2029 | &nbsp;&nbsp;&nbsp; 1607 |
| 32 | 6.50%, 03/15/2031 | &nbsp;&nbsp;&nbsp; 33 |
| 53576 | 6.50%, 04/15/2031 | &nbsp;&nbsp;&nbsp; 55233 |
| 13278 | 6.50%, 05/15/2031 | &nbsp;&nbsp;&nbsp; 13831 |
| 1062 | 6.50%, 06/15/2031 | &nbsp;&nbsp;&nbsp; 1098 |
| 53000 | 6.50%, 07/15/2031 | &nbsp;&nbsp;&nbsp; 54679 |
| 9450 | 6.50%, 08/15/2031 | &nbsp;&nbsp;&nbsp; 9707 |
| 16543 | 6.50%, 09/15/2031 | &nbsp;&nbsp;&nbsp; 16918 |
| 30943 | 6.50%, 10/15/2031 | &nbsp;&nbsp;&nbsp; 32556 |
| 109055 | 6.50%, 11/15/2031 | &nbsp;&nbsp;&nbsp; 111217 |
| 17067 | 6.50%, 12/15/2031 | &nbsp;&nbsp;&nbsp; 17576 |
| 34471 | 6.50%, 01/15/2032 | &nbsp;&nbsp;&nbsp; 35353 |
| 10470 | 6.50%, 02/15/2032 | &nbsp;&nbsp;&nbsp; 10804 |
| 19293 | 6.50%, 03/15/2032 | &nbsp;&nbsp;&nbsp; 19616 |
| 71101 | 6.50%, 04/15/2032 | &nbsp;&nbsp;&nbsp; 73571 |
| 172 | 6.50%, 05/15/2032 | &nbsp;&nbsp;&nbsp; 181 |
| 10213 | 6.50%, 06/15/2032 | &nbsp;&nbsp;&nbsp; 10494 |
| 136 | 7.00%, 02/15/2031 | &nbsp;&nbsp;&nbsp; 140 |
| 57 | 7.00%, 06/15/2031 | &nbsp;&nbsp;&nbsp; 58 |
|  |  | &nbsp;&nbsp;&nbsp; 141711608 |
|  | **Uniform Mortgage-Backed Security - 9.5%** | **Uniform Mortgage-Backed Security - 9.5%** |
| 5232000 | 3.50%, 01/01/2056<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 4836534 |
| 5225000 | 4.00%, 01/01/2040<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 5156208 |
| 28440000 | 4.50%, 01/01/2040<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 28449998 |
| 4595000 | 4.50%, 01/01/2055<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 4485373 |
| 7430000 | 5.50%, 01/01/2040<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 7616996 |
| 53694000 | 5.50%, 01/01/2055<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 54444781 |
| 26443000 | 6.00%, 01/01/2055<sup>(15)</sup>  | &nbsp;&nbsp;&nbsp; 27149755 |
|  |  | &nbsp;&nbsp;&nbsp; 132139645 |
|  | Total U.S. Government Agencies <br>(cost $586,181,266)<br>| &nbsp;&nbsp;&nbsp; $570348680 |
| **U.S. GOVERNMENT SECURITIES - 23.5%** | **U.S. GOVERNMENT SECURITIES - 23.5%** | **U.S. GOVERNMENT SECURITIES - 23.5%** |
|  | **U.S. Treasury Securities - 23.5%** | **U.S. Treasury Securities - 23.5%** |
|  | **U.S. Treasury Bonds - 13.4%** | **U.S. Treasury Bonds - 13.4%** |
| 24645000 | 1.25%, 05/15/2050 | &nbsp;&nbsp;&nbsp; $11796868 |
| 5115000 | 1.88%, 11/15/2051 | &nbsp;&nbsp;&nbsp; 2827236 |
| 7090000 | 2.25%, 08/15/2046 | &nbsp;&nbsp;&nbsp; 4665829 |
| 15065000 | 2.25%, 02/15/2052 | &nbsp;&nbsp;&nbsp; 9140218 |
| 7860000 | 2.38%, 11/15/2049 | &nbsp;&nbsp;&nbsp; 5048515 |
| 70315000 | 2.88%, 08/15/2045 | &nbsp;&nbsp;&nbsp; 52741743 |
| 6175000 | 3.00%, 02/15/2047 | &nbsp;&nbsp;&nbsp; 4648858 |
| 17565000 | 3.38%, 05/15/2044<sup>(16)</sup>  | &nbsp;&nbsp;&nbsp; 14496614 |
| 35500000 | 3.38%, 11/15/2048<sup>(17)</sup>  | &nbsp;&nbsp;&nbsp; 28087988 |
| 12035000 | 3.63%, 05/15/2053 | &nbsp;&nbsp;&nbsp; 9735657 |
| 28222000 | 4.25%, 08/15/2054 | &nbsp;&nbsp;&nbsp; 25516657 |
| 4685000 | 4.75%, 05/15/2055 | &nbsp;&nbsp;&nbsp; 4603745 |
| 6255000 | 4.75%, 08/15/2055 | &nbsp;&nbsp;&nbsp; 6149447 |
| 6250000 | 4.88%, 08/15/2045 | &nbsp;&nbsp;&nbsp; 6310547 |
|  |  | &nbsp;&nbsp;&nbsp; 185769922 |
|  | **U.S. Treasury Inflation-Indexed Bonds - 3.1%** | **U.S. Treasury Inflation-Indexed Bonds - 3.1%** |
| 11315016 | 0.25%, 02/15/2050<sup>(18)</sup>  | &nbsp;&nbsp;&nbsp; 6509708 |
| 3717263 | 0.63%, 02/15/2043<sup>(18)</sup>  | &nbsp;&nbsp;&nbsp; 2765134 |
| 19955911 | 0.75%, 02/15/2042<sup>(18)</sup>  | &nbsp;&nbsp;&nbsp; 15528837 |
| 8917834 | 0.75%, 02/15/2045<sup>(18)</sup>  | &nbsp;&nbsp;&nbsp; 6499113 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

44 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT SECURITIES - 23.5% - (continued)** | **U.S. GOVERNMENT SECURITIES - 23.5% - (continued)** | **U.S. GOVERNMENT SECURITIES - 23.5% - (continued)** | **U.S. GOVERNMENT SECURITIES - 23.5% - (continued)** |
|  | **U.S. Treasury Securities - 23.5% - (continued)** | **U.S. Treasury Securities - 23.5% - (continued)** | **U.S. Treasury Securities - 23.5% - (continued)** |
|  | **U.S. Treasury Inflation-Indexed Bonds - 3.1% - (continued)** | **U.S. Treasury Inflation-Indexed Bonds - 3.1% - (continued)** | **U.S. Treasury Inflation-Indexed Bonds - 3.1% - (continued)** |
| $3256546 | 1.00%, 02/15/2046<sup>(18)</sup>  | 1.00%, 02/15/2046<sup>(18)</sup>  | &nbsp;&nbsp;&nbsp; $2454050 |
| 11182825 | 1.38%, 02/15/2044<sup>(18)</sup>  | 1.38%, 02/15/2044<sup>(18)</sup>  | &nbsp;&nbsp;&nbsp; 9359523 |
|  |  |  | &nbsp;&nbsp;&nbsp; 43116365 |
|  | **U.S. Treasury Notes - 7.0%** | **U.S. Treasury Notes - 7.0%** | **U.S. Treasury Notes - 7.0%** |
| 16645000 | 2.25%, 11/15/2027 | 2.25%, 11/15/2027 | &nbsp;&nbsp;&nbsp; 16275689 |
| 29565000 | 3.88%, 07/15/2028 | 3.88%, 07/15/2028 | &nbsp;&nbsp;&nbsp; 29814455 |
| 32405000 | 4.13%, 11/30/2031 | 4.13%, 11/30/2031 | &nbsp;&nbsp;&nbsp; 32892341 |
| 17305000 | 4.25%, 11/15/2034 | 4.25%, 11/15/2034 | &nbsp;&nbsp;&nbsp; 17486837 |
|  |  |  | &nbsp;&nbsp;&nbsp; 96469322 |
|  | Total U.S. Government Securities <br>(cost $391,351,009)<br>|  | &nbsp;&nbsp;&nbsp; $325355609 |
|  | Total Long-Term Investments <br>(cost $1,622,058,774)<br>|  | &nbsp;&nbsp;&nbsp; $1532881954 |
| **SHORT-TERM INVESTMENTS - 1.2%** | **SHORT-TERM INVESTMENTS - 1.2%** | **SHORT-TERM INVESTMENTS - 1.2%** | **SHORT-TERM INVESTMENTS - 1.2%** |
|  | **Repurchase Agreements - 0.4%** | **Repurchase Agreements - 0.4%** | **Repurchase Agreements - 0.4%** |
| 6153351 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at <br> 3.82%, due on 01/02/2026 with a <br> maturity value of $6,154,657; <br> collateralized by U.S. Treasury Note at <br> 4.13%, maturing 05/31/2032, with a <br> market value of $6,276,588 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at <br> 3.82%, due on 01/02/2026 with a <br> maturity value of $6,154,657; <br> collateralized by U.S. Treasury Note at <br> 4.13%, maturing 05/31/2032, with a <br> market value of $6,276,588 | &nbsp;&nbsp;&nbsp; $6153351 |
|  | **Securities Lending Collateral - 0.8%** | **Securities Lending Collateral - 0.8%** | **Securities Lending Collateral - 0.8%** |
| 11013625 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(19)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(19)</sup>  | &nbsp;&nbsp;&nbsp; 11013625 |
|  | Total Short-Term Investments <br>(cost $17,166,976) | Total Short-Term Investments <br>(cost $17,166,976) | &nbsp;&nbsp;&nbsp; $17166976 |
|  | Total Investments <br>(cost $1,639,225,750)<br>| 111.8<br> %<br>| &nbsp;&nbsp;&nbsp; $1550048930 |
|  | Other Assets and Liabilities | (11.8)%<br>| &nbsp;&nbsp;&nbsp; (163631947)<br>|
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $1386416983 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

The Fund may refer to any one or more of the industry classifications used by one or more widely recognized market indices, ratings group and/or as defined by Fund management. Industry classifications may not be identical across all security types.

Equity industry classifications used in this report are the Global Industry Classification Standard, which was developed by and is the exclusive property and service mark of MSCI, Inc. and Standard & Poor's.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

<sup>(1)</sup> Security was purchased pursuant to Rule 144A under the Securities Act of 1933 and may be sold in transactions that are exempt from registration (typically only to qualified institutional buyers) or in a public offering registered under the Securities Act of 1933. At December 31, 2025, the aggregate value of these securities was $341,941,495, representing 24.7% of net assets. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(2)</sup> Variable or floating rate securities. Interest rate resets periodically. The rate shown is the effective interest rate as of period end. Security description also includes the reference rate and spread if published and available. Variable rate securities with a floor or ceiling feature are disclosed at the inherent rate, where applicable. Certain variable rate securities are not based on a published reference rate and spread but are determined by the issuer or agent and are based on current market conditions; these securities do not indicate a reference rate and spread in the description. For fixed to variable securities, the rate remains fixed until designated date stated in security description. 

<sup>(3)</sup> Securities disclosed are interest-only strips. 

<sup>(4)</sup> Security is a "step-up" bond where coupon increases or steps up at a predetermined date. Rate shown is current coupon rate. 

<sup>(5)</sup> Investment valued using significant unobservable inputs.

<sup>(6)</sup> Security is exempt from registration under Regulation S under the Securities Act of 1933, which exempts from registration securities offered and sold outside of the United States. Security may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933. At December 31, 2025, the aggregate value of these securities was $13,881,837, representing 1.0% of net assets. 

<sup>(7)</sup> Represents entire or partial securities on loan. See Note 8 in the accompanying Notes to Financial Statements for securities lending information. 

<sup>(8)</sup> Perpetual maturity security. Maturity date shown is the next call date or final legal maturity date, whichever comes first. 

<sup>(9)</sup> Security has the ability to pay in kind ("PIK") or pay income in cash. When applicable, separate rates of such payments are disclosed. 

<sup>(10)</sup> Senior floating rate interests generally pay interest rates which are periodically adjusted by reference to a base short-term, floating lending rate plus a premium. The base lending rates are primarily the Secured Overnight Financing Rate ("SOFR") and secondarily, the prime rate offered by one or more major United States banks (the "Prime Rate"). Senior floating rate interests often require prepayments from excess cash flows or permit the borrower to repay at its election. The rate at which the borrower repays cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturities shown. Base lending rates may be subject to a floor or cap. Unless otherwise noted, the interest rate disclosed for these securities represents the rate in effect as of December 31, 2025. 

<sup>(11)</sup> Non-income producing. For long-term debt securities, items identified are in default as to payment of interest and/or principal. 

<sup>(12)</sup> Securities disclosed are principal-only strips. 

<sup>(13)</sup> Security is a zero-coupon bond.

<sup>(14)</sup> Market value is less than $1.

<sup>(15)</sup> Represents or includes a TBA transaction.

<sup>(16)</sup> All, or a portion of the security, was pledged as collateral in connection with centrally cleared swap contracts. As of December 31, 2025, the market value of securities pledged was $5,265,494. 

<sup>(17)</sup> All, or a portion of the security, was pledged as collateral in connection with futures contracts. As of December 31, 2025, the market value of securities pledged was $5,534,521. 

<sup>(18)</sup> The principal amount for these securities are adjusted for inflation and the interest payments equal a fixed percentage of the inflation-adjusted principal amount. 

<sup>(19)</sup> Current yield as of period end.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

45 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Futures Contracts Outstanding at December 31, 2025**  | **Futures Contracts Outstanding at December 31, 2025**  | **Futures Contracts Outstanding at December 31, 2025**  | **Futures Contracts Outstanding at December 31, 2025**  | **Futures Contracts Outstanding at December 31, 2025**  |
| **Description** | **Number of** <br>**Contracts**<br>| **Expiration** <br>**Date**<br>| **Current** <br>**Notional** <br>**Amount**<br>| **Value and** <br>**Unrealized** <br>**Appreciation/** <br>**(Depreciation)**<br>|
| **Long position contracts:** | **Long position contracts:** | **Long position contracts:** | **Long position contracts:** | **Long position contracts:** |
| Australian 10-Year Bond Future | 761 | 03/16/2026 | &nbsp;&nbsp; $55601849 | &nbsp;&nbsp; $236095 |
| Euro BUXL 30-Year Bond Future | 26 | 03/06/2026 | &nbsp;&nbsp; 3364739 | &nbsp;&nbsp; (54834)<br>|
| U.S. Treasury 2-Year Note Future | 31 | 03/31/2026 | &nbsp;&nbsp; 6472461 | &nbsp;&nbsp; (3914)<br>|
| U.S. Treasury 5-Year Note Future | 780 | 03/31/2026 | &nbsp;&nbsp; 85257657 | &nbsp;&nbsp; (20000)<br>|
| U.S. Treasury 10-Year Note Future | 252 | 03/20/2026 | &nbsp;&nbsp; 28334250 | &nbsp;&nbsp; (203292)<br>|
| U.S. Treasury 10-Year Ultra Future | 428 | 03/20/2026 | &nbsp;&nbsp; 49226687 | &nbsp;&nbsp; (263254)<br>|
| **Total** |  |  |  | &nbsp;&nbsp; $(309199)<br>|
| **Short position contracts:** | **Short position contracts:** | **Short position contracts:** | **Short position contracts:** | **Short position contracts:** |
| Euro-BUND Future | (279) | 03/06/2026 | &nbsp;&nbsp; $(41827753)<br>| &nbsp;&nbsp; $264286 |
| Long Gilt Future | (196) | 03/27/2026 | &nbsp;&nbsp; (24139799)<br>| &nbsp;&nbsp; (58230)<br>|
| U.S. Treasury Long Bond Future | (59) | 03/20/2026 | &nbsp;&nbsp; (6820031)<br>| &nbsp;&nbsp; 94170 |
| U.S. Treasury Ultra Bond Future | (23) | 03/20/2026 | &nbsp;&nbsp; (2714000)<br>| &nbsp;&nbsp; 9308 |
| **Total** |  |  |  | &nbsp;&nbsp; $309534 |
| **Total futures contracts** | **Total futures contracts** | **Total futures contracts** | **Total futures contracts** | &nbsp;&nbsp; $335 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **TBA Sale Commitments Outstanding at December 31, 2025**  | **TBA Sale Commitments Outstanding at December 31, 2025**  | **TBA Sale Commitments Outstanding at December 31, 2025**  | **TBA Sale Commitments Outstanding at December 31, 2025**  | **TBA Sale Commitments Outstanding at December 31, 2025**  |
| **Description** | **Principal** <br>**Amount**<br>| **Maturity** <br>**Date**<br>| **Market** <br>**Value**<sup>†</sup> <br>| **Unrealized** <br>**Appreciation/** <br>**(Depreciation)**<br>|
| Government National Mortgage Association, 3.00% | &nbsp;&nbsp; $1000000 | &nbsp;&nbsp; 01/20/2055 | &nbsp;&nbsp; $(898398)<br>| &nbsp;&nbsp; $(4141)<br>|
| Government National Mortgage Association, 3.50% | &nbsp;&nbsp; 3200000 | &nbsp;&nbsp; 01/20/2055 | &nbsp;&nbsp; (2911623)<br>| &nbsp;&nbsp; 9627 |
| Government National Mortgage Association, 4.00% | &nbsp;&nbsp; 3875000 | &nbsp;&nbsp; 01/20/2055 | &nbsp;&nbsp; (3659907)<br>| &nbsp;&nbsp; (16653)<br>|
| Government National Mortgage Association, 4.50% | &nbsp;&nbsp; 915000 | &nbsp;&nbsp; 01/20/2056 | &nbsp;&nbsp; (891124)<br>| &nbsp;&nbsp; 751 |
| Uniform Mortgage-Backed Security, 2.00% | &nbsp;&nbsp; 2100000 | &nbsp;&nbsp; 01/01/2040 | &nbsp;&nbsp; (1943813)<br>| &nbsp;&nbsp; (2379)<br>|
| Uniform Mortgage-Backed Security, 2.00% | &nbsp;&nbsp; 17310000 | &nbsp;&nbsp; 01/01/2055 | &nbsp;&nbsp; (13988575)<br>| &nbsp;&nbsp; (60119)<br>|
| Uniform Mortgage-Backed Security, 2.50% | &nbsp;&nbsp; 25205000 | &nbsp;&nbsp; 01/01/2055 | &nbsp;&nbsp; (21304133)<br>| &nbsp;&nbsp; 61747 |
| Uniform Mortgage-Backed Security, 3.00% | &nbsp;&nbsp; 5145000 | &nbsp;&nbsp; 01/01/2056 | &nbsp;&nbsp; (4549908)<br>| &nbsp;&nbsp; (32156)<br>|
| Uniform Mortgage-Backed Security, 3.00% | &nbsp;&nbsp; 1925000 | &nbsp;&nbsp; 01/01/2041 | &nbsp;&nbsp; (1851685)<br>| &nbsp;&nbsp; 376 |
| Uniform Mortgage-Backed Security, 4.00% | &nbsp;&nbsp; 4324000 | &nbsp;&nbsp; 01/01/2056 | &nbsp;&nbsp; (4100988)<br>| &nbsp;&nbsp; (22746)<br>|
| Uniform Mortgage-Backed Security, 4.50% | &nbsp;&nbsp; 4595000 | &nbsp;&nbsp; 02/01/2056 | &nbsp;&nbsp; (4481783)<br>| &nbsp;&nbsp; (4889)<br>|
| Uniform Mortgage-Backed Security, 4.50% | &nbsp;&nbsp; 18395000 | &nbsp;&nbsp; 01/01/2055 | &nbsp;&nbsp; (17956135)<br>| &nbsp;&nbsp; (15332)<br>|
| Uniform Mortgage-Backed Security, 4.50% | &nbsp;&nbsp; 800000 | &nbsp;&nbsp; 01/01/2040 | &nbsp;&nbsp; (800281)<br>| &nbsp;&nbsp; (2875)<br>|
| Uniform Mortgage-Backed Security, 5.00% | &nbsp;&nbsp; 1160000 | &nbsp;&nbsp; 01/01/2055 | &nbsp;&nbsp; (1156738)<br>| &nbsp;&nbsp; (5302)<br>|
| Uniform Mortgage-Backed Security, 6.50% | &nbsp;&nbsp; 5890000 | &nbsp;&nbsp; 01/01/2055 | &nbsp;&nbsp; (6121127)<br>| &nbsp;&nbsp; (18535)<br>|
| **Total TBA sale commitments (proceeds receivable $86,503,592)** | **Total TBA sale commitments (proceeds receivable $86,503,592)** | **Total TBA sale commitments (proceeds receivable $86,503,592)** | &nbsp;&nbsp; $(86616218)<br>| &nbsp;&nbsp; $(112626)<br>|
| At December 31, 2025, the aggregate market value of TBA Sale Commitments represents (6.2)% of total net assets. | At December 31, 2025, the aggregate market value of TBA Sale Commitments represents (6.2)% of total net assets. | At December 31, 2025, the aggregate market value of TBA Sale Commitments represents (6.2)% of total net assets. | At December 31, 2025, the aggregate market value of TBA Sale Commitments represents (6.2)% of total net assets. | At December 31, 2025, the aggregate market value of TBA Sale Commitments represents (6.2)% of total net assets. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  | **Centrally Cleared Interest Rate Swap Contracts Outstanding at December 31, 2025**  |
| **Payments made** <br>**by Fund**<br>| **Payments received** <br>**by Fund**<br>| **Notional** <br>**Amount** | **Notional** <br>**Amount** | **Expiration** <br>**Date**<br>| **Periodic** <br>**Payment** <br>**Frequency**<br>| **Upfront** <br>**Premiums** <br>**Paid**<br>| **Upfront** <br>**Premiums** <br>**Received**<br>| **Value**<sup>†</sup> <br>| **Unrealized** <br>**Appreciation/** <br>**(Depreciation)**<br>|
| 3.70% Fixed | 12 Mo. USD SOFR | USD | &nbsp;&nbsp; 12100000 | &nbsp;&nbsp; 05/31/2029 | Annual | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(95218)<br>| &nbsp;&nbsp; $(95218)<br>|
| 4.16% Fixed | 12 Mo. USD SOFR | USD | &nbsp;&nbsp; 31330000 | &nbsp;&nbsp; 03/19/2045 | Annual | &nbsp;&nbsp; — | &nbsp;&nbsp; (58172)<br>| &nbsp;&nbsp; 24288 | &nbsp;&nbsp; 82460 |
| 2.97% Fixed | 12 Mo. USD SOFR | USD | &nbsp;&nbsp; 8430000 | &nbsp;&nbsp; 03/15/2053 | Annual | &nbsp;&nbsp; 24657 | &nbsp;&nbsp; — | &nbsp;&nbsp; 1764321 | &nbsp;&nbsp; 1739664 |
| 2.88% Fixed | 12 Mo. USD SOFR | USD | &nbsp;&nbsp; 3745000 | &nbsp;&nbsp; 03/15/2053 | Annual | &nbsp;&nbsp; 39506 | &nbsp;&nbsp; — | &nbsp;&nbsp; 841724 | &nbsp;&nbsp; 802218 |
| 3.25% Fixed | 12 Mo. USD SOFR | USD | &nbsp;&nbsp; 6235000 | &nbsp;&nbsp; 06/21/2053 | Annual | &nbsp;&nbsp; — | &nbsp;&nbsp; (62175)<br>| &nbsp;&nbsp; 990447 | &nbsp;&nbsp; 1052622 |
| **Total centrally cleared interest rate swaps contracts** | **Total centrally cleared interest rate swaps contracts** | **Total centrally cleared interest rate swaps contracts** | **Total centrally cleared interest rate swaps contracts** | **Total centrally cleared interest rate swaps contracts** | **Total centrally cleared interest rate swaps contracts** | &nbsp;&nbsp; $64163 | &nbsp;&nbsp; $(120347)<br>| &nbsp;&nbsp; $3525562 | &nbsp;&nbsp; $3581746 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Foreign Currency Contracts Outstanding at December 31, 2025**  | **Foreign Currency Contracts Outstanding at December 31, 2025**  | **Foreign Currency Contracts Outstanding at December 31, 2025**  | **Foreign Currency Contracts Outstanding at December 31, 2025**  | **Foreign Currency Contracts Outstanding at December 31, 2025**  | **Foreign Currency Contracts Outstanding at December 31, 2025**  | **Foreign Currency Contracts Outstanding at December 31, 2025**  |
| **Amount and Description of** <br>**Currency to be Purchased** | **Amount and Description of** <br>**Currency to be Purchased** | **Amount and Description of** <br>**Currency to be Sold** | **Amount and Description of** <br>**Currency to be Sold** | **Counterparty** | **Settlement** <br>**Date**<br>| **Appreciation/** <br>**(Depreciation)**<br>|
| 392000 | EUR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 461171 | USD | SSG | 03/18/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $1203 |
| 196000 | EUR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 231011 | USD | NWM | 03/18/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

46 <br>

------

**Hartford Total Return Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Foreign Currency Contracts Outstanding at December 31, 2025 – (continued)**  | **Foreign Currency Contracts Outstanding at December 31, 2025 – (continued)**  | **Foreign Currency Contracts Outstanding at December 31, 2025 – (continued)**  | **Foreign Currency Contracts Outstanding at December 31, 2025 – (continued)**  | **Foreign Currency Contracts Outstanding at December 31, 2025 – (continued)**  | **Foreign Currency Contracts Outstanding at December 31, 2025 – (continued)**  | **Foreign Currency Contracts Outstanding at December 31, 2025 – (continued)**  |
| **Amount and Description of**<br> **Currency to be Purchased** | **Amount and Description of**<br> **Currency to be Purchased** | **Amount and Description of**<br> **Currency to be Sold** | **Amount and Description of**<br> **Currency to be Sold** | **Counterparty** | **Settlement**<br> **Date**<br>| **Appreciation/**<br> **(Depreciation)**<br>|
| 422000 | EUR | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 498423 | USD | WFB | 03/18/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(663)<br>|
| 3765987 | USD | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3203000 | EUR | DEUT | 01/30/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3711)<br>|
| 10258386 | USD | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8726000 | EUR | DEUT | 03/18/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (34152)<br>|
| 2096623 | USD | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1563000 | GBP | DEUT | 01/30/2026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (10139)<br>|
| **Total foreign currency contracts** | **Total foreign currency contracts** | **Total foreign currency contracts** | **Total foreign currency contracts** | **Total foreign currency contracts** | **Total foreign currency contracts** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $(47287)<br>|

---

<sup>†</sup> See Significant Accounting Policies of accompanying Notes to Financial Statements regarding valuation of investments.

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Asset-Backed & Commercial Mortgage-Backed Securities | &nbsp;&nbsp; $238965816 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $236220820 | &nbsp;&nbsp; $2744996 |
| Convertible Bonds | &nbsp;&nbsp; 377712 | &nbsp;&nbsp; — | &nbsp;&nbsp; 377712 | &nbsp;&nbsp; — |
| Corporate Bonds | &nbsp;&nbsp; 361588585 | &nbsp;&nbsp; — | &nbsp;&nbsp; 361588585 | &nbsp;&nbsp; — |
| Foreign Government Obligations | &nbsp;&nbsp; 23040673 | &nbsp;&nbsp; — | &nbsp;&nbsp; 23040673 | &nbsp;&nbsp; — |
| Municipal Bonds | &nbsp;&nbsp; 13200908 | &nbsp;&nbsp; — | &nbsp;&nbsp; 13200908 | &nbsp;&nbsp; — |
| Senior Floating Rate Interests | &nbsp;&nbsp; 3971 | &nbsp;&nbsp; — | &nbsp;&nbsp; 3971 | &nbsp;&nbsp; — |
| U.S. Government Agencies | &nbsp;&nbsp; 570348680 | &nbsp;&nbsp; — | &nbsp;&nbsp; 570348680 | &nbsp;&nbsp; — |
| U.S. Government Securities | &nbsp;&nbsp; 325355609 | &nbsp;&nbsp; — | &nbsp;&nbsp; 325355609 | &nbsp;&nbsp; — |
| Short-Term Investments | &nbsp;&nbsp; 17166976 | &nbsp;&nbsp; 11013625 | &nbsp;&nbsp; 6153351 | &nbsp;&nbsp; — |
| Foreign Currency Contracts<sup>(2)</sup> <br>| &nbsp;&nbsp; 1378 | &nbsp;&nbsp; — | &nbsp;&nbsp; 1378 | &nbsp;&nbsp; — |
| Futures Contracts<sup>(2)</sup> <br>| &nbsp;&nbsp; 603859 | &nbsp;&nbsp; 603859 | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Swaps - Interest Rate<sup>(2)</sup> <br>| &nbsp;&nbsp; 3676964 | &nbsp;&nbsp; — | &nbsp;&nbsp; 3676964 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $1554331131 | &nbsp;&nbsp; $11617484 | &nbsp;&nbsp; $1539968651 | &nbsp;&nbsp; $2744996 |
| **Liabilities** |  |  |  |  |
| Foreign Currency Contracts<sup>(2)</sup> <br>| &nbsp;&nbsp; $(48665)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $(48665)<br>| &nbsp;&nbsp; $— |
| Futures Contracts<sup>(2)</sup> <br>| &nbsp;&nbsp; (603524)<br>| &nbsp;&nbsp; (603524)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Swaps - Interest Rate<sup>(2)</sup> <br>| &nbsp;&nbsp; (95218)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (95218)<br>| &nbsp;&nbsp; — |
| TBA Sale Commitments | &nbsp;&nbsp; (86616218)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (86616218)<br>| &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $(87363625)<br>| &nbsp;&nbsp; $(603524)<br>| &nbsp;&nbsp; $(86760101)<br>| &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3. <br> <sup>(2)</sup> Derivative instruments (excluding purchased and written options, if applicable) are valued at the unrealized appreciation/(depreciation) on the investments.

Level 3 investments at the beginning and/or end of the period in relation to net assets were not significant and accordingly, a reconciliation of Level 3 assets for the year ended December 31, 2025 is not presented.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

47 <br>

------

**Hartford Ultrashort Bond HLS Fund**

***Schedule of Investments***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> <br>|
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5%** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5%** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5%** |
|  | **Asset-Backed - Automobile - 27.1%** | **Asset-Backed - Automobile - 27.1%** |
| $1895000 | Ally Auto Receivables Trust 4.03%, 07/17/2028 | &nbsp;&nbsp;&nbsp; $1896647 |
| 268825 | American Heritage Auto Receivables Trust <br> 4.83%, 03/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 269400 |
| 41554 | AmeriCredit Automobile Receivables Trust <br> 1.01%, 01/19/2027 | &nbsp;&nbsp;&nbsp; 41490 |
|  | ARI Fleet Lease Trust |  |
| 2246459 | 4.38%, 01/17/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2253808 |
| 615000 | 4.59%, 03/15/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 619392 |
| 151639 | 5.30%, 11/15/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 152556 |
| 40775 | 5.41%, 02/17/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 40795 |
| 1886000 | 5.89%, 07/15/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1926247 |
| 152092 | 6.05%, 07/15/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 153254 |
|  | BMW Vehicle Lease Trust |  |
| 1590000 | 3.97%, 09/25/2028 | &nbsp;&nbsp;&nbsp; 1594253 |
| 713118 | 4.43%, 09/27/2027 | &nbsp;&nbsp;&nbsp; 715091 |
|  | BMW Vehicle Owner Trust |  |
| 987761 | 4.43%, 10/25/2027 | &nbsp;&nbsp;&nbsp; 989235 |
| 1061075 | 5.47%, 02/25/2028 | &nbsp;&nbsp;&nbsp; 1067476 |
|  | BofA Auto Trust |  |
| 2500000 | 4.35%, 11/20/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2516565 |
| 266710 | 4.52%, 11/22/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 267173 |
|  | Capital One Prime Auto Receivables Trust |  |
| 97000 | 3.17%, 04/15/2027 | &nbsp;&nbsp;&nbsp; 96934 |
| 4685000 | 3.88%, 01/16/2029 | &nbsp;&nbsp;&nbsp; 4688311 |
| 113512 | 4.61%, 10/15/2027 | &nbsp;&nbsp;&nbsp; 113661 |
| 1001368 | 4.87%, 02/15/2028 | &nbsp;&nbsp;&nbsp; 1005068 |
|  | CarMax Auto Owner Trust |  |
| 400000 | 4.42%, 08/15/2028 | &nbsp;&nbsp;&nbsp; 400982 |
| 1463345 | 4.59%, 07/17/2028 | &nbsp;&nbsp;&nbsp; 1467670 |
| 232712 | 4.75%, 10/15/2027 | &nbsp;&nbsp;&nbsp; 233210 |
| 26494 | 5.65%, 05/17/2027 | &nbsp;&nbsp;&nbsp; 26510 |
| 459749 | Chesapeake Funding II LLC 5.65%, <br> 05/15/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 461895 |
| 976420 | Citizens Auto Receivables Trust 5.83%, <br> 02/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 983078 |
|  | Enterprise Fleet Financing LLC |  |
| 18546 | 4.38%, 07/20/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 18555 |
| 153292 | 4.56%, 05/20/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 153384 |
| 1921239 | 5.23%, 03/20/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1935589 |
| 80511 | 5.51%, 01/22/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 80633 |
| 412961 | 5.56%, 04/22/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 415257 |
| 475421 | 5.74%, 12/20/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 477129 |
| 144438 | 5.76%, 10/22/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 144926 |
| 1467570 | 6.40%, 03/20/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1485621 |
|  | Ford Credit Auto Lease Trust |  |
| 3830000 | 4.37%, 03/15/2028 | &nbsp;&nbsp;&nbsp; 3840405 |
| 734193 | 5.06%, 05/15/2027 | &nbsp;&nbsp;&nbsp; 735570 |
|  | Ford Credit Auto Owner Trust |  |
| 1025000 | 3.91%, 04/15/2030 | &nbsp;&nbsp;&nbsp; 1028623 |
| 1461994 | 3.93%, 08/15/2027 | &nbsp;&nbsp;&nbsp; 1462174 |
| 1949402 | 4.47%, 12/15/2027 | &nbsp;&nbsp;&nbsp; 1954510 |
| 325222 | 4.59%, 10/15/2027 | &nbsp;&nbsp;&nbsp; 325888 |
| 2500000 | 4.85%, 08/15/2035<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2549912 |
|  | Ford Credit Floorplan Master Owner Trust A |  |
| 935000 | 4.63%, 04/15/2030 | &nbsp;&nbsp;&nbsp; 950525 |
| 1600000 | 4.92%, 05/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1605099 |
| 174121 | Foursight Capital Automobile Receivables Trust <br> 5.99%, 05/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 174711 |
| 189713 | GLS Auto Select Receivables Trust 6.37%, <br> 06/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 190582 |
|  | GM Financial Automobile Leasing Trust |  |
| 940000 | 4.19%, 10/20/2027 | &nbsp;&nbsp;&nbsp; 942043 |
| 250000 | 4.22%, 10/20/2028 | &nbsp;&nbsp;&nbsp; 250824 |
| 1115000 | 4.58%, 05/22/2028 | &nbsp;&nbsp;&nbsp; 1125006 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** |
|  | **Asset-Backed - Automobile - 27.1% - (continued)** | **Asset-Backed - Automobile - 27.1% - (continued)** |
|  | GM Financial Consumer Automobile <br> Receivables Trust |  |
| $1800000 | 3.88%, 12/18/2028 | &nbsp;&nbsp;&nbsp; $1801645 |
| 1295000 | 4.32%, 06/16/2028 | &nbsp;&nbsp;&nbsp; 1298266 |
| 287400 | 4.40%, 02/16/2028 | &nbsp;&nbsp;&nbsp; 287991 |
| 1091651 | 4.66%, 02/16/2028 | &nbsp;&nbsp;&nbsp; 1094380 |
| 3092605 | 5.45%, 06/16/2028 | &nbsp;&nbsp;&nbsp; 3114847 |
| 2640000 | GMF Floorplan Owner Revolving Trust 4.59%, <br> 03/15/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2662620 |
|  | Honda Auto Receivables Owner Trust |  |
| 242627 | 3.76%, 12/18/2028 | &nbsp;&nbsp;&nbsp; 242589 |
| 2011000 | 4.19%, 03/21/2028 | &nbsp;&nbsp;&nbsp; 2016358 |
| 702663 | 4.30%, 01/18/2028 | &nbsp;&nbsp;&nbsp; 704020 |
| 1581569 | 5.21%, 08/15/2028 | &nbsp;&nbsp;&nbsp; 1595315 |
|  | Hyundai Auto Lease Securitization Trust |  |
| 225000 | 4.37%, 01/18/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 225848 |
| 650920 | 4.58%, 09/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 653336 |
| 1430318 | 4.77%, 03/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1433802 |
| 1925000 | 4.83%, 01/18/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1944470 |
| 882702 | 5.02%, 03/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 884579 |
|  | Hyundai Auto Receivables Trust |  |
| 256326 | 2.35%, 04/17/2028 | &nbsp;&nbsp;&nbsp; 255889 |
| 1265000 | 3.88%, 04/15/2030 | &nbsp;&nbsp;&nbsp; 1267646 |
| 1230000 | 4.03%, 11/15/2028 | &nbsp;&nbsp;&nbsp; 1232594 |
| 1625000 | 4.32%, 10/15/2029 | &nbsp;&nbsp;&nbsp; 1637033 |
| 1165000 | 4.45%, 08/15/2028 | &nbsp;&nbsp;&nbsp; 1168677 |
| 1465000 | Hyundai Floorplan Master Owner Trust 4.01%, <br> 10/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1468026 |
| 1545000 | LAD Auto Receivables Trust 4.30%, <br> 07/17/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1546891 |
| 327898 | M&T Bank Auto Receivables Trust 4.63%, <br> 05/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 328650 |
|  | Mercedes-Benz Auto Lease Trust |  |
| 725000 | 4.23%, 02/15/2028 | &nbsp;&nbsp;&nbsp; 726606 |
| 595000 | 4.61%, 04/16/2029 | &nbsp;&nbsp;&nbsp; 602846 |
| 272106 | Mercedes-Benz Auto Receivables Trust 4.51%, <br> 11/15/2027 | &nbsp;&nbsp;&nbsp; 272561 |
| 2148906 | Nissan Auto Lease Trust 4.91%, 04/15/2027 | &nbsp;&nbsp;&nbsp; 2154400 |
|  | Nissan Auto Receivables Owner Trust |  |
| 1419964 | 2.07%, 12/17/2029 | &nbsp;&nbsp;&nbsp; 1414291 |
| 1805000 | 4.49%, 12/17/2029 | &nbsp;&nbsp;&nbsp; 1828615 |
|  | Porsche Financial Auto Securitization Trust |  |
| 2370000 | 3.91%, 03/22/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2371219 |
| 2098000 | 4.44%, 01/22/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2105645 |
| 484467 | 5.79%, 01/22/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 488191 |
|  | Porsche Innovative Lease Owner Trust |  |
| 2540000 | 4.61%, 10/20/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2568880 |
| 2575000 | 4.67%, 11/22/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2585281 |
| 2224494 | Santander Drive Auto Receivables Trust 4.63%, <br> 10/16/2028 | &nbsp;&nbsp;&nbsp; 2231289 |
|  | SBNA Auto Lease Trust |  |
| 233906 | 4.68%, 04/20/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 234144 |
| 198285 | 5.39%, 11/20/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 198626 |
| 2075000 | 5.55%, 12/20/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2100823 |
| 688934 | SCCU Auto Receivables Trust 4.67%, <br> 11/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 690785 |
|  | SFS Auto Receivables Securitization Trust |  |
| 925000 | 4.44%, 12/20/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 932718 |
| 2500000 | 4.55%, 06/20/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2516576 |
| 270125 | 4.65%, 05/22/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 270539 |
|  | Stellantis Financial Underwritten Enhanced <br> Lease Trust |  |
| 2790000 | 4.31%, 05/22/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2798845 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

48 <br>

------

**Hartford Ultrashort Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** |
|  | **Asset-Backed - Automobile - 27.1% - (continued)** | **Asset-Backed - Automobile - 27.1% - (continued)** |
| $2700000 | 4.47%, 07/20/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $2718535 |
|  | Toyota Auto Receivables Owner Trust |  |
| 1480000 | 3.89%, 08/15/2028 | &nbsp;&nbsp;&nbsp; 1481599 |
| 1295000 | 4.29%, 06/15/2028 | &nbsp;&nbsp;&nbsp; 1298683 |
| 830308 | 4.46%, 03/15/2028 | &nbsp;&nbsp;&nbsp; 832271 |
|  | Toyota Lease Owner Trust |  |
| 1085000 | 3.96%, 11/20/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1087673 |
| 1625000 | 4.21%, 09/20/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1627804 |
| 58959 | 4.31%, 02/22/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 58979 |
| 650000 | 5.26%, 06/20/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 654076 |
| 1750000 | USAA Auto Owner Trust 4.97%, 12/17/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1772200 |
| 414547 | USB Auto Owner Trust 4.51%, 06/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 415400 |
|  | Volkswagen Auto Lease Trust |  |
| 1395000 | 4.01%, 01/22/2029 | &nbsp;&nbsp;&nbsp; 1400461 |
| 2280000 | 4.43%, 12/20/2027 | &nbsp;&nbsp;&nbsp; 2288643 |
| 682937 | Volkswagen Auto Loan Enhanced Trust 4.65%, <br> 11/22/2027 | &nbsp;&nbsp;&nbsp; 684601 |
| 32894 | Westlake Automobile Receivables Trust 5.89%, <br> 02/16/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 32919 |
| 270000 | Westlake Flooring Master Trust 5.43%, <br> 02/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 270407 |
|  | Wheels Fleet Lease Funding 1 LLC |  |
| 1915000 | 4.57%, 01/18/2040<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1931661 |
| 168165 | 4.87%, 06/21/2039<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 169822 |
| 652837 | 5.80%, 04/18/2038<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 657001 |
| 405380 | 6.46%, 08/18/2038<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 410138 |
|  | World Omni Auto Receivables Trust |  |
| 2432423 | 1.90%, 03/15/2028 | &nbsp;&nbsp;&nbsp; 2423290 |
| 2500000 | 3.44%, 03/15/2028 | &nbsp;&nbsp;&nbsp; 2495629 |
|  | World Omni Automobile Lease Securitization <br> Trust |  |
| 2660000 | 4.42%, 04/17/2028 | &nbsp;&nbsp;&nbsp; 2682097 |
| 2525000 | 5.25%, 09/17/2029 | &nbsp;&nbsp;&nbsp; 2554951 |
|  |  | &nbsp;&nbsp;&nbsp; 133734859 |
|  | **Asset-Backed - Credit Card - 0.5%** | **Asset-Backed - Credit Card - 0.5%** |
| 2260000 | WF Card Issuance Trust 4.34%, 05/15/2030 | &nbsp;&nbsp;&nbsp; 2290001 |
|  | **Other Asset-Backed Securities - 7.1%** | **Other Asset-Backed Securities - 7.1%** |
| 64040 | Amur Equipment Finance Receivables XI LLC <br> 5.30%, 06/21/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 64168 |
| 577360 | Amur Equipment Finance Receivables XII LLC <br> 6.09%, 12/20/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 582148 |
| 1132864 | Amur Equipment Finance Receivables XIII LLC <br> 5.38%, 01/21/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1145624 |
| 2516058 | Amur Equipment Finance Receivables XV LLC <br> 4.70%, 09/22/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2541810 |
| 2438250 | Apidos CLO XXXII 4.98%, 01/20/2033, 3 mo. <br> USD Term SOFR + 1.10%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2439340 |
| 136121 | Auxilior Term Funding LLC 6.18%, 12/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 136796 |
| 2610000 | Bain Capital Credit CLO Ltd. 5.07%, <br> 10/23/2034, 3 mo. USD Term SOFR + <br> 1.21%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 2610324 |
| 675000 | Barings Equipment Finance LLC 4.02%, <br> 02/13/2029<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 676101 |
| 450000 | Benefit Street Partners CLO XXIII Ltd. 4.96%, <br> 04/25/2034, 3 mo. USD Term SOFR + <br> 1.10%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 449133 |
|  | CCG Receivables Trust |  |
| 1060000 | 4.14%, 08/15/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1062284 |
| 384707 | 4.48%, 10/14/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 386844 |
| 202152 | 5.82%, 09/16/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 202953 |
|  | CNH Equipment Trust |  |
| 753062 | 4.30%, 02/18/2028 | &nbsp;&nbsp;&nbsp; 753770 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** |
|  | **Other Asset-Backed Securities - 7.1% - (continued)** | **Other Asset-Backed Securities - 7.1% - (continued)** |
| $1216869 | 4.30%, 08/15/2028 | &nbsp;&nbsp;&nbsp; $1219533 |
| 1735000 | 4.37%, 11/15/2028 | &nbsp;&nbsp;&nbsp; 1741459 |
| 101647 | 5.42%, 10/15/2027 | &nbsp;&nbsp;&nbsp; 101773 |
| 367414 | Dext ABS LLC 6.56%, 05/15/2034<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 369460 |
| 1681102 | DLLAA LLC 4.70%, 10/20/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1687449 |
| 224148 | DLLAD LLC 5.50%, 08/20/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 225140 |
| 1300000 | Elmwood CLO 15 Ltd. 5.01%, 04/22/2035, 3 mo. <br> USD Term SOFR + 1.15%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1300377 |
| 156975 | GreatAmerica Leasing Receivables <br> Funding LLC 5.32%, 08/17/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 157124 |
|  | HPEFS Equipment Trust |  |
| 1135000 | 4.07%, 11/22/2032<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1136197 |
| 543016 | 5.18%, 05/20/2031<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 543917 |
|  | John Deere Owner Trust |  |
| 925000 | 4.28%, 07/17/2028 | &nbsp;&nbsp;&nbsp; 928247 |
| 330701 | 4.36%, 08/16/2027 | &nbsp;&nbsp;&nbsp; 330994 |
|  | Kubota Credit Owner Trust |  |
| 380000 | 4.48%, 04/17/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 381924 |
| 2446033 | 4.61%, 12/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2455826 |
| 766467 | 5.28%, 01/18/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 772183 |
| 161155 | 5.39%, 01/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 161320 |
|  | MMAF Equipment Finance LLC |  |
| 693944 | 5.20%, 09/13/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 695770 |
| 15325 | 5.79%, 11/13/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 15332 |
| 898278 | NYCTL Trust 4.84%, 11/10/2038<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 898417 |
| 438396 | Octagon Investment Partners 36 Ltd. 5.14%, <br> 04/15/2031, 3 mo. USD Term SOFR + <br> 1.23%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 438370 |
| 467075 | Octagon Investment Partners 39 Ltd. 5.03%, <br> 10/20/2030, 3 mo. USD Term SOFR + <br> 1.15%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 467002 |
| 1100000 | PFS Financing Corp. 4.85%, 02/15/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1119694 |
| 94423 | SCF Equipment Leasing LLC 4.82%, <br> 07/22/2030<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 94740 |
| 1000000 | Verizon Master Trust 3.96%, 10/21/2030 | &nbsp;&nbsp;&nbsp; 1002627 |
|  | Volvo Financial Equipment LLC |  |
| 660000 | 3.96%, 06/15/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 660588 |
| 810000 | 4.29%, 10/16/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 813313 |
| 385013 | 4.41%, 11/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 385775 |
| 1902199 | Voya CLO Ltd. 5.08%, 07/20/2032, 3 mo. USD <br> Term SOFR + 1.20%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1902718 |
|  |  | &nbsp;&nbsp;&nbsp; 35058564 |
|  | **Whole Loan Collateral CMO - 2.8%** | **Whole Loan Collateral CMO - 2.8%** |
| 416366 | Angel Oak Mortgage Trust 2.53%, <br> 01/26/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 397268 |
|  | BRAVO Residential Funding Trust |  |
| 196153 | 0.94%, 02/25/2049<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 184653 |
| 118328 | 0.97%, 03/25/2060<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 115900 |
| 660403 | 1.70%, 04/25/2060<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 618876 |
| 40868 | Bunker Hill Loan Depositary Trust 2.72%, <br> 11/25/2059<sup>(1)(3)</sup>  | &nbsp;&nbsp;&nbsp; 40636 |
|  | COLT Mortgage Loan Trust |  |
| 1307844 | 1.11%, 10/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1134757 |
| 210842 | 1.33%, 10/26/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 199971 |
| 1558999 | 1.40%, 10/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1336317 |
| 733098 | 1.73%, 11/26/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 666661 |
| 787679 | CSMC Trust 3.57%, 07/25/2049<sup>(1)(3)</sup>  | &nbsp;&nbsp;&nbsp; 762222 |
|  | Ellington Financial Mortgage Trust |  |
| 336166 | 0.93%, 06/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 286158 |
| 27370 | 2.74%, 11/25/2059<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 26590 |
|  | GCAT Trust |  |
| 2194884 | 1.26%, 07/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1863156 |
| 421765 | 1.92%, 08/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 394176 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

49 <br>

------

**Hartford Ultrashort Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** | **ASSET-BACKED & COMMERCIAL MORTGAGE-BACKED SECURITIES - 37.5% -** <br> **(continued)** |
|  | **Whole Loan Collateral CMO - 2.8% - (continued)** | **Whole Loan Collateral CMO - 2.8% - (continued)** |
|  | MFA Trust |  |
| $138162 | 1.01%, 01/26/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; $132007 |
| 365533 | 1.03%, 11/25/2064<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 324251 |
|  | New Residential Mortgage Loan Trust |  |
| 974433 | 1.16%, 11/27/2056<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 880606 |
| 294794 | 4.00%, 08/27/2057<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 287606 |
|  | OBX Trust |  |
| 21050 | 4.50%, 06/25/2057, 1 mo. USD Term SOFR + <br> 0.76%<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 20638 |
| 300208 | 5.12%, 06/25/2064<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 300773 |
| 1238232 | 5.45%, 05/25/2065<sup>(1)(3)</sup>  | &nbsp;&nbsp;&nbsp; 1243444 |
| 7936 | Residential Mortgage Loan Trust 2.38%, <br> 01/26/2060<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 7895 |
| 1554624 | SG Residential Mortgage Trust 1.16%, <br> 07/25/2061<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1312250 |
|  | Starwood Mortgage Residential Trust |  |
| 117331 | 0.94%, 05/25/2065<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 112372 |
| 25513 | 2.28%, 02/25/2050<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 24603 |
|  | Towd Point Mortgage Trust |  |
| 205373 | 2.75%, 06/25/2057<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 201862 |
| 171380 | 3.75%, 03/25/2058<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 170586 |
|  | Verus Securitization Trust |  |
| 857347 | 1.63%, 10/25/2066<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 757877 |
| 313631 | 5.45%, 05/25/2070<sup>(1)(3)</sup>  | &nbsp;&nbsp;&nbsp; 316431 |
|  |  | &nbsp;&nbsp;&nbsp; 14120542 |
|  | Total Asset-Backed & Commercial <br> Mortgage-Backed Securities <br>(cost $186,101,160) | &nbsp;&nbsp;&nbsp; $185203966 |
| **CORPORATE BONDS - 25.4%** | **CORPORATE BONDS - 25.4%** | **CORPORATE BONDS - 25.4%** |
|  | **Aerospace & Defense - 0.2%** | **Aerospace & Defense - 0.2%** |
| 900000 | Northrop Grumman Systems Corp. 7.75%, <br> 03/15/2026 | &nbsp;&nbsp;&nbsp; $903177 |
|  | **Auto Manufacturers - 3.0%** | **Auto Manufacturers - 3.0%** |
|  | American Honda Finance Corp. |  |
| 1125000 | 4.55%, 07/09/2027 | &nbsp;&nbsp;&nbsp; 1135470 |
| 1400000 | 4.95%, 01/09/2026 | &nbsp;&nbsp;&nbsp; 1400251 |
|  | BMW U.S. Capital LLC |  |
| 1550000 | 4.15%, 08/11/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1556143 |
| 2650000 | 4.65%, 08/13/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2660915 |
|  | Daimler Truck Finance North America LLC |  |
| 1550000 | 4.30%, 08/12/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1556686 |
| 565000 | 5.15%, 01/16/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 565185 |
| 1650000 | Hyundai Capital America 5.45%, 06/24/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1659957 |
| 2525000 | Mercedes-Benz Finance North America LLC <br> 4.88%, 07/31/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2538517 |
| 1900000 | Toyota Motor Credit Corp. 4.50%, 05/14/2027 | &nbsp;&nbsp;&nbsp; 1918251 |
|  |  | &nbsp;&nbsp;&nbsp; 14991375 |
|  | **Commercial Banks - 9.4%** | **Commercial Banks - 9.4%** |
| 1600000 | ABN AMRO Bank NV 6.34%, 09/18/2027, <br> (6.34% fixed rate until 09/18/2026; 1 yr. USD <br> CMT + 1.65% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1624557 |
|  | Bank of America Corp. |  |
| 1285000 | 4.62%, 05/09/2029, (4.62% fixed rate until <br> 05/09/2028; 6 mo. USD SOFR + 1.11% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1302046 |
| 925000 | 5.08%, 01/20/2027, (5.08% fixed rate until <br> 01/20/2026; 6 mo. USD SOFR + 1.29% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 925447 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 25.4% - (continued)** | **CORPORATE BONDS - 25.4% - (continued)** | **CORPORATE BONDS - 25.4% - (continued)** |
|  | **Commercial Banks - 9.4% - (continued)** | **Commercial Banks - 9.4% - (continued)** |
| $1475000 | 5.93%, 09/15/2027, (5.93% fixed rate until <br> 09/15/2026; 6 mo. USD SOFR + 1.34% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; $1494018 |
|  | Banque Federative du Credit Mutuel SA |  |
| 1250000 | 4.94%, 01/26/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1250730 |
| 875000 | 5.90%, 07/13/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 883711 |
| 2500000 | Barclays PLC 2.28%, 11/24/2027, (2.28% fixed <br> rate until 11/24/2026; 1 yr. USD CMT + 1.05% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 2459771 |
| 1125000 | BPCE SA 5.20%, 01/18/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1138447 |
| 1210000 | Canadian Imperial Bank of Commerce 5.24%, <br> 06/28/2027 | &nbsp;&nbsp;&nbsp; 1232931 |
|  | Citibank NA |  |
| 1625000 | 4.93%, 08/06/2026 | &nbsp;&nbsp;&nbsp; 1633514 |
| 2400000 | 5.44%, 04/30/2026 | &nbsp;&nbsp;&nbsp; 2409146 |
| 500000 | Citigroup, Inc. 1.46%, 06/09/2027, (1.46% fixed <br> rate until 06/09/2026; 6 mo. USD SOFR + <br> 0.77% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 494267 |
| 2575000 | Cooperatieve Rabobank UA 4.37%, 05/27/2027 | &nbsp;&nbsp;&nbsp; 2596915 |
| 2190000 | Credit Agricole SA 5.59%, 07/05/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2207616 |
| 1675000 | Goldman Sachs Bank USA 5.41%, 05/21/2027, <br> (5.41% fixed rate until 05/21/2026; 6 mo. <br> USD SOFR + 0.75% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1683779 |
| 1475000 | JP Morgan Chase & Co. 6.07%, 10/22/2027, <br> (6.07% fixed rate until 10/22/2026; 6 mo. <br> USD SOFR + 1.33% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1498190 |
| 780000 | Lloyds Banking Group PLC 5.46%, 01/05/2028, <br> (5.46% fixed rate until 01/05/2027; 1 yr. USD <br> CMT + 1.38% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 790483 |
| 1225000 | Morgan Stanley 5.05%, 01/28/2027, (5.05% <br> fixed rate until 01/28/2026; 6 mo. USD SOFR <br> + 1.30% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1225832 |
|  | Morgan Stanley Bank NA |  |
| 1500000 | 4.45%, 10/15/2027, (4.45% fixed rate until <br> 10/15/2026; 6 mo. USD SOFR + 0.68% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1505838 |
| 1250000 | 4.75%, 04/21/2026 | &nbsp;&nbsp;&nbsp; 1252359 |
| 1225000 | National Australia Bank Ltd. 4.97%, 01/12/2026 | &nbsp;&nbsp;&nbsp; 1225272 |
|  | PNC Bank NA |  |
| 1000000 | 4.54%, 05/13/2027, (4.54% fixed rate until <br> 05/13/2026; 6 mo. USD SOFR + 0.63% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1001455 |
| 1600000 | 4.78%, 01/15/2027, (4.78% fixed rate until <br> 12/15/2026; 6 mo. USD SOFR + 0.50% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1600422 |
| 875000 | Royal Bank of Canada 5.20%, 07/20/2026 | &nbsp;&nbsp;&nbsp; 881200 |
| 925000 | Societe Generale SA 6.45%, 01/12/2027, <br> (6.45% fixed rate until 01/12/2026; 1 yr. USD <br> CMT + 2.30% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 925507 |
| 1225000 | Standard Chartered PLC 6.17%, 01/09/2027, <br> (6.17% fixed rate until 01/09/2026; 1 yr. USD <br> CMT + 2.05% thereafter)<sup>(1)(2)</sup>  | &nbsp;&nbsp;&nbsp; 1225376 |
| 1950000 | Swedbank AB 6.14%, 09/12/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1978082 |
| 925000 | Toronto-Dominion Bank 5.10%, 01/09/2026<sup>(4)</sup>  | &nbsp;&nbsp;&nbsp; 925129 |
| 2575000 | Truist Bank 4.67%, 05/20/2027, (4.67% fixed <br> rate until 05/20/2026; 6 mo. USD SOFR + <br> 0.59% thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 2579412 |
|  | UBS AG |  |
| 2725000 | 1.25%, 06/01/2026 | &nbsp;&nbsp;&nbsp; 2693936 |
| 1575000 | 4.86%, 01/10/2028, (4.86% fixed rate until <br> 01/10/2027; 6 mo. USD SOFR + 0.72% <br> thereafter)<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 1588202 |
|  |  | &nbsp;&nbsp;&nbsp; 46233590 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

50 <br>

------

**Hartford Ultrashort Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 25.4% - (continued)** | **CORPORATE BONDS - 25.4% - (continued)** | **CORPORATE BONDS - 25.4% - (continued)** |
|  | **Diversified Financial Services - 0.6%** | **Diversified Financial Services - 0.6%** |
| $2400000 | Blackstone Holdings Finance Co. LLC 5.90%, <br> 11/03/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; $2476582 |
| 360000 | Equitable America Global Funding 3.95%, <br> 09/15/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 359441 |
|  |  | &nbsp;&nbsp;&nbsp; 2836023 |
|  | **Electric - 1.8%** | **Electric - 1.8%** |
| 1310000 | Alliant Energy Finance LLC 5.40%, <br> 06/06/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1327701 |
| 467415 | Consumers Securitization Funding LLC 5.55%, <br> 03/01/2028 | &nbsp;&nbsp;&nbsp; 472451 |
| 815000 | DTE Electric Co. 4.25%, 05/14/2027 | &nbsp;&nbsp;&nbsp; 820576 |
| 1459000 | Emera U.S. Finance LP 3.55%, 06/15/2026 | &nbsp;&nbsp;&nbsp; 1454284 |
| 500000 | FirstEnergy Pennsylvania Electric Co. 5.15%, <br> 03/30/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 501183 |
| 2625000 | Georgia Power Co. 4.00%, 09/15/2026, 3 mo. <br> USD SOFR + 0.28%<sup>(2)</sup>  | &nbsp;&nbsp;&nbsp; 2624952 |
| 1767327 | NYSEG Storm Funding LLC 4.71%, 05/01/2029 | &nbsp;&nbsp;&nbsp; 1787444 |
|  |  | &nbsp;&nbsp;&nbsp; 8988591 |
|  | **Food - 0.5%** | **Food - 0.5%** |
| 2565000 | Mars, Inc. 4.45%, 03/01/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2583510 |
|  | **Gas - 0.1%** | **Gas - 0.1%** |
| 535000 | Southern Co. Gas Capital Corp. 4.05%, <br> 09/15/2028 | &nbsp;&nbsp;&nbsp; 535169 |
|  | **Healthcare - Products - 0.3%** | **Healthcare - Products - 0.3%** |
| 1575000 | Stryker Corp. 4.55%, 02/10/2027 | &nbsp;&nbsp;&nbsp; 1585179 |
|  | **Healthcare - Services - 0.3%** | **Healthcare - Services - 0.3%** |
| 1300000 | UnitedHealth Group, Inc. 4.75%, 07/15/2026 | &nbsp;&nbsp;&nbsp; 1305487 |
|  | **Insurance - 3.9%** | **Insurance - 3.9%** |
|  | Athene Global Funding |  |
| 1600000 | 4.86%, 08/27/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1605985 |
| 2480000 | 5.68%, 02/23/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2485005 |
|  | Corebridge Global Funding |  |
| 2400000 | 4.90%, 01/07/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2439058 |
| 725000 | 5.75%, 07/02/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 731427 |
| 585000 | F&G Global Funding 4.65%, 09/08/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 588715 |
|  | Jackson National Life Global Funding |  |
| 1225000 | 5.50%, 01/09/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1225330 |
| 775000 | 5.55%, 07/02/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 790979 |
| 1200000 | Lincoln Financial Global Funding 4.63%, <br> 05/28/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1211395 |
|  | Metropolitan Life Global Funding I |  |
| 1225000 | 5.00%, 01/06/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1225119 |
| 2400000 | 5.05%, 01/06/2028<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2448899 |
| 1250000 | Pacific Life Global Funding II 5.50%, <br> 08/28/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1262769 |
| 1500000 | Principal Life Global Funding II 3.00%, <br> 04/18/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1495532 |
| 1525000 | Protective Life Global Funding 5.37%, <br> 01/06/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1525169 |
|  |  | &nbsp;&nbsp;&nbsp; 19035382 |
|  | **Lodging - 0.3%** | **Lodging - 0.3%** |
| 1525000 | Marriott International, Inc. 4.20%, 07/15/2027 | &nbsp;&nbsp;&nbsp; 1530450 |
|  | **Machinery - Construction & Mining - 0.3%** | **Machinery - Construction & Mining - 0.3%** |
| 1575000 | Caterpillar Financial Services Corp. 4.50%, <br> 01/07/2027 | &nbsp;&nbsp;&nbsp; 1587451 |
|  | **Machinery-Diversified - 0.3%** | **Machinery-Diversified - 0.3%** |
| 1575000 | John Deere Capital Corp. 4.50%, 01/08/2027 | &nbsp;&nbsp;&nbsp; 1586921 |

---

---

| | | |
|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** | **Market Value**<sup>†</sup> |
| **CORPORATE BONDS - 25.4% - (continued)** | **CORPORATE BONDS - 25.4% - (continued)** | **CORPORATE BONDS - 25.4% - (continued)** |
|  | **Mining - 0.5%** | **Mining - 0.5%** |
| $2275000 | Rio Tinto Finance USA PLC 4.38%, 03/12/2027 | &nbsp;&nbsp;&nbsp; $2290095 |
|  | **Pharmaceuticals - 0.8%** | **Pharmaceuticals - 0.8%** |
| 460000 | Bayer U.S. Finance LLC 6.13%, 11/21/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 466556 |
| 1225000 | CVS Health Corp. 5.00%, 02/20/2026 | &nbsp;&nbsp;&nbsp; 1225466 |
| 2500000 | Pfizer, Inc. 3.88%, 11/15/2027 | &nbsp;&nbsp;&nbsp; 2508196 |
|  |  | &nbsp;&nbsp;&nbsp; 4200218 |
|  | **Pipelines - 1.5%** | **Pipelines - 1.5%** |
| 245000 | Columbia Pipelines Holding Co. LLC 6.06%, <br> 08/15/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 247251 |
| 925000 | Enterprise Products Operating LLC 5.05%, <br> 01/10/2026 | &nbsp;&nbsp;&nbsp; 925010 |
| 2050000 | ONEOK, Inc. 5.55%, 11/01/2026 | &nbsp;&nbsp;&nbsp; 2072074 |
| 2500000 | Spectra Energy Partners LP 3.38%, 10/15/2026 | &nbsp;&nbsp;&nbsp; 2488707 |
| 1700000 | Williams Cos., Inc. 5.40%, 03/02/2026 | &nbsp;&nbsp;&nbsp; 1703703 |
|  |  | &nbsp;&nbsp;&nbsp; 7436745 |
|  | **REITS - 0.5%** | **REITS - 0.5%** |
| 2525000 | Realty Income Corp. 4.45%, 09/15/2026 | &nbsp;&nbsp;&nbsp; 2527565 |
|  | **Retail - 0.2%** | **Retail - 0.2%** |
| 800000 | AutoZone, Inc. 5.05%, 07/15/2026 | &nbsp;&nbsp;&nbsp; 804524 |
|  | **Semiconductors - 0.2%** | **Semiconductors - 0.2%** |
| 885000 | Intel Corp. 4.88%, 02/10/2026 | &nbsp;&nbsp;&nbsp; 885560 |
|  | **Telecommunications - 0.5%** | **Telecommunications - 0.5%** |
| 2575000 | NTT Finance Corp. 4.57%, 07/16/2027<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 2596727 |
|  | **Trucking & Leasing - 0.2%** | **Trucking & Leasing - 0.2%** |
| 1000000 | Penske Truck Leasing Co. LP/PTL Finance <br> Corp. 5.75%, 05/24/2026<sup>(1)</sup>  | &nbsp;&nbsp;&nbsp; 1004825 |
|  | Total Corporate Bonds <br>(cost $124,870,210) | &nbsp;&nbsp;&nbsp; $125448564 |
| **MUNICIPAL BONDS - 0.9%** | **MUNICIPAL BONDS - 0.9%** | **MUNICIPAL BONDS - 0.9%** |
|  | **General - 0.9%** | **General - 0.9%** |
| 2130000 | New York City Transitional Finance Auth, Future <br> Tax Secured, NY, Rev 3.81%, 11/01/2027<sup>(5)</sup>  | &nbsp;&nbsp;&nbsp; $2132668 |
| 2020000 | Philadelphia Auth for Industrial Dev, PA, Rev, <br> (AG) 6.35%, 04/15/2028 | &nbsp;&nbsp;&nbsp; 2097821 |
|  | Total Municipal Bonds <br>(cost $4,228,203)<br>| &nbsp;&nbsp;&nbsp; $4230489 |
| **U.S. GOVERNMENT AGENCIES - 6.4%** | **U.S. GOVERNMENT AGENCIES - 6.4%** | **U.S. GOVERNMENT AGENCIES - 6.4%** |
|  | **Mortgage-Backed Agencies - 6.4%** | **Mortgage-Backed Agencies - 6.4%** |
|  | **Federal Home Loan Mortgage Corp. - 1.6%** | **Federal Home Loan Mortgage Corp. - 1.6%** |
| 284106 | 1.00%, 05/15/2041 | &nbsp;&nbsp;&nbsp; $266461 |
| 2157 | 1.75%, 04/15/2027 | &nbsp;&nbsp;&nbsp; 2151 |
| 1148953 | 3.00%, 10/15/2045 | &nbsp;&nbsp;&nbsp; 1130549 |
| 40057 | 3.50%, 05/15/2026 | &nbsp;&nbsp;&nbsp; 39963 |
| 580806 | 4.00%, 03/15/2037 | &nbsp;&nbsp;&nbsp; 579966 |
| 2304669 | 4.75%, 09/25/2052 | &nbsp;&nbsp;&nbsp; 2307495 |
| 3747496 | 5.00%, 03/25/2043 | &nbsp;&nbsp;&nbsp; 3737057 |
|  |  | &nbsp;&nbsp;&nbsp; 8063642 |
|  | **Federal National Mortgage Association - 1.7%** | **Federal National Mortgage Association - 1.7%** |
| 1905744 | 1.50%, 06/25/2042 | &nbsp;&nbsp;&nbsp; 1840839 |
| 243942 | 1.75%, 09/25/2041 | &nbsp;&nbsp;&nbsp; 235663 |
| 4779319 | 2.50%, 06/01/2029 | &nbsp;&nbsp;&nbsp; 4712948 |
| 1248 | 3.50%, 08/25/2026 | &nbsp;&nbsp;&nbsp; 1245 |
| 126913 | 3.50%, 11/01/2034 | &nbsp;&nbsp;&nbsp; 126437 |
| 59736 | 3.50%, 11/25/2038 | &nbsp;&nbsp;&nbsp; 59545 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

51 <br>

------

**Hartford Ultrashort Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

---

| | | | |
|:---|:---|:---|:---|
| **Shares or Principal Amount** | **Shares or Principal Amount** |  | **Market Value**<sup>†</sup> |
| **U.S. GOVERNMENT AGENCIES - 6.4% - (continued)** | **U.S. GOVERNMENT AGENCIES - 6.4% - (continued)** | **U.S. GOVERNMENT AGENCIES - 6.4% - (continued)** | **U.S. GOVERNMENT AGENCIES - 6.4% - (continued)** |
|  | **Mortgage-Backed Agencies - 6.4% - (continued)** | **Mortgage-Backed Agencies - 6.4% - (continued)** | **Mortgage-Backed Agencies - 6.4% - (continued)** |
|  | **Federal National Mortgage Association - 1.7% - (continued)** | **Federal National Mortgage Association - 1.7% - (continued)** | **Federal National Mortgage Association - 1.7% - (continued)** |
| $610739 | 4.00%, 07/25/2040 | 4.00%, 07/25/2040 | &nbsp;&nbsp;&nbsp; $609802 |
| 563448 | 4.00%, 06/25/2041 | 4.00%, 06/25/2041 | &nbsp;&nbsp;&nbsp; 562272 |
|  |  |  | &nbsp;&nbsp;&nbsp; 8148751 |
|  | **Government National Mortgage Association - 3.1%** | **Government National Mortgage Association - 3.1%** | **Government National Mortgage Association - 3.1%** |
| 1767426 | 2.00%, 12/16/2040 | 2.00%, 12/16/2040 | &nbsp;&nbsp;&nbsp; 1673529 |
| 1127033 | 2.00%, 06/16/2041 | 2.00%, 06/16/2041 | &nbsp;&nbsp;&nbsp; 1085694 |
| 3255686 | 2.25%, 12/20/2039 | 2.25%, 12/20/2039 | &nbsp;&nbsp;&nbsp; 3167708 |
| 2245211 | 2.25%, 02/20/2044 | 2.25%, 02/20/2044 | &nbsp;&nbsp;&nbsp; 2185058 |
| 240851 | 2.50%, 09/20/2046 | 2.50%, 09/20/2046 | &nbsp;&nbsp;&nbsp; 233586 |
| 389483 | 3.50%, 01/20/2052 | 3.50%, 01/20/2052 | &nbsp;&nbsp;&nbsp; 386689 |
| 6751001 | 4.50%, 11/20/2043 | 4.50%, 11/20/2043 | &nbsp;&nbsp;&nbsp; 6769767 |
|  |  |  | &nbsp;&nbsp;&nbsp; 15502031 |
|  | Total U.S. Government Agencies <br>(cost $31,340,424)<br>|  | &nbsp;&nbsp;&nbsp; $31714424 |
| **U.S. GOVERNMENT SECURITIES - 14.9%** | **U.S. GOVERNMENT SECURITIES - 14.9%** | **U.S. GOVERNMENT SECURITIES - 14.9%** | **U.S. GOVERNMENT SECURITIES - 14.9%** |
|  | **U.S. Treasury Securities - 14.9%** | **U.S. Treasury Securities - 14.9%** | **U.S. Treasury Securities - 14.9%** |
|  | **U.S. Treasury Notes - 14.9%** | **U.S. Treasury Notes - 14.9%** | **U.S. Treasury Notes - 14.9%** |
| 27625000 | 1.38%, 08/31/2026 | 1.38%, 08/31/2026 | &nbsp;&nbsp;&nbsp; $27235392 |
| 11600000 | 2.88%, 08/15/2028 | 2.88%, 08/15/2028 | &nbsp;&nbsp;&nbsp; 11413765 |
| 34850000 | 3.63%, 08/31/2027 | 3.63%, 08/31/2027 | &nbsp;&nbsp;&nbsp; 34927596 |
|  | Total U.S. Government Securities <br>(cost $73,146,990)<br>|  | &nbsp;&nbsp;&nbsp; $73576753 |
|  | Total Long-Term Investments <br>(cost $419,686,987)<br>|  | &nbsp;&nbsp;&nbsp; $420174196 |
| **SHORT-TERM INVESTMENTS - 14.3%** | **SHORT-TERM INVESTMENTS - 14.3%** | **SHORT-TERM INVESTMENTS - 14.3%** | **SHORT-TERM INVESTMENTS - 14.3%** |
|  | **Repurchase Agreements - 1.1%** | **Repurchase Agreements - 1.1%** | **Repurchase Agreements - 1.1%** |
| 5540743 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value of <br> $5,541,919; collateralized by U.S. Treasury <br> Bond at 4.63%, maturing 11/15/2055, with <br> a market value of $5,651,700 | Fixed Income Clearing Corp. Repurchase <br> Agreement dated 12/31/2025 at 3.82%, <br> due on 01/02/2026 with a maturity value of <br> $5,541,919; collateralized by U.S. Treasury <br> Bond at 4.63%, maturing 11/15/2055, with <br> a market value of $5,651,700 | &nbsp;&nbsp;&nbsp; $5540743 |
|  | **Securities Lending Collateral - 0.0%** | **Securities Lending Collateral - 0.0%** | **Securities Lending Collateral - 0.0%** |
| 51205 | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(6)</sup>  | State Street Navigator Securities Lending <br> Government Money Market Portfolio, <br> 3.78%<sup>(6)</sup>  | &nbsp;&nbsp;&nbsp; 51205 |
|  | **U.S. Treasury Securities - 13.2%** | **U.S. Treasury Securities - 13.2%** | **U.S. Treasury Securities - 13.2%** |
|  | **U.S. Treasury Bills - 13.2%** | **U.S. Treasury Bills - 13.2%** | **U.S. Treasury Bills - 13.2%** |
| 34650000 | 3.27%, 01/13/2026<sup>(7)</sup>  | 3.27%, 01/13/2026<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 34609676 |
| 30375000 | 3.90%, 02/19/2026<sup>(7)</sup>  | 3.90%, 02/19/2026<sup>(7)</sup>  | &nbsp;&nbsp;&nbsp; 30212665 |
|  |  |  | &nbsp;&nbsp;&nbsp; 64822341 |
|  | Total Short-Term Investments <br>(cost $70,414,289) | Total Short-Term Investments <br>(cost $70,414,289) | &nbsp;&nbsp;&nbsp; $70414289 |
|  | Total Investments <br>(cost $490,101,276)<br>| 99.4<br> %<br>| &nbsp;&nbsp;&nbsp; $490588485 |
|  | Other Assets and Liabilities | 0.6<br> %<br>| &nbsp;&nbsp;&nbsp; 3132699 |
|  | Net Assets | 100.0<br> %<br>| &nbsp;&nbsp;&nbsp; $493721184 |

---

Note:

Percentage of investments as shown is the ratio of the total market value to net assets.

The Fund may refer to any one or more of the industry classifications used by one or more widely recognized market indices, ratings group and/or as defined by Fund management. Industry classifications may not be identical across all security types.

For Fund compliance purposes, the Fund may not use the same classification system. These classifications are used for financial reporting purposes.

See "Glossary" for abbreviation descriptions.

---

| | |
|:---|:---|
| <sup>(1)</sup> <br>| Security was purchased pursuant to Rule 144A under the Securities Act of 1933 <br> and may be sold in transactions that are exempt from registration (typically only to <br> qualified institutional buyers) or in a public offering registered under the Securities <br> Act of 1933. At December 31, 2025, the aggregate value of these securities was <br> $157,163,960, representing 31.8% of net assets.<br>|
| <sup>(2)</sup> <br>| Variable or floating rate securities. Interest rate resets periodically. The rate shown <br> is the effective interest rate as of period end. Security description also includes the <br> reference rate and spread if published and available. Variable rate securities with a <br> floor or ceiling feature are disclosed at the inherent rate, where applicable. Certain <br> variable rate securities are not based on a published reference rate and spread but <br> are determined by the issuer or agent and are based on current market conditions; <br> these securities do not indicate a reference rate and spread in the description. For <br> fixed to variable securities, the rate remains fixed until designated date stated in <br> security description.<br>|
| <sup>(3)</sup> <br>| Security is a "step-up" bond where coupon increases or steps up at a <br> predetermined date. Rate shown is current coupon rate.<br>|
| <sup>(4)</sup> <br>| Represents entire or partial securities on loan. See Note 8 in the accompanying <br> Notes to Financial Statements for securities lending information.<br>|
| <sup>(5)</sup> <br>| This security, or a portion of this security, was purchased on a when-issued, <br> delayed-delivery or delayed-draw basis. The cost of this security was $2,130,000 <br> at December 31, 2025.<br>|
| <sup>(6)</sup> <br>| Current yield as of period end. |
| <sup>(7)</sup> <br>| The rate shown represents current yield to maturity. |
| <sup>†</sup> | See Significant Accounting Policies of accompanying Notes to Financial <br> Statements regarding valuation of investments.<br>|

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

52 <br>

------

**Hartford Ultrashort Bond HLS Fund**

***Schedule of Investments – (continued)***

***December 31, 2025***

------

**Fair Value Summary**

The following is a summary of the fair valuations according to the inputs used as of December 31, 2025 in valuing the Fund's investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Description** | **Total** | **Level 1** | **Level 2** | **Level 3**<sup>(1)</sup> <br>|
| **Assets** |  |  |  |  |
| Asset-Backed & Commercial Mortgage-Backed Securities | &nbsp;&nbsp; $185203966 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $185203966 | &nbsp;&nbsp; $— |
| Corporate Bonds | &nbsp;&nbsp; 125448564 | &nbsp;&nbsp; — | &nbsp;&nbsp; 125448564 | &nbsp;&nbsp; — |
| Municipal Bonds | &nbsp;&nbsp; 4230489 | &nbsp;&nbsp; — | &nbsp;&nbsp; 4230489 | &nbsp;&nbsp; — |
| U.S. Government Agencies | &nbsp;&nbsp; 31714424 | &nbsp;&nbsp; — | &nbsp;&nbsp; 31714424 | &nbsp;&nbsp; — |
| U.S. Government Securities | &nbsp;&nbsp; 73576753 | &nbsp;&nbsp; — | &nbsp;&nbsp; 73576753 | &nbsp;&nbsp; — |
| Short-Term Investments | &nbsp;&nbsp; 70414289 | &nbsp;&nbsp; 51205 | &nbsp;&nbsp; 70363084 | &nbsp;&nbsp; — |
| **Total** | &nbsp;&nbsp; $490588485 | &nbsp;&nbsp; $51205 | &nbsp;&nbsp; $490537280 | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> For the year ended December 31, 2025, there were no transfers in and out of Level 3.

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

53 <br>

------

**Hartford HLS Funds**

***GLOSSARY: (abbreviations used in preceding Schedules of Investments)***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **Counterparty Abbreviations:** | **Counterparty Abbreviations:** |
| DEUT | Deutsche Bank Securities, Inc.  |
| NWM | NatWest Markets Plc  |
| SSG | State Street Global Markets LLC  |
| WFB | Wells Fargo Bank NA  |
| **Currency Abbreviations:** | **Currency Abbreviations:** |
| EUR | Euro Member Countries |
| GBP | British Pound |
| USD | United States Dollar |
| **Index Abbreviations:** | **Index Abbreviations:** |
| CMT | Constant Maturity Treasury Index  |
| ICE | Intercontinental Exchange, Inc.  |
| S&P | Standard & Poor's  |
| **Municipal Abbreviations:** | **Municipal Abbreviations:** |
| Auth | Authority  |
| Dev | Development  |
| GO | General Obligation  |
| Rev | Revenue  |

---

---

| | |
|:---|:---|
| **Other Abbreviations:** | **Other Abbreviations:** |
| ADR | American Depositary Receipt  |
| AG | Assured Guaranty Inc. |
| ASA | Allmennaksjeselskap  |
| BAM | Build America Mutual Assurance Co. |
| CLO | Collateralized Loan Obligation  |
| CMO | Collateralized Mortgage Obligation  |
| CVR | Contingent Value Rights  |
| ETF | Exchange-Traded Fund  |
| EURIBOR | Euro Interbank Offered Rate  |
| NPFG | National Public Finance Guarantee Corp. |
| Nyrt | New York REIT Inc  |
| PT | Perseroan Terbatas  |
| REIT | Real Estate Investment Trust  |
| SOFR | Secured Overnight Financing Rate  |
| ST APPROP | State Appropriation  |
| TBA | To Be Announced  |
| Tbk | Terbuka |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

54 <br>

------

**Hartford HLS Funds**

 ***Statements of Assets and Liabilities***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Hartford** <br>**Balanced** <br>**HLS Fund**<br>| **Hartford** <br>**Capital** <br>**Appreciation** <br>**HLS Fund**<br>| **Hartford** <br>**Disciplined** <br>**Equity** <br>**HLS Fund**<br>| **Hartford** <br>**Dividend and** <br>**Growth** <br>**HLS Fund**<br>| **Hartford** <br>**Healthcare** <br>**HLS Fund**<br>| **Hartford** <br>**International** <br>**Opportunities** <br>**HLS Fund**<br>|
| **Assets:** |  |  |  |  |  |  |
| Investments in securities, at market value<sup>(1)</sup>  | &nbsp;&nbsp; $1615382582 | &nbsp;&nbsp; $3670760080 | &nbsp;&nbsp;&nbsp; $2995971637 | &nbsp;&nbsp; $3444215459 | &nbsp;&nbsp; $113838002 | &nbsp;&nbsp; $833359540 |
| Repurchase agreements | &nbsp;&nbsp; 2361829 | &nbsp;&nbsp; 13874197 | &nbsp;&nbsp;&nbsp; 2184924 | &nbsp;&nbsp; 2050574 | &nbsp;&nbsp; 456747 | &nbsp;&nbsp; 1278570 |
| Cash | &nbsp;&nbsp; 8598173 | &nbsp;&nbsp; 54611529 | &nbsp;&nbsp;&nbsp; 8609269 | &nbsp;&nbsp; 8078887 | &nbsp;&nbsp; 1796438 | &nbsp;&nbsp; 5030618 |
| Cash collateral due from broker on futures <br> contracts<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; 4349649 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Foreign currency | &nbsp;&nbsp; — | &nbsp;&nbsp; 1120039 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 1678454 | &nbsp;&nbsp; 41408 | &nbsp;&nbsp; 362173 |
| Receivables: |  |  |  |  |  |  |
| Investment securities sold  | &nbsp;&nbsp; 6740138 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 2781229 | &nbsp;&nbsp; — | &nbsp;&nbsp; 1516901 |
| Fund shares sold | &nbsp;&nbsp; 79638 | &nbsp;&nbsp; 29899 | &nbsp;&nbsp;&nbsp; 189519 | &nbsp;&nbsp; 313910 | &nbsp;&nbsp; 69075 | &nbsp;&nbsp; 220280 |
| Dividends and interest  | &nbsp;&nbsp; 6250543 | &nbsp;&nbsp; 1936568 | &nbsp;&nbsp;&nbsp; 842137 | &nbsp;&nbsp; 3259276 | &nbsp;&nbsp; 94631 | &nbsp;&nbsp; 725707 |
| Securities lending income | &nbsp;&nbsp; 1427 | &nbsp;&nbsp; 2907 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 10648 | &nbsp;&nbsp; 848 | &nbsp;&nbsp; 5346 |
| Tax reclaims | &nbsp;&nbsp; 884089 | &nbsp;&nbsp; 286202 | &nbsp;&nbsp;&nbsp; 41690 | &nbsp;&nbsp; 1353131 | &nbsp;&nbsp; 40679 | &nbsp;&nbsp; 1713607 |
| Other assets | &nbsp;&nbsp; 10251 | &nbsp;&nbsp; 18483 | &nbsp;&nbsp;&nbsp; 16483 | &nbsp;&nbsp; 16419 | &nbsp;&nbsp; 4740 | &nbsp;&nbsp; 8308 |
| Total assets | &nbsp;&nbsp; 1640308670 | &nbsp;&nbsp; 3746989553 | &nbsp;&nbsp;&nbsp; 3007855659 | &nbsp;&nbsp; 3463757987 | &nbsp;&nbsp; 116342568 | &nbsp;&nbsp; 844221050 |
| **Liabilities:** |  |  |  |  |  |  |
| Obligation to return securities lending collateral | &nbsp;&nbsp; 14729893 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 45234710 | &nbsp;&nbsp; 138450 | &nbsp;&nbsp; 4518237 |
| Payables: |  |  |  |  |  |  |
| Investment securities purchased | &nbsp;&nbsp; 7430213 | &nbsp;&nbsp; 10350217 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 2116777 | &nbsp;&nbsp; 601830 | &nbsp;&nbsp; 305082 |
| Fund shares redeemed | &nbsp;&nbsp; 670444 | &nbsp;&nbsp; 1234992 | &nbsp;&nbsp;&nbsp; 3818156 | &nbsp;&nbsp; 1534380 | &nbsp;&nbsp; 59118 | &nbsp;&nbsp; 660604 |
| Investment management fees | &nbsp;&nbsp; 831998 | &nbsp;&nbsp; 2067245 | &nbsp;&nbsp;&nbsp; 1454207 | &nbsp;&nbsp; 1836238 | &nbsp;&nbsp; 83359 | &nbsp;&nbsp; 507273 |
| Transfer agent fees | &nbsp;&nbsp; 958 | &nbsp;&nbsp; 1486 | &nbsp;&nbsp;&nbsp; 1548 | &nbsp;&nbsp; 1129 | &nbsp;&nbsp; 996 | &nbsp;&nbsp; 1219 |
| Accounting services fees | &nbsp;&nbsp; 42606 | &nbsp;&nbsp; 92280 | &nbsp;&nbsp;&nbsp; 75372 | &nbsp;&nbsp; 83313 | &nbsp;&nbsp; 3635 | &nbsp;&nbsp; 23012 |
| Chief Compliance Officer fees | &nbsp;&nbsp; 888 | &nbsp;&nbsp; 1986 | &nbsp;&nbsp;&nbsp; 1604 | &nbsp;&nbsp; 1793 | &nbsp;&nbsp; 60 | &nbsp;&nbsp; 454 |
| Board of Directors' fees | &nbsp;&nbsp; 6980 | &nbsp;&nbsp; 15901 | &nbsp;&nbsp;&nbsp; 12883 | &nbsp;&nbsp; 14539 | &nbsp;&nbsp; 499 | &nbsp;&nbsp; 3519 |
| Variation margin on futures contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; 505728 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Foreign taxes | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 777971 |
| Distribution fees | &nbsp;&nbsp; 7585 | &nbsp;&nbsp; 16117 | &nbsp;&nbsp;&nbsp; 14697 | &nbsp;&nbsp; 15490 | &nbsp;&nbsp; 994 | &nbsp;&nbsp; 3335 |
| Accrued expenses | &nbsp;&nbsp; 80592 | &nbsp;&nbsp; 105165 | &nbsp;&nbsp;&nbsp; 92330 | &nbsp;&nbsp; 81958 | &nbsp;&nbsp; 33687 | &nbsp;&nbsp; 83145 |
| Total liabilities | &nbsp;&nbsp; 23802157 | &nbsp;&nbsp; 14391117 | &nbsp;&nbsp;&nbsp; 5470797 | &nbsp;&nbsp; 50920327 | &nbsp;&nbsp; 922628 | &nbsp;&nbsp; 6883851 |
| Net assets  | &nbsp;&nbsp; $1616506513 | &nbsp;&nbsp; $3732598436 | &nbsp;&nbsp;&nbsp; $3002384862 | &nbsp;&nbsp; $3412837660 | &nbsp;&nbsp; $115419940 | &nbsp;&nbsp; $837337199 |
| **Summary of Net Assets:** |  |  |  |  |  |  |
| Capital stock and paid-in-capital | &nbsp;&nbsp; $1088921899 | &nbsp;&nbsp; $2250685646 | &nbsp;&nbsp;&nbsp; $1293204629 | &nbsp;&nbsp; $1804123237 | &nbsp;&nbsp; $68409669 | &nbsp;&nbsp; $473241544 |
| Distributable earnings (loss) | &nbsp;&nbsp; 527584614 | &nbsp;&nbsp; 1481912790 | &nbsp;&nbsp;&nbsp; 1709180233 | &nbsp;&nbsp; 1608714423 | &nbsp;&nbsp; 47010271 | &nbsp;&nbsp; 364095655 |
| Net assets | &nbsp;&nbsp; $1616506513 | &nbsp;&nbsp; $3732598436 | &nbsp;&nbsp;&nbsp; $3002384862 | &nbsp;&nbsp; $3412837660 | &nbsp;&nbsp; $115419940 | &nbsp;&nbsp; $837337199 |
| Shares authorized | &nbsp;&nbsp; 9500000000 | &nbsp;&nbsp; 5450000000 | &nbsp;&nbsp;&nbsp; 3610000000 | &nbsp;&nbsp; 4000000000 | &nbsp;&nbsp; 800000000 | &nbsp;&nbsp; 2625000000 |
| Par value | &nbsp;&nbsp; $0.0010 | &nbsp;&nbsp; $0.0010 | &nbsp;&nbsp;&nbsp; $0.0010 | &nbsp;&nbsp; $0.0010 | &nbsp;&nbsp; $0.0010 | &nbsp;&nbsp; $0.0010 |
| **Class IA:**Net asset value per share | &nbsp;&nbsp; $29.28 | &nbsp;&nbsp; $53.23 | &nbsp;&nbsp;&nbsp; $23.19 | &nbsp;&nbsp; $22.87 | &nbsp;&nbsp; $17.85 | &nbsp;&nbsp; $20.57 |
| Shares outstanding | &nbsp;&nbsp; 48962628 | &nbsp;&nbsp; 62844868 | &nbsp;&nbsp;&nbsp; 114234709 | &nbsp;&nbsp; 132916770 | &nbsp;&nbsp; 5121454 | &nbsp;&nbsp; 36783903 |
| Net Assets | &nbsp;&nbsp; $1433637956 | &nbsp;&nbsp; $3345165094 | &nbsp;&nbsp;&nbsp; $2648771047 | &nbsp;&nbsp; $3040122429 | &nbsp;&nbsp; $91397658 | &nbsp;&nbsp; $756466306 |
| **Class IB:**Net asset value per share | &nbsp;&nbsp; $30.15 | &nbsp;&nbsp; $51.58 | &nbsp;&nbsp;&nbsp; $22.70 | &nbsp;&nbsp; $22.59 | &nbsp;&nbsp; $15.53 | &nbsp;&nbsp; $21.01 |
| Shares outstanding | &nbsp;&nbsp; 6065573 | &nbsp;&nbsp; 7217702 | &nbsp;&nbsp;&nbsp; 12804781 | &nbsp;&nbsp; 16502734 | &nbsp;&nbsp; 1547276 | &nbsp;&nbsp; 3849240 |
| Net Assets | &nbsp;&nbsp; $182868557 | &nbsp;&nbsp; $372320685 | &nbsp;&nbsp;&nbsp; $290664631 | &nbsp;&nbsp; $372715231 | &nbsp;&nbsp; $24022282 | &nbsp;&nbsp; $80870893 |
| **Class IC:**Net asset value per share | &nbsp;&nbsp; $— | &nbsp;&nbsp; $52.01 | &nbsp;&nbsp;&nbsp; $23.15 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— |
| Shares outstanding | &nbsp;&nbsp; — | &nbsp;&nbsp; 290600 | &nbsp;&nbsp;&nbsp; 2719310 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Net Assets | &nbsp;&nbsp; $— | &nbsp;&nbsp; $15112657 | &nbsp;&nbsp;&nbsp; $62949184 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— |
| Cost of investments | &nbsp;&nbsp; $1211317760 | &nbsp;&nbsp; $2429145296 | &nbsp;&nbsp;&nbsp; $1633530102 | &nbsp;&nbsp; $2367480946 | &nbsp;&nbsp; $72654262 | &nbsp;&nbsp; $573942959 |
| Cost of foreign currency | &nbsp;&nbsp; $— | &nbsp;&nbsp; $1122231 | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp; $1680597 | &nbsp;&nbsp; $44924 | &nbsp;&nbsp; $362060 |
| <sup>(1)</sup> Includes Investment in securities on loan, at <br> market value<br>| &nbsp;&nbsp; $14378343 | &nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp; $44270046 | &nbsp;&nbsp; $232913 | &nbsp;&nbsp; $11251631 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

55 <br>

------

**Hartford HLS Funds**

 ***Statements of Assets and Liabilities – (continued)***

***December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Hartford** <br>**MidCap** <br>**HLS Fund**<br>| **Hartford** <br>**Small Cap** <br>**Growth** <br>**HLS Fund**<br>| **Hartford** <br>**Small** <br>**Company** <br>**HLS Fund**<br>| **Hartford** <br>**Stock** <br>**HLS Fund**<br>| **Hartford** <br>**Total Return** <br>**Bond** <br>**HLS Fund**<br>| **Hartford** <br>**Ultrashort** <br>**Bond** <br>**HLS Fund**<br>|
| **Assets:** |  |  |  |  |  |  |
| Investments in securities, at market value<sup>(1)</sup>  | &nbsp;&nbsp; $717602782 | &nbsp;&nbsp; $558054582 | &nbsp;&nbsp;&nbsp; $432553604 | &nbsp;&nbsp; $1202749779 | &nbsp;&nbsp; $1543895579 | &nbsp;&nbsp; $485047742 |
| Repurchase agreements | &nbsp;&nbsp; 2638060 | &nbsp;&nbsp; 346267 | &nbsp;&nbsp;&nbsp; 575386 | &nbsp;&nbsp; 3506432 | &nbsp;&nbsp; 6153351 | &nbsp;&nbsp; 5540743 |
| Cash | &nbsp;&nbsp; 10384326 | &nbsp;&nbsp; 1366616 | &nbsp;&nbsp;&nbsp; 2269566 | &nbsp;&nbsp; 13813043 | &nbsp;&nbsp; 28288285 | &nbsp;&nbsp; 21788495 |
| Foreign currency | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 4957696 | &nbsp;&nbsp; — |
| Unrealized appreciation on foreign currency <br> contracts<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1378 | &nbsp;&nbsp; — |
| Receivables: |  |  |  |  |  |  |
| Investment securities sold  | &nbsp;&nbsp; 843925 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 116526277 | &nbsp;&nbsp; — |
| Fund shares sold | &nbsp;&nbsp; 83216 | &nbsp;&nbsp; 79974 | &nbsp;&nbsp;&nbsp; 36554 | &nbsp;&nbsp; 8120 | &nbsp;&nbsp; 84748 | &nbsp;&nbsp; 141976 |
| Dividends and interest  | &nbsp;&nbsp; 82761 | &nbsp;&nbsp; 147099 | &nbsp;&nbsp;&nbsp; 175845 | &nbsp;&nbsp; 948199 | &nbsp;&nbsp; 11137041 | &nbsp;&nbsp; 3061004 |
| Securities lending income | &nbsp;&nbsp; 508 | &nbsp;&nbsp; 5512 | &nbsp;&nbsp;&nbsp; 3019 | &nbsp;&nbsp; — | &nbsp;&nbsp; 5003 | &nbsp;&nbsp; 14 |
| Variation margin on centrally cleared swap <br> contracts<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 191036 | &nbsp;&nbsp; — |
| Tax reclaims | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 65543 | &nbsp;&nbsp; 78838 | &nbsp;&nbsp; — |
| Other assets | &nbsp;&nbsp; 7268 | &nbsp;&nbsp; 5195 | &nbsp;&nbsp;&nbsp; 6282 | &nbsp;&nbsp; 8766 | &nbsp;&nbsp; 9691 | &nbsp;&nbsp; 6333 |
| Total assets | &nbsp;&nbsp; 731642846 | &nbsp;&nbsp; 560005245 | &nbsp;&nbsp;&nbsp; 435620256 | &nbsp;&nbsp; 1221099882 | &nbsp;&nbsp; 1711328923 | &nbsp;&nbsp; 515586307 |
| **Liabilities:** |  |  |  |  |  |  |
| Unrealized depreciation on foreign currency <br> contracts<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 48665 | &nbsp;&nbsp; — |
| Obligation to return securities lending collateral | &nbsp;&nbsp; 10674516 | &nbsp;&nbsp; 12073029 | &nbsp;&nbsp;&nbsp; 8891073 | &nbsp;&nbsp; — | &nbsp;&nbsp; 11013625 | &nbsp;&nbsp; 51205 |
| TBA sale commitments, at market value | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 86616218 | &nbsp;&nbsp; — |
| Payables: |  |  |  |  |  |  |
| Investment securities purchased | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 907141 | &nbsp;&nbsp; 225427104 | &nbsp;&nbsp; 21059772 |
| Fund shares redeemed | &nbsp;&nbsp; 353681 | &nbsp;&nbsp; 1061785 | &nbsp;&nbsp;&nbsp; 209817 | &nbsp;&nbsp; 8011832 | &nbsp;&nbsp; 883328 | &nbsp;&nbsp; 498520 |
| Investment management fees | &nbsp;&nbsp; 453593 | &nbsp;&nbsp; 293482 | &nbsp;&nbsp;&nbsp; 278437 | &nbsp;&nbsp; 506592 | &nbsp;&nbsp; 568046 | &nbsp;&nbsp; 168277 |
| Transfer agent fees | &nbsp;&nbsp; 1115 | &nbsp;&nbsp; 1183 | &nbsp;&nbsp;&nbsp; 995 | &nbsp;&nbsp; 951 | &nbsp;&nbsp; 1043 | &nbsp;&nbsp; 979 |
| Accounting services fees | &nbsp;&nbsp; 21668 | &nbsp;&nbsp; 16516 | &nbsp;&nbsp;&nbsp; 13225 | &nbsp;&nbsp; 32406 | &nbsp;&nbsp; 37974 | &nbsp;&nbsp; 15813 |
| Chief Compliance Officer fees | &nbsp;&nbsp; 430 | &nbsp;&nbsp; 290 | &nbsp;&nbsp;&nbsp; 222 | &nbsp;&nbsp; 678 | &nbsp;&nbsp; 832 | &nbsp;&nbsp; 283 |
| Board of Directors' fees | &nbsp;&nbsp; 3217 | &nbsp;&nbsp; 2351 | &nbsp;&nbsp;&nbsp; 1790 | &nbsp;&nbsp; 5323 | &nbsp;&nbsp; 6212 | &nbsp;&nbsp; 2205 |
| Variation margin on futures contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 210127 | &nbsp;&nbsp; — |
| Distribution fees | &nbsp;&nbsp; 2817 | &nbsp;&nbsp; 8752 | &nbsp;&nbsp;&nbsp; 1559 | &nbsp;&nbsp; 4088 | &nbsp;&nbsp; 5892 | &nbsp;&nbsp; 2652 |
| Accrued expenses | &nbsp;&nbsp; 54199 | &nbsp;&nbsp; 47810 | &nbsp;&nbsp;&nbsp; 48046 | &nbsp;&nbsp; 58813 | &nbsp;&nbsp; 92874 | &nbsp;&nbsp; 65417 |
| Total liabilities | &nbsp;&nbsp; 11565236 | &nbsp;&nbsp; 13505198 | &nbsp;&nbsp;&nbsp; 9445164 | &nbsp;&nbsp; 9527824 | &nbsp;&nbsp; 324911940 | &nbsp;&nbsp; 21865123 |
| Net assets  | &nbsp;&nbsp; $720077610 | &nbsp;&nbsp; $546500047 | &nbsp;&nbsp;&nbsp; $426175092 | &nbsp;&nbsp; $1211572058 | &nbsp;&nbsp; $1386416983 | &nbsp;&nbsp; $493721184 |
| **Summary of Net Assets:** |  |  |  |  |  |  |
| Capital stock and paid-in-capital | &nbsp;&nbsp; $545838857 | &nbsp;&nbsp; $391041493 | &nbsp;&nbsp;&nbsp; $356414432 | &nbsp;&nbsp; $572563382 | &nbsp;&nbsp; $1654496676 | &nbsp;&nbsp; $484419979 |
| Distributable earnings (loss) | &nbsp;&nbsp; 174238753 | &nbsp;&nbsp; 155458554 | &nbsp;&nbsp;&nbsp; 69760660 | &nbsp;&nbsp; 639008676 | &nbsp;&nbsp; (268079693)<br>| &nbsp;&nbsp; 9301205 |
| Net assets | &nbsp;&nbsp; $720077610 | &nbsp;&nbsp; $546500047 | &nbsp;&nbsp;&nbsp; $426175092 | &nbsp;&nbsp; $1211572058 | &nbsp;&nbsp; $1386416983 | &nbsp;&nbsp; $493721184 |
| Shares authorized | &nbsp;&nbsp; 2400000000 | &nbsp;&nbsp; 700000000 | &nbsp;&nbsp;&nbsp; 1500000000 | &nbsp;&nbsp; 4000000000 | &nbsp;&nbsp; 5000000000 | &nbsp;&nbsp; 14000000000 |
| Par value | &nbsp;&nbsp; $0.0010 | &nbsp;&nbsp; $0.0010 | &nbsp;&nbsp;&nbsp; $0.0010 | &nbsp;&nbsp; $0.0010 | &nbsp;&nbsp; $0.0010 | &nbsp;&nbsp; $0.0010 |
| **Class IA:**Net asset value per share | &nbsp;&nbsp; $23.20 | &nbsp;&nbsp; $24.58 | &nbsp;&nbsp;&nbsp; $19.94 | &nbsp;&nbsp; $93.33 | &nbsp;&nbsp; $9.59 | &nbsp;&nbsp; $10.33 |
| Shares outstanding | &nbsp;&nbsp; 28141356 | &nbsp;&nbsp; 13772934 | &nbsp;&nbsp;&nbsp; 19508861 | &nbsp;&nbsp; 11926341 | &nbsp;&nbsp; 129713454 | &nbsp;&nbsp; 41590397 |
| Net Assets | &nbsp;&nbsp; $652761055 | &nbsp;&nbsp; $338495186 | &nbsp;&nbsp;&nbsp; $388919078 | &nbsp;&nbsp; $1113127785 | &nbsp;&nbsp; $1243513070 | &nbsp;&nbsp; $429581422 |
| **Class IB:**Net asset value per share | &nbsp;&nbsp; $21.25 | &nbsp;&nbsp; $22.54 | &nbsp;&nbsp;&nbsp; $16.42 | &nbsp;&nbsp; $93.22 | &nbsp;&nbsp; $9.54 | &nbsp;&nbsp; $10.33 |
| Shares outstanding | &nbsp;&nbsp; 3167581 | &nbsp;&nbsp; 9226602 | &nbsp;&nbsp;&nbsp; 2268383 | &nbsp;&nbsp; 1056010 | &nbsp;&nbsp; 14983503 | &nbsp;&nbsp; 6212065 |
| Net Assets | &nbsp;&nbsp; $67316555 | &nbsp;&nbsp; $208004861 | &nbsp;&nbsp;&nbsp; $37256014 | &nbsp;&nbsp; $98444273 | &nbsp;&nbsp; $142903913 | &nbsp;&nbsp; $64139762 |
| Cost of investments | &nbsp;&nbsp; $592829034 | &nbsp;&nbsp; $429340482 | &nbsp;&nbsp;&nbsp; $315962967 | &nbsp;&nbsp; $721408789 | &nbsp;&nbsp; $1639225750 | &nbsp;&nbsp; $490101276 |
| Cost of foreign currency | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $4956140 | &nbsp;&nbsp; $— |
| Proceeds of TBA sale commitments | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $86503592 | &nbsp;&nbsp; $— |
| <sup>(1)</sup> Includes Investment in securities on loan, at market <br> value<br>| &nbsp;&nbsp; $10449385 | &nbsp;&nbsp; $14783873 | &nbsp;&nbsp;&nbsp; $9596054 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $10614000 | &nbsp;&nbsp; $49007 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

56 <br>

------

**Hartford HLS Funds**

 ***Statements of Operations***

***For the Year Ended December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Hartford** <br>**Balanced** <br>**HLS Fund**<br>| **Hartford** <br>**Capital** <br>**Appreciation** <br>**HLS Fund**<br>| **Hartford** <br>**Disciplined** <br>**Equity** <br>**HLS Fund**<br>| **Hartford** <br>**Dividend and** <br>**Growth** <br>**HLS Fund**<br>| **Hartford** <br>**Healthcare** <br>**HLS Fund**<br>| **Hartford** <br>**International** <br>**Opportunities** <br>**HLS Fund**<br>|
| **Investment Income:** |  |  |  |  |  |  |
| Dividends | &nbsp;&nbsp; $16063511 | &nbsp;&nbsp; $45246529 | &nbsp;&nbsp;&nbsp; $29810810 | &nbsp;&nbsp; $71598768 | &nbsp;&nbsp; $1174853 | &nbsp;&nbsp; $22069296 |
| Interest | &nbsp;&nbsp; 25673295 | &nbsp;&nbsp; 3051154 | &nbsp;&nbsp;&nbsp; 420194 | &nbsp;&nbsp; 1249880 | &nbsp;&nbsp; 53346 | &nbsp;&nbsp; 580828 |
| Securities lending — net | &nbsp;&nbsp; 10431 | &nbsp;&nbsp; 14725 | &nbsp;&nbsp;&nbsp; 55 | &nbsp;&nbsp; 250995 | &nbsp;&nbsp; 7867 | &nbsp;&nbsp; 33725 |
| Less: Foreign tax withheld | &nbsp;&nbsp; (160502)<br>| &nbsp;&nbsp; (373982)<br>| &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (753798)<br>| &nbsp;&nbsp; (7687)<br>| &nbsp;&nbsp; (1855373)<br>|
| Total investment income, net | &nbsp;&nbsp; 41586735 | &nbsp;&nbsp; 47938426 | &nbsp;&nbsp;&nbsp; 30231059 | &nbsp;&nbsp; 72345845 | &nbsp;&nbsp; 1228379 | &nbsp;&nbsp; 20828476 |
| **Expenses:** |  |  |  |  |  |  |
| Investment management fees | &nbsp;&nbsp; 10233464 | &nbsp;&nbsp; 23494078 | &nbsp;&nbsp;&nbsp; 16613665 | &nbsp;&nbsp; 20696010 | &nbsp;&nbsp; 933096 | &nbsp;&nbsp; 5954790 |
| Administrative services fees |  |  |  |  |  |  |
| Class IC | &nbsp;&nbsp; — | &nbsp;&nbsp; 39013 | &nbsp;&nbsp;&nbsp; 158580 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Transfer agent fees |  |  |  |  |  |  |
| Class IA | &nbsp;&nbsp; 5103 | &nbsp;&nbsp; 7937 | &nbsp;&nbsp;&nbsp; 8128 | &nbsp;&nbsp; 6046 | &nbsp;&nbsp; 4695 | &nbsp;&nbsp; 6479 |
| Class IB | &nbsp;&nbsp; 655 | &nbsp;&nbsp; 896 | &nbsp;&nbsp;&nbsp; 915 | &nbsp;&nbsp; 752 | &nbsp;&nbsp; 1249 | &nbsp;&nbsp; 680 |
| Class IC | &nbsp;&nbsp; — | &nbsp;&nbsp; 38 | &nbsp;&nbsp;&nbsp; 200 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Distribution fees |  |  |  |  |  |  |
| Class IB | &nbsp;&nbsp; 459586 | &nbsp;&nbsp; 915949 | &nbsp;&nbsp;&nbsp; 725461 | &nbsp;&nbsp; 906528 | &nbsp;&nbsp; 57667 | &nbsp;&nbsp; 196435 |
| Class IC | &nbsp;&nbsp; — | &nbsp;&nbsp; 39013 | &nbsp;&nbsp;&nbsp; 158580 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Custodian fees | &nbsp;&nbsp; 10156 | &nbsp;&nbsp; 35175 | &nbsp;&nbsp;&nbsp; 11892 | &nbsp;&nbsp; 30942 | &nbsp;&nbsp; 5056 | &nbsp;&nbsp; 34920 |
| Registration and filing fees | &nbsp;&nbsp; 12539 | &nbsp;&nbsp; 18572 | &nbsp;&nbsp;&nbsp; 18441 | &nbsp;&nbsp; 12921 | &nbsp;&nbsp; 12534 | &nbsp;&nbsp; 13264 |
| Accounting services fees | &nbsp;&nbsp; 256571 | &nbsp;&nbsp; 545678 | &nbsp;&nbsp;&nbsp; 444914 | &nbsp;&nbsp; 492421 | &nbsp;&nbsp; 21803 | &nbsp;&nbsp; 138926 |
| Board of Directors' fees | &nbsp;&nbsp; 38324 | &nbsp;&nbsp; 86431 | &nbsp;&nbsp;&nbsp; 69932 | &nbsp;&nbsp; 77981 | &nbsp;&nbsp; 2593 | &nbsp;&nbsp; 19494 |
| Chief Compliance Officer fees | &nbsp;&nbsp; 3279 | &nbsp;&nbsp; 7444 | &nbsp;&nbsp;&nbsp; 6044 | &nbsp;&nbsp; 6622 | &nbsp;&nbsp; 212 | &nbsp;&nbsp; 1660 |
| Audit and tax fees | &nbsp;&nbsp; 39410 | &nbsp;&nbsp; 32665 | &nbsp;&nbsp;&nbsp; 33868 | &nbsp;&nbsp; 27182 | &nbsp;&nbsp; 25747 | &nbsp;&nbsp; 33671 |
| Other expenses | &nbsp;&nbsp; 133677 | &nbsp;&nbsp; 216163 | &nbsp;&nbsp;&nbsp; 178361 | &nbsp;&nbsp; 199906 | &nbsp;&nbsp; 25739 | &nbsp;&nbsp; 104549 |
| Total expenses (before waivers and fees paid indirectly) | &nbsp;&nbsp; 11192764 | &nbsp;&nbsp; 25439052 | &nbsp;&nbsp;&nbsp; 18428981 | &nbsp;&nbsp; 22457311 | &nbsp;&nbsp; 1090391 | &nbsp;&nbsp; 6504868 |
| Management fee waivers | &nbsp;&nbsp; (485091)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Commission recapture | &nbsp;&nbsp; (11540)<br>| &nbsp;&nbsp; (15509)<br>| &nbsp;&nbsp;&nbsp; (8421)<br>| &nbsp;&nbsp; (47793)<br>| &nbsp;&nbsp; (478)<br>| &nbsp;&nbsp; (746)<br>|
| Total waivers and fees paid indirectly | &nbsp;&nbsp; (496631)<br>| &nbsp;&nbsp; (15509)<br>| &nbsp;&nbsp;&nbsp; (8421)<br>| &nbsp;&nbsp; (47793)<br>| &nbsp;&nbsp; (478)<br>| &nbsp;&nbsp; (746)<br>|
| Total expenses | &nbsp;&nbsp; 10696133 | &nbsp;&nbsp; 25423543 | &nbsp;&nbsp;&nbsp; 18420560 | &nbsp;&nbsp; 22409518 | &nbsp;&nbsp; 1089913 | &nbsp;&nbsp; 6504122 |
| **Net Investment Income (Loss)** | &nbsp;&nbsp; 30890602 | &nbsp;&nbsp; 22514883 | &nbsp;&nbsp;&nbsp; 11810499 | &nbsp;&nbsp; 49936327 | &nbsp;&nbsp; 138466 | &nbsp;&nbsp; 14324354 |
| **Net Realized Gain (Loss) on Investments, Other Financial** <br> **Instruments and Foreign Currency Transactions on:**<br>|  |  |  |  |  |  |
| Investments | &nbsp;&nbsp; 137495444 | &nbsp;&nbsp; 298075905 | &nbsp;&nbsp;&nbsp; 351730835 | &nbsp;&nbsp; 589450846 | &nbsp;&nbsp; 6608060 | &nbsp;&nbsp; 93317571 |
| Less: Foreign taxes paid on realized capital gains | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (399765)<br>|
| Futures contracts | &nbsp;&nbsp; 128154 | &nbsp;&nbsp; 6621584 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Other foreign currency transactions | &nbsp;&nbsp; (12184)<br>| &nbsp;&nbsp; 123160 | &nbsp;&nbsp;&nbsp; 7 | &nbsp;&nbsp; 155074 | &nbsp;&nbsp; 3349 | &nbsp;&nbsp; 202170 |
| **Net Realized Gain (Loss) on Investments, Other Financial** <br> **Instruments and Foreign Currency Transactions**<br>| &nbsp;&nbsp; 137611414 | &nbsp;&nbsp; 304820649 | &nbsp;&nbsp;&nbsp; 351730842 | &nbsp;&nbsp; 589605920 | &nbsp;&nbsp; 6611409 | &nbsp;&nbsp; 93119976 |
| **Net Changes in Unrealized Appreciation (Depreciation) of** <br> **Investments, Other Financial Instruments and Foreign** <br> **Currency Transactions of:**<br>|  |  |  |  |  |  |
| Investments\* | &nbsp;&nbsp; 16143101 | &nbsp;&nbsp; 138547575 | &nbsp;&nbsp;&nbsp; 30394962 | &nbsp;&nbsp; (109021512)<br>| &nbsp;&nbsp; 9473689 | &nbsp;&nbsp; 110654709 |
| Futures contracts | &nbsp;&nbsp; (22182)<br>| &nbsp;&nbsp; 1578131 | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Translation of other assets and liabilities in foreign <br> currencies<br>| &nbsp;&nbsp; 110530 | &nbsp;&nbsp; 65675 | &nbsp;&nbsp;&nbsp; 2768 | &nbsp;&nbsp; 27136 | &nbsp;&nbsp; 9876 | &nbsp;&nbsp; 209717 |
| **Net Changes in Unrealized Appreciation (Depreciation) of** <br> **Investments, Other Financial Instruments and Foreign** <br> **Currency Transactions**<br>| &nbsp;&nbsp; 16231449 | &nbsp;&nbsp; 140191381 | &nbsp;&nbsp;&nbsp; 30397730 | &nbsp;&nbsp; (108994376)<br>| &nbsp;&nbsp; 9483565 | &nbsp;&nbsp; 110864426 |
| **Net Gain (Loss) on Investments, Other Financial** <br> **Instruments and Foreign Currency Transactions**<br>| &nbsp;&nbsp; 153842863 | &nbsp;&nbsp; 445012030 | &nbsp;&nbsp;&nbsp; 382128572 | &nbsp;&nbsp; 480611544 | &nbsp;&nbsp; 16094974 | &nbsp;&nbsp; 203984402 |
| **Net Increase (Decrease) in Net Assets Resulting from** <br> **Operations**<br>| &nbsp;&nbsp; $184733465 | &nbsp;&nbsp; $467526913 | &nbsp;&nbsp;&nbsp; $393939071 | &nbsp;&nbsp; $530547871 | &nbsp;&nbsp; $16233440 | &nbsp;&nbsp; $218308756 |
| \* Includes change in unrealized appreciation (depreciation) <br> on deferred capital gains tax<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $230820 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

57 <br>

------

**Hartford HLS Funds**

 ***Statements of Operations – (continued)***

***For the Year Ended December 31, 2025***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Hartford** <br>**MidCap** <br>**HLS Fund**<br>| **Hartford** <br>**Small Cap** <br>**Growth** <br>**HLS Fund**<br>| **Hartford** <br>**Small** <br>**Company** <br>**HLS Fund**<br>| **Hartford** <br>**Stock** <br>**HLS Fund**<br>| **Hartford** <br>**Total Return** <br>**Bond** <br>**HLS Fund**<br>| **Hartford** <br>**Ultrashort** <br>**Bond** <br>**HLS Fund**<br>|
| **Investment Income:** |  |  |  |  |  |  |
| Dividends | &nbsp;&nbsp; $4031263 | &nbsp;&nbsp; $2352636 | &nbsp;&nbsp;&nbsp; $2101081 | &nbsp;&nbsp; $20005099 | &nbsp;&nbsp; $62680 | &nbsp;&nbsp; $— |
| Interest | &nbsp;&nbsp; 258428 | &nbsp;&nbsp; 138976 | &nbsp;&nbsp;&nbsp; 187268 | &nbsp;&nbsp; 1141571 | &nbsp;&nbsp; 68517188 | &nbsp;&nbsp; 23497679 |
| Securities lending — net | &nbsp;&nbsp; 253535 | &nbsp;&nbsp; 43235 | &nbsp;&nbsp;&nbsp; 14578 | &nbsp;&nbsp; 3075 | &nbsp;&nbsp; 24015 | &nbsp;&nbsp; 1821 |
| Less: Foreign tax withheld | &nbsp;&nbsp; (1116)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; (139596)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Total investment income, net | &nbsp;&nbsp; 4542110 | &nbsp;&nbsp; 2534847 | &nbsp;&nbsp;&nbsp; 2302927 | &nbsp;&nbsp; 21010149 | &nbsp;&nbsp; 68603883 | &nbsp;&nbsp; 23499500 |
| **Expenses:** |  |  |  |  |  |  |
| Investment management fees | &nbsp;&nbsp; 5625560 | &nbsp;&nbsp; 3280570 | &nbsp;&nbsp;&nbsp; 3072466 | &nbsp;&nbsp; 5988917 | &nbsp;&nbsp; 7190272 | &nbsp;&nbsp; 2051409 |
| Transfer agent fees |  |  |  |  |  |  |
| Class IA | &nbsp;&nbsp; 5837 | &nbsp;&nbsp; 4319 | &nbsp;&nbsp;&nbsp; 5448 | &nbsp;&nbsp; 5255 | &nbsp;&nbsp; 5614 | &nbsp;&nbsp; 5089 |
| Class IB | &nbsp;&nbsp; 609 | &nbsp;&nbsp; 2566 | &nbsp;&nbsp;&nbsp; 533 | &nbsp;&nbsp; 463 | &nbsp;&nbsp; 610 | &nbsp;&nbsp; 754 |
| Distribution fees |  |  |  |  |  |  |
| Class IB | &nbsp;&nbsp; 183807 | &nbsp;&nbsp; 493939 | &nbsp;&nbsp;&nbsp; 90539 | &nbsp;&nbsp; 249655 | &nbsp;&nbsp; 367826 | &nbsp;&nbsp; 165375 |
| Custodian fees | &nbsp;&nbsp; 4493 | &nbsp;&nbsp; 14353 | &nbsp;&nbsp;&nbsp; 11821 | &nbsp;&nbsp; 6099 | &nbsp;&nbsp; 23559 | &nbsp;&nbsp; 3645 |
| Registration and filing fees | &nbsp;&nbsp; 12688 | &nbsp;&nbsp; 14993 | &nbsp;&nbsp;&nbsp; 12941 | &nbsp;&nbsp; 12539 | &nbsp;&nbsp; 13940 | &nbsp;&nbsp; 12525 |
| Accounting services fees | &nbsp;&nbsp; 133889 | &nbsp;&nbsp; 95915 | &nbsp;&nbsp;&nbsp; 78478 | &nbsp;&nbsp; 197474 | &nbsp;&nbsp; 243412 | &nbsp;&nbsp; 96915 |
| Board of Directors' fees | &nbsp;&nbsp; 18419 | &nbsp;&nbsp; 12299 | &nbsp;&nbsp;&nbsp; 9603 | &nbsp;&nbsp; 29145 | &nbsp;&nbsp; 34776 | &nbsp;&nbsp; 12119 |
| Chief Compliance Officer fees | &nbsp;&nbsp; 1623 | &nbsp;&nbsp; 974 | &nbsp;&nbsp;&nbsp; 833 | &nbsp;&nbsp; 2469 | &nbsp;&nbsp; 2887 | &nbsp;&nbsp; 1023 |
| Audit and tax fees | &nbsp;&nbsp; 32077 | &nbsp;&nbsp; 32547 | &nbsp;&nbsp;&nbsp; 31700 | &nbsp;&nbsp; 32069 | &nbsp;&nbsp; 41734 | &nbsp;&nbsp; 45133 |
| Other expenses | &nbsp;&nbsp; 79335 | &nbsp;&nbsp; 54838 | &nbsp;&nbsp;&nbsp; 52024 | &nbsp;&nbsp; 105725 | &nbsp;&nbsp; 143640 | &nbsp;&nbsp; 68730 |
| Total expenses (before waivers and fees paid indirectly) | &nbsp;&nbsp; 6098337 | &nbsp;&nbsp; 4007313 | &nbsp;&nbsp;&nbsp; 3366386 | &nbsp;&nbsp; 6629810 | &nbsp;&nbsp; 8068270 | &nbsp;&nbsp; 2462717 |
| Commission recapture | &nbsp;&nbsp; (5495)<br>| &nbsp;&nbsp; (11523)<br>| &nbsp;&nbsp;&nbsp; (5284)<br>| &nbsp;&nbsp; (4218)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Total waivers and fees paid indirectly | &nbsp;&nbsp; (5495)<br>| &nbsp;&nbsp; (11523)<br>| &nbsp;&nbsp;&nbsp; (5284)<br>| &nbsp;&nbsp; (4218)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Total expenses | &nbsp;&nbsp; 6092842 | &nbsp;&nbsp; 3995790 | &nbsp;&nbsp;&nbsp; 3361102 | &nbsp;&nbsp; 6625592 | &nbsp;&nbsp; 8068270 | &nbsp;&nbsp; 2462717 |
| **Net Investment Income (Loss)** | &nbsp;&nbsp; (1550732)<br>| &nbsp;&nbsp; (1460943)<br>| &nbsp;&nbsp;&nbsp; (1058175)<br>| &nbsp;&nbsp; 14384557 | &nbsp;&nbsp; 60535613 | &nbsp;&nbsp; 21036783 |
| **Net Realized Gain (Loss) on Investments, Other Financial** <br> **Instruments and Foreign Currency Transactions on:**<br>|  |  |  |  |  |  |
| Investments | &nbsp;&nbsp; 64352408 | &nbsp;&nbsp; 40394118 | &nbsp;&nbsp;&nbsp; 22732422 | &nbsp;&nbsp; 161552434 | &nbsp;&nbsp; (32132968)<br>| &nbsp;&nbsp; 116777 |
| Purchased options contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (47999)<br>| &nbsp;&nbsp; — |
| Futures contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (3893486)<br>| &nbsp;&nbsp; — |
| Swap contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1436408 | &nbsp;&nbsp; — |
| Foreign currency contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (2381881)<br>| &nbsp;&nbsp; — |
| Other foreign currency transactions | &nbsp;&nbsp; 1367 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 1092 | &nbsp;&nbsp; 15635 | &nbsp;&nbsp; 526897 | &nbsp;&nbsp; — |
| **Net Realized Gain (Loss) on Investments, Other Financial** <br> **Instruments and Foreign Currency Transactions**<br>| &nbsp;&nbsp; 64353775 | &nbsp;&nbsp; 40394118 | &nbsp;&nbsp;&nbsp; 22733514 | &nbsp;&nbsp; 161568069 | &nbsp;&nbsp; (36493029)<br>| &nbsp;&nbsp; 116777 |
| **Net Changes in Unrealized Appreciation (Depreciation) of** <br> **Investments, Other Financial Instruments and Foreign** <br> **Currency Transactions of:**<br>|  |  |  |  |  |  |
| Investments | &nbsp;&nbsp; (65423494)<br>| &nbsp;&nbsp; (3077242)<br>| &nbsp;&nbsp;&nbsp; 28270965 | &nbsp;&nbsp; (82324290)<br>| &nbsp;&nbsp; 81683282 | &nbsp;&nbsp; 1308012 |
| Futures contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 718591 | &nbsp;&nbsp; — |
| Swap contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (1057540)<br>| &nbsp;&nbsp; — |
| Foreign currency contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (686004)<br>| &nbsp;&nbsp; — |
| Translation of other assets and liabilities in foreign currencies | &nbsp;&nbsp; 9 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; 1767 | &nbsp;&nbsp; 109118 | &nbsp;&nbsp; — |
| **Net Changes in Unrealized Appreciation (Depreciation) of** <br> **Investments, Other Financial Instruments and Foreign** <br> **Currency Transactions**<br>| &nbsp;&nbsp; (65423485)<br>| &nbsp;&nbsp; (3077242)<br>| &nbsp;&nbsp;&nbsp; 28270965 | &nbsp;&nbsp; (82322523)<br>| &nbsp;&nbsp; 80767447 | &nbsp;&nbsp; 1308012 |
| **Net Gain (Loss) on Investments, Other Financial Instruments** <br> **and Foreign Currency Transactions**<br>| &nbsp;&nbsp; (1069710)<br>| &nbsp;&nbsp; 37316876 | &nbsp;&nbsp;&nbsp; 51004479 | &nbsp;&nbsp; 79245546 | &nbsp;&nbsp; 44274418 | &nbsp;&nbsp; 1424789 |
| **Net Increase (Decrease) in Net Assets Resulting from** <br> **Operations**<br>| &nbsp;&nbsp; $(2620442)<br>| &nbsp;&nbsp; $35855933 | &nbsp;&nbsp;&nbsp; $49946304 | &nbsp;&nbsp; $93630103 | &nbsp;&nbsp; $104810031 | &nbsp;&nbsp; $22461572 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

58 <br>

------

**Hartford HLS Funds**

 ***Statements of Changes in Net Assets*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Hartford Balanced** <br>**HLS Fund** | **Hartford Balanced** <br>**HLS Fund** | **Hartford Capital** <br>**Appreciation HLS Fund** | **Hartford Capital** <br>**Appreciation HLS Fund** |
|  | **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>|
| **Operations:** |  |  |  |  |
| Net investment income (loss) | &nbsp;&nbsp; $30890602 | &nbsp;&nbsp; $33111439 | &nbsp;&nbsp; $22514883 | &nbsp;&nbsp; $27932265 |
| Net realized gain (loss) on investments, other financial instruments and foreign currency <br> transactions<br>| &nbsp;&nbsp; 137611414 | &nbsp;&nbsp; 151270198 | &nbsp;&nbsp; 304820649 | &nbsp;&nbsp; 496823584 |
| Net changes in unrealized appreciation (depreciation) of investments, other financial <br> instruments and foreign currency transactions<br>| &nbsp;&nbsp; 16231449 | &nbsp;&nbsp; (3876711)<br>| &nbsp;&nbsp; 140191381 | &nbsp;&nbsp; 188228404 |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | &nbsp;&nbsp; 184733465 | &nbsp;&nbsp; 180504926 | &nbsp;&nbsp; 467526913 | &nbsp;&nbsp; 712984253 |
| **Distributions to Shareholders:** |  |  |  |  |
| Class IA | &nbsp;&nbsp; (161236557)<br>| &nbsp;&nbsp; (127661244)<br>| &nbsp;&nbsp; (403275869)<br>| &nbsp;&nbsp; (161203349)<br>|
| Class IB | &nbsp;&nbsp; (19705360)<br>| &nbsp;&nbsp; (15623886)<br>| &nbsp;&nbsp; (45619734)<br>| &nbsp;&nbsp; (17979552)<br>|
| Class IC | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (1905331)<br>| &nbsp;&nbsp; (712861)<br>|
| Total distributions | &nbsp;&nbsp; (180941917)<br>| &nbsp;&nbsp; (143285130)<br>| &nbsp;&nbsp; (450800934)<br>| &nbsp;&nbsp; (179895762)<br>|
| **Capital Share Transactions:** |  |  |  |  |
| Sold | &nbsp;&nbsp; 13789232 | &nbsp;&nbsp; 14814673 | &nbsp;&nbsp; 28874358 | &nbsp;&nbsp; 21089857 |
| Issued on reinvestment of distributions | &nbsp;&nbsp; 180941917 | &nbsp;&nbsp; 143285130 | &nbsp;&nbsp; 450800934 | &nbsp;&nbsp; 179895762 |
| Redeemed | &nbsp;&nbsp; (230636297)<br>| &nbsp;&nbsp; (247285686)<br>| &nbsp;&nbsp; (523718580)<br>| &nbsp;&nbsp; (553739635)<br>|
| Net increase (decrease) from capital share transactions | &nbsp;&nbsp; (35905148)<br>| &nbsp;&nbsp; (89185883)<br>| &nbsp;&nbsp; (44043288)<br>| &nbsp;&nbsp; (352754016)<br>|
| **Net Increase (Decrease) in Net Assets** | &nbsp;&nbsp; (32113600)<br>| &nbsp;&nbsp; (51966087)<br>| &nbsp;&nbsp; (27317309)<br>| &nbsp;&nbsp; 180334475 |
| **Net Assets:** |  |  |  |  |
| Beginning of period  | &nbsp;&nbsp; 1648620113 | &nbsp;&nbsp; 1700586200 | &nbsp;&nbsp; 3759915745 | &nbsp;&nbsp; 3579581270 |
| End of period | &nbsp;&nbsp; $1616506513 | &nbsp;&nbsp; $1648620113 | &nbsp;&nbsp; $3732598436 | &nbsp;&nbsp; $3759915745 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

59 <br>

------

**Hartford HLS Funds**

 ***Statements of Changes in Net Assets – (continued)*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Hartford Disciplined** <br>**Equity HLS Fund** | **Hartford Disciplined** <br>**Equity HLS Fund** | **Hartford Dividend** <br>**and Growth HLS Fund** | **Hartford Dividend** <br>**and Growth HLS Fund** |
|  | **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>|
| **Operations:** |  |  |  |  |
| Net investment income (loss) | &nbsp;&nbsp; $11810499 | &nbsp;&nbsp; $15338968 | &nbsp;&nbsp; $49936327 | &nbsp;&nbsp; $63067975 |
| Net realized gain (loss) on investments and foreign currency transactions | &nbsp;&nbsp; 351730842 | &nbsp;&nbsp; 311843085 | &nbsp;&nbsp; 589605920 | &nbsp;&nbsp; 499967064 |
| Net changes in unrealized appreciation (depreciation) of investments and foreign currency <br> transactions<br>| &nbsp;&nbsp; 30397730 | &nbsp;&nbsp; 328953786 | &nbsp;&nbsp; (108994376)<br>| &nbsp;&nbsp; (144268131)<br>|
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | &nbsp;&nbsp; 393939071 | &nbsp;&nbsp; 656135839 | &nbsp;&nbsp; 530547871 | &nbsp;&nbsp; 418766908 |
| **Distributions to Shareholders:** |  |  |  |  |
| Class IA | &nbsp;&nbsp; (263646122)<br>| &nbsp;&nbsp; (123659813)<br>| &nbsp;&nbsp; (505397957)<br>| &nbsp;&nbsp; (255244168)<br>|
| Class IB | &nbsp;&nbsp; (29254456)<br>| &nbsp;&nbsp; (13971168)<br>| &nbsp;&nbsp; (62214722)<br>| &nbsp;&nbsp; (31926825)<br>|
| Class IC | &nbsp;&nbsp; (6190183)<br>| &nbsp;&nbsp; (2893595)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Total distributions | &nbsp;&nbsp; (299090761)<br>| &nbsp;&nbsp; (140524576)<br>| &nbsp;&nbsp; (567612679)<br>| &nbsp;&nbsp; (287170993)<br>|
| **Capital Share Transactions:** |  |  |  |  |
| Sold | &nbsp;&nbsp; 30910702 | &nbsp;&nbsp; 30453902 | &nbsp;&nbsp; 59304354 | &nbsp;&nbsp; 85899175 |
| Issued on reinvestment of distributions | &nbsp;&nbsp; 299090761 | &nbsp;&nbsp; 140524576 | &nbsp;&nbsp; 567612679 | &nbsp;&nbsp; 287170993 |
| Redeemed | &nbsp;&nbsp; (404789622)<br>| &nbsp;&nbsp; (423886889)<br>| &nbsp;&nbsp; (465779796)<br>| &nbsp;&nbsp; (679546208)<br>|
| Net increase (decrease) from capital share transactions | &nbsp;&nbsp; (74788159)<br>| &nbsp;&nbsp; (252908411)<br>| &nbsp;&nbsp; 161137237 | &nbsp;&nbsp; (306476040)<br>|
| **Net Increase (Decrease) in Net Assets** | &nbsp;&nbsp; 20060151 | &nbsp;&nbsp; 262702852 | &nbsp;&nbsp; 124072429 | &nbsp;&nbsp; (174880125)<br>|
| **Net Assets:** |  |  |  |  |
| Beginning of period  | &nbsp;&nbsp; 2982324711 | &nbsp;&nbsp; 2719621859 | &nbsp;&nbsp; 3288765231 | &nbsp;&nbsp; 3463645356 |
| End of period | &nbsp;&nbsp; $3002384862 | &nbsp;&nbsp; $2982324711 | &nbsp;&nbsp; $3412837660 | &nbsp;&nbsp; $3288765231 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

60 <br>

------

**Hartford HLS Funds**

 ***Statements of Changes in Net Assets – (continued)*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Hartford Healthcare** <br>**HLS Fund** | **Hartford Healthcare** <br>**HLS Fund** | **Hartford International** <br>**Opportunities HLS Fund** | **Hartford International** <br>**Opportunities HLS Fund** |
|  | **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>|
| **Operations:** |  |  |  |  |
| Net investment income (loss) | &nbsp;&nbsp; $138466 | &nbsp;&nbsp; $(149138)<br>| &nbsp;&nbsp; $14324354 | &nbsp;&nbsp; $13172573 |
| Net realized gain (loss) on investments and foreign currency transactions | &nbsp;&nbsp; 6611409 | &nbsp;&nbsp; 6431189 | &nbsp;&nbsp; 93119976 | &nbsp;&nbsp; 66282934 |
| Net changes in unrealized appreciation (depreciation) of investments and foreign currency <br> transactions<br>| &nbsp;&nbsp; 9483565 | &nbsp;&nbsp; (4450562)<br>| &nbsp;&nbsp; 110864426 | &nbsp;&nbsp; (8644247)<br>|
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | &nbsp;&nbsp; 16233440 | &nbsp;&nbsp; 1831489 | &nbsp;&nbsp; 218308756 | &nbsp;&nbsp; 70811260 |
| **Distributions to Shareholders:** |  |  |  |  |
| Class IA | &nbsp;&nbsp; (4853668)<br>| &nbsp;&nbsp; (797065)<br>| &nbsp;&nbsp; (17421119)<br>| &nbsp;&nbsp; (11938546)<br>|
| Class IB | &nbsp;&nbsp; (1389201)<br>| &nbsp;&nbsp; (208541)<br>| &nbsp;&nbsp; (1670162)<br>| &nbsp;&nbsp; (981972)<br>|
| Total distributions | &nbsp;&nbsp; (6242869)<br>| &nbsp;&nbsp; (1005606)<br>| &nbsp;&nbsp; (19091281)<br>| &nbsp;&nbsp; (12920518)<br>|
| **Capital Share Transactions:** |  |  |  |  |
| Sold | &nbsp;&nbsp; 7377610 | &nbsp;&nbsp; 6947541 | &nbsp;&nbsp; 58283212 | &nbsp;&nbsp; 40185344 |
| Issued on reinvestment of distributions | &nbsp;&nbsp; 6242869 | &nbsp;&nbsp; 1005606 | &nbsp;&nbsp; 19091281 | &nbsp;&nbsp; 12920518 |
| Redeemed | &nbsp;&nbsp; (25807068)<br>| &nbsp;&nbsp; (29738628)<br>| &nbsp;&nbsp; (265172244)<br>| &nbsp;&nbsp; (157403061)<br>|
| Net increase (decrease) from capital share transactions | &nbsp;&nbsp; (12186589)<br>| &nbsp;&nbsp; (21785481)<br>| &nbsp;&nbsp; (187797751)<br>| &nbsp;&nbsp; (104297199)<br>|
| **Net Increase (Decrease) in Net Assets** | &nbsp;&nbsp; (2196018)<br>| &nbsp;&nbsp; (20959598)<br>| &nbsp;&nbsp; 11419724 | &nbsp;&nbsp; (46406457)<br>|
| **Net Assets:** |  |  |  |  |
| Beginning of period  | &nbsp;&nbsp; 117615958 | &nbsp;&nbsp; 138575556 | &nbsp;&nbsp; 825917475 | &nbsp;&nbsp; 872323932 |
| End of period | &nbsp;&nbsp; $115419940 | &nbsp;&nbsp; $117615958 | &nbsp;&nbsp; $837337199 | &nbsp;&nbsp; $825917475 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

61 <br>

------

**Hartford HLS Funds**

 ***Statements of Changes in Net Assets – (continued)*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Hartford MidCap** <br>**HLS Fund** | **Hartford MidCap** <br>**HLS Fund** | **Hartford Small** <br>**Cap Growth HLS Fund** | **Hartford Small** <br>**Cap Growth HLS Fund** |
|  | **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>|
| **Operations:** |  |  |  |  |
| Net investment income (loss) | &nbsp;&nbsp; $(1550732)<br>| &nbsp;&nbsp; $(2871878)<br>| &nbsp;&nbsp; $(1460943)<br>| &nbsp;&nbsp; $(1604783)<br>|
| Net realized gain (loss) on investments and foreign currency transactions | &nbsp;&nbsp; 64353775 | &nbsp;&nbsp; 156271872 | &nbsp;&nbsp; 40394118 | &nbsp;&nbsp; 140114118 |
| Net changes in unrealized appreciation (depreciation) of investments and foreign currency <br> transactions<br>| &nbsp;&nbsp; (65423485)<br>| &nbsp;&nbsp; (97645737)<br>| &nbsp;&nbsp; (3077242)<br>| &nbsp;&nbsp; (34381923)<br>|
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | &nbsp;&nbsp; (2620442)<br>| &nbsp;&nbsp; 55754257 | &nbsp;&nbsp; 35855933 | &nbsp;&nbsp; 104127412 |
| **Distributions to Shareholders:** |  |  |  |  |
| Class IA | &nbsp;&nbsp; (129446072)<br>| &nbsp;&nbsp; (18435999)<br>| &nbsp;&nbsp; (68562516)<br>| &nbsp;&nbsp; (1702372)<br>|
| Class IB | &nbsp;&nbsp; (14367175)<br>| &nbsp;&nbsp; (2140506)<br>| &nbsp;&nbsp; (43939891)<br>| &nbsp;&nbsp; (191953)<br>|
| Total distributions | &nbsp;&nbsp; (143813247)<br>| &nbsp;&nbsp; (20576505)<br>| &nbsp;&nbsp; (112502407)<br>| &nbsp;&nbsp; (1894325)<br>|
| **Capital Share Transactions:** |  |  |  |  |
| Sold | &nbsp;&nbsp; 20927134 | &nbsp;&nbsp; 24000179 | &nbsp;&nbsp; 41826368 | &nbsp;&nbsp; 59599921 |
| Issued on reinvestment of distributions | &nbsp;&nbsp; 143813247 | &nbsp;&nbsp; 20576505 | &nbsp;&nbsp; 112132511 | &nbsp;&nbsp; 1887894 |
| Redeemed | &nbsp;&nbsp; (131222578)<br>| &nbsp;&nbsp; (347916930)<br>| &nbsp;&nbsp; (95124799)<br>| &nbsp;&nbsp; (361890205)<br>|
| Net increase (decrease) from capital share transactions | &nbsp;&nbsp; 33517803 | &nbsp;&nbsp; (303340246)<br>| &nbsp;&nbsp; 58834080 | &nbsp;&nbsp; (300402390)<br>|
| **Net Increase (Decrease) in Net Assets** | &nbsp;&nbsp; (112915886)<br>| &nbsp;&nbsp; (268162494)<br>| &nbsp;&nbsp; (17812394)<br>| &nbsp;&nbsp; (198169303)<br>|
| **Net Assets:** |  |  |  |  |
| Beginning of period  | &nbsp;&nbsp; 832993496 | &nbsp;&nbsp; 1101155990 | &nbsp;&nbsp; 564312441 | &nbsp;&nbsp; 762481744 |
| End of period | &nbsp;&nbsp; $720077610 | &nbsp;&nbsp; $832993496 | &nbsp;&nbsp; $546500047 | &nbsp;&nbsp; $564312441 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

62 <br>

------

**Hartford HLS Funds**

 ***Statements of Changes in Net Assets – (continued)*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Hartford Small** <br>**Company HLS Fund** | **Hartford Small** <br>**Company HLS Fund** | **Hartford Stock** <br>**HLS Fund** | **Hartford Stock** <br>**HLS Fund** |
|  | **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>|
| **Operations:** |  |  |  |  |
| Net investment income (loss) | &nbsp;&nbsp; $(1058175)<br>| &nbsp;&nbsp; $(831185)<br>| &nbsp;&nbsp; $14384557 | &nbsp;&nbsp; $19188209 |
| Net realized gain (loss) on investments and foreign currency transactions | &nbsp;&nbsp; 22733514 | &nbsp;&nbsp; 29302155 | &nbsp;&nbsp; 161568069 | &nbsp;&nbsp; 155766358 |
| Net changes in unrealized appreciation (depreciation) of investments and foreign currency <br> transactions<br>| &nbsp;&nbsp; 28270965 | &nbsp;&nbsp; 20256494 | &nbsp;&nbsp; (82322523)<br>| &nbsp;&nbsp; (61005801)<br>|
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | &nbsp;&nbsp; 49946304 | &nbsp;&nbsp; 48727464 | &nbsp;&nbsp; 93630103 | &nbsp;&nbsp; 113948766 |
| **Distributions to Shareholders:** |  |  |  |  |
| Class IA | &nbsp;&nbsp; (1617305)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (160622695)<br>| &nbsp;&nbsp; (55200279)<br>|
| Class IB | &nbsp;&nbsp; (93906)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (13867227)<br>| &nbsp;&nbsp; (4636580)<br>|
| Total distributions | &nbsp;&nbsp; (1711211)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (174489922)<br>| &nbsp;&nbsp; (59836859)<br>|
| **Capital Share Transactions:** |  |  |  |  |
| Sold | &nbsp;&nbsp; 14335883 | &nbsp;&nbsp; 15995957 | &nbsp;&nbsp; 6984746 | &nbsp;&nbsp; 6557457 |
| Issued on reinvestment of distributions | &nbsp;&nbsp; 1711211 | &nbsp;&nbsp; — | &nbsp;&nbsp; 174489922 | &nbsp;&nbsp; 59836859 |
| Redeemed | &nbsp;&nbsp; (64836791)<br>| &nbsp;&nbsp; (70164884)<br>| &nbsp;&nbsp; (170841303)<br>| &nbsp;&nbsp; (178320572)<br>|
| Net increase (decrease) from capital share transactions | &nbsp;&nbsp; (48789697)<br>| &nbsp;&nbsp; (54168927)<br>| &nbsp;&nbsp; 10633365 | &nbsp;&nbsp; (111926256)<br>|
| **Net Increase (Decrease) in Net Assets** | &nbsp;&nbsp; (554604)<br>| &nbsp;&nbsp; (5441463)<br>| &nbsp;&nbsp; (70226454)<br>| &nbsp;&nbsp; (57814349)<br>|
| **Net Assets:** |  |  |  |  |
| Beginning of period  | &nbsp;&nbsp; 426729696 | &nbsp;&nbsp; 432171159 | &nbsp;&nbsp; 1281798512 | &nbsp;&nbsp; 1339612861 |
| End of period | &nbsp;&nbsp; $426175092 | &nbsp;&nbsp; $426729696 | &nbsp;&nbsp; $1211572058 | &nbsp;&nbsp; $1281798512 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

63 <br>

------

**Hartford HLS Funds**

 ***Statements of Changes in Net Assets – (continued)*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Hartford Total** <br>**Return Bond HLS Fund** | **Hartford Total** <br>**Return Bond HLS Fund** | **Hartford Ultrashort** <br>**Bond HLS Fund** | **Hartford Ultrashort** <br>**Bond HLS Fund** |
|  | **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2025**<br>| **For the** <br>**Year Ended** <br>**December 31,** <br>**2024**<br>|
| **Operations:** |  |  |  |  |
| Net investment income (loss) | &nbsp;&nbsp; $60535613 | &nbsp;&nbsp; $71937562 | &nbsp;&nbsp; $21036783 | &nbsp;&nbsp; $25365945 |
| Net realized gain (loss) on investments, other financial instruments and foreign currency <br> transactions<br>| &nbsp;&nbsp; (36493029)<br>| &nbsp;&nbsp; (15123285)<br>| &nbsp;&nbsp; 116777 | &nbsp;&nbsp; 194515 |
| Net changes in unrealized appreciation (depreciation) of investments, other financial <br> instruments and foreign currency transactions<br>| &nbsp;&nbsp; 80767447 | &nbsp;&nbsp; (15765215)<br>| &nbsp;&nbsp; 1308012 | &nbsp;&nbsp; 2149615 |
| **Net Increase (Decrease) in Net Assets Resulting from Operations** | &nbsp;&nbsp; 104810031 | &nbsp;&nbsp; 41049062 | &nbsp;&nbsp; 22461572 | &nbsp;&nbsp; 27710075 |
| **Distributions to Shareholders:** |  |  |  |  |
| Class IA | &nbsp;&nbsp; (67564962)<br>| &nbsp;&nbsp; (57330959)<br>| &nbsp;&nbsp; (22307001)<br>| &nbsp;&nbsp; (20217668)<br>|
| Class IB | &nbsp;&nbsp; (7592544)<br>| &nbsp;&nbsp; (5337196)<br>| &nbsp;&nbsp; (3088056)<br>| &nbsp;&nbsp; (2853816)<br>|
| Total distributions | &nbsp;&nbsp; (75157506)<br>| &nbsp;&nbsp; (62668155)<br>| &nbsp;&nbsp; (25395057)<br>| &nbsp;&nbsp; (23071484)<br>|
| **Capital Share Transactions:** |  |  |  |  |
| Sold | &nbsp;&nbsp; 106963525 | &nbsp;&nbsp; 164881149 | &nbsp;&nbsp; 45069504 | &nbsp;&nbsp; 35399816 |
| Issued on reinvestment of distributions | &nbsp;&nbsp; 75157506 | &nbsp;&nbsp; 62668155 | &nbsp;&nbsp; 25395057 | &nbsp;&nbsp; 23071484 |
| Redeemed | &nbsp;&nbsp; (549502126)<br>| &nbsp;&nbsp; (269396656)<br>| &nbsp;&nbsp; (101774532)<br>| &nbsp;&nbsp; (96929068)<br>|
| Net increase (decrease) from capital share transactions | &nbsp;&nbsp; (367381095)<br>| &nbsp;&nbsp; (41847352)<br>| &nbsp;&nbsp; (31309971)<br>| &nbsp;&nbsp; (38457768)<br>|
| **Net Increase (Decrease) in Net Assets** | &nbsp;&nbsp; (337728570)<br>| &nbsp;&nbsp; (63466445)<br>| &nbsp;&nbsp; (34243456)<br>| &nbsp;&nbsp; (33819177)<br>|
| **Net Assets:** |  |  |  |  |
| Beginning of period  | &nbsp;&nbsp; 1724145553 | &nbsp;&nbsp; 1787611998 | &nbsp;&nbsp; 527964640 | &nbsp;&nbsp; 561783817 |
| End of period | &nbsp;&nbsp; $1386416983 | &nbsp;&nbsp; $1724145553 | &nbsp;&nbsp; $493721184 | &nbsp;&nbsp; $527964640 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

64 <br>

------

**Hartford HLS Funds**

***Financial Highlights***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** |
| **Class**  | **Net** <br>**Asset** <br>**Value at** <br>**Beginning** <br>**of Period**<br>| **Net** <br>**Investment** <br>**Income** <br>**(Loss)**<br>| **Net** <br>**Realized** <br>**and** <br>**Unrealized** <br>**Gain (Loss)** <br>**on** <br>**Investments**<br>| **Total from** <br>**Investment** <br>**Operations**<br>| **Dividends** <br>**from Net** <br>**Investment** <br>**Income**<br>| **Distributions** <br>**from** <br>**Capital** <br>**Gains**<br>| **Total** <br>**Dividends** <br>**and** <br>**Distributions**<br>| **Net** <br>**Asset** <br>**Value at** <br>**End of** <br>**Period**<br>| **Total** <br>**Return**<sup>(2)</sup> <br>| **Net** <br>**Assets** <br>**at End** <br>**of Period** <br>**(000s)**<br>| **Ratio of** <br>**Expenses** <br>**to** <br>**Average** <br>**Net** <br>**Assets** <br>**Before** <br>**Adjust-** <br>**ments**<sup>(3)(4)</sup> <br>| **Ratio of** <br>**Expenses** <br>**to** <br>**Average** <br>**Net** <br>**Assets** <br>**After** <br>**Adjust-** <br>**ments**<sup>(3)(4)</sup> <br>| **Ratio of** <br>**Net** <br>**Investment** <br>**Income** <br>**(Loss) to** <br>**Average** <br>**Net Assets**<br>| **Portfolio** <br>**Turnover**<br>|
| **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  | **Hartford Balanced HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $29.33 | $0.58 | $2.85 | $3.43 | $(0.57)<br>| $(2.91)<br>| $(3.48)<br>| $29.28 | 12.14<br> %<br>| &nbsp;&nbsp; $1433638 | 0.66<br> %<br>| 0.63<br> %<br>| 1.94<br> %<br>| 66 %<sup>(5)</sup><br>|
| IB | 30.11 | 0.52 | 2.92 | 3.44 | (0.49)<br>| (2.91)<br>| (3.40)<br>| 30.15 | 11.86 | &nbsp;&nbsp; 182869 | 0.91 | 0.88 | 1.69 | 66 <br><sup>(5)</sup><br>|
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $28.76 | $0.60 | $2.62 | $3.22 | $(0.59)<br>| $(2.06)<br>| $(2.65)<br>| $29.33 | 11.21<br> %<br>| &nbsp;&nbsp; $1460250 | 0.66<br> %<br>| 0.63<br> %<br>| 1.98<br> %<br>| 50 %<sup>(5)</sup><br>|
| IB | 29.46 | 0.53 | 2.69 | 3.22 | (0.51)<br>| (2.06)<br>| (2.57)<br>| 30.11 | 10.94 | &nbsp;&nbsp; 188371 | 0.91 | 0.88 | 1.73 | 50 <br><sup>(5)</sup><br>|
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $26.27 | $0.54 | $3.28 | $3.82 | $(0.53)<br>| $(0.80)<br>| $(1.33)<br>| $28.76 | 14.78<br> %<br>| &nbsp;&nbsp; $1502119 | 0.66<br> %<br>| 0.63<br> %<br>| 1.96<br> %<br>| 57 %<sup>(5)</sup><br>|
| IB | 26.88 | 0.48 | 3.35 | 3.83 | (0.45)<br>| (0.80)<br>| (1.25)<br>| 29.46 | 14.50 | &nbsp;&nbsp; 198467 | 0.91 | 0.88 | 1.71 | 57 <br><sup>(5)</sup><br>|
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $35.47 | $0.44 | $(5.08)<br>| $(4.64)<br>| $(0.53)<br>| $(4.03)<br>| $(4.56)<br>| $26.27 | (13.42)%<br>| &nbsp;&nbsp; $1499116 | 0.65<br> %<br>| 0.62<br> %<br>| 1.44<br> %<br>| 53 %<sup>(5)</sup><br>|
| IB | 36.18 | 0.37 | (5.19)<br>| (4.82)<br>| (0.45)<br>| (4.03)<br>| (4.48)<br>| 26.88 | (13.66)<br>| &nbsp;&nbsp; 200282 | 0.90 | 0.87 | 1.19 | 53 <br><sup>(5)</sup><br>|
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $31.56 | $0.44 | $5.70 | $6.14 | $(0.35)<br>| $(1.88)<br>| $(2.23)<br>| $35.47 | 19.64<br> %<br>| &nbsp;&nbsp; $1948846 | 0.66<br> %<br>| 0.63<br> %<br>| 1.29<br> %<br>| 48 %<sup>(5)</sup><br>|
| IB | 32.15 | 0.36 | 5.81 | 6.17 | (0.26)<br>| (1.88)<br>| (2.14)<br>| 36.18 | 19.37 | &nbsp;&nbsp; 259957 | 0.91 | 0.88 | 1.04 | 48 <br><sup>(5)</sup><br>|
| **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  | **Hartford Capital Appreciation HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $53.19 | $0.34 | $6.59 | $6.93 | $(0.34)<br>| $(6.55)<br>| $(6.89)<br>| $53.23 | 13.72<br> %<br>| &nbsp;&nbsp; $3345165 | 0.67<br> %<br>| 0.67<br> %<br>| 0.65<br> %<br>| 58<br> %<br>|
| IB | 51.76 | 0.20 | 6.38 | 6.58 | (0.21)<br>| (6.55)<br>| (6.76)<br>| 51.58 | 13.42 | &nbsp;&nbsp; 372321 | 0.92 | 0.92 | 0.40 | 58 |
| IC | 52.13 | 0.08 | 6.42 | 6.50 | (0.07)<br>| (6.55)<br>| (6.62)<br>| 52.01 | 13.16 | &nbsp;&nbsp; 15113 | 1.17 | 1.17 | 0.15 | 58 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $46.05 | $0.40 | $9.34 | $9.74 | $(0.41)<br>| $(2.19)<br>| $(2.60)<br>| $53.19 | 21.19<br> %<br>| &nbsp;&nbsp; $3360829 | 0.67<br> %<br>| 0.67<br> %<br>| 0.78<br> %<br>| 72<br> %<br>|
| IB | 44.87 | 0.26 | 9.10 | 9.36 | (0.28)<br>| (2.19)<br>| (2.47)<br>| 51.76 | 20.90 | &nbsp;&nbsp; 382792 | 0.92 | 0.92 | 0.53 | 72 |
| IC | 45.18 | 0.14 | 9.15 | 9.29 | (0.15)<br>| (2.19)<br>| (2.34)<br>| 52.13 | 20.60 | &nbsp;&nbsp; 16294 | 1.17 | 1.17 | 0.28 | 72 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $39.37 | $0.38 | $7.42 | $7.80 | $(0.38)<br>| $(0.74)<br>| $(1.12)<br>| $46.05 | 19.97<br> %<br>| &nbsp;&nbsp; $3194008 | 0.67<br> %<br>| 0.67<br> %<br>| 0.88<br> %<br>| 49<br> %<br>|
| IB | 38.39 | 0.26 | 7.23 | 7.49 | (0.27)<br>| (0.74)<br>| (1.01)<br>| 44.87 | 19.67 | &nbsp;&nbsp; 371021 | 0.92 | 0.92 | 0.63 | 49 |
| IC | 38.65 | 0.16 | 7.27 | 7.43 | (0.16)<br>| (0.74)<br>| (0.90)<br>| 45.18 | 19.38 | &nbsp;&nbsp; 14552 | 1.17 | 1.17 | 0.38 | 49 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $54.26 | $0.32 | $(8.52)<br>| $(8.20)<br>| $(0.41)<br>| $(6.28)<br>| $(6.69)<br>| $39.37 | (15.28)%<br>| &nbsp;&nbsp; $3034471 | 0.67<br> %<br>| 0.67<br> %<br>| 0.71<br> %<br>| 64<br> %<br>|
| IB | 53.10 | 0.20 | (8.33)<br>| (8.13)<br>| (0.30)<br>| (6.28)<br>| (6.58)<br>| 38.39 | (15.48)<br>| &nbsp;&nbsp; 359906 | 0.92 | 0.92 | 0.46 | 64 |
| IC | 53.33 | 0.07 | (8.35)<br>| (8.28)<br>| (0.12)<br>| (6.28)<br>| (6.40)<br>| 38.65 | (15.71)<br>| &nbsp;&nbsp; 13837 | 1.17 | 1.17 | 0.16 | 64 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $51.85 | $0.33 | $7.27 | $7.60 | $(0.26)<br>| $(4.93)<br>| $(5.19)<br>| $54.26 | 14.76<br> %<br>| &nbsp;&nbsp; $3986182 | 0.67<br> %<br>| 0.67<br> %<br>| 0.61<br> %<br>| 58<br> %<br>|
| IB | 50.85 | 0.19 | 7.11 | 7.30 | (0.12)<br>| (4.93)<br>| (5.05)<br>| 53.10 | 14.45 | &nbsp;&nbsp; 483113 | 0.92 | 0.92 | 0.36 | 58 |
| IC | 51.08 | 0.06 | 7.14 | 7.20 | (0.02)<br>| (4.93)<br>| (4.95)<br>| 53.33 | 14.18 | &nbsp;&nbsp; 41107 | 1.17 | 1.17 | 0.11 | 58 |
| **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  | **Hartford Disciplined Equity HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $22.54 | $0.10 | $3.00 | $3.10 | $(0.09)<br>| $(2.36)<br>| $(2.45)<br>| $23.19 | 14.32<br> %<br>| &nbsp;&nbsp; $2648771 | 0.59<br> %<br>| 0.59<br> %<br>| 0.44<br> %<br>| 35<br> %<br>|
| IB | 22.12 | 0.04 | 2.94 | 2.98 | (0.04)<br>| (2.36)<br>| (2.40)<br>| 22.70 | 14.01 | &nbsp;&nbsp; 290665 | 0.84 | 0.84 | 0.19 | 35 |
| IC | 22.54 | (0.01)<br>| 2.99 | 2.98 | (0.01)<br>| (2.36)<br>| (2.37)<br>| 23.15 | 13.75 | &nbsp;&nbsp; 62949 | 1.09 | 1.09 | &nbsp;&nbsp; (0.06)<br>| 35 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $18.86 | $0.12 | $4.63 | $4.75 | $(0.13)<br>| $(0.94)<br>| $(1.07)<br>| $22.54 | 25.37<br> %<br>| &nbsp;&nbsp; $2612607 | 0.59<br> %<br>| 0.59<br> %<br>| 0.56<br> %<br>| 27<br> %<br>|
| IB | 18.52 | 0.07 | 4.55 | 4.62 | (0.08)<br>| (0.94)<br>| (1.02)<br>| 22.12 | 25.10 | &nbsp;&nbsp; 302753 | 0.84 | 0.84 | 0.31 | 27 |
| IC | 18.86 | 0.01 | 4.63 | 4.64 | (0.02)<br>| (0.94)<br>| (0.96)<br>| 22.54 | 24.76 | &nbsp;&nbsp; 66964 | 1.09 | 1.09 | 0.06 | 27 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

65 <br>

------

**Hartford HLS Funds**

***Financial Highlights – (continued)***

------

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** |
| **Class**  | **Net**<br> **Asset**<br> **Value at**<br> **Beginning**<br> **of Period**<br>| **Net**<br> **Investment**<br> **Income**<br> **(Loss)**<br>| **Net**<br> **Realized**<br> **and**<br> **Unrealized**<br> **Gain (Loss)**<br> **on**<br> **Investments**<br>| **Total from**<br> **Investment**<br> **Operations**<br>| **Dividends**<br> **from Net**<br> **Investment**<br> **Income**<br>| **Distributions**<br> **from**<br> **Capital**<br> **Gains**<br>| **Total**<br> **Dividends**<br> **and**<br> **Distributions**<br>| **Net**<br> **Asset**<br> **Value at**<br> **End of**<br> **Period**<br>| **Total**<br> **Return**<sup>(2)</sup><br>| **Net**<br> **Assets**<br> **at End**<br> **of Period**<br> **(000s)**<br>| **Ratio of**<br> **Expenses**<br> **to**<br> **Average**<br> **Net**<br> **Assets**<br> **Before**<br> **Adjust-**<br> **ments**<sup>(3)(4)</sup><br>| **Ratio of**<br> **Expenses**<br> **to**<br> **Average**<br> **Net**<br> **Assets**<br> **After**<br> **Adjust-**<br> **ments**<sup>(3)(4)</sup><br>| **Ratio of**<br> **Net**<br> **Investment**<br> **Income**<br> **(Loss) to**<br> **Average**<br> **Net Assets**<br>| **Portfolio**<br> **Turnover**<br>|
| **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  | **Hartford Disciplined Equity HLS Fund – (continued)**  |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $15.78 | $0.16 | $3.18 | $3.34 | $(0.15)<br>| $(0.11)<br>| $(0.26)<br>| $18.86 | 21.24<br> %<br>| &nbsp;&nbsp; $2371805 | 0.59<br> %<br>| 0.59<br> %<br>| 0.90<br> %<br>| 22<br> %<br>|
| IB | 15.50 | 0.11 | 3.12 | 3.23 | (0.10)<br>| (0.11)<br>| (0.21)<br>| 18.52 | 20.95 | &nbsp;&nbsp; 283695 | 0.84 | 0.84 | 0.66 | 22 |
| IC | 15.78 | 0.07 | 3.18 | 3.25 | (0.06)<br>| (0.11)<br>| (0.17)<br>| 18.86 | 20.66 | &nbsp;&nbsp; 64122 | 1.09 | 1.09 | 0.41 | 22 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $20.85 | $0.16 | $(4.06)<br>| $(3.90)<br>| $(0.18)<br>| $(0.99)<br>| $(1.17)<br>| $15.78 | (18.96)%<br>| &nbsp;&nbsp; $2196538 | 0.59<br> %<br>| 0.59<br> %<br>| 0.90<br> %<br>| 13<br> %<br>|
| IB | 20.51 | 0.11 | (4.00)<br>| (3.89)<br>| (0.13)<br>| (0.99)<br>| (1.12)<br>| 15.50 | (19.20)<br>| &nbsp;&nbsp; 272407 | 0.84 | 0.84 | 0.65 | 13 |
| IC | 20.85 | 0.07 | (4.06)<br>| (3.99)<br>| (0.09)<br>| (0.99)<br>| (1.08)<br>| 15.78 | (19.40)<br>| &nbsp;&nbsp; 62585 | 1.09 | 1.09 | 0.40 | 13 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $17.40 | $0.13 | $4.29 | $4.42 | $(0.12)<br>| $(0.85)<br>| $(0.97)<br>| $20.85 | 25.52<br> %<br>| &nbsp;&nbsp; $2997803 | 0.60<br> %<br>| 0.60<br> %<br>| 0.64<br> %<br>| 14<br> %<br>|
| IB | 17.13 | 0.08 | 4.21 | 4.29 | (0.06)<br>| (0.85)<br>| (0.91)<br>| 20.51 | 25.21 | &nbsp;&nbsp; 385018 | 0.85 | 0.85 | 0.39 | 14 |
| IC | 17.40 | 0.03 | 4.28 | 4.31 | (0.01)<br>| (0.85)<br>| (0.86)<br>| 20.85 | 24.92 | &nbsp;&nbsp; 88474 | 1.10 | 1.10 | 0.14 | 14 |
| **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  | **Hartford Dividend and Growth HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $23.38 | $0.36 | $3.41 | $3.77 | $(0.36)<br>| $(3.92)<br>| $(4.28)<br>| $22.87 | 17.49<br> %<br>| &nbsp;&nbsp; $3040122 | 0.66<br> %<br>| 0.66<br> %<br>| 1.55<br> %<br>| 62<br> %<br>|
| IB | 23.15 | 0.30 | 3.36 | 3.66 | (0.30)<br>| (3.92)<br>| (4.22)<br>| 22.59 | 17.19 | &nbsp;&nbsp; 372715 | 0.91 | 0.91 | 1.30 | 62 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $22.63 | $0.45 | $2.42 | $2.87 | $(0.46)<br>| $(1.66)<br>| $(2.12)<br>| $23.38 | 12.67<br> %<br>| &nbsp;&nbsp; $2918912 | 0.66<br> %<br>| 0.66<br> %<br>| 1.84<br> %<br>| 31<br> %<br>|
| IB | 22.42 | 0.38 | 2.41 | 2.79 | (0.40)<br>| (1.66)<br>| (2.06)<br>| 23.15 | 12.42 | &nbsp;&nbsp; 369853 | 0.91 | 0.91 | 1.59 | 31 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $22.04 | $0.38 | $2.58 | $2.96 | $(0.34)<br>| $(2.03)<br>| $(2.37)<br>| $22.63 | 14.18<br> %<br>| &nbsp;&nbsp; $3085357 | 0.66<br> %<br>| 0.66<br> %<br>| 1.69<br> %<br>| 27<br> %<br>|
| IB | 21.86 | 0.32 | 2.56 | 2.88 | (0.29)<br>| (2.03)<br>| (2.32)<br>| 22.42 | 13.89 | &nbsp;&nbsp; 378288 | 0.91 | 0.91 | 1.44 | 27 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $27.58 | $0.38 | $(2.83)<br>| $(2.45)<br>| $(0.40)<br>| $(2.69)<br>| $(3.09)<br>| $22.04 | (8.93)%<br>| &nbsp;&nbsp; $2986097 | 0.65<br> %<br>| 0.65<br> %<br>| 1.52<br> %<br>| 23<br> %<br>|
| IB | 27.38 | 0.31 | (2.80)<br>| (2.49)<br>| (0.34)<br>| (2.69)<br>| (3.03)<br>| 21.86 | (9.15)<br>| &nbsp;&nbsp; 379001 | 0.90 | 0.90 | 1.27 | 23 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $22.19 | $0.35 | $6.67 | $7.02 | $(0.34)<br>| $(1.29)<br>| $(1.63)<br>| $27.58 | 32.00<br> %<br>| &nbsp;&nbsp; $3654208 | 0.66<br> %<br>| 0.66<br> %<br>| 1.36<br> %<br>| 21<br> %<br>|
| IB | 22.04 | 0.28 | 6.62 | 6.90 | (0.27)<br>| (1.29)<br>| (1.56)<br>| 27.38 | 31.68 | &nbsp;&nbsp; 470882 | 0.91 | 0.91 | 1.12 | 21 |
| **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  | **Hartford Healthcare HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $16.36 | $0.03 | $2.40 | $2.43 | $(0.13)<br>| $(0.81)<br>| $(0.94)<br>| $17.85 | 16.10<br> %<br>| &nbsp;&nbsp; $91398 | 0.94<br> %<br>| 0.94<br> %<br>| 0.18<br> %<br>| 50<br> %<br>|
| IB | 14.35 | (0.01)<br>| 2.08 | 2.07 | (0.08)<br>| (0.81)<br>| (0.89)<br>| 15.53 | 15.79 | &nbsp;&nbsp; 24022 | 1.19 | 1.19 | &nbsp;&nbsp; (0.07)<br>| 50 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $16.41 | $(0.01)<br>| $0.09 | $0.08 | $(0.02)<br>| $(0.11)<br>| $(0.13)<br>| $16.36 | 0.39<br> %<br>| &nbsp;&nbsp; $92588 | 0.93<br> %<br>| 0.93<br> %<br>| &nbsp;&nbsp; (0.06)%<br>| 42<br> %<br>|
| IB | 14.42 | (0.05)<br>| 0.09 | 0.04 |  | (0.11)<br>| (0.11)<br>| 14.35 | 0.19 | &nbsp;&nbsp; 25028 | 1.18 | 1.18 | &nbsp;&nbsp; (0.30)<br>| 42 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $16.05 | $0.02 | $0.63 | $0.65 | $(0.08)<br>| $(0.21)<br>| $(0.29)<br>| $16.41 | 4.11<br> %<br>| &nbsp;&nbsp; $109010 | 0.92<br> %<br>| 0.92<br> %<br>| 0.13<br> %<br>| 28<br> %<br>|
| IB | 14.14 | (0.02)<br>| 0.55 | 0.53 | (0.04)<br>| (0.21)<br>| (0.25)<br>| 14.42 | 3.81 | &nbsp;&nbsp; 29565 | 1.17 | 1.17 | &nbsp;&nbsp; (0.12)<br>| 28 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $23.57 | $0.03 | $(2.90)<br>| $(2.87)<br>| $— | $(4.65)<br>| $(4.65)<br>| $16.05 | (11.24)%<br>| &nbsp;&nbsp; $120656 | 0.91<br> %<br>| 0.91<br> %<br>| 0.14<br> %<br>| 34<br> %<br>|
| IB | 21.47 | (0.02)<br>| (2.66)<br>| (2.68)<br>|  | (4.65)<br>| (4.65)<br>| 14.14 | (11.47)<br>| &nbsp;&nbsp; 32411 | 1.16 | 1.16 | &nbsp;&nbsp; (0.11)<br>| 34 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $23.88 | $(0.01)<br>| $2.44 | $2.43 | $(0.06)<br>| $(2.68)<br>| $(2.74)<br>| $23.57 | 10.01<br> %<br>| &nbsp;&nbsp; $164964 | 0.92<br> %<br>| 0.92<br> %<br>| &nbsp;&nbsp; (0.05)%<br>| 51<br> %<br>|
| IB | 21.97 | (0.07)<br>| 2.25 | 2.18 |  | (2.68)<br>| (2.68)<br>| 21.47 | 9.76 | &nbsp;&nbsp; 40427 | 1.17 | 1.17 | &nbsp;&nbsp; (0.30)<br>| 51 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

66 <br>

------

**Hartford HLS Funds**

***Financial Highlights – (continued)***

------

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** |
| **Class**  | **Net**<br> **Asset**<br> **Value at**<br> **Beginning**<br> **of Period**<br>| **Net**<br> **Investment**<br> **Income**<br> **(Loss)**<br>| **Net**<br> **Realized**<br> **and**<br> **Unrealized**<br> **Gain (Loss)**<br> **on**<br> **Investments**<br>| **Total from**<br> **Investment**<br> **Operations**<br>| **Dividends**<br> **from Net**<br> **Investment**<br> **Income**<br>| **Distributions**<br> **from**<br> **Capital**<br> **Gains**<br>| **Total**<br> **Dividends**<br> **and**<br> **Distributions**<br>| **Net**<br> **Asset**<br> **Value at**<br> **End of**<br> **Period**<br>| **Total**<br> **Return**<sup>(2)</sup><br>| **Net**<br> **Assets**<br> **at End**<br> **of Period**<br> **(000s)**<br>| **Ratio of**<br> **Expenses**<br> **to**<br> **Average**<br> **Net**<br> **Assets**<br> **Before**<br> **Adjust-**<br> **ments**<sup>(3)(4)</sup><br>| **Ratio of**<br> **Expenses**<br> **to**<br> **Average**<br> **Net**<br> **Assets**<br> **After**<br> **Adjust-**<br> **ments**<sup>(3)(4)</sup><br>| **Ratio of**<br> **Net**<br> **Investment**<br> **Income**<br> **(Loss) to**<br> **Average**<br> **Net Assets**<br>| **Portfolio**<br> **Turnover**<br>|
| **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  | **Hartford International Opportunities HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $16.16 | $0.32 | $4.56 | $4.88 | $(0.32)<br>| $(0.15)<br>| $(0.47)<br>| $20.57 | 30.41<br> %<br>| &nbsp;&nbsp; $756466 | 0.76<br> %<br>| 0.76<br> %<br>| 1.76<br> %<br>| 43<br> %<br>|
| IB | 16.50 | 0.28 | 4.65 | 4.93 | (0.27)<br>| (0.15)<br>| (0.42)<br>| 21.01 | 30.06 | &nbsp;&nbsp; 80871 | 1.01 | 1.01 | 1.50 | 43 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $15.13 | $0.25 | $1.03 | $1.28 | $(0.25)<br>| $— | $(0.25)<br>| $16.16 | 8.40<br> %<br>| &nbsp;&nbsp; $751450 | 0.76<br> %<br>| 0.76<br> %<br>| 1.54<br> %<br>| 43<br> %<br>|
| IB | 15.45 | 0.21 | 1.05 | 1.26 | (0.21)<br>|  | (0.21)<br>| 16.50 | 8.08 | &nbsp;&nbsp; 74467 | 1.01 | 1.01 | 1.30 | 43 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $13.71 | $0.22 | $1.37 | $1.59 | $(0.17)<br>| $— | $(0.17)<br>| $15.13 | 11.72<br> %<br>| &nbsp;&nbsp; $791135 | 0.76<br> %<br>| 0.76<br> %<br>| 1.54<br> %<br>| 54<br> %<br>|
| IB | 13.99 | 0.19 | 1.40 | 1.59 | (0.13)<br>|  | (0.13)<br>| 15.45 | 11.45 | &nbsp;&nbsp; 81189 | 1.01 | 1.01 | 1.29 | 54 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $20.90 | $0.27 | $(4.13)<br>| $(3.86)<br>| $(0.29)<br>| $(3.04)<br>| $(3.33)<br>| $13.71 | (18.14)%<br>| &nbsp;&nbsp; $787084 | 0.75<br> %<br>| 0.75<br> %<br>| 1.69<br> %<br>| 91<br> %<br>|
| IB | 21.21 | 0.24 | (4.19)<br>| (3.95)<br>| (0.23)<br>| (3.04)<br>| (3.27)<br>| 13.99 | (18.32)<br>| &nbsp;&nbsp; 84305 | 1.00 | 1.00 | 1.44 | 91 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $19.58 | $0.22 | $1.31 | $1.53 | $(0.21)<br>| $— | $(0.21)<br>| $20.90 | 7.82<br> %<br>| &nbsp;&nbsp; $1064640 | 0.73<br> %<br>| 0.73<br> %<br>| 1.09<br> %<br>| 95<br> %<br>|
| IB | 19.86 | 0.18 | 1.32 | 1.50 | (0.15)<br>|  | (0.15)<br>| 21.21 | 7.57 | &nbsp;&nbsp; 112357 | 0.98 | 0.98 | 0.84 | 95 |
| **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  | **Hartford MidCap HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $28.37 | $(0.05)<br>| $0.18 <br><sup>(6)</sup><br>| $0.13 | $— | $(5.30)<br>| $(5.30)<br>| $23.20 | (0.38)%<br>| &nbsp;&nbsp; $652761 | 0.76<br> %<br>| 0.76<br> %<br>| &nbsp;&nbsp; (0.18)%<br>| 60<br> %<br>|
| IB | 26.48 | (0.11)<br>| 0.18 <br><sup>(6)</sup><br>| 0.07 |  | (5.30)<br>| (5.30)<br>| 21.25 | (0.65)<br>| &nbsp;&nbsp; 67317 | 1.01 | 1.01 | &nbsp;&nbsp; (0.43)<br>| 60 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $27.35 | $(0.08)<br>| $1.78 | $1.70 | $— | $(0.68)<br>| $(0.68)<br>| $28.37 | 6.28<br> %<br>| &nbsp;&nbsp; $752764 | 0.75<br> %<br>| 0.75<br> %<br>| &nbsp;&nbsp; (0.28)%<br>| 75<br> %<br>|
| IB | 25.63 | (0.14)<br>| 1.67 | 1.53 |  | (0.68)<br>| (0.68)<br>| 26.48 | 6.03 | &nbsp;&nbsp; 80229 | 1.00 | 1.00 | &nbsp;&nbsp; (0.52)<br>| 75 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $25.69 | $(0.03)<br>| $3.67 | $3.64 | $(0.01)<br>| $(1.97)<br>| $(1.98)<br>| $27.35 | 14.83<br> %<br>| &nbsp;&nbsp; $1009741 | 0.73<br> %<br>| 0.73<br> %<br>| &nbsp;&nbsp; (0.10)%<br>| 40<br> %<br>|
| IB | 24.24 | (0.09)<br>| 3.45 | 3.36 |  | (1.97)<br>| (1.97)<br>| 25.63 | 14.54 | &nbsp;&nbsp; 91415 | 0.98 | 0.98 | &nbsp;&nbsp; (0.35)<br>| 40 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $40.31 | $0.02 | $(9.57)<br>| $(9.55)<br>| $(0.29)<br>| $(4.78)<br>| $(5.07)<br>| $25.69 | (24.27)%<br>| &nbsp;&nbsp; $1051771 | 0.71<br> %<br>| 0.71<br> %<br>| 0.06<br> %<br>| 44<br> %<br>|
| IB | 38.35 | (0.05)<br>| (9.09)<br>| (9.14)<br>| (0.19)<br>| (4.78)<br>| (4.97)<br>| 24.24 | (24.46)<br>| &nbsp;&nbsp; 88337 | 0.96 | 0.96 | &nbsp;&nbsp; (0.18)<br>| 44 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $43.44 | $0.29 | $3.97 | $4.26 | $— | $(7.39)<br>| $(7.39)<br>| $40.31 | 9.91<br> %<br>| &nbsp;&nbsp; $1973242 | 0.69<br> %<br>| 0.69<br> %<br>| 0.65<br> %<br>| 28<br> %<br>|
| IB | 41.76 | 0.15 | 3.83 | 3.98 |  | (7.39)<br>| (7.39)<br>| 38.35 | 9.62 | &nbsp;&nbsp; 130071 | 0.94 | 0.94 | 0.37 | 28 |
| **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  | **Hartford Small Cap Growth HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $29.00 | $(0.05)<br>| $1.57 | $1.52 | $(0.81)<br>| $(5.13)<br>| $(5.94)<br>| $24.58 | 6.83<br> %<br>| &nbsp;&nbsp; $338495 | 0.66<br> %<br>| 0.66<br> %<br>| &nbsp;&nbsp; (0.18)%<br>| 86<br> %<br>|
| IB | 27.09 | (0.10)<br>| 1.42 | 1.32 | (0.74)<br>| (5.13)<br>| (5.87)<br>| 22.54 | 6.54 | &nbsp;&nbsp; 208005 | 0.91 | 0.91 | &nbsp;&nbsp; (0.43)<br>| 86 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $25.71 | $(0.04)<br>| $3.41 | $3.37 | $(0.08)<br>| $— | $(0.08)<br>| $29.00 | 13.12<br> %<br>| &nbsp;&nbsp; $361596 | 0.65<br> %<br>| 0.65<br> %<br>| &nbsp;&nbsp; (0.15)%<br>| 69<br> %<br>|
| IB | 24.03 | (0.10)<br>| 3.19 | 3.09 | (0.03)<br>|  | (0.03)<br>| 27.09 | 12.84 | &nbsp;&nbsp; 202716 | 0.90 | 0.90 | &nbsp;&nbsp; (0.39)<br>| 69 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $21.71 | $0.02 | $3.98 | $4.00 | $— | $— | $— | $25.71 | 18.42<br> %<br>| &nbsp;&nbsp; $569738 | 0.65<br> %<br>| 0.65<br> %<br>| 0.08<br> %<br>| 63<br> %<br>|
| IB | 20.35 | (0.04)<br>| 3.72 | 3.68 |  |  |  | 24.03 | 18.08 | &nbsp;&nbsp; 192744 | 0.90 | 0.90 | &nbsp;&nbsp; (0.16)<br>| 63 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $36.60 | $(0.02)<br>| $(10.09)<br>| $(10.11)<br>| $— | $(4.78)<br>| $(4.78)<br>| $21.71 | (28.46)%<br>| &nbsp;&nbsp; $522920 | 0.64<br> %<br>| 0.64<br> %<br>| &nbsp;&nbsp; (0.06)%<br>| 52<br> %<br>|
| IB | 34.77 | (0.07)<br>| (9.57)<br>| (9.64)<br>|  | (4.78)<br>| (4.78)<br>| 20.35 | (28.61)<br>| &nbsp;&nbsp; 170021 | 0.89 | 0.89 | &nbsp;&nbsp; (0.30)<br>| 52 |

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

67 <br>

------

**Hartford HLS Funds**

***Financial Highlights – (continued)***

------

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** |
| **Class**  | **Net**<br> **Asset**<br> **Value at**<br> **Beginning**<br> **of Period**<br>| **Net**<br> **Investment**<br> **Income**<br> **(Loss)**<br>| **Net**<br> **Realized**<br> **and**<br> **Unrealized**<br> **Gain (Loss)**<br> **on**<br> **Investments**<br>| **Total from**<br> **Investment**<br> **Operations**<br>| **Dividends**<br> **from Net**<br> **Investment**<br> **Income**<br>| **Distributions**<br> **from**<br> **Capital**<br> **Gains**<br>| **Total**<br> **Dividends**<br> **and**<br> **Distributions**<br>| **Net**<br> **Asset**<br> **Value at**<br> **End of**<br> **Period**<br>| **Total**<br> **Return**<sup>(2)</sup><br>| **Net**<br> **Assets**<br> **at End**<br> **of Period**<br> **(000s)**<br>| **Ratio of**<br> **Expenses**<br> **to**<br> **Average**<br> **Net**<br> **Assets**<br> **Before**<br> **Adjust-**<br> **ments**<sup>(3)(4)</sup><br>| **Ratio of**<br> **Expenses**<br> **to**<br> **Average**<br> **Net**<br> **Assets**<br> **After**<br> **Adjust-**<br> **ments**<sup>(3)(4)</sup><br>| **Ratio of**<br> **Net**<br> **Investment**<br> **Income**<br> **(Loss) to**<br> **Average**<br> **Net Assets**<br>| **Portfolio**<br> **Turnover**<br>|
| **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  | **Hartford Small Cap Growth HLS Fund – (continued)**  |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $38.15 | $(0.04)<br>| $1.68 | $1.64 | $— | $(3.19)<br>| $(3.19)<br>| $36.60 | 4.02<br> %<br>| &nbsp;&nbsp; $1153860 | 0.63<br> %<br>| 0.63<br> %<br>| &nbsp;&nbsp; (0.11)%<br>| 44<br> %<br>|
| IB | 36.48 | (0.13)<br>| 1.61 | 1.48 |  | (3.19)<br>| (3.19)<br>| 34.77 | 3.76 | &nbsp;&nbsp; 224883 | 0.88 | 0.88 | &nbsp;&nbsp; (0.36)<br>| 44 |
| **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  | **Hartford Small Company HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $17.73 | $(0.04)<br>| $2.33 | $2.29 | $(0.08)<br>| $— | $(0.08)<br>| $19.94 | 12.96<br> %<br>| &nbsp;&nbsp; $388919 | 0.81<br> %<br>| 0.81<br> %<br>| &nbsp;&nbsp; (0.24)%<br>| 68<br> %<br>|
| IB | 14.61 | (0.07)<br>| 1.92 | 1.85 | (0.04)<br>|  | (0.04)<br>| 16.42 | 12.68 | &nbsp;&nbsp; 37256 | 1.06 | 1.06 | &nbsp;&nbsp; (0.49)<br>| 68 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $15.83 | $(0.03)<br>| $1.93 | $1.90 | $— | $— | $— | $17.73 | 12.00<br> %<br>| &nbsp;&nbsp; $388252 | 0.80<br> %<br>| 0.80<br> %<br>| &nbsp;&nbsp; (0.17)%<br>| 41<br> %<br>|
| IB | 13.09 | (0.06)<br>| 1.58 | 1.52 |  |  |  | 14.61 | 11.61 | &nbsp;&nbsp; 38477 | 1.05 | 1.05 | &nbsp;&nbsp; (0.42)<br>| 41 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $13.57 | $(0.00 )<sup>(7)</sup><br>| $2.26 | $2.26 | $— | $— | $— | $15.83 | 16.65<br> %<br>| &nbsp;&nbsp; $392112 | 0.80<br> %<br>| 0.80<br> %<br>| 0.01<br> %<br>| 39<br> %<br>|
| IB | 11.24 | (0.03)<br>| 1.88 | 1.85 |  |  |  | 13.09 | 16.46 | &nbsp;&nbsp; 40059 | 1.05 | 1.05 | &nbsp;&nbsp; (0.24)<br>| 39 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $24.57 | $(0.01)<br>| $(7.33)<br>| $(7.34)<br>| $— | $(3.66)<br>| $(3.66)<br>| $13.57 | (30.88)%<br>| &nbsp;&nbsp; $379584 | 0.79<br> %<br>| 0.79<br> %<br>| &nbsp;&nbsp; (0.08)%<br>| 87<br> %<br>|
| IB | 21.25 | (0.05)<br>| (6.30)<br>| (6.35)<br>|  | (3.66)<br>| (3.66)<br>| 11.24 | (31.07)<br>| &nbsp;&nbsp; 38011 | 1.04 | 1.04 | &nbsp;&nbsp; (0.33)<br>| 87 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $27.44 | $(0.14)<br>| $0.66 | $0.52 | $— | $(3.39)<br>| $(3.39)<br>| $24.57 | 1.56<br> %<br>| &nbsp;&nbsp; $590597 | 0.77<br> %<br>| 0.77<br> %<br>| &nbsp;&nbsp; (0.51)%<br>| 111<br> %<br>|
| IB | 24.23 | (0.19)<br>| 0.60 | 0.41 |  | (3.39)<br>| (3.39)<br>| 21.25 | 1.30 | &nbsp;&nbsp; 60025 | 1.02 | 1.02 | &nbsp;&nbsp; (0.79)<br>| 111 |
| **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  | **Hartford Stock HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $100.50 | $1.17 | $6.41 | $7.58 | $(1.12)<br>| $(13.63)<br>| $(14.75)<br>| $93.33 | 7.97<br> %<br>| &nbsp;&nbsp; $1113128 | 0.52<br> %<br>| 0.52<br> %<br>| 1.19<br> %<br>| 36<br> %<br>|
| IB | 100.42 | 0.92 | 6.39 | 7.31 | (0.88)<br>| (13.63)<br>| (14.51)<br>| 93.22 | 7.69 | &nbsp;&nbsp; 98444 | 0.77 | 0.77 | 0.94 | 36 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $96.68 | $1.48 | $7.06 | $8.54 | $(1.65)<br>| $(3.07)<br>| $(4.72)<br>| $100.50 | 8.74<br> %<br>| &nbsp;&nbsp; $1177593 | 0.51<br> %<br>| 0.51<br> %<br>| 1.45<br> %<br>| 16<br> %<br>|
| IB | 96.60 | 1.22 | 7.05 | 8.27 | (1.38)<br>| (3.07)<br>| (4.45)<br>| 100.42 | 8.47 | &nbsp;&nbsp; 104206 | 0.76 | 0.76 | 1.20 | 16 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $95.62 | $1.45 | $5.62 | $7.07 | $(1.25)<br>| $(4.76)<br>| $(6.01)<br>| $96.68 | 7.72<br> %<br>| &nbsp;&nbsp; $1228741 | 0.51<br> %<br>| 0.51<br> %<br>| 1.53<br> %<br>| 8<br> %<br>|
| IB | 95.55 | 1.21 | 5.61 | 6.82 | (1.01)<br>| (4.76)<br>| (5.77)<br>| 96.60 | 7.45 | &nbsp;&nbsp; 110872 | 0.76 | 0.76 | 1.28 | 8 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $113.91 | $1.40 | $(7.51)<br>| $(6.11)<br>| $(1.62)<br>| $(10.56)<br>| $(12.18)<br>| $95.62 | (5.14)%<br>| &nbsp;&nbsp; $1286070 | 0.51<br> %<br>| 0.51<br> %<br>| 1.37<br> %<br>| 10<br> %<br>|
| IB | 113.84 | 1.14 | (7.50)<br>| (6.36)<br>| (1.37)<br>| (10.56)<br>| (11.93)<br>| 95.55 | (5.37)<br>| &nbsp;&nbsp; 118218 | 0.76 | 0.76 | 1.12 | 10 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $95.52 | $1.38 | $22.20 | $23.58 | $(1.30)<br>| $(3.89)<br>| $(5.19)<br>| $113.91 | 24.98<br> %<br>| &nbsp;&nbsp; $1506206 | 0.51<br> %<br>| 0.51<br> %<br>| 1.32<br> %<br>| 15<br> %<br>|
| IB | 95.48 | 1.12 | 22.15 | 23.27 | (1.02)<br>| (3.89)<br>| (4.91)<br>| 113.84 | 24.67 | &nbsp;&nbsp; 142700 | 0.76 | 0.76 | 1.07 | 15 |
| **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  | **Hartford Total Return Bond HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $9.45 | $0.39 | $0.29 | $0.68 | $(0.54)<br>| $— | $(0.54)<br>| $9.59 | 7.30<br> %<br>| &nbsp;&nbsp; $1243513 | 0.51<br> %<br>| 0.51<br> %<br>| 4.06<br> %<br>| 53 %<sup>(8)</sup><br>|
| IB | 9.40 | 0.36 | 0.29 | 0.65 | (0.51)<br>|  | (0.51)<br>| 9.54 | 7.04 | &nbsp;&nbsp; 142904 | 0.76 | 0.76 | 3.80 | 53 <br><sup>(8)</sup><br>|
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $9.57 | $0.39 | $(0.16)<br>| $0.23 | $(0.35)<br>| $— | $(0.35)<br>| $9.45 | 2.33<br> %<br>| &nbsp;&nbsp; $1571992 | 0.51<br> %<br>| 0.51<br> %<br>| 4.11<br> %<br>| 50 %<sup>(8)</sup><br>|
| IB | 9.52 | 0.37 | (0.16)<br>| 0.21 | (0.33)<br>|  | (0.33)<br>| 9.40 | 2.07 | &nbsp;&nbsp; 152153 | 0.76 | 0.76 | 3.86 | 50 <br><sup>(8)</sup><br>|

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

68 <br>

------

**Hartford HLS Funds**

***Financial Highlights – (continued)***

------

---

| | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Selected Per-Share Data***<sup>(1)</sup> ***—*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** | ***— Ratios and Supplemental Data —*** |
| **Class**  | **Net**<br> **Asset**<br> **Value at**<br> **Beginning**<br> **of Period**<br>| **Net**<br> **Investment**<br> **Income**<br> **(Loss)**<br>| **Net**<br> **Realized**<br> **and**<br> **Unrealized**<br> **Gain (Loss)**<br> **on**<br> **Investments**<br>| **Total from**<br> **Investment**<br> **Operations**<br>| **Dividends**<br> **from Net**<br> **Investment**<br> **Income**<br>| **Distributions**<br> **from**<br> **Capital**<br> **Gains**<br>| **Total**<br> **Dividends**<br> **and**<br> **Distributions**<br>| **Net**<br> **Asset**<br> **Value at**<br> **End of**<br> **Period**<br>| **Total**<br> **Return**<sup>(2)</sup><br>| **Net**<br> **Assets**<br> **at End**<br> **of Period**<br> **(000s)**<br>| **Ratio of**<br> **Expenses**<br> **to**<br> **Average**<br> **Net**<br> **Assets**<br> **Before**<br> **Adjust-**<br> **ments**<sup>(3)(4)</sup><br>| **Ratio of**<br> **Expenses**<br> **to**<br> **Average**<br> **Net**<br> **Assets**<br> **After**<br> **Adjust-**<br> **ments**<sup>(3)(4)</sup><br>| **Ratio of**<br> **Net**<br> **Investment**<br> **Income**<br> **(Loss) to**<br> **Average**<br> **Net Assets**<br>| **Portfolio**<br> **Turnover**<br>|
| **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  | **Hartford Total Return Bond HLS Fund – (continued)**  |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $9.27 | $0.35 | $0.28 | $0.63 | $(0.33)<br>| $— | $(0.33)<br>| $9.57 | 6.97<br> %<br>| &nbsp;&nbsp; $1621072 | 0.50<br> %<br>| 0.50<br> %<br>| 3.77<br> %<br>| 52 %<sup>(8)</sup><br>|
| IB | 9.22 | 0.33 | 0.27 | 0.60 | (0.30)<br>|  | (0.30)<br>| 9.52 | 6.69 | &nbsp;&nbsp; 166540 | 0.75 | 0.75 | 3.51 | 52 <br><sup>(8)</sup><br>|
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $11.29 | $0.29 | $(1.88)<br>| $(1.59)<br>| $(0.31)<br>| $(0.12)<br>| $(0.43)<br>| $9.27 | (14.21)%<br>| &nbsp;&nbsp; $1592156 | 0.50<br> %<br>| 0.50<br> %<br>| 2.87<br> %<br>| 58 %<sup>(8)</sup><br>|
| IB | 11.22 | 0.26 | (1.87)<br>| (1.61)<br>| (0.27)<br>| (0.12)<br>| (0.39)<br>| 9.22 | (14.41)<br>| &nbsp;&nbsp; 175651 | 0.75 | 0.75 | 2.62 | 58 <br><sup>(8)</sup><br>|
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $11.98 | $0.24 | $(0.35)<br>| $(0.11)<br>| $(0.29)<br>| $(0.29)<br>| $(0.58)<br>| $11.29 | (0.95)%<br>| &nbsp;&nbsp; $2045579 | 0.50<br> %<br>| 0.50<br> %<br>| 2.09<br> %<br>| 61 %<sup>(8)</sup><br>|
| IB | 11.91 | 0.21 | (0.35)<br>| (0.14)<br>| (0.26)<br>| (0.29)<br>| (0.55)<br>| 11.22 | (1.18)<br>| &nbsp;&nbsp; 237952 | 0.75 | 0.75 | 1.84 | 61 <br><sup>(8)</sup><br>|
| **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  | **Hartford Ultrashort Bond HLS Fund**  |
| For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  | For the Year Ended December 31, 2025  |
| IA | $10.41 | $0.43 | $0.03 | $0.46 | $(0.54)<br>| $— | $(0.54)<br>| $10.33 | 4.51<br> %<br>| &nbsp;&nbsp; $429581 | 0.45<br> %<br>| 0.45<br> %<br>| 4.13<br> %<br>| 70<br> %<br>|
| IB | 10.40 | 0.41 | 0.03 | 0.44 | (0.51)<br>|  | (0.51)<br>| 10.33 | 4.32 | &nbsp;&nbsp; 64140 | 0.70 | 0.70 | 3.88 | 70 |
| For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  | For the Year Ended December 31, 2024  |
| IA | $10.34 | $0.49 | $0.04 | $0.53 | $(0.46)<br>| $— | $(0.46)<br>| $10.41 | 5.20<br> %<br>| &nbsp;&nbsp; $458676 | 0.45<br> %<br>| 0.45<br> %<br>| 4.67<br> %<br>| 63<br> %<br>|
| IB | 10.33 | 0.46 | 0.04 | 0.50 | (0.43)<br>|  | (0.43)<br>| 10.40 | 4.91 | &nbsp;&nbsp; 69288 | 0.70 | 0.70 | 4.42 | 63 |
| For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  | For the Year Ended December 31, 2023  |
| IA | $9.96 | $0.40 | $0.11 | $0.51 | $(0.13)<br>| $— | $(0.13)<br>| $10.34 | 5.18<br> %<br>| &nbsp;&nbsp; $486165 | 0.44<br> %<br>| 0.44<br> %<br>| 3.95<br> %<br>| 56<br> %<br>|
| IB | 9.95 | 0.37 | 0.11 | 0.48 | (0.10)<br>|  | (0.10)<br>| 10.33 | 4.88 | &nbsp;&nbsp; 75619 | 0.69 | 0.69 | 3.70 | 56 |
| For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  | For the Year Ended December 31, 2022  |
| IA | $10.00 | $0.11 | $(0.13)<br>| $(0.02)<br>| $(0.02)<br>| $— | $(0.02)<br>| $9.96 | (0.17)%<br>| &nbsp;&nbsp; $529433 | 0.43<br> %<br>| 0.43<br> %<br>| 1.10<br> %<br>| 66<br> %<br>|
| IB | 9.99 | 0.08 | (0.12)<br>| (0.04)<br>|  |  |  | 9.95 | (0.40)<br>| &nbsp;&nbsp; 83560 | 0.68 | 0.68 | 0.84 | 66 |
| For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  | For the Year Ended December 31, 2021  |
| IA | $10.09 | $0.02 | $(0.04)<br>| $(0.02)<br>| $(0.07)<br>| $— | $(0.07)<br>| $10.00 | (0.19)%<br>| &nbsp;&nbsp; $605732 | 0.44<br> %<br>| 0.44<br> %<br>| 0.15<br> %<br>| 73<br> %<br>|
| IB | 10.09 | (0.01)<br>| (0.04)<br>| (0.05)<br>| (0.05)<br>|  | (0.05)<br>| 9.99 | (0.46)<br>| &nbsp;&nbsp; 97279 | 0.69 | 0.69 | &nbsp;&nbsp; (0.10)<br>| 73 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **FINANCIAL HIGHLIGHTS FOOTNOTES**  | **FINANCIAL HIGHLIGHTS FOOTNOTES**  |
| <sup>(1)</sup> | Information presented relates to a share outstanding throughout the indicated period. Net investment income (loss) per share amounts are calculated based on average <br> shares outstanding unless otherwise noted.<br>|
| <sup>(2)</sup> | The figures do not include sales charges or other fees which may be applied at the variable contract level or by a qualified pension or retirement plan. Any such additional sales charges <br> or other fees would lower the Fund's performance.<br>|
| <sup>(3)</sup> | Ratios do not include expenses of other investment companies, if applicable. |
| <sup>(4)</sup> | Adjustments include waivers and reimbursements, if applicable. Ratios do not include fees paid indirectly (see Expenses in the accompanying Notes to Financial Statements).  |
| <sup>(5)</sup> | Portfolio turnover excludes TBA roll transactions. Had TBA roll transactions been included, the portfolio turnover rate would have been 67%, 55%, 59%, 61% and 49% for the fiscal <br> years ended December 31, 2025, December 31, 2024, December 31, 2023, December 31, 2022 and December 31, 2021, respectively.<br>|
| <sup>(6)</sup> | Per share amount was not in accord with the net realized and unrealized gain (loss) for the period because of the timing of transactions in shares of the Fund and the amount and <br> timing of per-share net realized and unrealized gain (loss) on such shares.<br>|
| <sup>(7)</sup> | Per share amount is less than $0.005. |
| <sup>(8)</sup> | Portfolio turnover excludes TBA roll transactions. Had TBA roll transactions been included, the portfolio turnover rate would have been 378%, 354%, 422%, 431% and 494% for the <br> fiscal years ended December 31, 2025, December 31, 2024, December 31, 2023, December 31, 2022 and December 31, 2021, respectively .<br>|

---

*The accompanying notes are an integral part of these financial statements.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

69 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements***

 ***December 31, 2025*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**1.** **Organization:**

Hartford Series Fund, Inc. (the "Company") is an open-end registered management investment company comprised of twelve series, as of December 31, 2025. Financial statements for the series of the Company listed below (each, a "Fund" and collectively, the "Funds") are included in this report.

---

| |
|:---|
| Hartford Series Fund, Inc.:  |
| Hartford Balanced HLS Fund (the "Balanced HLS Fund")  |
| Hartford Capital Appreciation HLS Fund (the "Capital Appreciation HLS Fund")  |
| Hartford Disciplined Equity HLS Fund (the "Disciplined Equity HLS Fund")  |
| Hartford Dividend and Growth HLS Fund (the "Dividend and Growth HLS Fund")  |
| Hartford Healthcare HLS Fund (the "Healthcare HLS Fund")  |
| Hartford International Opportunities HLS Fund (the "International Opportunities HLS Fund")  |
| Hartford MidCap HLS Fund (the "MidCap HLS Fund")  |
| Hartford Small Cap Growth HLS Fund (the "Small Cap Growth HLS Fund")  |
| Hartford Small Company HLS Fund (the "Small Company HLS Fund")  |
| Hartford Stock HLS Fund (the "Stock HLS Fund")  |
| Hartford Total Return Bond HLS Fund (the "Total Return Bond HLS Fund")  |
| Hartford Ultrashort Bond HLS Fund (the "Ultrashort Bond HLS Fund") |

---

The assets of each Fund are separate, and a shareholder's interest is limited to the Fund in which shares are held. The Company is organized under the laws of the State of Maryland and is registered with the U.S. Securities and Exchange Commission (the "SEC") under the Investment Company Act of 1940, as amended (the "1940 Act"). Each Fund serves as an underlying investment option for certain variable annuity and variable life insurance separate accounts of insurance companies and certain qualified pension or retirement plans. Owners of variable annuity contracts and policyholders of variable life insurance contracts may choose the Funds if permitted in the variable insurance contract prospectus. In addition, participants in certain qualified pension or retirement plans may choose the Funds if permitted by their plans.

At a meeting held February 13-14, 2024, the Board of Directors of Hartford HLS Series Fund II, Inc. approved the reorganization of the Hartford Small Cap Growth HLS Fund, a series of Hartford HLS Series Fund II, Inc., into a newly created "shell" series of the Company. Effective immediately before the opening of business on April 29, 2024, the Small Cap Growth HLS Fund, a series of the Company, acquired all of the assets and liabilities of the Hartford Small Cap Growth HLS Fund (the "Predecessor Fund"), a series of Hartford HLS Series Fund II, Inc., in a tax-free reorganization and adopted the accounting and performance history of the Predecessor Fund (the "Reorganization"). At the time of the Reorganization, the Small Cap Growth HLS Fund had the same investment objective, investment strategies, and investment policies as the Predecessor Fund.

Each Fund has registered for sale Class IA and IB shares. Each of Capital Appreciation HLS Fund and Disciplined Equity HLS Fund also has registered for sale Class IC shares. Class IA and Class IB shares of each Fund are closed to certain investors. Each of Small Cap Growth HLS Fund and Small Company HLS Fund is closed to new investors, subject to certain exceptions set forth in the Funds' prospectus. Each class is offered at the per share net asset value ("NAV") without a sales charge. Class IB shares are subject to distribution and service fees charged pursuant to a Distribution Plan adopted in accordance with Rule 12b-1 under the 1940 Act. Class IC shares are subject to distribution fees charged pursuant to a Distribution Plan adopted in accordance with Rule 12b-1 under the 1940 Act and Class IC shares are also subject to an administrative services fee.

Each Fund is a diversified open-end management investment company. Each Fund applies specialized accounting and reporting standards under Accounting Standards Codification Topic 946, "Financial Services – Investment Companies."

**2.** **Significant Accounting Policies:**

The following is a summary of significant accounting policies of each Fund used in the preparation of its financial statements, which are in accordance with United States Generally Accepted Accounting Principles ("U.S. GAAP"). The preparation of financial statements in accordance with U.S. GAAP may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)

*Determination of Net Asset Value* – The NAV of each class of each Fund's shares is determined as of the close of regular trading on the New York Stock Exchange (the "Exchange") (normally 4:00 p.m. Eastern Time) (the "NYSE Close") on each day that the Exchange is open

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

70 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

("Valuation Date"). If the Exchange is closed due to weather or other extraordinary circumstances on a day it would typically be open for business, each Fund may treat such day as a typical business day and accept purchase and redemption orders and calculate each Fund's NAV in accordance with applicable law. The NAV of each class of each Fund's shares is determined by dividing the value of the Fund's net assets attributable to the class of shares by the number of shares outstanding for that class. Information that becomes known to the Funds after the NAV has been calculated on a particular day will not generally be used to retroactively adjust the NAV determined earlier that day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)

*Investment Valuation and Fair Value Measurements* – For purposes of calculating the NAV of each class of each Fund, portfolio securities and other assets held in the Fund's portfolio for which market prices are readily available are valued at market value. Market value is generally determined on the basis of official close price or last reported trade price. If no trades were reported, market value is based on prices obtained from a quotation reporting system, established market makers (including evaluated prices), or independent pricing services. Pricing vendors may use matrix pricing or valuation models that utilize certain inputs and assumptions to derive values, including transaction data, credit quality information, general market conditions, news, and other factors and assumptions.

With respect to a Fund's investments that do not have readily available market prices, the Company's Board of Directors (the "Board") has designated Hartford Funds Management Company, LLC (the "Investment Manager" or "HFMC") as its valuation designee to perform fair valuations pursuant to Rule 2a-5 under the 1940 Act (the "Valuation Designee").

If market prices are not readily available or deemed unreliable, the Valuation Designee determines the fair value of the security or other instrument in good faith under policies and procedures approved by and under the supervision of the Board ("Valuation Procedures").

The Valuation Designee has delegated the day-to-day responsibility for implementing the Valuation Procedures to the Valuation Committee (the "Valuation Committee"). The Valuation Committee will consider all available relevant factors in determining an investment's fair value. The Valuation Designee reports fair value matters to the Audit Committee of the Board.

Prices of foreign equities that are principally traded on certain foreign markets will generally be adjusted daily pursuant to a fair value pricing service in order to reflect an adjustment for the factors occurring after the close of certain foreign markets but before the NYSE Close. Securities and other instruments that are primarily traded on foreign markets may trade on days that are not business days of the Funds. The value of the foreign securities or other instruments in which a Fund invests may change on days when a shareholder will not be able to purchase or redeem shares of the Fund.

Fixed income investments (other than short-term obligations) and non-exchange traded derivatives held by a Fund are normally valued at prices supplied by independent pricing services in accordance with the Valuation Procedures. Short-term investments maturing in 60 days or less are generally valued at amortized cost, which approximates fair value.

Exchange-traded derivatives, such as options, futures and options on futures, are valued at the last sale price determined by the exchange where such instruments principally trade as of the close of such exchange ("Exchange Close"). If a last sale price is not available, the value will be the mean of the most recently quoted bid and ask prices as of the Exchange Close. If a mean of the bid and ask prices cannot be calculated for the day, the value will be the most recently quoted bid price as of the Exchange Close. Over-the-counter derivatives are normally valued based on prices supplied by independent pricing services in accordance with the Valuation Procedures.

Investments valued in currencies other than U.S. dollars are converted to U.S. dollars using the prevailing spot currency exchange rates obtained from independent pricing services for calculation of the NAV. As a result, the NAV of a Fund's shares may be affected by changes in the value of currencies in relation to the U.S. dollar. The value of securities or other instruments traded in markets outside the United States or denominated in currencies other than the U.S. dollar may be affected significantly on a day that the Exchange is closed and the market value may change on days when an investor is not able to purchase or redeem shares of a Fund.

Foreign currency contracts represent agreements to exchange currencies on specific future dates at predetermined rates. Foreign currency contracts are valued using foreign currency exchange rates and forward rates as provided by an independent pricing service on the Valuation Date.

Shares of investment companies listed and traded on an exchange are valued in the same manner as any exchange-listed equity security. Investments in investment companies that are not listed or traded on an exchange ("Non-Traded Funds"), if any, are valued at the respective NAV of each Non-Traded Fund on the Valuation Date. Such Non-Traded Funds and listed investment companies may use fair value pricing as disclosed in their prospectuses.

Financial instruments for which prices are not available from an independent pricing service may be valued using quotations obtained from one or more dealers that make markets in the respective financial instrument in accordance with the Valuation Procedures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

71 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

U.S. GAAP defines fair value as the price that a Fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants. The U.S. GAAP fair value measurement standards require disclosure of a fair value hierarchy for each major category of assets and liabilities. Various inputs are used in determining the fair value of each Fund's investments. These inputs are summarized into three broad hierarchy levels. This hierarchy is based on whether the valuation inputs are observable or unobservable. These levels are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Quoted prices in active markets for identical investments. Level 1 may include exchange traded instruments, such as domestic equities, some foreign equities, options, futures, mutual funds, exchange traded funds, rights and warrants.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar investments; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 2 may include debt investments that are traded less frequently than exchange traded instruments and which are valued using independent pricing services; foreign equities, which are principally traded on certain foreign markets and are adjusted daily pursuant to a fair value pricing service in order to reflect an adjustment for the factors occurring after the close of certain foreign markets but before the NYSE Close; senior floating rate interests, which are valued using an aggregate of dealer bids; short-term investments, which are valued at amortized cost; and swaps, which are valued based upon the terms of each swap contract.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Significant unobservable inputs that are supported by limited or no market activity. Level 3 may include financial instruments whose values are determined using indicative market quotes or require significant management judgment or estimation. These unobservable valuation inputs may include estimates for current yields, maturity/duration, prepayment speed, and indicative market quotes for comparable investments along with other assumptions relating to credit quality, collateral value, complexity of the investment structure, general market conditions and liquidity. This category may include investments where trading has been halted or there are certain restrictions on trading. While these investments are priced using unobservable inputs, the valuation of these investments reflects the best available data and management believes the prices are a reasonable representation of exit price.

Valuation levels are not necessarily indicative of the risk associated with investing in such investments. Individual investments within any of the above mentioned asset classes may be assigned a different hierarchical level than those presented above, as individual circumstances dictate.

For additional information, refer to the Fair Value Summary and the Level 3 roll-forward reconciliation, if applicable, which follows each Fund's Schedule of Investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)

*Investment Transactions and Investment Income* – Investment transactions are recorded as of the trade date (the date the order to buy or sell is executed) for financial reporting purposes. Investments purchased or sold on a when-issued or delayed-delivery basis may be settled a month or more after the trade date. Realized gains and losses are determined on the basis of identified cost.

The trade date for senior floating rate interests purchased in the primary loan market is considered the date on which the loan allocations are determined. The trade date for senior floating rate interests purchased in the secondary loan market is the date on which the transaction is entered into.

Dividend income from domestic securities is accrued on the ex-dividend date. In general, dividend income from foreign securities is recorded on the ex-date; however, dividend notifications in certain foreign jurisdictions may not be available in a timely manner and as a result, such Fund will record the dividend as soon as the relevant details (i.e., rate per share, payment date, shareholders of record, etc.) are publicly available. Interest income, including amortization of premium, accretion of discounts, inflation adjustments and additional principal received in-kind in lieu of cash, is accrued on a daily basis. Paydown gains and losses on mortgage-related and other asset-backed securities are included in interest income in the Statements of Operations, as applicable.

Idle cash and currency balances may be swept into overnight sweep accounts held in a demand deposit account at State Street Bank and Trust Company ("State Street") that earn interest, which are classified as interest income on the Statements of Operations.

Please refer to Note 8 for Securities Lending information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)

*Taxes* – A Fund may be subject to taxes imposed on realized gains on securities of certain foreign countries in which such Fund invests. A Fund may also be subject to taxes withheld on foreign dividends and interest from securities in which such Fund invests. The amount of any foreign taxes withheld and foreign tax expense is included on the accompanying Statements of Operations as a reduction to net investment income or net realized or unrealized gain (loss) on investments in these securities, if applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e)

*Foreign Currency Transactions* – Assets and liabilities denominated in currencies other than U.S. dollars are translated into U.S. dollars at the exchange rates in effect on the Valuation Date. Purchases and sales of investments, income and expenses are translated into U.S. dollars at the exchange rates on the dates of such transactions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

72 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

A Fund does not isolate that portion of portfolio investment valuation resulting from fluctuations in the foreign currency exchange rates from the fluctuations arising from changes in the market prices of investments held. Exchange rate fluctuations are included with the net realized and unrealized gain or loss on investments in the accompanying financial statements.

Net realized foreign exchange gains or losses arise from sales of foreign currencies and the difference between asset and liability amounts initially stated in foreign currencies and the U.S. dollar value of the amounts actually received or paid. Net unrealized foreign exchange gains or losses arise from changes in the value of other assets and liabilities at the end of the reporting period, resulting from changes in the exchange rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f)

*Joint Trading Account* – A Fund may invest cash balances into a joint trading account that may be invested in one or more repurchase agreements. As of December 31, 2025, there were no repurchase agreements purchased through joint trading accounts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g)

*Fund Share Valuation and Dividend Distributions to Shareholders* – Orders for each class of each Fund's shares are executed in accordance with the investment instructions of the contract holders and plan participants. The NAV of each class of each Fund's shares is determined as of the close of business on each business day of the Exchange (see Note 2(a)). The NAV is determined separately for each class of shares of each Fund by dividing the Fund's net assets attributable to that class by the number of shares of the class outstanding. Each class of shares offered by each Fund has equal rights as to assets and voting privileges (except that shareholders of a class have exclusive voting rights regarding any matter relating solely to that class of shares). Income and non-class specific expenses are allocated daily to each class on the basis of the relative net assets of the class of the Fund. Realized and unrealized gains and losses are allocated daily based on the relative net assets of each class of shares of each Fund.

Orders for the purchase of a Fund's shares received prior to the close of the Exchange on any day the Exchange is open for business are priced at the NAV determined as of the close of the Exchange. Orders received after the close of the Exchange, or on a day on which the Exchange and/or the Funds are not open for business, are priced at the next determined NAV.

Dividends are declared pursuant to a policy adopted by the Company's Board of Directors. Dividends and/or distributions to shareholders are recorded on ex-date. The policy of each Fund is to pay dividends from net investment income and realized capital gains, if any, at least once per year. Income dividends and capital gains distributions are determined in accordance with federal income tax regulations, which may differ from U.S. GAAP with respect to character and timing (see Federal Income Taxes: Distributions and Components of Distributable Earnings and Reclassification of Capital Accounts notes).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h)

*Segment Reporting* – The Funds adopted Financial Accounting Standards Board Accounting Standards Update 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures ("ASU 2023-07"). Each Fund operates in one segment. The segment derives its revenues from Fund investments made in accordance with the defined investment strategy of such Fund, as prescribed in its prospectus. The Chief Operating Decision Maker ("CODM") is the Senior Leadership Committee of the Investment Manager. The CODM monitors the operating results of each Fund. The financial information the CODM leverages to assess the segment's performance and to make decisions for each Fund's single segment is consistent with that presented within the Fund's financial statements and financial highlights.

**3.** **Securities and Other Investments:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)

*Restricted Securities* – Each Fund may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities, if applicable, is included at the end of each Fund's Schedule of Investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)

*Investments Purchased on a When-Issued or Delayed-Delivery Basis* – Delivery and payment for investments that have been purchased by a Fund on a forward commitment, or when-issued or delayed-delivery basis, take place beyond the customary settlement period. A Fund may dispose of or renegotiate a delayed-delivery transaction after it is entered into, and may sell delayed-delivery investments before they are delivered, which may result in a realized gain or loss. During this period, such investments are subject to market fluctuations. See each Fund's Schedule of Investments, if applicable, for when-issued or delayed-delivery investments as of December 31, 2025.

A Fund may enter into to-be announced ("TBA") commitments. TBA commitments are forward agreements for the purchase or sale of mortgage-backed securities for a fixed price, with payment and delivery on an agreed-upon future settlement date. The specific securities to be delivered are not identified at the trade date; however, delivered securities must meet specified terms, including issuer, rate and mortgage terms. Although a Fund may enter into TBA commitments with the intention of acquiring or delivering securities for its portfolio, the Fund can extend the settlement date, roll the transaction, or dispose of a commitment prior to settlement if deemed appropriate to do so. If the TBA commitment is closed through the acquisition of an offsetting TBA commitment, a Fund realizes a gain or loss. In a TBA roll transaction, a Fund generally purchases or sells the initial TBA commitment prior to the agreed upon settlement date and enters into a new

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

73 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

TBA commitment for future delivery or receipt of the mortgage-backed securities. TBA commitments involve a risk of loss if the value of the security to be purchased or sold declines or increases, respectively, prior to settlement date. See each Fund's Schedule of Investments, if applicable, for TBA commitments as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)

*Senior Floating Rate Interests* – Certain Funds may invest in senior floating rate interests. Senior floating rate interests generally hold the most senior position in the capital structure of a business entity (the "Borrower"), are typically secured by specific collateral and have a claim on the assets and/or stock of the Borrower that is senior to that held by subordinated debt holders and stockholders of the Borrower. Senior floating rate interests are typically structured and administered by a financial institution that acts as the agent of the lenders participating in the senior floating rate interest. A Fund may invest in multiple series or tranches of a senior floating rate interest, which may have varying terms and carry different associated risks. A Fund may also enter into unfunded loan commitments, which are contractual obligations for future funding. Unfunded loan commitments may include revolving credit facilities, which may obligate a Fund to supply additional cash to the Borrower on demand. Unfunded loan commitments represent a future obligation in full. A Fund may receive a commitment fee based on the undrawn portion of the underlying line of credit portion of a senior floating rate interest. In certain circumstances, a Fund may receive various fees upon the restructure of a senior floating rate interest by a borrower. Fees earned/paid may be recorded as a component of income or realized gain/loss in the Statements of Operations.

Senior floating rate interests are typically rated below-investment-grade, which suggests they are more likely to default and generally pay higher interest rates than investment-grade loans. A default could lead to non-payment of income, which would result in a reduction of income to a Fund, and there can be no assurance that the liquidation of any collateral would satisfy the Borrower's obligation in the event of non-payment of scheduled interest or principal payments, or that such collateral could be readily liquidated. See each Fund's Schedule of Investments, if applicable, for outstanding senior floating rate interests as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)

*Mortgage-Related and Other Asset-Backed Securities* – A Fund may invest in mortgage-related and other asset-backed securities. These securities include mortgage pass-through securities, collateralized mortgage obligations, commercial mortgage-backed securities, stripped mortgage-backed securities, asset-backed securities, collateralized debt obligations and other securities that directly or indirectly represent a participation in, or are secured by and payable from, mortgage loans on real property. Mortgage-related securities are created from pools of residential or commercial mortgage loans, including mortgage loans made by savings and loan institutions, mortgage bankers, commercial banks and others. Asset-backed securities are created from many types of assets, including auto loans, credit card receivables, home equity loans, and student loans. These securities provide a monthly payment that consists of both interest and principal payments. Interest payments may be determined by fixed or adjustable rates. The rate of prepayments on underlying mortgages will affect the price and volatility of a mortgage-related security, and may have the effect of shortening or extending the effective duration of the security relative to what was anticipated at the time of purchase. The timely payment of principal and interest of certain mortgage-related securities is guaranteed by the full faith and credit of the United States Government. Mortgage-related and other asset-backed securities created and guaranteed by non-governmental issuers, including government-sponsored corporations, may be supported by various forms of insurance or guarantees, but there can be no assurance that the private insurers or guarantors can meet their obligations under the insurance policies or guarantee arrangements. See each Fund's Schedule of Investments, if applicable, for mortgage-related and other asset-backed securities as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e)

*Inflation-Indexed Bonds* – Certain Funds may invest in inflation-indexed bonds. Inflation-indexed bonds are fixed income investments whose principal value is periodically adjusted to the rate of inflation. The interest rate on these bonds is generally fixed at issuance at a rate lower than typical bonds. Over the life of an inflation-indexed bond, however, interest will be paid based on a principal value, which is adjusted for inflation. Any increase or decrease in the principal amount of an inflation-indexed bond will be included as interest income on the Statements of Operations, even though investors do not receive the principal amount until maturity. See each Fund's Schedule of Investments, if applicable, for inflation-indexed bonds as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f)

*Repurchase Agreements* – A repurchase agreement is an agreement between two parties whereby one party sells the other a security at a specified price with a commitment to repurchase the security later at an agreed-upon price, date and interest payment. Each Fund is permitted to enter into fully collateralized repurchase agreements. The Company's Board of Directors has delegated to the sub-adviser, as applicable, the responsibility of evaluating the creditworthiness of the banks and securities dealers with which the Funds will engage in repurchase agreements. The sub-adviser will monitor such transactions to ensure that the value of underlying collateral will be at least equal to the total amount of the repurchase obligation as required by the valuation provision of the repurchase agreement, including the accrued interest. Repurchase agreements carry the risk that the market value of the securities declines below the repurchase price. A Fund could also lose money if it is unable to recover the securities and the value of any collateral held is less than the value of the securities. In the event the borrower commences bankruptcy proceedings, a court may characterize the transaction as a loan. If a Fund has not perfected a security interest in the underlying collateral, the Fund may be required to return the underlying collateral to the borrower's estate and be treated as an unsecured creditor. As an unsecured creditor, the Fund could lose some or all of the principal and interest involved in the transaction. See each Fund's Schedule of Investments, if applicable, for repurchase agreements as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

74 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**4.** **Financial Derivative Instruments:**

The following disclosures contain information on the derivative instruments used by a Fund during the period, the credit-risk-related contingent features in certain derivative instruments, and how such derivative instruments affect the financial position and results of operations of the applicable Fund. The location and fair value amounts of these instruments on the Statements of Assets and Liabilities and the realized gains and losses and changes in unrealized gains and losses on the Statements of Operations, each categorized by type of derivative contract, are included in the following Additional Derivative Instrument Information footnote. The derivative instruments outstanding as of period-end are disclosed in the notes to the Schedules of Investments, if applicable. The amounts of realized gains and losses and changes in unrealized gains and losses on derivative instruments during the period are disclosed in the Statements of Operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)

*Futures Contracts* – A Fund may enter into futures contracts. A futures contract is an agreement between two parties to buy or sell an asset at a set price on a future date. A Fund may use futures contracts to manage risk or obtain exposure to the investment markets, commodities, or movements in interest rates and currency values. The primary risks associated with the use of futures contracts are the imperfect correlation between the change in market value of the investments held by a Fund and the prices of futures contracts and the possibility of an illiquid market. Upon entering into a futures contract, a Fund is required to deposit with a futures commission merchant ("FCM") an amount of cash or U.S. Government or Agency Obligations in accordance with the initial margin requirements of the broker or exchange. Futures contracts are marked to market daily and an appropriate amount equal to the change in value ("variation margin") is paid or received by a Fund. Gains or losses are recognized but not considered realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin disclosed on the Statements of Assets and Liabilities.

During the year ended December 31, 2025, each of Balanced HLS Fund, Capital Appreciation HLS Fund and Total Return Bond HLS Fund had used Futures Contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)

*Foreign Currency Contracts* – A Fund may enter into foreign currency contracts that obligate the Fund to purchase or sell currencies at specified future dates. Foreign currency contracts may be used in connection with settling purchases or sales of securities to hedge the currency exposure associated with some or all of a Fund's investments and/or as part of an investment strategy. Foreign currency contracts are marked to market daily and the change in value is recorded by a Fund as an unrealized gain or loss. A Fund will record a realized gain or loss when the foreign currency contract is settled.

Foreign currency contracts involve elements of market risk in excess of the amounts reflected in the Statements of Assets and Liabilities. In addition, risks may arise upon entering into these contracts from the potential inability of the counterparties to meet the terms of the contracts and from unanticipated movements in the value of the foreign currencies relative to the U.S. dollar. Upon entering into a foreign currency contract, a Fund may be required to post margin equal to its outstanding exposure thereunder.

During the year ended December 31, 2025, the Total Return Bond HLS Fund had used Foreign Currency Contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)

*Options Contracts* – An option contract is a contract sold by one party to another party that offers the buyer the right, but not the obligation, to buy (call) or sell (put) an investment or other financial asset at an agreed-upon price during a specific period of time or on a specific date. Option contracts are either over-the-counter ("OTC") options or executed in a registered exchange ("exchange-traded options"). A Fund may write (sell) covered call and put options on futures, swaps ("swaptions"), securities, commodities or currencies. Writing put options may increase a Fund's exposure to the underlying instrument. Writing call options may decrease a Fund's exposure to the underlying instrument. Premiums received from writing options that expire are treated as realized gains. Premiums received from writing options that are exercised or closed are added to the proceeds or offset amounts paid on the underlying futures, swaps, investments or currency transactions to determine the realized gain or loss. A Fund, as a writer of an option, has no control over whether the underlying instrument may be sold (call) or purchased (put) and as a result bears the market risk of an unfavorable change in the price of the instrument underlying the written option. There is the risk a Fund may not be able to enter into a closing transaction because of an illiquid market. A Fund may also purchase put and call options. Purchasing call options may increase a Fund's exposure to the underlying instrument. Purchasing put options may decrease a Fund's exposure to the underlying instrument. A Fund pays a premium, which is included on the Fund's Statements of Assets and Liabilities as an investment and is subsequently marked to market to reflect the current value of the option. Premiums paid for purchasing options that expire are treated as realized losses. Certain options may be purchased with premiums to be determined on a future date. The premiums for these options are based upon implied volatility parameters at specified terms. The risk associated with purchasing put and call options is generally limited to the premium paid. Premiums paid for purchasing options that are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain or loss. Entering into OTC options also exposes a Fund to counterparty risk. Counterparty risk is the possibility that the counterparty to the agreements may default on its obligation to perform or disagree as to the meaning of the contractual terms in the agreements.

During the year ended December 31, 2025, the Total Return Bond HLS Fund had used Options Contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

75 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)

*Swap Contracts* – A Fund may invest in swap contracts. Swap contracts are agreements to exchange or swap investment cash flows, assets, foreign currencies or market-linked returns at specified future intervals. Swap contracts are either privately negotiated in the over-the-counter market ("OTC swaps") or cleared through a central counterparty or derivatives clearing organization ("centrally cleared swaps"). A Fund may enter into credit default, total return, cross-currency, interest rate, inflation and other forms of swap contracts to manage its exposure to credit, currency, interest rate, commodity and inflation risk. Swap contracts are also used to gain exposure to certain markets. In connection with these contracts, investments or cash may be identified as collateral or margin in accordance with the terms of the respective swap contracts and/or master netting arrangement to provide assets of value and recourse in the event of default or bankruptcy/insolvency.

Swaps are valued in accordance with the Valuation Procedures. Changes in market value, if any, are reflected as a component of net changes in unrealized appreciation or depreciation on the Statements of Operations. Daily changes in valuation of centrally cleared swaps, if any, are recorded as a receivable or payable for the change in value ("variation margin") on the Statements of Assets and Liabilities. Realized gains or losses on centrally cleared swaps are recorded upon the termination of the swaps. OTC swap payments received or paid at the beginning of the measurement period are reflected as such on the Statements of Assets and Liabilities and represent premiums paid or received upon entering into the swap contract to compensate for differences between the stated terms of the swap contract and prevailing market conditions (credit spreads, currency exchange rates, interest rates and other relevant factors). These upfront premiums are recorded as realized gains or losses on the Statements of Operations upon termination or maturity of the swap. A liquidation payment received or made at the termination or maturity of the swap is recorded as a realized gain or loss on the Statements of Operations. Net periodic payments received or paid by a Fund are included as part of realized gains or losses on the Statements of Operations.

Entering into these contracts involves, to varying degrees, elements of liquidation, counterparty, credit and market risk in excess of the amounts recognized on the Statements of Assets and Liabilities. Such risks involve the possibility that there will be no liquid market for these contracts, that the counterparty to the contracts may default on its obligation to perform or disagree as to the meaning of contractual terms in the contracts, and that there may be unfavorable changes in market conditions (credit spreads, currency exchange rates, interest rates and other relevant factors).

To seek to mitigate counterparty risk associated with OTC swaps, a Fund may enter into a master netting arrangement between a Fund and the counterparty, which allows for the netting of payments made or received (although such amounts are presented on a gross basis within the Statements of Assets and Liabilities, as applicable) as well as the posting of collateral to a Fund to cover the Fund's exposure to the counterparty. In a centrally cleared swap, while a Fund enters into an agreement with a clearing broker to execute contracts with a counterparty, the performance of the swap is guaranteed by the central clearinghouse, which reduces the Fund's exposure to counterparty risk. However, the Fund is still exposed to a certain amount of counterparty risk through the clearing broker and clearinghouse. The clearinghouse attempts to minimize this risk to its participants through the use of mandatory margin requirements, daily cash settlements and other procedures. Likewise, the clearing broker reduces its risk through margin requirements and required segregation of customer balances.

*Interest Rate Swap Contracts* – A Fund may use interest rate swaps to hedge interest rate and duration risk. In a typical interest rate swap, one party agrees to make regular payments equal to a floating interest rate, based on a specified interest rate or benchmark (e.g. Secured Overnight Financing Rate ("SOFR")), multiplied by a notional amount, in return for payments equal to a fixed rate multiplied by the same amount, for a specific period of time. The net interest received or paid on interest rate swap contracts is recorded as a realized gain or loss. Interest rate swaps are marked to market daily and the change, if any, is recorded as an unrealized gain or loss in the Statements of Operations. When the interest rate swap contract is terminated early, a Fund records a realized gain or loss equal to the difference between the current market value and the upfront premium or cost.

If an interest rate swap contract provides for payments in different currencies, the parties might agree to exchange the notional amount as well. Interest rate swaps may also depend on other prices or rates, such as the value of an index. The risks of interest rate swaps include changes in market conditions, which will affect the value of the contract or the cash flows and the possible inability of the counterparty to fulfill its obligations under the contract.

During the year ended December 31, 2025, the Total Return Bond HLS Fund had used Interest Rate Swap Contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

76 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e)

*Additional Derivative Instrument Information:*

**Balanced HLS Fund** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** |
|  | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** |
|  | **Interest Rate** <br>**Contracts**<br>| **Foreign** <br>**Currency** <br>**Contracts**<br>| **Credit** <br>**Contracts**<br>| **Equity** <br>**Contracts**<br>| **Commodity** <br>**Contracts**<br>| **Total** |
| **Realized Gain (Loss) on Derivatives Recognized as a Result of Operations:** |  |  |  |  |  |  |
| Net realized gain (loss) on futures contracts | &nbsp;&nbsp; $128154 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $128154 |
| Total | &nbsp;&nbsp; $128154 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $128154 |
| **Net Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized** <br> **as a Result of Operations:**<br>|  |  |  |  |  |  |
| Net change in unrealized appreciation (depreciation) of futures contracts | &nbsp;&nbsp; $(22182)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(22182)<br>|
| Total | &nbsp;&nbsp; $(22182)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(22182)<br>|

---

**For the year ended December 31, 2025, the average monthly amount or number per contract outstanding for each derivative type was as follows:** 

---

| | |
|:---|:---|
| **Derivative Description** | **Average Notional** <br>**Par, Contracts** <br>**or Face Amount**<br>|
| Futures Contracts Number of Long Contracts | &nbsp;&nbsp; 41 |
| Futures Contracts Number of Short Contracts | &nbsp;&nbsp; (1)<br>|

---

**Capital Appreciation HLS Fund** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** |
|  | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** |
|  | **Interest Rate** <br>**Contracts**<br>| **Foreign** <br>**Currency** <br>**Contracts**<br>| **Credit** <br>**Contracts**<br>| **Equity** <br>**Contracts**<br>| **Commodity** <br>**Contracts**<br>| **Total** |
| **Liabilities:** |  |  |  |  |  |  |
| Unrealized depreciation on futures contracts<sup>(1)</sup> <br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $720606 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $720606 |
| Total | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $720606 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $720606 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> Amount represents the cumulative appreciation and depreciation on futures contracts as disclosed within the Schedule of Investments under the open "Futures Contracts" section. Only current day's variation margin, if any, is reported within the Statement of Assets and Liabilities. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** |
|  | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** |
|  | **Interest Rate** <br>**Contracts**<br>| **Foreign** <br>**Currency** <br>**Contracts**<br>| **Credit** <br>**Contracts**<br>| **Equity** <br>**Contracts**<br>| **Commodity** <br>**Contracts**<br>| **Total** |
| **Realized Gain (Loss) on Derivatives Recognized as a Result of Operations:** |  |  |  |  |  |  |
| Net realized gain (loss) on futures contracts | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $6621584 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $6621584 |
| Total | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $6621584 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $6621584 |
| **Net Change in Unrealized Appreciation (Depreciation) on Derivatives** <br> **Recognized as a Result of Operations:**<br>|  |  |  |  |  |  |
| Net change in unrealized appreciation (depreciation) of futures contracts | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $1578131 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $1578131 |
| Total | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $1578131 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $1578131 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

77 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

**Capital Appreciation HLS Fund – (continued)** 

**For the year ended December 31, 2025, the average monthly amount or number per contract outstanding for each derivative type was as follows:** 

---

| | |
|:---|:---|
| **Derivative Description** | **Average Notional** <br>**Par, Contracts** <br>**or Face Amount**<br>|
| Futures Contracts Number of Long Contracts | &nbsp;&nbsp; 199 |

---

**Total Return Bond HLS Fund** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Assets and Liabilities as of December 31, 2025:** |
|  | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** |
|  | **Interest Rate** <br>**Contracts**<br>| **Foreign** <br>**Currency** <br>**Contracts**<br>| **Credit** <br>**Contracts**<br>| **Equity** <br>**Contracts**<br>| **Commodity** <br>**Contracts**<br>| **Total** |
| **Assets:** |  |  |  |  |  |  |
| Unrealized appreciation on futures contracts<sup>(1)</sup> <br>| &nbsp;&nbsp; $603859 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $603859 |
| Unrealized appreciation on foreign currency contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; 1378 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1378 |
| Unrealized appreciation on swap contracts<sup>(2)</sup> <br>| &nbsp;&nbsp; 3676964 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 3676964 |
| Total | &nbsp;&nbsp; $4280823 | &nbsp;&nbsp; $1378 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $4282201 |
| **Liabilities:** |  |  |  |  |  |  |
| Unrealized depreciation on futures contracts<sup>(1)</sup> <br>| &nbsp;&nbsp; $603524 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $603524 |
| Unrealized depreciation on foreign currency contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; 48665 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 48665 |
| Unrealized depreciation on swap contracts<sup>(2)</sup> <br>| &nbsp;&nbsp; 95218 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 95218 |
| Total | &nbsp;&nbsp; $698742 | &nbsp;&nbsp; $48665 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $747407 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> Amount represents the cumulative appreciation and depreciation on futures contracts as disclosed within the Schedule of Investments under the open "Futures Contracts" section. Only current day's variation margin, if any, is reported within the Statement of Assets and Liabilities. 

<sup>(2)</sup> Amount represents the cumulative appreciation and depreciation on centrally cleared swaps, if applicable, as disclosed within the Schedule of Investments. Only the current day's variation margin, if any, is reported within the Statement of Assets and Liabilities. OTC swaps are reported within the Statement of Assets and Liabilities within Unrealized appreciation and depreciation on OTC swap contracts, if applicable. 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** | **The Effect of Derivative Instruments on the Statement of Operations for the year ended December 31, 2025:** |
|  | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** | **Risk Exposure Category** |
|  | **Interest Rate** <br>**Contracts**<br>| **Foreign** <br>**Currency** <br>**Contracts**<br>| **Credit** <br>**Contracts**<br>| **Equity** <br>**Contracts**<br>| **Commodity** <br>**Contracts**<br>| **Total** |
| **Realized Gain (Loss) on Derivatives Recognized as a Result of** <br> **Operations:**<br>|  |  |  |  |  |  |
| Net realized gain (loss) on purchased options contracts | &nbsp;&nbsp; $(47999)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(47999)<br>|
| Net realized gain (loss) on futures contracts | &nbsp;&nbsp; (3893486)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (3893486)<br>|
| Net realized gain (loss) on swap contracts | &nbsp;&nbsp; 1436408 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1436408 |
| Net realized gain (loss) on foreign currency contracts | &nbsp;&nbsp; — | &nbsp;&nbsp; (2381881)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (2381881)<br>|
| Total | &nbsp;&nbsp; $(2505077)<br>| &nbsp;&nbsp; $(2381881)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(4886958)<br>|
| **Net Change in Unrealized Appreciation (Depreciation) on Derivatives** <br> **Recognized as a Result of Operations:**<br>|  |  |  |  |  |  |
| Net change in unrealized appreciation (depreciation) of futures contracts | &nbsp;&nbsp; $718591 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $718591 |
| Net change in unrealized appreciation (depreciation) of swap contracts | &nbsp;&nbsp; (1057540)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (1057540)<br>|
| Net change in unrealized appreciation (depreciation) of foreign currency <br> contracts<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; (686004)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (686004)<br>|
| Total | &nbsp;&nbsp; $(338949)<br>| &nbsp;&nbsp; $(686004)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(1024953)<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

78 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

**Total Return Bond HLS Fund – (continued)** 

**For the year ended December 31, 2025, the average monthly amount or number per contract outstanding for each derivative type was as follows:** 

---

| | |
|:---|:---|
| **Derivative Description** | **Average Notional** <br>**Par, Contracts** <br>**or Face Amount**<br>|
| Purchased Options at Notional Amount | &nbsp;&nbsp; $2687500 |
| Futures Contracts Number of Long Contracts | &nbsp;&nbsp; 1906 |
| Futures Contracts Number of Short Contracts | &nbsp;&nbsp; (1303)<br>|
| Swap Contracts at Notional Amount | &nbsp;&nbsp; $69277500 |
| Foreign Currency Contracts Purchased at Contract Amount | &nbsp;&nbsp; $3473565 |
| Foreign Currency Contracts Sold at Contract Amount | &nbsp;&nbsp; $25146372 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f)

*Balance Sheet Offsetting Information* – Set forth below are tables which disclose both gross information and net information about instruments and transactions eligible for offset in the financial statements, and instruments and transactions that are subject to a master netting arrangement, as well as amounts related to margin, reflected as financial collateral (including cash collateral), held at clearing brokers, counterparties and a Fund's custodian. The master netting arrangements allow the clearing brokers to net any collateral held in or on behalf of a Fund, or liabilities or payment obligations of the clearing brokers to a Fund, against any liabilities or payment obligations of the Fund to the clearing brokers. A Fund is required to deposit financial collateral (including cash collateral) at the Fund's custodian on behalf of clearing brokers and counterparties to continually meet the original and maintenance requirements established by the clearing brokers and counterparties. Such requirements are specific to the respective clearing broker or counterparty. Certain master netting arrangements may not be enforceable in a bankruptcy.

The following tables present a Fund's derivative assets and liabilities, presented on a gross basis as no amounts are netted within the Statements of Assets and Liabilities, by counterparty net of amounts available for offset under a master netting agreement or similar agreement ("MNA") and net of the related collateral received/pledged by a Fund as of December 31, 2025:

---

| | | |
|:---|:---|:---|
| **Capital Appreciation HLS Fund**  |  |  |
| **Derivative Financial Instruments:** | **Assets** | **Liabilities** |
| Futures contracts | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(720606)<br>|
| Total gross amount of derivative assets and liabilities in the Statement of Assets and Liabilities | &nbsp;&nbsp; — | &nbsp;&nbsp; (720606)<br>|
| Derivatives not subject to a MNA | &nbsp;&nbsp; — | &nbsp;&nbsp; 720606 |
| Total gross amount of assets and liabilities subject to MNA or similar agreements | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Total Return Bond HLS Fund**  |  |  |
| **Derivative Financial Instruments:** | **Assets** | **Liabilities** |
| Foreign currency contracts | &nbsp;&nbsp; $1378 | &nbsp;&nbsp; $(48665)<br>|
| Futures contracts | &nbsp;&nbsp; 603859 | &nbsp;&nbsp; (603524)<br>|
| Swap contracts | &nbsp;&nbsp; 3676964 | &nbsp;&nbsp; (95218)<br>|
| Total gross amount of derivative assets and liabilities in the Statement of Assets and Liabilities | &nbsp;&nbsp; 4282201 | &nbsp;&nbsp; (747407)<br>|
| Derivatives not subject to a MNA | &nbsp;&nbsp; (4280823)<br>| &nbsp;&nbsp; 698742 |
| Total gross amount of assets and liabilities subject to MNA or similar agreements | &nbsp;&nbsp; $1378 | &nbsp;&nbsp; $(48665)<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Counterparty** | **Gross Amount** <br>**of Assets**<br>| **Financial** <br>**Instruments** <br>**and Derivatives** <br>**Available** <br>**for Offset**<br>| **Non-cash** <br>**Collateral** <br>**Received**<sup>\*</sup> <br>| **Cash** <br>**Collateral** <br>**Received**<sup>\*</sup> <br>| **Net Amount** <br>**of Assets**<br>|
| NatWest Markets Plc | &nbsp;&nbsp; $175 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $175 |
| State Street Global Markets LLC | &nbsp;&nbsp; 1203 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1203 |
| Total | &nbsp;&nbsp; $1378 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $1378 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

79 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Counterparty** | **Gross Amount** <br>**of Liabilities**<br>| **Financial** <br>**Instruments** <br>**and Derivatives** <br>**Available** <br>**for Offset**<br>| **Non-cash** <br>**Collateral** <br>**Pledged**<sup>\*</sup> <br>| **Cash** <br>**Collateral** <br>**Pledged**<sup>\*</sup> <br>| **Net Amount** <br>**of Liabilities**<br>|
| Deutsche Bank Securities, Inc. | &nbsp;&nbsp; $(48002)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(48002)<br>|
| Wells Fargo Bank NA | &nbsp;&nbsp; (663)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (663)<br>|
| Total | &nbsp;&nbsp; $(48665)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(48665)<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* In some instances, the actual collateral received and/or pledged may be more than the amount shown.

**5.** **Principal Risks:**

A Fund's investments expose it to various types of risks associated with financial instruments and the markets. A Fund may be exposed to the risks described below. Each Fund's prospectus provides details of its principal risks.

The market values of equity securities, such as common stocks and preferred stocks, or equity related derivative investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company, such as real or perceived adverse economic conditions, changes in the general outlook for corporate earnings, changes in interest or currency rates or adverse investor sentiment generally. The market value of equity securities may also decline due to factors which affect a particular industry or industries, such as labor shortages or increased production costs and competitive conditions within an industry. Equity securities and equity related investments generally have greater market price volatility than fixed income securities.

Certain investments held by a Fund expose the Fund to various risks which may include, but are not limited to, interest rate, prepayment, and extension risks. Interest rate risk is the risk that fixed income securities will decline in value because of changes in interest rates. As nominal interest rates rise, the values of certain fixed income securities held by a Fund are likely to decrease. A nominal interest rate can be described as the sum of a real interest rate and an expected inflation rate. Fixed income securities with longer durations tend to be more sensitive to changes in interest rates, usually making them more volatile than securities with shorter durations. Duration is useful primarily as a measure of the sensitivity of a fixed income security's market price to interest rate (i.e., yield) movements. Senior floating rate interests and securities subject to prepayment and extension risk generally offer less potential for gains when interest rates decline. Rising interest rates may cause prepayments to occur at a slower than expected rate, thereby effectively lengthening the maturity of the security and making the security more sensitive to interest rate changes. Prepayment and extension risk are major risks of mortgage-backed securities, senior floating rate interests and certain asset-backed securities. For certain asset-backed securities, the actual maturity may be less than the stated maturity shown in the Schedule of Investments, if applicable. As a result, the timing of income recognition relating to these securities may vary based upon the actual maturity.

Investing in the securities of non-U.S. issuers, whether directly or indirectly, involves certain considerations and risks not typically associated with securities of U.S. issuers. Such risks include, but are not limited to: generally less liquid and less efficient securities markets; generally greater price volatility; exchange rate fluctuations; imposition of restrictions on the expatriation of funds or other protectionist measures; less publicly available information about issuers; the imposition of withholding or other taxes; higher transaction and custody costs; settlement delays and risk of loss attendant in settlement procedures; difficulties in enforcing contractual obligations; less regulation of securities markets; different accounting, disclosure and reporting requirements; more substantial governmental involvement in the economy; higher inflation rates; and greater social, economic and political uncertainties. Non-U.S. issuers may also be affected by political, social, economic or diplomatic developments in a foreign country or region or the U.S. (including the imposition of sanctions, tariffs, or other governmental restrictions). These risks are heightened for investments in issuers from countries with less developed markets.

Credit risk depends largely on the perceived financial health of bond issuers. In general, the credit rating is inversely related to the credit risk of the issuer. Higher rated bonds generally are deemed to have less credit risk, while lower or unrated bonds are deemed to have higher risk of default. The share price, yield and total return of a fund that holds securities with higher credit risk may be more volatile than those of a fund that holds bonds with lower credit risk. A Fund may be exposed to counterparty risk, or the risk that an institution or other entity with which a Fund has unsettled or open transactions will default.

Geopolitical events (including wars, military conflicts, trade disputes, tariffs, economic sanctions, export controls, retaliatory measures, pandemics and epidemics) may inject uncertainty into the global financial markets. Investments in Russia are subject to political, economic, legal, market and currency risks, as well as the risks related to the economic sanctions on Russia imposed by the United States and/or other countries. Such sanctions which affect companies in many sectors, including energy, financial services and defense, among others, have adversely affected and could continue to adversely affect the global energy and financial markets and, thus, have adversely affected and could continue to adversely affect the value of a Fund's investments, even beyond any direct exposure the Fund may have to Russian issuers or the adjoining geographic regions. In addition, certain transactions have or may be prohibited and/or existing investments have or may become illiquid (e.g., because transacting in certain existing investments is prohibited), which could cause a Fund to sell other portfolio holdings at a disadvantageous time or price in order to meet redemptions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

80 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

A widespread health crisis, such as a global pandemic, could cause substantial market volatility, exchange trading suspensions or restrictions and closures of securities exchanges and businesses, impact the ability to complete redemptions, and adversely impact Fund performance.

**6.** **Federal Income Taxes:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)

Each Fund intends to continue to qualify as a Regulated Investment Company ("RIC") under Subchapter M of the Internal Revenue Code ("IRC") by distributing substantially all of its taxable net investment income and net realized capital gains to its shareholders each year. Each Fund has distributed substantially all of its income and capital gains in prior years, if applicable, and intends to distribute substantially all of its income and capital gains during the calendar year ending December 31, 2025. Accordingly, no provision for federal income or excise taxes has been made in the accompanying financial statements. Distributions from short-term capital gains are treated as ordinary income distributions for federal income tax purposes.

Management evaluated each Fund's investments in foreign markets for the current tax year. As of December 31, 2025, the International Opportunity HLS Fund incurred foreign income tax payments that met the disclosure threshold. The other Funds incurred foreign income tax payments that were considered immaterial for disclosure purposes.

The cash payments for income taxes made by the International Opportunity HLS Fund to foreign jurisdictions, after accounting for any refunds, were as follows:

---

| | |
|:---|:---|
|  | **International** <br>**Opportunities** <br>**HLS Fund** <br>|
| **Income taxes by foreign jurisdiction:** |  |
| Canada | $146053 |
| France | 314209 |
| Germany | 358779 |
| India | 457964 |
| Italy | 167784 |
| Japan | 215916 |
| South Korea | 142596 |
| Taiwan | 116061 |
| Other\* | 335776 |
| Total income taxes paid, net of refunds | $2255138 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>\*</sup> Represents foreign jurisdictions where taxes paid, net of refunds received, were less than 5% of the total income taxes paid by the Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)

*Net Investment Income (Loss), Net Realized Gains (Losses) and Distributions* – Net investment income (loss) and net realized gains (losses) may differ for financial statement and tax purposes primarily because of losses deferred due to wash sale adjustments, foreign currency gains and losses, adjustments related to Passive Foreign Investment Companies ("PFICs"), reclassification of dividend income, RICs, certain derivatives, losses deferred due to straddle adjustments and partnerships. The character of distributions made during the year from net investment income or net realized gains may differ from their ultimate characterization for federal income tax purposes. Also, due to the timing of dividend distributions, the fiscal year in which amounts are distributed may differ from the year that the income or realized gains (losses) were recorded by each Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

81 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)

*Distributions and Components of Distributable Earnings* – The tax character of distributions paid by each Fund for the years ended December 31, 2025 and December 31, 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Year Ended** <br>**December 31, 2025** | **For the Year Ended** <br>**December 31, 2025** | **For the Year Ended** <br>**December 31, 2024** | **For the Year Ended** <br>**December 31, 2024** |
| **Fund** | **Ordinary** <br>**Income**<br>| **Long-Term** <br>**Capital Gains**<sup>(1)</sup> <br>| **Ordinary** <br>**Income**<br>| **Long-Term** <br>**Capital Gains**<sup>(1)</sup> <br>|
| Balanced HLS Fund | &nbsp;&nbsp; $47060598 | &nbsp;&nbsp; $133881319 | &nbsp;&nbsp; $47163403 | &nbsp;&nbsp; $96121727 |
| Capital Appreciation HLS Fund | &nbsp;&nbsp; 99517551 | &nbsp;&nbsp; 351283383 | &nbsp;&nbsp; 157267574 | &nbsp;&nbsp; 22628188 |
| Disciplined Equity HLS Fund | &nbsp;&nbsp; 14819992 | &nbsp;&nbsp; 284270769 | &nbsp;&nbsp; 43664311 | &nbsp;&nbsp; 96860265 |
| Dividend and Growth HLS Fund | &nbsp;&nbsp; 117921946 | &nbsp;&nbsp; 449690733 | &nbsp;&nbsp; 105907545 | &nbsp;&nbsp; 181263448 |
| Healthcare HLS Fund | &nbsp;&nbsp; 2909567 | &nbsp;&nbsp; 3333302 | &nbsp;&nbsp; 108182 | &nbsp;&nbsp; 897424 |
| International Opportunities HLS Fund | &nbsp;&nbsp; 12910659 | &nbsp;&nbsp; 6180622 | &nbsp;&nbsp; 12920518 | &nbsp;&nbsp; — |
| MidCap HLS Fund | &nbsp;&nbsp; 7467155 | &nbsp;&nbsp; 136346092 | &nbsp;&nbsp; 4779454 | &nbsp;&nbsp; 15797051 |
| Small Cap Growth HLS Fund | &nbsp;&nbsp; 14919369 | &nbsp;&nbsp; 97583038 | &nbsp;&nbsp; 1894325 | &nbsp;&nbsp; — |
| Small Company HLS Fund | &nbsp;&nbsp; 1711211 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Stock HLS Fund | &nbsp;&nbsp; 20232769 | &nbsp;&nbsp; 154257153 | &nbsp;&nbsp; 22131065 | &nbsp;&nbsp; 37705794 |
| Total Return Bond HLS Fund | &nbsp;&nbsp; 75157506 | &nbsp;&nbsp; — | &nbsp;&nbsp; 62668155 | &nbsp;&nbsp; — |
| Ultrashort Bond HLS Fund | &nbsp;&nbsp; 25395057 | &nbsp;&nbsp; — | &nbsp;&nbsp; 23071484 | &nbsp;&nbsp; — |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> The Funds designate these distributions as long-term capital gains dividends pursuant to IRC Sec 852(b)(3)(c).

As of December 31, 2025, the components of total accumulated earnings (deficit) for each Fund on a tax basis are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Fund**  | **Undistributed** <br>**Ordinary** <br>**Income**<br>| **Undistributed** <br>**Long-Term** <br>**Capital Gains**<br>| **Accumulated** <br>**Capital and** <br>**Other Losses**<br>| **Other** <br>**Temporary** <br>**Differences**<br>| **Unrealized** <br>**Appreciation** <br>**(Depreciation)** <br>**on Investments**<br>| **Total** <br>**Accumulated** <br>**Earnings** <br>**(Deficit)**<br>|
| Balanced HLS Fund | &nbsp;&nbsp; $8416474 | &nbsp;&nbsp; $120391277 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(670988)<br>| &nbsp;&nbsp; $399447851 | &nbsp;&nbsp; $527584614 |
| Capital Appreciation HLS Fund | &nbsp;&nbsp; 27788959 | &nbsp;&nbsp; 227883438 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1226240393 | &nbsp;&nbsp; 1481912790 |
| Disciplined Equity HLS Fund | &nbsp;&nbsp; 1944749 | &nbsp;&nbsp; 344905640 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1362329844 | &nbsp;&nbsp; 1709180233 |
| Dividend and Growth HLS Fund | &nbsp;&nbsp; 25808538 | &nbsp;&nbsp; 507775226 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1075130659 | &nbsp;&nbsp; 1608714423 |
| Healthcare HLS Fund | &nbsp;&nbsp; 166929 | &nbsp;&nbsp; 5814761 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 41028581 | &nbsp;&nbsp; 47010271 |
| International Opportunities HLS Fund | &nbsp;&nbsp; 27452595 | &nbsp;&nbsp; 80319150 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 256323910 | &nbsp;&nbsp; 364095655 |
| MidCap HLS Fund | &nbsp;&nbsp; 863366 | &nbsp;&nbsp; 50174515 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 123200872 | &nbsp;&nbsp; 174238753 |
| Small Cap Growth HLS Fund | &nbsp;&nbsp; — | &nbsp;&nbsp; 32959224 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 122499330 | &nbsp;&nbsp; 155458554 |
| Small Company HLS Fund | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; (44342784)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; 114103444 | &nbsp;&nbsp; 69760660 |
| Stock HLS Fund | &nbsp;&nbsp; 5209962 | &nbsp;&nbsp; 151882128 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 481916586 | &nbsp;&nbsp; 639008676 |
| Total Return Bond HLS Fund | &nbsp;&nbsp; 56050142 | &nbsp;&nbsp; — | &nbsp;&nbsp; (235898533)<br>| &nbsp;&nbsp; (2504867)<br>| &nbsp;&nbsp; (85726435)<br>| &nbsp;&nbsp; (268079693)<br>|
| Ultrashort Bond HLS Fund | &nbsp;&nbsp; 21150523 | &nbsp;&nbsp; — | &nbsp;&nbsp; (12336527)<br>| &nbsp;&nbsp; — | &nbsp;&nbsp; 487209 | &nbsp;&nbsp; 9301205 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)

*Reclassification of Capital Accounts* – The Funds may record reclassifications in their capital accounts. These reclassifications have no impact on the total net assets of the Funds. The reclassifications are a result of permanent differences between U.S. GAAP and tax accounting for such items as net operating losses, subsequent adjustments to wash sales, reclassification of dividend income, and partnerships. Adjustments are made to reflect the impact these items have on the current and future earnings distributions to shareholders. Therefore, the source of the Funds' distributions may be shown in the accompanying Statements of Changes in Net Assets as from distributable earnings or from capital depending on the type of book and tax differences that exist. For the year ended December 31, 2025, the Funds recorded reclassifications to increase (decrease) the accounts listed below:

---

| | | |
|:---|:---|:---|
| **Fund**  | **Paid-in-Capital** | **Distributable** <br>**Earnings (Loss)**<br>|
| Capital Appreciation HLS Fund | &nbsp;&nbsp; $(12997)<br>| &nbsp;&nbsp; $12997 |
| Disciplined Equity HLS Fund | &nbsp;&nbsp; (4380)<br>| &nbsp;&nbsp; 4380 |
| MidCap HLS Fund | &nbsp;&nbsp; (41841)<br>| &nbsp;&nbsp; 41841 |
| Small Cap Growth HLS Fund | &nbsp;&nbsp; (1531624)<br>| &nbsp;&nbsp; 1531624 |
| Small Company HLS Fund | &nbsp;&nbsp; (1406202)<br>| &nbsp;&nbsp; 1406202 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e)

*Capital Loss Carryforward* – Under the Regulated Investment Company Modernization Act of 2010, funds are permitted to carry forward capital losses for an unlimited period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

82 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

At December 31, 2025 (tax year end), each Fund's capital loss carryforwards for U.S. federal income tax purposes were as follows:

---

| | | |
|:---|:---|:---|
| **Fund**  | **Short-Term** <br>**Capital Loss** <br>**Carryforward with** <br>**No Expiration**<br>| **Long-Term** <br>**Capital Loss** <br>**Carryforward with** <br>**No Expiration**<br>|
| Small Company HLS Fund | &nbsp;&nbsp; $44342784 | &nbsp;&nbsp; $— |
| Total Return Bond HLS Fund | &nbsp;&nbsp; 89716938 | &nbsp;&nbsp; 146181595 |
| Ultrashort Bond HLS Fund | &nbsp;&nbsp; 654287 | &nbsp;&nbsp; 11682240 |

---

During the year ended December 31, 2025, the Small Company HLS Fund utilized $20,889,219, Total Return Bond HLS Fund utilized $835,413 and Ultrashort Bond HLS Fund utilized $46,024 of prior year capital loss carryforwards.

The Balanced HLS Fund, Capital Appreciation HLS Fund, Disciplined Equity HLS Fund, Dividend and Growth HLS Fund, Healthcare HLS Fund, International Opportunities HLS Fund, MidCap HLS Fund, Small Cap Growth HLS Fund and Stock HLS Fund had no capital loss carryforwards for U.S. federal tax purposes as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f)

*Tax Basis of Investments* – The aggregate cost of investments for federal income tax purposes at December 31, 2025 is different from book purposes primarily due to wash sale loss deferrals, mark-to-market adjustments on PFICs, partnership adjustments and reclassification of dividend income. The net unrealized appreciation/(depreciation) on investments for tax purposes, which consists of gross unrealized appreciation and depreciation is also different from book purposes primarily due to wash sale loss deferrals and mark-to-market adjustments on derivatives, mark-to-market adjustments on PFICs, partnership adjustments, and reclassification of dividend income. Both the cost and unrealized appreciation and depreciation for federal income tax purposes are disclosed below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Fund** | **Tax Cost** | **Gross Unrealized** <br>**Appreciation**<br>| **Gross Unrealized** <br>**(Depreciation)**<br>| **Net Unrealized** <br>**Appreciation** <br>**(Depreciation)**<br>|
| Balanced HLS Fund  | &nbsp;&nbsp; $1218429451 | &nbsp;&nbsp; $427970743 | &nbsp;&nbsp; $(28655783)<br>| &nbsp;&nbsp; $399314960 |
| Capital Appreciation HLS Fund  | &nbsp;&nbsp; 2458419063 | &nbsp;&nbsp; 1267117083 | &nbsp;&nbsp; (40901869)<br>| &nbsp;&nbsp; 1226215214 |
| Disciplined Equity HLS Fund  | &nbsp;&nbsp; 1635827091 | &nbsp;&nbsp; 1426662908 | &nbsp;&nbsp; (64333438)<br>| &nbsp;&nbsp; 1362329470 |
| Dividend and Growth HLS Fund  | &nbsp;&nbsp; 2371133231 | &nbsp;&nbsp; 1121901717 | &nbsp;&nbsp; (46768915)<br>| &nbsp;&nbsp; 1075132802 |
| Healthcare HLS Fund  | &nbsp;&nbsp; 73266310 | &nbsp;&nbsp; 43528025 | &nbsp;&nbsp; (2499586)<br>| &nbsp;&nbsp; 41028439 |
| International Opportunities HLS Fund  | &nbsp;&nbsp; 577724101 | &nbsp;&nbsp; 267415892 | &nbsp;&nbsp; (10501883)<br>| &nbsp;&nbsp; 256914009 |
| MidCap HLS Fund  | &nbsp;&nbsp; 597039979 | &nbsp;&nbsp; 158436105 | &nbsp;&nbsp; (35235242)<br>| &nbsp;&nbsp; 123200863 |
| Small Cap Growth HLS Fund  | &nbsp;&nbsp; 435901519 | &nbsp;&nbsp; 151500755 | &nbsp;&nbsp; (29001425)<br>| &nbsp;&nbsp; 122499330 |
| Small Company HLS Fund  | &nbsp;&nbsp; 319025546 | &nbsp;&nbsp; 130051636 | &nbsp;&nbsp; (15948192)<br>| &nbsp;&nbsp; 114103444 |
| Stock HLS Fund  | &nbsp;&nbsp; 724341392 | &nbsp;&nbsp; 489807974 | &nbsp;&nbsp; (7893155)<br>| &nbsp;&nbsp; 481914819 |
| Total Return Bond HLS Fund  | &nbsp;&nbsp; 1639244329 | &nbsp;&nbsp; 18482802 | &nbsp;&nbsp; (104183130)<br>| &nbsp;&nbsp; (85700328)<br>|
| Ultrashort Bond HLS Fund  | &nbsp;&nbsp; 490101276 | &nbsp;&nbsp; 2078697 | &nbsp;&nbsp; (1591488)<br>| &nbsp;&nbsp; 487209 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g)

*Accounting for Uncertainty in Income Taxes* – Pursuant to provisions set forth by U.S. GAAP, HFMC reviews each Fund's tax positions for all open tax years. As of December 31, 2025, HFMC had reviewed the open tax years and concluded that there was no reason to record a liability for net unrecognized tax obligations relating to uncertain income tax positions. Each Fund files U.S. tax returns. Although the statute of limitations for examining a Fund's U.S. tax returns remains open for three years, no examination is currently in progress. The Funds recognize interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the Statements of Operations. During the year ended December 31, 2025, the Funds did not incur any interest or penalties.

**7.** **Expenses:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)

*Investment Management Agreement* – HFMC serves as each Fund's investment manager. The Company, on behalf of each Fund, has entered into an Investment Management Agreement with HFMC. HFMC is an indirect subsidiary of The Hartford Insurance Group, Inc. (formerly, The Hartford Financial Services Group, Inc.) ("The Hartford"). HFMC has overall investment supervisory responsibility for each Fund. In addition, HFMC provides administrative personnel, services, equipment, facilities and office space for proper operation of each Fund. HFMC has contracted with Wellington Management Company LLP ("Wellington Management") under a sub-advisory agreement and Wellington Management performs the daily investment of the assets of each Fund in accordance with the Fund's investment objective and policies. Each Fund pays a fee to HFMC. HFMC pays a sub-advisory fee to Wellington Management out of its management fee.

The schedule below reflects the rates of compensation paid to HFMC for investment management services rendered as of December 31, 2025; the rates are accrued daily and paid monthly based on each Fund's average daily net assets, at the following annual rates:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

83 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

---

| | |
|:---|:---|
| **Fund** | **Management Fee Rates** |
| Balanced HLS Fund \* | 0.6800% on first $250 million and; |
|  | 0.6550% on next $250 million and; |
|  | 0.6450% on next $500 million and; |
|  | 0.5950% on next $4 billion and; |
|  | 0.5925% on next $5 billion and; |
|  | 0.5900% over $10 billion |
| Capital Appreciation HLS Fund  | 0.7750% on first $250 million and; |
|  | 0.7250% on next $250 million and; |
|  | 0.6750% on next $500 million and; |
|  | 0.6250% on next $1.5 billion and; |
|  | 0.6200% on next $2.5 billion and; |
|  | 0.6150% on next $5 billion and; |
|  | 0.6100% over $10 billion |
| Disciplined Equity HLS Fund  | 0.6000% on first $1 billion and; |
|  | 0.5500% on next $4 billion and; |
|  | 0.5300% on next $5 billion and; |
|  | 0.5000% over $10 billion |
| Dividend and Growth HLS Fund  | 0.6900% on first $250 million and; |
|  | 0.6425% on next $250 million and; |
|  | 0.6325% on next $500 million and; |
|  | 0.6250% on next $1.5 billion and; |
|  | 0.6200% on next $2.5 billion and; |
|  | 0.6150% on next $5 billion and; |
|  | 0.6100% over $10 billion |
| Healthcare HLS Fund  | 0.8500% on first $250 million and; |
|  | 0.8000% on next $250 million and; |
|  | 0.7500% on next $4.5 billion and; |
|  | 0.7475% on next $5 billion and; |
|  | 0.7450% over $10 billion |
| International Opportunities HLS Fund  | 0.7750% on first $250 million and; |
|  | 0.7250% on next $250 million and; |
|  | 0.6750% on next $500 million and; |
|  | 0.6250% on next $1.5 billion and; |
|  | 0.6200% on next $2.5 billion and; |
|  | 0.6150% on next $5 billion and; |
|  | 0.6100% over $10 billion |
| MidCap HLS Fund  | 0.7750% on first $250 million and; |
|  | 0.7250% on next $250 million and; |
|  | 0.6750% on next $500 million and; |
|  | 0.6250% on next $4 billion and; |
|  | 0.6225% on next $5 billion and; |
|  | 0.6200% over $10 billion |
| Small Cap Growth HLS Fund  | 0.7000% on first $100 million and; |
|  | 0.6000% on next $4.9 billion and; |
|  | 0.5800% on next $5 billion and; |
|  | 0.5700% over $10 billion |
| Small Company HLS Fund  | 0.7750% on first $250 million and; |
|  | 0.7250% on next $250 million and; |
|  | 0.6750% on next $500 million and; |
|  | 0.6000% on next $500 million and; |
|  | 0.5500% on next $3.5 billion and; |
|  | 0.5300% on next $5 billion and; |
|  | 0.5200% over $10 billion |
| Stock HLS Fund  | 0.5250% on first $250 million and; |
|  | 0.5000% on next $250 million and; |
|  | 0.4750% on next $500 million and; |
|  | 0.4500% on next $4 billion and; |
|  | 0.4475% on next $5 billion and; |
|  | 0.4450% over $10 billion |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

84 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

---

| | |
|:---|:---|
| **Fund** | **Management Fee Rates** |
| Total Return Bond HLS Fund  | 0.5250% on first $250 million and; |
|  | 0.5000% on next $250 million and; |
|  | 0.4750% on next $500 million and; |
|  | 0.4500% on next $1.5 billion and; |
|  | 0.4450% on next $2.5 billion and; |
|  | 0.4300% on next $5 billion and; |
|  | 0.4200% over $10 billion |
| Ultrashort Bond HLS Fund  | 0.4000% on first $5 billion and; |
|  | 0.3800% on next $5 billion and; |
|  | 0.3700% over $10 billion |

---

<sup>\*</sup>

HFMC voluntarily waived a portion of its contractual management fee equal to 0.03% as an annual percentage rate of the Balanced HLS Fund's average daily net assets from January 1, 2025 through December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)

*Accounting Services Agreement* – HFMC provides the Funds with accounting services pursuant to a fund accounting agreement by and between the Company, on behalf of each Fund, and HFMC. HFMC has delegated certain accounting and administrative service functions to State Street. In consideration of services rendered and expenses assumed pursuant to the fund accounting agreement, each Fund pays HFMC a fee. The fund accounting fee for each Fund is equal to the greater of: (A) the sum of (i) the sub-accounting fee payable by HFMC with respect to the Fund; (ii) the fee payable for tax preparation services for the Fund; and (iii) the amount of expenses that HFMC allocates for providing the fund accounting services to the Fund; plus a target profit margin; or (B) $40,000 per year; provided, however, that to the extent the annual amount of the fund accounting fee exceeds 0.02% of the Fund's average net assets (calculated during its current fiscal year), HFMC shall waive such portion of the fund accounting fee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)

*Operating Expenses* – Allocable expenses incurred by the Company are allocated to each series within the Company, and allocated to classes within each such series, in proportion to the average daily net assets of such series and classes, except where allocation of certain expenses is more fairly made directly to a Fund or to specific classes within a Fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)

*Fees Paid Indirectly* – The Company has entered into agreements with State Street Global Markets, LLC and Russell Implementation Services, Inc. to partially recapture non-discounted trade commissions. Such rebates are used to pay a portion of a Fund's expenses. For the year ended December 31, 2025, these amounts, if any, are included in the Statements of Operations.

The ratio of expenses to average net assets in the accompanying financial highlights excludes the reduction in expenses related to fees paid indirectly. The impacted annualized expense ratio after waivers reflecting the reduction for fees paid indirectly for the period is as follows for Small Company HLS Fund: Class IA (0.80%) and Class IB (1.05%). The amount of fees recaptured by the other Funds did not impact the ratio of expenses to average net assets in the financial highlights.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e)

*Distribution Plans for Class IB and Class IC Shares* – Hartford Funds Distributors, LLC ("HFD"), an indirect subsidiary of The Hartford, is the principal underwriter and distributor of each Fund. The Company has adopted a Distribution Plan pursuant to Rule 12b-1 of the 1940 Act for Class IB shares of the Funds and for certain Funds, has adopted a Distribution Plan pursuant to Rule 12b-1 of the 1940 Act for Class IC shares.

Pursuant to the Class IB Distribution Plans, a Fund may pay HFD a fee of up to 0.25% of the average daily net assets of the Fund attributable to its Class IB shares for distribution financing activities and shareholder account servicing activities. The entire amount of the fee may be used for shareholder servicing expenses and/or distribution expenses. Pursuant to the Class IC Distribution Plans, a Fund may pay HFD a fee of up to 0.25% of the average daily net assets of the Fund attributable to its Class IC shares for distribution financing activities.

The Board has the authority to suspend or reduce these payments at any point in time. The distribution fees paid during the period can be found on the Statements of Operations. Each Fund's 12b-1 fees are accrued daily and paid monthly or at such other intervals as the Company's Board of Directors may determine.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f)

*Administrative Services Fee for Class IC Shares* – Certain Funds may pay an administrative services fee to third party insurance companies annually up to 0.25% of the average daily net assets of the Fund attributable to its Class IC shares for recordkeeping and/or other administrative services provided to such Class IC shares. The total administrative services fees paid during the period are shown on the Statements of Operations. These fees are accrued daily and paid monthly.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g)

*Remuneration Paid to Directors and Officers* – For the year ended December 31, 2025, the remuneration paid to directors is disclosed in the Statements of Operations under the caption "Board of Directors' fees." The Funds pay a portion of the Company's chief compliance officer's ("CCO") compensation, but otherwise do not pay salaries or compensation to any of their officers or directors who are employed by HFMC

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

85 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

and/or The Hartford or its subsidiaries. For the year ended December 31, 2025, the compensation paid to the CCO is included on the Statements of Operations as "Chief Compliance Officer fees".

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h)

Hartford Administrative Services Company ("HASCO"), an indirect subsidiary of The Hartford, provides transfer agent services to each Fund. Pursuant to a sub-transfer agency agreement between HASCO and SS&C GIDS, Inc. ("SS&C"), HASCO has delegated certain transfer agent, dividend disbursing agent and shareholder servicing agent functions to SS&C. The costs and expenses of such delegation are borne by HASCO, not by the Funds. Each Fund pays HASCO a fixed fee annually, plus out of pocket expenses for providing such services. The accrued amount shown in the Statements of Operations reflects the amounts charged by HASCO. These fees are accrued daily and paid monthly.

For the year ended December 31, 2025, the effective rate of compensation paid to HASCO for transfer agency services as a percentage of each Class' average daily net assets is as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Fund**  | **Class IA** | **Class IB** | **Class IC** |
| Balanced HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |
| Capital Appreciation HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| 0.00<br> %\*<br>|
| Disciplined Equity HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| 0.00<br> %\*<br>|
| Dividend and Growth HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |
| Healthcare HLS Fund | 0.01<br> %<br>| 0.01<br> %<br>| &nbsp;&nbsp; N/A |
| International Opportunities HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |
| MidCap HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |
| Small Cap Growth HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |
| Small Company HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |
| Stock HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |
| Total Return Bond HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |
| Ultrashort Bond HLS Fund | 0.00<br> %\*<br>| 0.00<br> %\*<br>| &nbsp;&nbsp; N/A |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>\*</sup> Percentage rounds to zero.

**8.** **Securities Lending:** 

A Fund may lend portfolio securities to certain borrowers in U.S. and non-U.S. markets in an amount not to exceed one-third (33 1/3%) of the value of its total assets. A Fund may lend portfolio securities, provided that the borrower provides collateral that is maintained in an amount at least equal to the current market value of the securities loaned. Cash collateral is invested for the benefit of a Fund by the Fund's lending agent pursuant to collateral investment guidelines. The collateral is marked to market daily, in an amount at least equal to the current market value of the securities loaned. The contractual maturities of the securities lending transactions are considered overnight and continuous.

A Fund is subject to certain risks while its securities are on loan, including the following: (i) the risk that the borrower defaults on the loan and the collateral is inadequate to cover the Fund's loss; (ii) the risk that the earnings on the collateral invested are not sufficient to pay fees incurred in connection with the loan; (iii) the Fund could lose money in the event of a decline in the value of the collateral provided for loaned securities or a decline in the value of any investments made with cash collateral; (iv) the risk that the borrower may use the loaned securities to cover a short sale, which may in turn place downward pressure on the market prices of the loaned securities; (v) the risk that return of loaned securities could be delayed and interfere with portfolio management decisions; (vi) the risk that any efforts to restrict or recall the securities for purposes of voting may not be effective; and (vii) operational risks (i.e., the risk of losses resulting from problems in the settlement and accounting process especially so in certain international markets). These events could also trigger adverse tax consequences for a Fund.

A Fund retains loan fees and the interest on cash collateral investments but is required to pay the borrower a rebate for the use of cash collateral. In cases where the lent security is of high value to borrowers, there may be a negative rebate (i.e., a net payment from the borrower to the applicable Fund). Upon termination of a loan, a Fund is required to return to the borrower an amount equal to the cash collateral, plus any rebate owed to the borrowers.

The net income earned on the securities lending (after payment of rebates and the lending agent's fee) is included on the Statements of Operations as Investment Income from securities lending. A Fund also receives payments from the borrower during the period of the loan, equivalent to dividends and interest earned on the securities loaned, which are recorded as Investment Income from dividends or interest, respectively, on the Statements of Operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

86 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

The following table presents for each Fund that lends its portfolio securities the market value of the securities on loan and the cash and non-cash collateral posted by the borrower as of December 31, 2025.

---

| | | | |
|:---|:---|:---|:---|
| **Fund** | **Investment Securities on Loan, at market value,** <br>**Presented on the Statements of Assets and Liabilities**<br>| **Cash** <br>**Collateral**<sup>(1)</sup> <br>| **Non-Cash** <br>**Collateral**<sup>(1)</sup> <br>|
| Balanced HLS Fund | &nbsp;&nbsp; $14378343 | &nbsp;&nbsp; $14729893 | &nbsp;&nbsp; $— |
| Capital Appreciation HLS Fund | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Disciplined Equity HLS Fund | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Dividend and Growth HLS Fund | &nbsp;&nbsp; 44270046 | &nbsp;&nbsp; 45234710 | &nbsp;&nbsp; — |
| Healthcare HLS Fund | &nbsp;&nbsp; 232913 | &nbsp;&nbsp; 138450 | &nbsp;&nbsp; 102676 |
| International Opportunities HLS Fund | &nbsp;&nbsp; 11251631 | &nbsp;&nbsp; 4518237 | &nbsp;&nbsp; 7372356 |
| MidCap HLS Fund | &nbsp;&nbsp; 10449385 | &nbsp;&nbsp; 10674516 | &nbsp;&nbsp; — |
| Small Cap Growth HLS Fund | &nbsp;&nbsp; 14783873 | &nbsp;&nbsp; 12073029 | &nbsp;&nbsp; 3055952 |
| Small Company HLS Fund | &nbsp;&nbsp; 9596054 | &nbsp;&nbsp; 8891073 | &nbsp;&nbsp; 924151 |
| Stock HLS Fund | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; — |
| Total Return Bond HLS Fund | &nbsp;&nbsp; 10614000 | &nbsp;&nbsp; 11013625 | &nbsp;&nbsp; — |
| Ultrashort Bond HLS Fund | &nbsp;&nbsp; 49007 | &nbsp;&nbsp; 51205 | &nbsp;&nbsp; — |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(1)</sup> It is each Fund's policy to obtain additional collateral from, or return excess collateral to, the borrower by the end of the next business day following the valuation date of the securities loaned. Therefore, the value of the collateral held may be temporarily less than that required under the lending contract due to timing. 

**9.** **Investment Transactions:** 

For the year ended December 31, 2025, the cost of purchases and proceeds from sales of investment securities (excluding short-term investments) were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Fund** | **Cost of Purchases** <br>**Excluding U.S.** <br>**Government** <br>**Obligations**<br>| **Sales Proceeds** <br>**Excluding U.S.** <br>**Government** <br>**Obligations**<br>| **Cost of Purchases** <br>**For U.S. Government** <br>**Obligations**<br>| **Sales Proceeds** <br>**For U.S. Government** <br>**Obligations**<br>| **Total Cost of** <br>**Purchases**<br>| **Total Sales** <br>**Proceeds**<br>|
| Balanced HLS Fund | &nbsp;&nbsp; $611312462 | &nbsp;&nbsp; $758868644 | &nbsp;&nbsp; $441321135 | &nbsp;&nbsp; $461931701 | &nbsp;&nbsp; $1052633597 | &nbsp;&nbsp; $1220800345 |
| Capital Appreciation HLS Fund | &nbsp;&nbsp; 2075114656 | &nbsp;&nbsp; 2522287113 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 2075114656 | &nbsp;&nbsp; 2522287113 |
| Disciplined Equity HLS Fund | &nbsp;&nbsp; 1036534238 | &nbsp;&nbsp; 1400856813 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1036534238 | &nbsp;&nbsp; 1400856813 |
| Dividend and Growth HLS Fund | &nbsp;&nbsp; 2012327930 | &nbsp;&nbsp; 2338550278 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 2012327930 | &nbsp;&nbsp; 2338550278 |
| Healthcare HLS Fund | &nbsp;&nbsp; 54425625 | &nbsp;&nbsp; 73646024 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 54425625 | &nbsp;&nbsp; 73646024 |
| International Opportunities HLS Fund | &nbsp;&nbsp; 347813080 | &nbsp;&nbsp; 533743782 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 347813080 | &nbsp;&nbsp; 533743782 |
| MidCap HLS Fund | &nbsp;&nbsp; 465056715 | &nbsp;&nbsp; 586050262 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 465056715 | &nbsp;&nbsp; 586050262 |
| Small Cap Growth HLS Fund | &nbsp;&nbsp; 454721248 | &nbsp;&nbsp; 503870561 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 454721248 | &nbsp;&nbsp; 503870561 |
| Small Company HLS Fund | &nbsp;&nbsp; 276345390 | &nbsp;&nbsp; 313823980 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 276345390 | &nbsp;&nbsp; 313823980 |
| Stock HLS Fund | &nbsp;&nbsp; 441704607 | &nbsp;&nbsp; 580127431 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 441704607 | &nbsp;&nbsp; 580127431 |
| Total Return Bond HLS Fund | &nbsp;&nbsp; 555390457 | &nbsp;&nbsp; 723942813 | &nbsp;&nbsp; 231913119 | &nbsp;&nbsp; 449828279 | &nbsp;&nbsp; 787303576 | &nbsp;&nbsp; 1173771092 |
| Ultrashort Bond HLS Fund | &nbsp;&nbsp; 233015709 | &nbsp;&nbsp; 212467762 | &nbsp;&nbsp; 57063696 | &nbsp;&nbsp; 71337545 | &nbsp;&nbsp; 290079405 | &nbsp;&nbsp; 283805307 |

---

**10.** **Capital Share Transactions:** 

The following information is for the years ended December 31, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Year Ended** <br>**December 31, 2025** | **For the Year Ended** <br>**December 31, 2025** | **For the Year Ended** <br>**December 31, 2024** | **For the Year Ended** <br>**December 31, 2024** |
|  | **Shares** | **Amount** | **Shares** | **Amount** |
| **Balanced HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 409885 | &nbsp;&nbsp;&nbsp;&nbsp; $12144117 | &nbsp;&nbsp;&nbsp;&nbsp; 463529 | &nbsp;&nbsp;&nbsp;&nbsp; $13939268 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 5584649 | &nbsp;&nbsp;&nbsp;&nbsp; 161236557 | &nbsp;&nbsp;&nbsp;&nbsp; 4270906 | &nbsp;&nbsp;&nbsp;&nbsp; 127661244 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (6821839)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (202893519)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (7178186)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (215915189)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (827305)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (29512845)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2443751)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (74314677)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 54114 | &nbsp;&nbsp;&nbsp;&nbsp; $1645115 | &nbsp;&nbsp;&nbsp;&nbsp; 28076 | &nbsp;&nbsp;&nbsp;&nbsp; $875405 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 664334 | &nbsp;&nbsp;&nbsp;&nbsp; 19705360 | &nbsp;&nbsp;&nbsp;&nbsp; 509669 | &nbsp;&nbsp;&nbsp;&nbsp; 15623886 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (909659)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (27742778)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1018350)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (31370497)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (191211)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (6392303)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (480605)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (14871206)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (1018516)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(35905148)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2924356)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(89185883)<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

87 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Year Ended**<br> **December 31, 2025** | **For the Year Ended**<br> **December 31, 2025** | **For the Year Ended**<br> **December 31, 2024** | **For the Year Ended**<br> **December 31, 2024** |
|  | **Shares** | **Amount** | **Shares** | **Amount** |
| **Capital Appreciation HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 510890 | &nbsp;&nbsp;&nbsp;&nbsp; $25669811 | &nbsp;&nbsp;&nbsp;&nbsp; 342579 | &nbsp;&nbsp;&nbsp;&nbsp; $17610367 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 7846314 | &nbsp;&nbsp;&nbsp;&nbsp; 403275868 | &nbsp;&nbsp;&nbsp;&nbsp; 3021134 | &nbsp;&nbsp;&nbsp;&nbsp; 161203349 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (8697384)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (460967993)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (9538481)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (488441644)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (340180)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (32022314)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (6174768)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (309627928)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 55604 | &nbsp;&nbsp;&nbsp;&nbsp; $2839400 | &nbsp;&nbsp;&nbsp;&nbsp; 55309 | &nbsp;&nbsp;&nbsp;&nbsp; $2764816 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 917334 | &nbsp;&nbsp;&nbsp;&nbsp; 45619734 | &nbsp;&nbsp;&nbsp;&nbsp; 346469 | &nbsp;&nbsp;&nbsp;&nbsp; 17979552 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (1151389)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (59320579)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1274730)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (63374046)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (178451)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (10861445)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (872952)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (42629678)<br>|
| **Class IC** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 7004 | &nbsp;&nbsp;&nbsp;&nbsp; $365147 | &nbsp;&nbsp;&nbsp;&nbsp; 14175 | &nbsp;&nbsp;&nbsp;&nbsp; $714674 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 38113 | &nbsp;&nbsp;&nbsp;&nbsp; 1905332 | &nbsp;&nbsp;&nbsp;&nbsp; 13651 | &nbsp;&nbsp;&nbsp;&nbsp; 712861 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (67112)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (3430008)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (37306)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1923945)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (21995)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1159529)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (9480)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (496410)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (540626)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(44043288)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (7057200)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(352754016)<br>|
| **Disciplined Equity HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 1086453 | &nbsp;&nbsp;&nbsp;&nbsp; $23177021 | &nbsp;&nbsp;&nbsp;&nbsp; 975656 | &nbsp;&nbsp;&nbsp;&nbsp; $21069264 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 11910841 | &nbsp;&nbsp;&nbsp;&nbsp; 263646122 | &nbsp;&nbsp;&nbsp;&nbsp; 5591379 | &nbsp;&nbsp;&nbsp;&nbsp; 123659813 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (14675546)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (334654176)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (16442839)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (354598425)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (1678252)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (47831033)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (9875804)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (209869348)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 286053 | &nbsp;&nbsp;&nbsp;&nbsp; $6219650 | &nbsp;&nbsp;&nbsp;&nbsp; 378815 | &nbsp;&nbsp;&nbsp;&nbsp; $7986211 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 1353636 | &nbsp;&nbsp;&nbsp;&nbsp; 29254457 | &nbsp;&nbsp;&nbsp;&nbsp; 645161 | &nbsp;&nbsp;&nbsp;&nbsp; 13971168 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (2523666)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (56537043)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2653460)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (55859362)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (883977)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (21062936)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1629484)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (33901983)<br>|
| **Class IC** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 66365 | &nbsp;&nbsp;&nbsp;&nbsp; $1514031 | &nbsp;&nbsp;&nbsp;&nbsp; 66816 | &nbsp;&nbsp;&nbsp;&nbsp; $1398427 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 281116 | &nbsp;&nbsp;&nbsp;&nbsp; 6190182 | &nbsp;&nbsp;&nbsp;&nbsp; 131543 | &nbsp;&nbsp;&nbsp;&nbsp; 2893595 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (598902)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (13598403)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (627658)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (13429102)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (251421)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (5894190)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (429299)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (9137080)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (2813650)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(74788159)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (11934587)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(252908411)<br>|
| **Dividend and Growth HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 2214442 | &nbsp;&nbsp;&nbsp;&nbsp; $51892597 | &nbsp;&nbsp;&nbsp;&nbsp; 3299854 | &nbsp;&nbsp;&nbsp;&nbsp; $79257205 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 23099396 | &nbsp;&nbsp;&nbsp;&nbsp; 505397957 | &nbsp;&nbsp;&nbsp;&nbsp; 10654822 | &nbsp;&nbsp;&nbsp;&nbsp; 255244168 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (17220356)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (403756270)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (25469404)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (619305017)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 8093482 | &nbsp;&nbsp;&nbsp;&nbsp; 153534284 | &nbsp;&nbsp;&nbsp;&nbsp; (11514728)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (284803644)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 319910 | &nbsp;&nbsp;&nbsp;&nbsp; $7411757 | &nbsp;&nbsp;&nbsp;&nbsp; 278429 | &nbsp;&nbsp;&nbsp;&nbsp; $6641970 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 2884492 | &nbsp;&nbsp;&nbsp;&nbsp; 62214722 | &nbsp;&nbsp;&nbsp;&nbsp; 1346804 | &nbsp;&nbsp;&nbsp;&nbsp; 31926825 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (2680238)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (62023526)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2519657)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (60241191)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 524164 | &nbsp;&nbsp;&nbsp;&nbsp; 7602953 | &nbsp;&nbsp;&nbsp;&nbsp; (894424)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (21672396)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 8617646 | &nbsp;&nbsp;&nbsp;&nbsp; $161137237 | &nbsp;&nbsp;&nbsp;&nbsp; (12409152)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(306476040)<br>|
| **Healthcare HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 419586 | &nbsp;&nbsp;&nbsp;&nbsp; $6773564 | &nbsp;&nbsp;&nbsp;&nbsp; 352180 | &nbsp;&nbsp;&nbsp;&nbsp; $6200375 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 330857 | &nbsp;&nbsp;&nbsp;&nbsp; 4853667 | &nbsp;&nbsp;&nbsp;&nbsp; 42262 | &nbsp;&nbsp;&nbsp;&nbsp; 797065 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (1289213)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (20805787)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1377406)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (24124235)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (538770)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (9178556)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (982964)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (17126795)<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

88 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Year Ended**<br> **December 31, 2025** | **For the Year Ended**<br> **December 31, 2025** | **For the Year Ended**<br> **December 31, 2024** | **For the Year Ended**<br> **December 31, 2024** |
|  | **Shares** | **Amount** | **Shares** | **Amount** |
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 42373 | &nbsp;&nbsp;&nbsp;&nbsp; $604046 | &nbsp;&nbsp;&nbsp;&nbsp; 48662 | &nbsp;&nbsp;&nbsp;&nbsp; $747166 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 108786 | &nbsp;&nbsp;&nbsp;&nbsp; 1389202 | &nbsp;&nbsp;&nbsp;&nbsp; 12593 | &nbsp;&nbsp;&nbsp;&nbsp; 208541 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (348575)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (5001281)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (366151)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (5614393)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (197416)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (3008033)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (304896)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (4658686)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (736186)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(12186589)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1287860)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(21785481)<br>|
| **International Opportunities HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 3059216 | &nbsp;&nbsp;&nbsp;&nbsp; $56059879 | &nbsp;&nbsp;&nbsp;&nbsp; 2372445 | &nbsp;&nbsp;&nbsp;&nbsp; $38426206 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 913057 | &nbsp;&nbsp;&nbsp;&nbsp; 17421119 | &nbsp;&nbsp;&nbsp;&nbsp; 706841 | &nbsp;&nbsp;&nbsp;&nbsp; 11938546 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (13697197)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (248832762)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (8846284)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (142473718)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (9724924)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (175351764)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (5766998)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (92108966)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 120209 | &nbsp;&nbsp;&nbsp;&nbsp; $2223333 | &nbsp;&nbsp;&nbsp;&nbsp; 105985 | &nbsp;&nbsp;&nbsp;&nbsp; $1759138 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 85605 | &nbsp;&nbsp;&nbsp;&nbsp; 1670162 | &nbsp;&nbsp;&nbsp;&nbsp; 56893 | &nbsp;&nbsp;&nbsp;&nbsp; 981972 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (870364)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (16339482)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (904678)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (14929343)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (664550)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (12445987)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (741800)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (12188233)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (10389474)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(187797751)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (6508798)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(104297199)<br>|
| **MidCap HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 713954 | &nbsp;&nbsp;&nbsp;&nbsp; $19053632 | &nbsp;&nbsp;&nbsp;&nbsp; 808485 | &nbsp;&nbsp;&nbsp;&nbsp; $22656543 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 5281997 | &nbsp;&nbsp;&nbsp;&nbsp; 129446072 | &nbsp;&nbsp;&nbsp;&nbsp; 667971 | &nbsp;&nbsp;&nbsp;&nbsp; 18435999 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (4389498)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (117004222)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (11864079)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (330175251)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 1606453 | &nbsp;&nbsp;&nbsp;&nbsp; 31495482 | &nbsp;&nbsp;&nbsp;&nbsp; (10387623)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (289082709)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 75916 | &nbsp;&nbsp;&nbsp;&nbsp; $1873502 | &nbsp;&nbsp;&nbsp;&nbsp; 50846 | &nbsp;&nbsp;&nbsp;&nbsp; $1343636 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 638842 | &nbsp;&nbsp;&nbsp;&nbsp; 14367175 | &nbsp;&nbsp;&nbsp;&nbsp; 82997 | &nbsp;&nbsp;&nbsp;&nbsp; 2140506 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (577037)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (14218356)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (670331)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (17741679)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 137721 | &nbsp;&nbsp;&nbsp;&nbsp; 2022321 | &nbsp;&nbsp;&nbsp;&nbsp; (536488)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (14257537)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 1744174 | &nbsp;&nbsp;&nbsp;&nbsp; $33517803 | &nbsp;&nbsp;&nbsp;&nbsp; (10924111)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(303340246)<br>|
| **Small Cap Growth HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 785748 | &nbsp;&nbsp;&nbsp;&nbsp; $19769072 | &nbsp;&nbsp;&nbsp;&nbsp; 1595154 | &nbsp;&nbsp;&nbsp;&nbsp; $44397307 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 2988283 | &nbsp;&nbsp;&nbsp;&nbsp; 68192620 | &nbsp;&nbsp;&nbsp;&nbsp; 58663 | &nbsp;&nbsp;&nbsp;&nbsp; 1695941 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (2471239)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (64302481)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (11347111)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (332860115)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 1302792 | &nbsp;&nbsp;&nbsp;&nbsp; 23659211 | &nbsp;&nbsp;&nbsp;&nbsp; (9693294)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (286766867)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 931431 | &nbsp;&nbsp;&nbsp;&nbsp; $22057296 | &nbsp;&nbsp;&nbsp;&nbsp; 578707 | &nbsp;&nbsp;&nbsp;&nbsp; $15202614 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 2097370 | &nbsp;&nbsp;&nbsp;&nbsp; 43939891 | &nbsp;&nbsp;&nbsp;&nbsp; 7101 | &nbsp;&nbsp;&nbsp;&nbsp; 191953 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (1285360)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (30822318)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1124694)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (29030090)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 1743441 | &nbsp;&nbsp;&nbsp;&nbsp; 35174869 | &nbsp;&nbsp;&nbsp;&nbsp; (538886)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (13635523)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 3046233 | &nbsp;&nbsp;&nbsp;&nbsp; $58834080 | &nbsp;&nbsp;&nbsp;&nbsp; (10232180)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(300402390)<br>|
| **Small Company HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 745953 | &nbsp;&nbsp;&nbsp;&nbsp; $12984384 | &nbsp;&nbsp;&nbsp;&nbsp; 831713 | &nbsp;&nbsp;&nbsp;&nbsp; $14201094 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 89950 | &nbsp;&nbsp;&nbsp;&nbsp; 1617305 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (3229906)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (57971467)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (3693170)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (62397140)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (2394003)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (43369778)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2861457)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (48196046)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 94255 | &nbsp;&nbsp;&nbsp;&nbsp; $1351499 | &nbsp;&nbsp;&nbsp;&nbsp; 126300 | &nbsp;&nbsp;&nbsp;&nbsp; $1794863 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 6336 | &nbsp;&nbsp;&nbsp;&nbsp; 93906 | &nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; — |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (465127)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (6865324)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (554477)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (7767744)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (364536)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (5419919)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (428177)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (5972881)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (2758539)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(48789697)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (3289634)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(54168927)<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

89 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Year Ended**<br> **December 31, 2025** | **For the Year Ended**<br> **December 31, 2025** | **For the Year Ended**<br> **December 31, 2024** | **For the Year Ended**<br> **December 31, 2024** |
|  | **Shares** | **Amount** | **Shares** | **Amount** |
| **Stock HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 54173 | &nbsp;&nbsp;&nbsp;&nbsp; $5337038 | &nbsp;&nbsp;&nbsp;&nbsp; 49632 | &nbsp;&nbsp;&nbsp;&nbsp; $5088447 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 1745979 | &nbsp;&nbsp;&nbsp;&nbsp; 160622696 | &nbsp;&nbsp;&nbsp;&nbsp; 534553 | &nbsp;&nbsp;&nbsp;&nbsp; 55200279 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (1590669)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (156100376)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1576533)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (161072547)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 209483 | &nbsp;&nbsp;&nbsp;&nbsp; 9859358 | &nbsp;&nbsp;&nbsp;&nbsp; (992348)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (100783821)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 16676 | &nbsp;&nbsp;&nbsp;&nbsp; $1647708 | &nbsp;&nbsp;&nbsp;&nbsp; 14376 | &nbsp;&nbsp;&nbsp;&nbsp; $1469010 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 151176 | &nbsp;&nbsp;&nbsp;&nbsp; 13867226 | &nbsp;&nbsp;&nbsp;&nbsp; 44937 | &nbsp;&nbsp;&nbsp;&nbsp; 4636580 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (149540)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (14740927)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (169376)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (17248025)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 18312 | &nbsp;&nbsp;&nbsp;&nbsp; 774007 | &nbsp;&nbsp;&nbsp;&nbsp; (110063)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (11142435)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; 227795 | &nbsp;&nbsp;&nbsp;&nbsp; $10633365 | &nbsp;&nbsp;&nbsp;&nbsp; (1102411)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(111926256)<br>|
| **Total Return Bond HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 10500012 | &nbsp;&nbsp;&nbsp;&nbsp; $101193374 | &nbsp;&nbsp;&nbsp;&nbsp; 16270594 | &nbsp;&nbsp;&nbsp;&nbsp; $155436683 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 7226199 | &nbsp;&nbsp;&nbsp;&nbsp; 67564962 | &nbsp;&nbsp;&nbsp;&nbsp; 5922620 | &nbsp;&nbsp;&nbsp;&nbsp; 57330959 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (54383351)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (524498993)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (25263417)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (242182908)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (36657140)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (355740657)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (3070203)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (29415266)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 601918 | &nbsp;&nbsp;&nbsp;&nbsp; $5770151 | &nbsp;&nbsp;&nbsp;&nbsp; 990795 | &nbsp;&nbsp;&nbsp;&nbsp; $9444466 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 815526 | &nbsp;&nbsp;&nbsp;&nbsp; 7592544 | &nbsp;&nbsp;&nbsp;&nbsp; 553651 | &nbsp;&nbsp;&nbsp;&nbsp; 5337196 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (2619375)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (25003133)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2854411)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (27213748)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (1201931)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (11640438)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1309965)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (12432086)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (37859071)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(367381095)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (4380168)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(41847352)<br>|
| **Ultrashort Bond HLS Fund** |  |  |  |  |
| **Class IA** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 3472506 | &nbsp;&nbsp;&nbsp;&nbsp; $36374427 | &nbsp;&nbsp;&nbsp;&nbsp; 2690600 | &nbsp;&nbsp;&nbsp;&nbsp; $28037421 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 2191258 | &nbsp;&nbsp;&nbsp;&nbsp; 22307001 | &nbsp;&nbsp;&nbsp;&nbsp; 1970533 | &nbsp;&nbsp;&nbsp;&nbsp; 20217668 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (8139474)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (85180087)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (7629858)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (79749705)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (2475710)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (26498659)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (2968725)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (31494616)<br>|
| **Class IB** |  |  |  |  |
| Shares Sold | &nbsp;&nbsp;&nbsp;&nbsp; 835458 | &nbsp;&nbsp;&nbsp;&nbsp; $8695077 | &nbsp;&nbsp;&nbsp;&nbsp; 706062 | &nbsp;&nbsp;&nbsp;&nbsp; $7362395 |
| Shares Issued for Reinvested Dividends | &nbsp;&nbsp;&nbsp;&nbsp; 303345 | &nbsp;&nbsp;&nbsp;&nbsp; 3088056 | &nbsp;&nbsp;&nbsp;&nbsp; 278150 | &nbsp;&nbsp;&nbsp;&nbsp; 2853816 |
| Shares Redeemed | &nbsp;&nbsp;&nbsp;&nbsp; (1587845)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (16594445)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (1646000)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (17179363)<br>|
| Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (449042)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (4811312)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (661788)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (6963152)<br>|
| Total Net Increase (Decrease) | &nbsp;&nbsp;&nbsp;&nbsp; (2924752)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(31309971)<br>| &nbsp;&nbsp;&nbsp;&nbsp; (3630513)<br>| &nbsp;&nbsp;&nbsp;&nbsp; $(38457768)<br>|

---

**11.** **Line of Credit:** 

Each Fund participates in a committed line of credit pursuant to a credit agreement dated February 27, 2025. Each Fund may borrow under the line of credit for temporary or emergency purposes. The Funds (together with certain other Hartford mutual funds and ETFs) may borrow up to $350 million in the aggregate, subject to asset coverage and other limitations specified in the credit agreement. As of February 27, 2025, the interest rate on borrowings is equal to the higher of the Federal Funds Effective Rate and the Overnight Bank Funding Rate, plus an applicable margin. The facility also charges a commitment fee. From January 1, 2025 through February 27, 2025, the Funds (together with certain other Hartford mutual funds and ETFs) had a similar agreement that enabled them to participate in a $350 million committed line of credit. The fees incurred by the Funds in connection with the committed lines of credit during the period appear in the Statements of Operations under "Other expenses." During and as of the year ended December 31, 2025, none of the Funds had borrowings under these facilities.

**12.** **Indemnifications:** 

Under the Company's organizational documents, the Company shall indemnify its officers and directors to the full extent required or permitted under Maryland General Corporation Law and federal securities laws. In addition, the Company, on behalf of each Fund, may enter into contracts that contain a variety of indemnifications. The Company's maximum exposure under these arrangements is unknown. However, as of the date of these financial statements, the Company has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

90 <br>

------

**Hartford HLS Funds**

 ***Notes to Financial Statements – (continued)***

 ***December 31, 2025*** 

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**13.** **Subsequent Events:**

Management has evaluated all subsequent transactions and events through the date on which these financial statements were issued and has determined that no additional items require disclosure in these financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

91 <br>

------

**Report of Independent Registered Public Accounting Firm**

***To the Board of Directors of Hartford Series Fund, Inc. and Shareholders of Hartford Balanced HLS Fund, Hartford Capital Appreciation HLS Fund, Hartford Disciplined Equity HLS Fund, Hartford Dividend and Growth HLS Fund, Hartford Healthcare HLS Fund, Hartford International Opportunities HLS Fund, Hartford MidCap HLS Fund, Hartford Small Cap Growth HLS Fund, Hartford Small Company HLS Fund, Hartford Stock HLS Fund, Hartford Total Return Bond HLS Fund, and Hartford Ultrashort Bond HLS Fund***

------

**Opinions on the Financial Statements**

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Hartford Balanced HLS Fund, Hartford Capital Appreciation HLS Fund, Hartford Disciplined Equity HLS Fund, Hartford Dividend and Growth HLS Fund, Hartford Healthcare HLS Fund, Hartford International Opportunities HLS Fund, Hartford MidCap HLS Fund, Hartford Small Cap Growth HLS Fund, Hartford Small Company HLS Fund, Hartford Stock HLS Fund, Hartford Total Return Bond HLS Fund, and Hartford Ultrashort Bond HLS Fund (constituting Hartford Series Fund, Inc., hereafter collectively referred to as the "Funds") as of December 31, 2025, the related statements of operations for the year ended December 31, 2025, the statements of changes in net assets for each of the two years in the period ended December 31, 2025, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2025 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of December 31, 2025, the results of each of their operations for the year then ended, the changes in each of their net assets for each of the two years in the period ended December 31, 2025 and each of the financial highlights for each of the five years in the period ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America.

**Basis for Opinions**

These financial statements are the responsibility of the Funds' management. Our responsibility is to express an opinion on the Funds' financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2025 by correspondence with the custodian, transfer agent, agent bank, portfolio companies and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

February 13, 2026

We have served as the auditor of one or more investment companies in the Hartford Funds group of investment companies since 2020.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

92 <br>

------

**Hartford HLS Funds**

**Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.** 

------

Not applicable. There were no changes in or disagreements with accountants during the period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

93 <br>

------

**Hartford HLS Funds**

**Item 9. Proxy Disclosures for Open-End Management Investment Companies.** 

------

Not applicable. There were no matters submitted to a vote of shareholders during the period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

94 <br>

------

**Hartford HLS Funds**

**Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.** 

------

The aggregate remuneration paid by Hartford Series Fund, Inc. (the "Company") during the period January 1, 2025 through December 31, 2025:

(1) All directors and all members of any advisory board for regular compensation: $350,408.

(2) Each director and each member of an advisory board for special compensation: Not applicable.

(3) All officers: Except for a portion of the CCO's compensation, none of the series of the Company paid any remuneration to their officers. The aggregate remuneration paid to the CCO by all of the series of the Company is as follows: $36,114.

(4) Each person of whom any officer or director of the Funds is an affiliated person: Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

95 <br>

------

**Hartford HLS Funds**

**Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.**

***Approval of Investment Management and Investment Sub-Advisory Agreements (Unaudited)***

------

Hartford Series Fund, Inc.

**Hartford Balanced HLS Fund**

**Hartford Capital Appreciation HLS Fund**

**Hartford Disciplined Equity HLS Fund**

**Hartford Dividend and Growth HLS Fund**

**Hartford Healthcare HLS Fund**

**Hartford International Opportunities HLS Fund**

**Hartford MidCap HLS Fund**

**Hartford Small Cap Growth HLS Fund**

**Hartford Small Company HLS Fund**

**Hartford Stock HLS Fund**

**Hartford Total Return Bond HLS Fund**

**Hartford Ultrashort Bond HLS Fund**

(each, a "Fund" and collectively, the "Funds")

Section 15(c) of the Investment Company Act of 1940, as amended (the "1940 Act"), requires that each mutual fund's board of directors, including a majority of those directors who are not "interested persons" of the mutual fund, as defined in the 1940 Act (the "Independent Directors"), annually review and consider the continuation of the mutual fund's investment advisory and sub-advisory agreements. At its meeting held on September 10-11, 2025, the Board of Directors (the "Board") of Hartford Series Fund, Inc. ("HLS"), including the Independent Directors, unanimously voted to approve (i) the continuation of an investment management agreement (the "Management Agreement") by and between HLS, on behalf of each of its series listed above, and Hartford Funds Management Company, LLC ("HFMC"); and (ii) the continuation of an investment sub-advisory agreement (the "Sub-Advisory Agreement" and together with the Management Agreement, the "Agreements") between HFMC and each Fund's sub-adviser, Wellington Management Company LLP (the "Sub-adviser," and together with HFMC, the "Advisers"), with respect to each Fund.

In the months preceding the September 10-11, 2025 meeting, the Board requested and reviewed written responses from the Advisers to questions posed to the Advisers on behalf of the Independent Directors and supporting materials relating to those questions and responses. In addition, the Board considered such additional information as it deemed reasonably necessary to evaluate the Agreements, as applicable, with respect to each Fund, which included information furnished to the Board and its committees at their meetings throughout the year and in between regularly scheduled meetings on particular matters as the need arose, as well as information specifically prepared in connection with the approval of the continuation of the Agreements that was presented at the Board's meetings held on June 17-18, 2025 and September 10-11, 2025. Information provided to the Board and its committees at their meetings throughout the year included, among other things, reports on Fund performance, legal, compliance and risk management matters, sales and marketing activity, shareholder services, and the other services provided to each Fund by the Advisers and their affiliates. The members of the Board also considered the materials and presentations by Fund officers and representatives of HFMC received at the Board's meetings on June 17-18, 2025 and September 10-11, 2025 concerning the Agreements, Fund fees and expenses, performance and other investment-related matters.

The Independent Directors engaged service providers to assist them with evaluating the Agreements with respect to each Fund, as applicable. Broadridge Financial Solutions, Inc. ("Broadridge"), an independent provider of investment company data, was retained to provide the Board with reports on how each Fund's contractual management fees, actual management fees, total expense ratios and investment performance compared to those of an appropriate group of investment companies selected by Broadridge. The Independent Directors also engaged an independent consultant (the "Consultant") to assist them in evaluating each Fund's fees and expenses.

In determining whether to approve the continuation of the Agreements for a Fund, the members of the Board reviewed and evaluated information and factors they believed to be relevant and appropriate through the exercise of their reasonable business judgment. While individual members of the Board may have weighed certain factors differently, the Board's determination to approve the continuation of the Agreements was based on a comprehensive consideration of all information provided to the Board throughout the year and specifically with respect to the continuation of the Agreements. The Board was also furnished with an analysis of its fiduciary obligations in connection with its evaluation of the Agreements. Throughout the evaluation process, the Board was assisted by counsel for the Funds and the Independent Directors were also separately assisted by independent legal counsel. In connection with their deliberations, the Independent Directors met separately with independent legal counsel and the Consultant on June 11, 2025 and in executive session on several occasions to consider their responsibilities under relevant laws and regulations and to discuss the materials presented and other matters deemed relevant to their consideration of the approval of the continuation of the Agreements. As a result of the discussions that occurred during the June 11, 2025 and June 17-18, 2025 meetings, the Independent Directors presented HFMC

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

96 <br>

------

**Hartford HLS Funds**

**Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.**

***Approval of Investment Management and Investment Sub-Advisory Agreements (Unaudited) – (continued)***

------

and its affiliates with requests for additional information on certain topics. HFMC responded to these requests with additional information in connection with the September 10-11, 2025 meeting. A more detailed summary of the important, but not necessarily all, factors the Board considered with respect to its approval of the continuation of the Agreements is provided below.

*Nature, Extent and Quality of Services Provided by the Advisers*

The Board requested and considered information concerning the nature, extent and quality of the services provided to each Fund by the Advisers. The Board considered, among other things, the terms of the Agreements and the range of services provided by the Advisers. The Board considered the Advisers' professional personnel who provide services to the Funds, including each Adviser's ability and experience in attracting and retaining qualified personnel to service the Funds. The Board considered each Adviser's reputation and overall financial strength, as well as each Adviser's willingness to consider and implement organizational and operational changes designed to enhance services to the funds managed by HFMC and its affiliates (the "Hartford funds"). In addition, the Board considered the quality of each Adviser's communications with the Board and responsiveness to Board inquiries and requests made from time to time with respect to the Funds and other Hartford funds.

The Board also requested and evaluated information concerning each Adviser's regulatory and compliance environment. In this regard, the Board reviewed information about each Adviser's compliance policies and procedures and compliance history, and a report from the Funds' Chief Compliance Officer about each Adviser's compliance with applicable laws and regulations, including responses to regulatory developments and any compliance or other issues raised by regulators. The Board also noted the Advisers' support of the Funds' compliance control structure, as applicable, including the resources devoted by the Advisers in support of the Funds' obligations pursuant to Rule 38a-1 under the 1940 Act and the Funds' risk management programs, as well as the efforts of the Advisers to address cybersecurity risks. The Board also considered HFMC's investments in business continuity planning designed to benefit the Funds. The Board also noted HFMC's commitment to maintaining high quality systems and expending substantial resources to prepare for and respond to ongoing changes to the market, regulatory and control environments in which the Funds and their service providers operate.

With respect to HFMC, the Board noted that, under the Management Agreement, HFMC is responsible for the management of the Funds, including oversight of fund operations and service providers, and the provision of investment advisory and administrative services in connection with selecting, monitoring and supervising the Sub-adviser. In this regard, the Board evaluated information about the nature and extent of responsibilities retained and risks assumed by HFMC that were not delegated to, or assumed by, the Sub-adviser. The Board considered HFMC's ongoing monitoring of people, process and performance, including its quarterly reviews of each of the Hartford funds, semi-annual meetings with the leaders of each Fund's portfolio management team, and ongoing oversight of the Hartford funds' portfolio managers. The Board noted that HFMC has demonstrated a record of initiating changes to the portfolio management and/or investment strategies of the Hartford funds when warranted. The Board considered HFMC's periodic due diligence reviews of the Sub-adviser and ongoing oversight of the Sub-adviser's investment approach and results, process for monitoring best execution of portfolio trades and other trading operations by the Sub-adviser, and approach to risk management with respect to the Funds. The Board considered HFMC's oversight of the securities lending program for the Funds that engage in securities lending and noted the income earned by the Funds that participate in such program. The Board also considered HFMC's day-to-day oversight of each Fund's compliance with its investment objective and policies as well as with applicable laws and regulations, noting that regulatory and other developments had over time led to an increase in the scope of HFMC's oversight in this regard.

In addition, the Board considered HFMC's overall strategic plan for, and ongoing commitment to review and re-assess, the Hartford funds product line-up. The Board considered that HFMC is responsible for providing the Funds' officers.

With respect to the Sub-adviser, which provides certain day-to-day portfolio management services for the Funds, subject to oversight by HFMC, the Board considered, among other things, the Sub-adviser's investment personnel, investment philosophy and process, investment research capabilities and resources, performance record, trade execution capabilities and experience. The Board considered the experience and expertise of each Fund's portfolio manager(s) and the Sub-adviser's method for compensating the portfolio manager(s). The Board also considered the Sub-adviser's succession planning practices to ensure continuity of portfolio management services provided to the Funds and HFMC's oversight of these practices.

The Board considered the benefits to shareholders of investing in a fund that is part of the family of Hartford funds. The Board considered HFMC's efforts to provide investors in the Hartford funds with a broad range of investment styles and asset classes.

Based on these considerations, the Board concluded that it was satisfied with the nature, extent and quality of the services provided to each Fund by HFMC and the Sub-adviser.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

97 <br>

------

**Hartford HLS Funds**

**Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.**

***Approval of Investment Management and Investment Sub-Advisory Agreements (Unaudited) – (continued)***

------

*Performance of each Fund and the Advisers*

The Board considered the investment performance of each Fund. In this regard, the Board reviewed the performance of each Fund over different time periods and evaluated HFMC's analysis of each Fund's performance for these time periods. The Board considered information and materials provided to the Board by the Advisers concerning Fund performance, as well as information from Broadridge comparing the investment performance of each Fund to an appropriate universe of peer funds selected by Broadridge. The Board noted that while it found the comparative data provided by Broadridge generally useful in evaluating a Hartford fund's investment performance, the Board recognized the limitations of such data, including that notable differences may exist between a Hartford fund and its peers. For details regarding each Fund's performance, see the Fund-by-Fund synopsis below.

The Board considered the detailed investment analytics reports provided by HFMC's Investment Advisory Group throughout the year, including in connection with the approval of the continuation of the Agreements. These reports included, among other things, information on each Fund's gross returns and net returns, the Fund's investment performance compared to one or more appropriate benchmarks and relevant groups or categories of peer funds, various statistics concerning the Fund's portfolio, a narrative summary of various factors affecting Fund performance, and commentary on the effect of current and recent market conditions. The Board also noted that the Hartford Capital Appreciation HLS Fund utilizes a multiple sleeve structure whereby each sleeve has a distinct investment philosophy and analytical process and considered the performance attributions of the underlying portfolio managers. The Board considered the Advisers' work with the Investment Committee, which assists the Board in evaluating the performance of each Fund at periodic meetings throughout the year and specifically with respect to the approval of the continuation of the Agreements. The Board considered that the Investment Committee, in its evaluation of investment performance at meetings throughout the year, focused particular attention on information indicating less favorable performance of certain Hartford funds for specific time periods and discussed with HFMC's Investment Advisory Group the reasons for such performance as well as any specific actions that the Advisers had taken, or had agreed to take, to seek to enhance Fund investment performance and the results of those actions. The Board also considered information provided by the Consultant relating to each Fund's performance track record.

Based on these considerations, the Board concluded that it had continued confidence in HFMC's and the Sub-adviser's overall capabilities to manage the Funds.

*Costs of the Services and Profitability of the Advisers*

The Board reviewed information regarding HFMC's cost to provide investment management and related services to each Fund and HFMC's profitability, both overall and for each Fund, on a pre-tax basis without regard to distribution expenses. The Board also requested and reviewed information about the profitability to HFMC and its affiliates from all services provided to each Fund and all aspects of their relationship with the Fund, including information regarding profitability trends over time and information provided by Broadridge analyzing the profitability of investment managers to other fund complexes. The Board also requested and received information relating to the operations and profitability of the Sub-adviser. The Board considered representations from HFMC and the Sub-adviser that the Sub-adviser's fees were negotiated at arm's length on a Fund-by-Fund basis and that the sub-advisory fees are paid by HFMC and not the Funds. Accordingly, the Board concluded that the profitability of the Sub-adviser is a less relevant factor with respect to the Board's consideration of the Sub-Advisory Agreement.

The Board considered that the Independent Directors' prior independent consultant had previously reviewed the methodologies and estimates used by HFMC in calculating profitability in connection with the continuation of the Management Agreement, including a description of the methodology used to allocate certain expenses. The Board noted that the prior independent consultant previously reported that such process is reasonable, sound and consistent with common industry practice. The Board noted that HFMC's process for calculating and reporting Fund profitability is consistent with the process previously reviewed by the prior independent consultant.

Based on these considerations, the Board concluded that the profits realized by HFMC and its affiliates from their relationships with each Fund were not excessive.

*Comparison of Fees and Services Provided by the Advisers*

The Board considered comparative information with respect to the services rendered to and the management fees to be paid by each Fund to HFMC and the total expense ratios of the Fund. The Board also considered comparative information with respect to the sub-advisory fees to be paid by HFMC to the Sub-adviser with respect to each Fund. In this regard, the Board requested and reviewed information from HFMC and the Sub-adviser relating to the management and sub-advisory fees, including the sub-advisory fee schedule for each Fund and the amount of the management fee retained

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

98 <br>

------

**Hartford HLS Funds**

**Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.**

***Approval of Investment Management and Investment Sub-Advisory Agreements (Unaudited) – (continued)***

------

by HFMC, and total operating expenses for each Fund. The Board also reviewed information from Broadridge comparing each Fund's contractual management fees, actual management fees and total expense ratios relative to an appropriate group of funds selected by Broadridge. For details regarding each Fund's fees and expenses, see the Fund-by-Fund synopsis below.

The Board considered the methodology used by Broadridge to select the funds included in the expense groups. While the Board recognized that comparisons between a Fund and its peer funds may be imprecise given, among other differences, the different service levels and characteristics of mutual funds and the different business models and cost structures of the Advisers, the comparative information provided by Broadridge assisted the Board in evaluating the reasonableness of each Fund's fees and total operating expenses. In addition, the Board considered the independent analysis and views of the Consultant regarding each Fund's fees and total operating expenses in the context of the Fund's investment performance.

The Board also received information regarding fees charged by the Sub-adviser to any other clients with investment strategies similar to those of the Funds, including any institutional separate account clients and registered fund clients for which the Sub-adviser serves as either primary investment adviser or sub-adviser. The Board considered the explanations provided by the Sub-adviser about any differences between the Sub-adviser's services to the Funds and the services the Sub-adviser provides to other types of clients. In this regard, the Board reviewed information about the generally broader scope of services and compliance, reporting and other legal burdens and risks of managing registered funds compared with those associated with managing assets of non-registered fund clients such as institutional separate accounts.

Based on these considerations, the Board concluded that each Fund's fees and total operating expenses, in conjunction with the information about quality of services, profitability, economies of scale, and other matters considered, were reasonable in light of the services provided.

*Economies of Scale*

The Board considered information regarding economies of scale, including the extent to which economies of scale may be realized as a Fund grows and whether fee levels reflect these economies of scale for the benefit of shareholders of the Fund. The Board reviewed the breakpoints in the management fee schedule for each Fund, which reduce fee rates as the Fund's assets grow over time. The Board recognized that a Fund with assets beyond the highest breakpoint level will continue to benefit from economies of scale because additional assets are charged the lowest breakpoint fee resulting in lower effective management fee rates. The Board also recognized that a fee schedule that reaches a breakpoint at a lower asset level provides shareholders with the benefit of anticipated or potential economies of scale. The Board considered that fee waivers that reduce a Fund's expenses at all asset levels can have the same effect as breakpoints in sharing economies of scale with shareholders and provide protection from an increase in expenses if the Fund's assets decline. In addition, the Board considered that initially setting competitive fee rates, pricing a Fund to scale at inception and making additional investments intended to enhance services available to shareholders are other means of sharing anticipated or potential economies of scale with shareholders. The Board also considered that HFMC has been active in managing expenses of the Hartford funds in recent years, which has resulted in benefits being realized by shareholders. The Board also noted that, for the Hartford Healthcare HLS Fund, the Fund's current low asset levels have kept the Fund from fully realizing the benefits of anticipated or potential economies of scale. The Board considered HFMC's assessment of the low asset levels for the Hartford Healthcare HLS Fund. The Board considered that the Funds are closed to certain investors.

The Board reviewed and evaluated materials from Broadridge showing how management fee schedules of peer funds reflect economies of scale for the benefit of shareholders as a peer fund's assets hypothetically increase over time. Based on information provided by HFMC and Broadridge, the Board recognized that there is no uniform methodology for establishing breakpoints or uniform pattern in asset levels that trigger breakpoints or the amounts of breakpoints triggered.

After considering all of the information available to it, the Board concluded that it was satisfied with the extent to which economies of scale, if any, would be shared for the benefit of each Fund's shareholders based on currently available information and the effective management fees and total expense ratios for the Fund at its current and reasonably anticipated asset levels. The Board noted, however, that it would continue to monitor any future growth in each Fund's assets and the appropriateness of additional management fee breakpoints or other methods to share benefits from economies of scale as part of its future review of the Agreements.

*Other Benefits*

The Board considered other benefits to the Advisers and their affiliates from their relationships with the Funds.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

99 <br>

------

**Hartford HLS Funds**

**Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.**

***Approval of Investment Management and Investment Sub-Advisory Agreements (Unaudited) – (continued)***

------

The Board noted that HFMC receives fees for fund accounting and related services from the Funds, and the Board considered information on the profitability to HFMC from providing such services to the Funds. The Board also considered that Hartford Administrative Services Company ("HASCO"), the Funds' transfer agent and an affiliate of HFMC, receives transfer agency compensation from the Funds, and the Board reviewed information about the profitability to HASCO of the Funds' transfer agency function. The Board considered information provided by HFMC indicating that the transfer agency fees charged by HASCO to the Funds were fair and reasonable based on available industry data about fees charged by transfer agents to other mutual funds. The Board also noted that HFMC and HASCO had delegated certain fund accounting services and transfer agency services, respectively, to external service providers, subject to oversight.

The Board also considered that Hartford Funds Distributors, LLC ("HFD"), an affiliate of HFMC, serves as principal underwriter of the Funds. The Board noted that, as principal underwriter, HFD receives distribution and service fees from the Funds. The Board considered that HFD has entered into an agreement with the Sub-adviser and Wellington Trust Company NA to provide certain marketing support services in connection with certain collective investment trust vehicles managed by the Sub-adviser.

The Board considered the benefits, if any, to the Sub-adviser from any use of a Fund's brokerage commissions to obtain soft dollar research.

*Fund-by-Fund Factors*

For purposes of evaluating a Fund's performance, the Board considered the Fund's performance relative to similarly managed funds and the Fund's performance relative to its benchmark. In particular, the Board considered the Fund's performance of its Class IA shares (net of all fees and expenses), as of March 31, 2025, and compared that performance to the Fund's peer universe, which includes all funds within the same classification or category, as determined by Broadridge. The Board considered the Fund's performance relative to its peer universe by evaluating its quintile ranking, with the 1st quintile representing the top performing funds within a peer universe and the 5th quintile representing the lowest performing funds. For purposes of evaluating the Fund's performance relative to its benchmark, the Board considered the Fund's performance of its Class IA shares (net of all fees and expenses) as of March 31, 2025. The Board considered Fund performance to be "in line with" a Fund's benchmark where it was 50 basis points above or below the benchmark return. With respect to fees and expenses, the Board considered the Fund's contractual management fee, actual management fee, and total operating expenses of its Class IA shares, as compared to the Fund's expense peer group, which includes a group of similarly sized funds selected by Broadridge.

Hartford Balanced HLS Fund

• The Board noted that the Fund's performance was in the 3rd quintile versus its peer universe for the 1- and 3-year periods and the 2nd quintile for the 5-year period. The Board also noted that the Fund's performance was below its custom blended benchmark for the 1- and 3-year periods and in line with its benchmark for the 5-year period.

• The Board noted that the Fund's contractual management fee, actual management fee and total expenses were in the 4th quintile of its expense group. The Board noted that HFMC had voluntarily agreed to waive a portion of its management fee for the Fund.

Hartford Capital Appreciation HLS Fund

• The Board noted that the Fund's performance was in the 3rd quintile versus its peer universe for the 1-year period and the 4th quintile for the 3- and 5-year periods. The Board also noted that the Fund's performance was below its benchmark for the 1-, 3- and 5-year periods. The Board noted recent changes to the Fund's portfolio management team.

• The Board noted that the Fund's contractual management fee and actual management fee were in the 4th quintile of its expense group, while its total expenses were in the 3rd quintile.

Hartford Disciplined Equity HLS Fund

• The Board noted that the Fund's performance was in the 2nd quintile, 3rd quintile, and 4th quintile versus its peer universe for the 1-, 3- and 5-year periods, respectively. The Board also noted that the Fund's performance was below its benchmark for the 1-, 3- and 5-year periods. The Board noted recent changes to the Fund's portfolio management team.

• The Board noted that the Fund's contractual management fee, actual management fee and total expenses were in the 3rd quintile of its expense group.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

100 <br>

------

**Hartford HLS Funds**

**Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.**

***Approval of Investment Management and Investment Sub-Advisory Agreements (Unaudited) – (continued)***

------

Hartford Dividend and Growth HLS Fund

• The Board noted that the Fund's performance was in the 4th quintile, 3rd quintile, and 1st quintile versus its peer universe for the 1-, 3- and 5-year periods, respectively. The Board also noted that the Fund's performance was below its benchmark for the 1-, 3- and 5-year periods.

• The Board noted that the Fund's contractual management fee and its total expenses were in the 4th quintile of its expense group, while its actual management fee was in the 5th quintile.

Hartford Healthcare HLS Fund

• The Board noted that the Fund's performance was in the 4th quintile versus its peer universe for the 1- and 5-year periods and 5th quintile for the 3-year period. The Board also noted that the Fund's performance was below its benchmark for the 1-, 3- and 5-year periods. The Board noted recent changes to the Fund's portfolio management team.

• The Board noted that the Fund's contractual management fee was in the 3rd quintile of its expense group, while its actual management fee and total expenses were in the 4th quintile.

Hartford International Opportunities HLS Fund

• The Board noted that the Fund's performance was in the 1st quintile, 3rd quintile and 2nd quintile versus its peer universe for the 1-, 3- and 5-year periods, respectively. The Board also noted that the Fund's performance was above its benchmark for the 1- and 5-year periods and in line with its benchmark for the 3-year period. The Board noted recent changes to the Fund's portfolio management team.

• The Board noted that the Fund's contractual management fee, actual management fee and total expenses were in the 2nd quintile of its expense group.

Hartford MidCap HLS Fund

• The Board noted that the Fund's performance was in the 5th quintile versus its peer universe for the 1-, 3- and 5-year periods. The Board also noted that the Fund's performance was below its benchmark for the 1-, 3- and 5-year periods. The Board noted recent changes to the Fund's portfolio management team.

• The Board noted that the Fund's contractual management fee, actual management fee and total expenses were in the 3rd quintile of its expense group.

Hartford Small Cap Growth HLS Fund

• The Board noted that the Fund's performance was in the 4th quintile, 3rd quintile, and 5th quintile versus its peer universe for the 1-, 3- and 5-year periods, respectively. The Board also noted that the Fund's performance was below its benchmark for the 1-, 3- and 5-year periods. The Board noted recent changes to the Fund's portfolio management team.

• The Board noted that the Fund's contractual management fee, actual management fee and total expenses were in the 1st quintile of its expense group.

Hartford Small Company HLS Fund

• The Board noted that the Fund's performance was in the 2nd quintile, 4th quintile, and 3rd quintile versus its peer universe for the 1-, 3- and 5-year periods, respectively. The Board also noted that the Fund's performance was in line with its benchmark for the 1-year period, below its benchmark for the 3-year period and above its benchmark for the 5-year period.

• The Board noted that the Fund's contractual management fee and total expenses were in the 1st quintile of its expense group, while its actual management fee was in the 2nd quintile.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

101 <br>

------

**Hartford HLS Funds**

**Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.**

***Approval of Investment Management and Investment Sub-Advisory Agreements (Unaudited) – (continued)***

------

Hartford Stock HLS Fund

• The Board noted that the Fund's performance was in the 5th quintile versus its peer universe for the 1-, 3- and 5-year periods. The Board also noted that the Fund's performance was below its benchmark for the 1-, 3- and 5-year periods. The Board noted recent and upcoming changes to the Fund's portfolio management team.

• The Board noted that the Fund's contractual management fee, actual management fee and total expenses were in the 1st quintile of its expense group.

Hartford Total Return Bond HLS Fund

• The Board noted that the Fund's performance was in the 1st quintile versus its peer universe for the 1-, 3- and 5-year periods. The Board also noted that the Fund's performance was in line with its benchmark for the 1-year period and above its benchmark for the 3- and 5-year periods. The Board noted upcoming changes to the Fund's portfolio management team.

• The Board noted that the Fund's contractual management fee was in the 2nd quintile of its expense group, while its actual management fee and its total expenses were in the 3rd quintile.

Hartford Ultrashort Bond HLS Fund

• The Board noted that the Fund's performance was in the 1st quintile versus its peer universe for the 1-year period and the 3rd quintile for the 3- and 5-year periods. The Board also noted that the Fund's performance was in line with its benchmark for the 1-, 3- and 5-year periods.

• The Board noted that the Fund's contractual management fee and actual management fee were in the 2nd quintile of its expense group, while its total expenses were in the 3rd quintile.

\* \* \* \*

Based upon the review of the factors summarized above, among others, the Board concluded that it is in the best interests of each Fund and its shareholders for the Board to approve the continuation of the Agreements for an additional year. In reaching this decision, the Board did not assign relative weights to the factors discussed above or deem any one or group of them to be controlling in and of themselves.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

102 <br>

------

**Hartford HLS Funds**

***Index Glossary for Indices Included in the Annual Shareholder Report (Unaudited)***

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| |
|:---|
| **Bloomberg Short Treasury 9-12 Month Index** (reflects no deduction <br> for fees, expenses or taxes) includes aged US Treasury bills, notes <br> and bonds with a remaining maturity from 1 up to (but not including) <br> 12 months. It excludes zero coupon strips.<br>|
| **Bloomberg US Aggregate Bond Index** (reflects no deduction for fees, <br> expenses or taxes) is composed of securities that cover the US <br> investment grade fixed rate bond market, with index components for <br> government and corporate securities, mortgage pass-through <br> securities, and asset-backed securities. <br>|
| **Bloomberg US Government/Credit Bond Index** (reflects no deduction <br> for fees, expenses or taxes) measures the non-securitized component <br> of the US Aggregate Index. It includes investment grade, US <br> dollar-denominated, fixed-rate Treasuries, government-related and <br> corporate securities.<br>|
| **ICE BofA US 3-Month Treasury Bill Index** (reflects no deduction for <br> fees, expenses or taxes) is comprised of a single issue purchased at <br> the beginning of the month and held for a full month. At the end of the <br> month that issue is sold and rolled into a newly selected issue. The <br> issue selected at each month-end rebalancing is the outstanding <br> Treasury Bill that matures closest to, but not beyond, three months <br> from the rebalancing date. To qualify for selection, an issue must have <br> settled on or before the month-end rebalancing date.<br>|
| **MSCI ACWI ex USA Index (Net)** (reflects reinvested dividends net of <br> withholding taxes but reflects no deduction for fees, expenses or other <br> taxes) is designed to capture large and mid cap securities across <br> developed markets (excluding the US) and emerging market countries.<br>|
| **Russell 1000 Index** (reflects no deduction for fees, expenses or taxes) <br> is designed to measure the performance of the 1,000 largest <br> companies in the Russell 3000 Index. The Russell 3000 Index is <br> designed to measure the performance of the 3,000 largest US <br> companies based on total market capitalizations.<br>|
| **Russell 1000 Value Index** (reflects no deduction for fees, expenses or <br> taxes) is designed to measure the performance of those Russell 1000 <br> Index companies with lower price-to-book ratios and lower forecasted <br> growth values. The Russell 1000 Index is designed to measure the <br> performance of the 1,000 largest companies in the Russell 3000 Index <br> based on their market capitalization and current index membership. <br>|
| **Russell 2000 Growth Index** (reflects no deduction for fees, expenses <br> or taxes) is designed to measure the performance of those Russell <br> 2000 Index companies with higher price-to-book ratios and higher <br> forecasted growth values. The Russell 2000 Index is an index <br> comprised of 2,000 of the smallest US-domiciled company common <br> stocks based on a combination of their market capitalization and <br> current index membership.<br>|
| **Russell 3000 Index** (reflects no deduction for fees, expenses or taxes) <br> is designed to measure the performance of the 3,000 largest US <br> companies based on total market capitalization.<br>|

---

---

| |
|:---|
| **Russell Midcap Growth Index** (reflects no deduction for fees, <br> expenses or taxes) is designed to measure the performance of the <br> mid-cap growth segment of the US equity universe. It includes those <br> Russell Midcap Index companies with relatively higher price-to-book <br> ratios, higher I/B/E/S forecast medium term (2 year) growth and higher <br> sales per share historical growth (5 years).<br>|
| **S&P 500 Index** (reflects no deduction for fees, expenses or taxes) is a <br> float-adjusted market capitalization-weighted index composed of 500 <br> widely held common stocks.<br>|
| **S&P Composite 1500 Health Care Index** (reflects no deduction for <br> fees, expenses or taxes) is a float-adjusted market <br> capitalization-weighted index comprised of those companies included <br> in the S&P Composite 1500 that are classified as members of the <br> Global Industry Classification Standard (GICS<sup>®</sup>) health care sector.<br>|
| **Additional Information Regarding Bloomberg Index(es).** <br> "Bloomberg®" and the above referenced Bloomberg index(es) are <br> service marks of Bloomberg Finance L.P. and its affiliates, including <br> Bloomberg Index Services Limited ("BISL"), the administrator of the <br> index (collectively, "Bloomberg"), and have been licensed for use for <br> certain purposes by Hartford Funds Management Company, LLC <br> ("HFMC"). The Funds are not sponsored, endorsed, sold or promoted <br> by Bloomberg. Bloomberg does not make any representation or <br> warranty, express or implied, to the owners of or counterparties to the <br> Funds or any member of the public regarding the advisability of <br> investing in securities generally or in the Funds particularly. The only <br> relationship of Bloomberg to HFMC is the licensing of certain <br> trademarks, trade names and service marks and of the above <br> referenced Bloomberg index(es), which is determined, composed and <br> calculated by BISL without regard to HFMC or the Funds. Bloomberg <br> has no obligation to take the needs of HFMC or the owners of the <br> Funds into consideration in determining, composing or calculating the <br> above referenced Bloomberg index(es). Bloomberg is not responsible <br> for and has not participated in the determination of the timing of, <br> prices at, or quantities of the Funds to be issued. Bloomberg shall not <br> have any obligation or liability, including, without limitation, to the <br> Funds' customers, in connection with the administration, marketing or <br> trading of the Funds. <br>|
| *BLOOMBERG DOES NOT GUARANTEE THE ACCURACY AND/OR* <br> *THE COMPLETENESS OF THE ABOVE REFERENCED BLOOMBERG* <br> *INDEX(ES) OR ANY DATA RELATED THERETO AND SHALL HAVE NO* <br> *LIABILITY FOR ANY ERRORS, OMISSIONS OR INTERRUPTIONS* <br> *THEREIN. BLOOMBERG DOES NOT MAKE ANY WARRANTY,* <br> *EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY* <br> *HFMC, OWNERS OF THE FUNDS OR ANY OTHER PERSON OR* <br> *ENTITY FROM THE USE OF THE ABOVE REFERENCED* <br> *BLOOMBERG INDEX(ES) OR ANY DATA RELATED THERETO.* <br> *BLOOMBERG DOES NOT MAKE ANY EXPRESS OR IMPLIED* <br> *WARRANTIES AND EXPRESSLY DISCLAIMS ALL WARRANTIES OF* <br> *MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE* <br> *OR USE WITH RESPECT TO THE ABOVE REFERENCED* <br> *BLOOMBERG INDEX(ES) OR ANY DATA RELATED THERETO.* <br> *WITHOUT LIMITING ANY OF THE FOREGOING, TO THE MAXIMUM* <br> *EXTENT ALLOWED BY LAW, BLOOMBERG, ITS LICENSORS, AND* <br> *ITS AND THEIR RESPECTIVE EMPLOYEES, CONTRACTORS,* <br> *AGENTS, SUPPLIERS, AND VENDORS SHALL HAVE NO LIABILITY* <br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

103 <br>

------

**Hartford HLS Funds**

***Index Glossary for Indices Included in the Annual Shareholder Report (Unaudited) – (continued)***

------

---

| |
|:---|
| *OR RESPONSIBILITY WHATSOEVER FOR ANY INJURY OR* <br> *DAMAGES --WHETHER DIRECT, INDIRECT, CONSEQUENTIAL,* <br> *INCIDENTAL, PUNITIVE OR OTHERWISE --ARISING IN* <br> *CONNECTION WITH THE ABOVE REFERENCED BLOOMBERG* <br> *INDEX(ES) OR ANY DATA OR VALUES RELATING THERETO* <br> *--WHETHER ARISING FROM THEIR NEGLIGENCE OR OTHERWISE,* <br> *EVEN IF NOTIFIED OF THE POSSIBILITY THEREOF.*<br>|
| **Additional Information Regarding MSCI Indices.** <br>Neither MSCI nor any other party involved in or related to compiling, <br> computing or creating the MSCI data makes any express or implied <br> warranties or representations with respect to such data (or the results <br> to be obtained by the use thereof), and all such parties hereby <br> expressly disclaim all warranties of originality, accuracy, <br> completeness, merchantability or fitness for a particular purpose with <br> respect to any of such data. Without limiting any of the foregoing, in <br> no event shall MSCI, any of its affiliates or any third party involved in <br> or related to compiling, computing or creating the data have any <br> liability for any direct, indirect, special, punitive, consequential or any <br> other damages (including lost profits) even if notified of the possibility <br> of such damages. No further distribution or dissemination of the MSCI <br> data is permitted without MSCI's express written consent. <br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

104 <br>

------

Series of Hartford Series Fund, Inc. (each a "Fund" and collectively, the "Funds") are not subsidiaries of The Hartford Insurance Group, Inc. ("The Hartford") but are underwritten, distributed by and advised by subsidiaries of The Hartford. Investments in the Funds are not guaranteed by The Hartford or any other entity.

This report is submitted for the general information of the shareholders of the Funds referenced in this report. It is not authorized for distribution to persons who are not shareholders of one or more Funds referenced in this report unless preceded or accompanied by a current prospectus for the relevant Funds. Nothing herein contained is to be considered an offer of sale or a solicitation of an offer to buy shares of any Fund listed in this report.

The information cannot be used or relied upon for the purpose of avoiding IRS penalties. These materials are not intended to provide tax, accounting or legal advice. As with all matters of a tax or legal nature, you should consult your own tax or legal counsel for advice.

**Investors should carefully consider a Fund's investment objectives, risks, charges and expenses. This and other important information is contained in the Fund's prospectus and summary prospectus, which can be obtained by visiting hartfordfunds.com. Please read it carefully before investing.**

The Funds are distributed by Hartford Funds Distributors, LLC.

HLSAR25 02/26 Printed in the U.S.A.

![](g949371img116ba7d52.jpg)

------

#### Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.

#### Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.

#### Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.

#### Item 15. Submission of Matters to a Vote of Security Holders.
There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant's board of directors, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.

#### Item 16. Controls and Procedures.
(a) The registrant's principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the "1940 Act") (17 CFR 270.30a-3(c))) are generally effective to provide reasonable assurance, as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)).

------

(b) There were no changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d)) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant's internal control over financial reporting.

#### Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.

#### Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.

#### Item 19. Exhibits.

---

| | |
|:---|:---|
| (a)(1) | [Code of Ethics is filed herewith.](d949371dex99codeeth.htm) |
| (a)(2) | Not applicable. |
| (a)(3) | [Separate certifications for each principal executive officer and principal financial officer of the registrant as required by Rule 30a-2(a) under the 1940 Act (17 CFR 270.30a-2(a)) and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto.](d949371dex99cert.htm) |
| (a)(4) | Not applicable |
| (a)(5) | Not applicable |
| (b) | [Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto.](d949371dex99906cert.htm) |

---

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **HARTFORD SERIES FUND, INC.** | **HARTFORD SERIES FUND, INC.** |
| Date: February 20, 2026 | By: | <u>/s/ Gregory A. Frost</u> |
|  |  | Gregory A. Frost |
|  |  | Chief Executive Officer and President (principal executive officer) |

---

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| Date: February 20, 2026 | By: | <u>/s/ Gregory A. Frost</u> |
|  |  | Gregory A. Frost |
|  |  | Chief Executive Officer and President (principal executive officer) |
| Date: February 20, 2026 | By: | <u>/s/ Ankit Puri</u> |
|  |  | Ankit Puri |
|  |  | Treasurer (principal financial officer) |

---

## Ex-99.Code

**THE HARTFORD FUNDS FAMILY OF FUNDS** 

**<u>SARBANES-OXLEY CODE OF ETHICS FOR SENIOR OFFICERS</u>** 

**I.**  **<u>Introduction</u>** 

The Boards of Directors/Trustees (collectively, the "<u>Board</u>") of each registrant, and each series thereof, that is registered with the U.S. Securities and Exchange Commission ("SEC") as a management investment company under the Investment Company Act of 1940, as amended (the "Investment Company Act") and is part of the Hartford Funds Family of Funds (each, a "<u>Fund</u>" and collectively, the "<u>Funds</u>") have established this Code of Ethics ("Code") in accordance with Section 406 of the Sarbanes-Oxley Act of 2002. This Code does not supersede or otherwise affect the separate code of ethics that the Fund has adopted pursuant to Rule 17j-1 under the Investment Company Act.

**II.**  **<u>Covered Officers/Purpose of Code</u>** 

This Code applies to each Fund's Chief Executive Officer and Treasurer (collectively, the "Covered Officers") for the purpose of promoting:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between
personal and professional relationships;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● full, fair, accurate, timely and understandable disclosure in reports and documents that the Fund files with,
or submits to, the SEC and in other public communications made by the Fund;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● compliance with applicable laws and governmental rules and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● the prompt internal reporting of violations of this Code to an appropriate person or persons identified
herein; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● accountability for adherence to this Code.

Each Covered Officer owes a duty to the Funds to adhere to a high standard of business ethics, and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest. Each Covered Officer should encourage his or her colleagues who provide services to the Funds, whether directly or indirectly, to do the same.

For purposes of this Code, the Compliance Officer is the Fund's Chief Compliance Officer or his or her delegate.

**III.**  **<u>Covered Officers Should Handle Ethically Actual and Apparent Conflicts of Interest</u>** 

A "conflict of interest" occurs when a Covered Officer's private interest interferes with the interests of, or his or her service to, a Fund. For example, a conflict of interest would arise if a Covered Officer, or a member of his or her family, receives improper personal benefits as a result of his or her position with the Fund.

Certain conflicts of interest covered by this Code arise out of the relationships between Covered Officers and a Fund and already are subject to conflict of interest provisions in the Investment Company Act and the Investment Advisers Act of 1940, as amended (the "Investment Advisers Act"). For example,

------

Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with the Fund. The compliance programs and procedures of the Funds and their investment adviser and distributor are designed to prevent, or identify and correct, violations of these provisions. This Code does not, and is not intended to, repeat or replace these programs and procedures.

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between the Funds and their investment adviser and distributor, or affiliates of the investment adviser and distributor (together, the "Service Providers"), of which the Covered Officers are also officers or employees. As a result, this Code recognizes that the Covered Officers will, in the normal course of their duties, be involved in establishing policies and implementing decisions which will have different effects on the investment adviser, the distributor, Service Providers and the Funds. The participation of the Covered Officers in such activities is inherent in these contractual relationships and is consistent with the performance by the Covered Officers of their duties as officers of the Funds and, if addressed in conformity with the provisions of the Investment Company Act and the Investment Advisers Act, will be deemed to have been handled ethically.

Other conflicts of interest are covered by this Code, even if such conflicts of interest are not subject to provisions in the Investment Company Act and the Investment Advisers Act. Covered Officers should keep in mind that the following list of prohibitions does not cover every possible situation. The overarching principle – that the personal interest of a Covered Officer should not be placed improperly before the interest of the Funds– should be the guiding principle in all circumstances.

Each Covered Officer must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● not use his or her personal influence or personal relationships improperly to influence investment decisions
or financial reporting by the Funds whereby the Covered Officer would benefit personally to the detriment of the Funds;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● not cause the Funds to take action, or fail to take action, for the individual personal benefit of the Covered
Officer rather than the benefit of the Funds; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● not use material non-public knowledge of portfolio transactions made
or contemplated for the Funds to profit personally or cause others to profit, by the market effect of such transactions.

There are some conflict of interest situations that should be discussed with the Compliance Officer of a Fund if material. Examples of these include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● any outside business activity that detracts from the ability of a Covered Officer to devote appropriate time
and attention to his or her responsibilities as a Covered Officer of the Fund;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● the receipt of any non-nominal gifts related to the business of the
Fund that may be inconsistent with any policy on gifts established by the Fund's investment adviser and distributor from time to time; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● a direct or indirect personal financial interest in commissions, transaction charges or spreads paid by the
Fund for effecting portfolio transactions or for selling or redeeming shares other than an interest arising from the Covered Officer's employment, such as compensation or equity ownership.

**IV.**  **<u>Disclosure and Compliance</u>** 

Each Covered Officer:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● must familiarize himself or herself with the disclosure requirements applicable to a Fund and its disclosure
controls and procedures;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● must not knowingly misrepresent, or cause others to misrepresent, facts about the Fund to others, whether
within or outside the Fund, including to the Fund's directors and independent accountants, and to governmental regulators and self-regulatory organizations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● should, to the extent appropriate within his or her area of responsibility, consult with other officers and
employees of the Fund and its investment adviser and distributor and take other appropriate steps with the goal of promoting full, fair, accurate and timely disclosure in the reports and documents the Fund files with, or submits to, the SEC and that
are signed or certified by him or her;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● must cooperate with the Fund's independent accountants, regulatory agencies and internal auditors in
their review or inspection of the Fund and its operations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● comply with all laws, rules, and regulations applicable to the Fund's operations and business.

**V.**  **<u>Confidentiality</u>** 

Covered Officers must maintain the confidentiality of information entrusted to them by the Fund, except when disclosure is authorized by Fund counsel or required by laws or regulations. Whenever possible, Covered Officers should consult with Fund counsel if they believe they have a legal obligation to disclose confidential information. Confidential information includes all non-public information that might be of use to competitors, or harmful to the Fund or its shareholders, if disclosed. The obligation to preserve confidential information continues even after employment as a Covered Officer ends.

**VI.**  **<u>Reporting and Accountability</u>** 

Each Covered Officer must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● upon adoption of this Code (or upon becoming a Covered Officer), affirm in writing that he or she has received
and read this Code, and understands it (Appendix A);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● annually thereafter affirm that he or she has complied with the requirements of this Code (Appendix A);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● not retaliate against any person for reports of potential violations that are made in good faith; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● notify the Compliance Officer promptly if he or she knows of any violation of this Code. Failure to do so is
itself a violation of this Code.

The Compliance Officer is responsible for applying this Code to specific situations in which questions are presented under it and has the authority to interpret this Code in any particular situation.

**VII.**  **<u>Investigations, Enforcements and Waivers</u>** 

The Funds will follow these procedures in investigating and enforcing this Code:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● the Compliance Officer will take all appropriate action to investigate any violations and potential violations
reported to him or her;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● if, after such investigation, the Compliance Officer believes that no violation has occurred, the Compliance
Officer is not required to take any further action;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● any matter that the Compliance Officer believes is a violation will be reported to the Board of the Fund, or,
if applicable Compliance Committee after such investigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● if the Board determines that a violation has occurred, it will consider appropriate action, which may, without
limitation, include review of, and appropriate modifications to,

------

applicable policies and procedures; or notification to appropriate personnel of the investment adviser, distributor or their respective boards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● the Board will be responsible for granting waivers, as appropriate; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● any changes to or waivers of this Code will, to the extent required, be disclosed as provided by SEC rules.

**VIII.**  **<u>Recordkeeping</u>** 

*General*. The Fund requires accurate recording and reporting of information in order to make responsible business decisions. All of the Fund's books, records, accounts and financial statements must be maintained in reasonable detail, must appropriately reflect the Fund's transactions and must conform both to applicable legal requirements and to the Fund's system of internal controls.

*Code Records*. A copy of this Code, any amendments hereto, and any reports or other records created in relation to waivers of or amendments to provisions of this Code shall be kept as records of the Fund for six years from the end of the fiscal year in which such document was created. Such records shall be furnished to the SEC or its staff upon request.

**IX.**  **<u>Amendments to the Code</u>** 

The Covered Officers and the Compliance Officer are encouraged to recommend improvements to this Code to the Board, and the Board may amend the Code in its discretion. In connection with any amendment to the Code, the Compliance Officer shall prepare a brief description of the amendment to the Board.

**X.**  **<u>Confidentiality</u>** 

All reports and records prepared or maintained pursuant to this Code will be considered confidential and will be maintained and protected accordingly. Except as otherwise required by law or this Code, such matters will not be disclosed to anyone other than the Board, the Funds' investment adviser and distributor, and their respective counsel.

**XI.**  **<u>Internal Use</u>** 

This Code is intended solely for the internal use by the Funds. This Code is a statement of certain fundamental principles, policies and procedures that govern the Covered Officers in the conduct of the Funds' business. It is not intended to and does not create any rights in any employee, investor, supplier, competitor, shareholder or any other person.

**Adopted: May 13, 2003** 

*Revision History* 

May 3, 2016

November 7, 2017

February 1, 2025 *(Revisions included an administrative non-material change that replaced references to registrant names with a single reference to "the Hartford Family of Funds." No other revisions were made.)*

------

**Appendix A** 

**Sarbanes-Oxley Code of Ethics for Senior Officers** 

**Initial and Annual Certification of Compliance** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Name (please print)** 

**This is to certify that I have received a copy of the Sarbanes-Oxley Code of Ethics (the "Code") for Senior Officers for the Hartford Funds Family of Funds.** 

**I have read and understand the Code. Moreover, I agree to promptly report to the Chief Compliance Officer any violation or possible violation of this Code of which I become aware.** 

**Check one:** 

**Initial** 

**[ ] I further certify that I am subject to the Code and will comply with each of the Code's provisions to which I am subject.** 

**Annual** 

**[ ] I further certify that I have complied with and will continue to comply with each of the provisions of the Code to which I am subject.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Signature** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Date**

## Ex-99.Cert

**<u>CERTIFICATION</u>**

I, Gregory A. Frost, certify that:

1. I have reviewed this report on Form N-CSR of Hartford Series Fund, Inc. (File Number 811-08629, CIK Number 0001053425);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 20, 2026

---

| |
|:---|
| <u>/s/ Gregory A. Frost</u> |
| Gregory A. Frost |
| Chief Executive Officer and President (principal executive officer) |

---

------

**<u>CERTIFICATION</u>**

I, Ankit Puri, certify that:

1. I have reviewed this report on Form N-CSR of Hartford Series Fund, Inc. (File Number 811-08629, CIK Number 0001053425);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 20, 2026

---

| |
|:---|
| <u>/s/ Ankit Puri</u> |
| Ankit Puri |
| Treasurer (principal financial officer) |

---

## Exhibit 99.906

**CERTIFICATION** 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Hartford Series Fund, Inc. (the "Registrant") does hereby certify, to such officer's knowledge, that:

The annual report on Form N-CSR of the Registrant for the period ended December 31, 2025 (the "Form N-CSR") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

---

| | | |
|:---|:---|:---|
| Date: February 20, 2026 | By: | <u>/s/ Gregory A. Frost</u> |
|  |  | Gregory A. Frost |
|  |  | Chief Executive Officer and President (principal executive officer) |
| Date: February 20, 2026 | By: | <u>/s/ Ankit Puri</u> |
|  |  | Ankit Puri |
|  |  | Treasurer (principal financial officer) |

---

This certification is being furnished to the Securities and Exchange Commission pursuant to Rule 30a-2(b) under the Investment Company Act of 1940, as amended, and 18 U.S.C. Section 1350 and is not being filed as part of the Report with the Securities and Exchange Commission.